import{_ as v}from"./TableOfContents.350b81a9.js";import{_ as j}from"./client-only.9ea0fff6.js";import k from"./Icon.0af13321.js";import{_ as f}from"./ContentImage.7f5d5375.js";import{_ as g}from"./CardInfo.ca5c87de.js";import{_ as b,o,c as u,b as t,w as s,a as e,d as a,h as i,f as x,g as w,i as p}from"./entry.bdcb2a36.js";import"./useUserPreferences.43e3b6e9.js";import"./config.a375f3b7.js";const q={},V={class:"flex flex-col items-start lg:flex-row-reverse lg:justify-end xl:gap-10 2xl:gap-20"},S={class:"e-article",lang:"et",style:{hyphens:"auto"}},A=e("h1",{class:"mb-0"},"Viirused",-1),I=e("h5",{class:"font-normal uppercase leading-tight"},"Viirused: teadusinfo",-1),M={id:"s1"},D=e("h2",{id:"s1t"},"1. Viirused versus bakterid",-1),z=e("p",{class:"font-bold"}," Bakterid ja viirused vÃµivad pÃµhjustada paljusid tuntud nakkushaigusi. Kuid millised on erinevused nende kahe nakkusetekitaja vahel? ",-1),O=e("p",null,[e("span",{class:"e-term font-Heading"},"Bakterid"),a(" on Ã¼livÃ¤ikesed mikroorganismid, mis koosnevad Ã¼hest rakust. Nad on vÃ¤ga mitmekesised ja vÃµivad olla erineva kuju ja struktuuriga.Bakterid vÃµivad elada peaaegu igas mÃµeldavas keskkonnas, sealhulgas inimkehas vÃµi selle pinnal, kuid vaid kÃ¤putÃ¤is baktereid pÃµhjustab inimestel infektsioone. Neid baktereid nimetatakse "),e("i",null,"patogeenseteks"),a(".")],-1),C=e("p",null,[e("span",{class:"e-term font-Heading"},"Viirused"),a(" on isegi vÃ¤iksemad kui bakterid. Nagu bakterid, on nad vÃ¤ga mitmekesised ning erineva kuju ja tunnustega. Viirused on parasiidid. See tÃ¤hendab, et nad vajavad kasvamiseks elusaid rakke vÃµi kudesid. Viirused vÃµivad tungida keharakkudesse, kasutades rakkude komponente kasvamiseks ja paljunemiseks. MÃµned viirused tapavad peremeesrakke oma elutsÃ¼kli osana. Erinevused viiruste ja bakterite vahel on nÃ¤ha joonisel 1 ja tabelis 1.")],-1),F=e("b",null,"Joonis 1.",-1),N=i('<table class="mt-20"><caption class="text-left pb-4"><b>Tabel 1.</b> Erinevused bakterite ja viiruste vahel</caption><thead><tr><th></th><th>Bakterid</th><th>Viirused</th></tr></thead><tbody><tr><th class="align-baseline"> Elus vÃµi eluta? </th><td><b>Elusorganism.</b><br> Bakterid on elusorganismid, mis koosnevad Ã¼hest rakust, mis suudab toota energiat, teha ise toitu, liikuda ja paljuneda (tavaliselt jagunemise teel). See vÃµimaldab bakteritel elada paljudes kohtades â€“ pinnases, vees, taimedes ja inimkehas â€“ ning teenida mitmeid eesmÃ¤rke. <br> Bakterite hulka kuuluvad nii parasiidid kui ka mitteparasiidid. </td><td><b>Elusa ja eluta looduse piirimail.</b><br>Viirused kasvavad ja paljunevad ainult peremeesrakkudes, mida nad nakatavad. VÃ¤ljaspool neid elusrakke leiduvad viirused on uinuvad. Nende &quot;elu&quot; nÃµuab seetÃµttu elusraku biokeemilise tegevuse Ã¼levÃµtmist.<br>KÃµik viirused on rakusisesed parasiidid. </td></tr><tr><th class="align-baseline">Rakulisus</th><td>Koosneb Ã¼hest rakust.</td><td>Ei koosne rakkudest.</td></tr><tr><th class="align-baseline">Paljunemine</th><td>Jaguneb kaheks</td><td>Tungib peremeesrakku ja vÃµtab raku Ã¼le, pÃµhjustades viiruse DNA/RNA koopiate tegemise. HÃ¤vitab peremeesraku, vabastades uusi viirusi.</td></tr><tr><th class="align-baseline">Suurus</th><td>Bakterid on palju suuremad, nende suurus jÃ¤Ã¤b vahemikku 800 nm kuni 1000 nm. Baktereid saab nÃ¤ha valgusmikroskoobi abil.</td><td>Viiruste suurus on vahemikus 20 nm kuni 400 nm. Viirused on nÃ¤htavad ainult elektronmikroskoobi all.</td></tr><tr><th class="align-baseline">Kasu</th><td>Paljud bakterid on kasulikud. N: teatud bakterid on vajalikud soolestikus.</td><td>Viirused ei ole Ã¼ldjuhul kasulikud, kuid leiavad rakendust geenitehnoloogias.</td></tr><tr><th class="align-baseline">Infektsioon</th><td>Bakteriaalne infektsioon piirdub tavaliselt mÃµne kehaosaga, mida kirjeldatakse kui lokaliseeritud infektsiooni. Infektsioonid vÃµivad olla pÃµhjustatud bakteritest vÃµi bakterite poolt toodetud toksiinidest (endotoksiinidest).</td><td>Viirusinfektsioon on sÃ¼steemne. Viirused nakatavad peremeesrakku ja paljunevad seejÃ¤rel tuhandetes, lahkudes peremeesrakust ja nakatades teisi keharakke.</td></tr><tr><th class="align-baseline">Haigus</th><td>Bakteriaalsete haiguste hulka kuuluvad kopsupÃµletik, tuberkuloos, teetanus ja toidumÃ¼rgitus.</td><td>Viirusinfektsioonist pÃµhjustatud sÃ¼steemsete haiguste hulka kuuluvad gripp, leetrid, lastehalvatus, AIDS ja COVID-19.</td></tr><tr><th class="align-baseline">Ravi</th><td>Antibiootikumid, ennetavad vaktsiinid.</td><td>Vaktsiinid takistavad levikut ja viirusevastased ravimid aitavad paljunemist aeglustada, kuid ei suuda seda tÃ¤ielikult peatada.</td></tr></tbody></table>',1),$=e("b",null,"Antibiootikumid",-1),P=e("b",null,"Viirusevastased ravimid",-1),B=e("b",null,"ImmuunsÃ¼steem",-1),T=i('<section class="e-card"><h4 class="mt-4">Viited</h4><ul class="text-sm break-all"><li><a href="https://courses.lumenlearning.com/suny-biology2xmaster/chapter/prevention-and-treatment-of-viral-infections/" target="_blank" rel="noopener noreferrer">https://courses.lumenlearning.com/suny-biology2xmaster/chapter/prevention-and-treatment-of-viral-infections/</a></li><li><a href="https://bodell.mtchs.org/OnlineBio/BIOCD/text/chapter16" target="_blank" rel="noopener noreferrer">https://bodell.mtchs.org/OnlineBio/BIOCD/text/chapter16</a></li><li><a href="http://www.hcrowder.com/disease-reading.html" target="_blank" rel="noopener noreferrer"> http://www.hcrowder.com/disease-reading.html</a></li></ul></section>',1),E=i('<hr class="mt-10 mb-40"><section id="s2"><h2 id="s2t">2. Miks antibiootikumid ei tapa viiruseid?</h2><p> Antibiootikumid ei saa tappa viirusi, kuna viirustel on teistsugune struktuur ja paljunemine kui bakteritel. Antibiootikumid avaldavad toimet bakterite (mitte viiruste) kasvumehhanismidele, et tappa vÃµi pÃ¤rssida konkreetseid baktereid. </p><p> Veelgi enam, antibiootikumide Ã¼lekasutamine vÃµi ebaÃµige kasutamine on tekitanud Ã¼lemaailmse tervishoiuprobleemi, nn <a href="https://www.drugs.com/article/antibiotic-resistance.html" target="_blank" rel="noopener noreferrer">antibiootikumiresistentsuse</a>. Vaata tabelist 2, millistel juhtudel vÃµivad antibiootikumid abiks olla ja millistel mitte (NB! otsuse antibiootikumi kasutamise kohta teeb igal juhul arst). </p><table class="leading-tight e-card"><caption class="text-left pb-4"><b>Tabel 2.</b> Vajadus antibiootikumide jÃ¤rele Ã¼lemiste hingamisteede nakkushaiguste korral </caption><thead class="border text-center"><tr><th rowspan="2" class="border p-1">Common respiÂ­ratory infections</th><th colspan="3" class="border p-1">Common cause</th><th rowspan="2" class="border p-1">Are<br>antiÂ­biotics needed</th></tr><tr><th class="border p-1">Virus</th><th class="border p-1">Virus or bacteria</th><th class="border p-1">Bacteria</th></tr></thead><tbody class="text-center"><tr><td class="border p-1">Common cold / runny nose</td><td class="border p-1">Yes</td><td class="border p-1"></td><td class="border p-1"></td><td class="border p-1">No</td></tr><tr><td class="border p-1">Sore throat (except strep)</td><td class="border p-1">Yes</td><td class="border p-1"></td><td class="border p-1"></td><td class="border p-1">No</td></tr><tr><td class="border p-1">COVID-19</td><td class="border p-1">Yes</td><td class="border p-1"></td><td class="border p-1"></td><td class="border p-1">No</td></tr><tr><td class="border p-1">Flu</td><td class="border p-1">Yes</td><td class="border p-1"></td><td class="border p-1"></td><td class="border p-1">No</td></tr><tr><td class="border p-1">Bronchitis / chest cold<br><span class="text-sm italic">(in otherwise healthy children and adults)</span> *</td><td class="border p-1"></td><td class="border p-1">Yes</td><td class="border p-1"></td><td class="border p-1">No *</td></tr><tr><td class="border p-1">Middle ear infection</td><td class="border p-1"></td><td class="border p-1">Yes</td><td class="border p-1"></td><td class="border p-1">Maybe</td></tr><tr><td class="border p-1">Sinus infection</td><td class="border p-1"></td><td class="border p-1">Yes</td><td class="border p-1"></td><td class="border p-1">Maybe</td></tr><tr><td class="border p-1">Strep throat</td><td class="border p-1"></td><td class="border p-1"></td><td class="border p-1">Yes</td><td class="border p-1">Yes</td></tr><tr><td class="border p-1">Whooping couch</td><td class="border p-1"></td><td class="border p-1"></td><td class="border p-1">Yes</td><td class="border p-1">Yes</td></tr></tbody><tfoot class="border text-center"><tr><td colspan="5" class="py-0 px-3"><p class="text-sm italic">* Studies shows that in otherwise healthy children and adults, antibiotics for bronchitis won&#39;t help patients feel better.</p><p class="text-xs text-slate-400">Source: <a href="https://www.cdc.gov/antibiotic-use/images/VirusOrBacteria-Original-1200by675.jpg" target="_blank" rel="noopener noreferrer">https://www.cdc.gov/antibiotic-use/images/VirusOrBacteria-Original-1200by675.jpg</a></p></td></tr></tfoot></table><section class="e-card"><h4 class="mt-0">Viited</h4><ul class="text-sm break-all"><li><a href="https://www.drugs.com/article/antibiotics-and-viruses.html" target="_blank" rel="noopener noreferrer">https://www.drugs.com/article/antibiotics-and-viruses.html</a></li><li><a href="https://www.virology.ws/2009/10/19/ten-cool-facts-about-viruses/" target="_blank" rel="noopener noreferrer">https://www.virology.ws/2009/10/19/ten-cool-facts-about-viruses/</a></li></ul></section></section><hr class="mt-10 mb-40">',3),R={id:"s3"},H=e("h2",{id:"s3t"},"3. Kuidas vaktsiinid toimivad",-1),W=e("h3",null,"Organismi loomulik vastus",-1),K=e("p",null,[e("span",{class:"e-term font-Heading"},"Patogeen"),a(" on bakter, viirus, parasiit vÃµi seen, mis vÃµib pÃµhjustada organismis haigusi. Iga patogeen koosneb mitmest osast, mis on tavaliselt konkreetsele patogeenile ainulaadsed. Patogeeni osa, mis pÃµhjustab antikehade moodustumist, nimetatakse antigeeniks. Patogeeni antigeenile vastuseks toodetud antikehad on immuunsÃ¼steemi oluline osa. Antikehi vÃµib pidada seetÃµtt keha kaitsesÃ¼steemi â€œsÃµduriteksâ€. Iga meie immuunsÃ¼steemi antikeha on â€œkoolitatudâ€ Ã¤ra tundma Ã¼hte kindlat antigeeni. Meie kehas on tuhandeid erinevaid antikehi. Kui inimkeha puutub esimest korda kokku antigeeniga, kulub immuunsÃ¼steemil aega, et reageerida ja toota antigeenile spetsiifilisi antikehi (Joonis 2). ")],-1),Y=e("p",null," Kui antigeenspetsiifilised antikehad on toodetud, tÃ¶Ã¶tavad nad koos Ã¼lejÃ¤Ã¤nud immuunsÃ¼steemiga patogeeni hÃ¤vitamiseks ja haiguse peatamiseks. Ãœhe patogeeni vastased antikehad ei kaitse Ã¼ldiselt teise patogeeni eest, vÃ¤lja arvatud juhul, kui kaks patogeeni on Ã¼ksteisega vÃ¤ga sarnased. Kui keha toodab antikehi oma esmase vastusena antigeenile, loob see ka antikehi tootvad mÃ¤lurakud, mis jÃ¤Ã¤vad ellu ka pÃ¤rast seda, kui antikehad patogeeni hÃ¤vitavad. Kui keha puutub sama patogeeniga kokku rohkem kui Ã¼ks kord, on antikeha vastus palju kiirem ja tÃµhusam kui esimesel korral, kuna mÃ¤lurakkude abil toodetakse kiiresti selle antigeeni vastaseid antikehi. See tÃ¤hendab, et kui inimene puutub tulevikus kokku ohtliku patogeeniga, suudab tema immuunsÃ¼steem koheselt reageerida, kaitstes teda haiguste eest. ",-1),U=e("b",null,"Joonis 2.",-1),J=e("h3",null,"Mil moel vaktsiinid toimivad?",-1),L=e("p",null," Vaktsiinid vÃ¤hendavad haigestumisriski, aktiveerides keha loomulikud kaitsemehhanismid. ",-1),Q=e("p",null," Vaktsiinid sisaldavad teatud antigeeni nÃµrgestatud vÃµi mitteaktiivseid osi, mis kÃ¤ivitavad organismis immuunvastuse (Joonis 3). Uuemad vaktsiinid sisaldavad pigem antigeenide tootmise â€œjuhiseidâ€ kui antigeeni ennast. Olenemata sellest, kas vaktsiin koosneb antigeenist endast vÃµi juhistest, et organism hakkaks antigeeni (N: viiruse Ã¼hte valku) tootma, ei pÃµhjusta see inimesel haigust, vaid paneb tema immuunsÃ¼steemi sellele reageerima, nagu oleks see esmane reaktsioon tegelikule patogeenile. ",-1),G=e("b",null,"Joonis 3.",-1),X=i('<p> Kui keha on juba viirusega kokku puutunud ja viirusele immuunvastuse andnud (tootes B- ja T-rakud), salvestab see B- ja T-rakud, nii et kui sama viirus vÃµi bakter kunagi uuesti keha nakatab, asub immuunsÃ¼steem kaitsele, et vÃ¤ltida haigestumist patogeeniga. </p><h3> Vaktsineerimine ja sellega seotud vÃ¤ljakutsed </h3><p> Meil â€‹â€‹on olemas vaktsiinid enam kui 20 eluohtliku haiguse ennetamiseks, aidates igas vanuses inimestel elada kauem ja tervemalt. Vaktsineerimine hoiab praegu igal aastal Ã¤ra 2â€“3 miljoni surmajuhtumi sellistesse haigustesse nagu difteeria, teetanus, lÃ¤kakÃ¶ha, gripp ja leetrid. </p><p> Kuigi meil on vaktsiiinid paljude tÃµsiste viirusnakkuste, nagu leetrid, mumps, A- ja B-hepatiit, vastu, suudavad mÃµned viirused â€“ nÃ¤iteks need, mis pÃµhjustavad kÃ¼lmetushaigusi, muteeruda. Kui viirus muteerub, muutub see piisavalt nii, et immuunsÃ¼steem ei pruugi seda enam Ã¤ra tunda, st ta ei tea, kuidas seda tappa. Nii vÃµib viirus nakatada organismi, kuna see â€œhiilibâ€ immuunsÃ¼steemist kÃµrvale. Seega on seda tÃ¼Ã¼pi viiruste vastu vaktsineerimine keerulisem. </p><section class="e-card"><h4 class="mt-0">Viited</h4><ul class="text-sm break-all"><li><a href="https://www.who.int/news-room/feature-stories/detail/how-do-vaccines-work" target="_blank" rel="noopener noreferrer">https://www.who.int/news-room/feature-stories/detail/how-do-vaccines-work</a></li><li><a href="https://www.nytimes.com/interactive/2020/health/pfizer-biontech-covid-19-vaccine.html" target="_blank" rel="noopener noreferrer">https://www.nytimes.com/interactive/2020/health/pfizer-biontech-covid-19-vaccine.html</a></li><li><a href="https://media.nature.com/original/magazine-assets/d41586-021-03552-w/d41586-021-03552-w.pdf" target="_blank" rel="noopener noreferrer">https://media.nature.com/original/magazine-assets/d41586-021-03552-w/d41586-021-03552-w.pdf</a></li><li><a href="https://opentextbc.ca/biology/chapter/12-1-viruses/" target="_blank" rel="noopener noreferrer">https://opentextbc.ca/biology/chapter/12-1-viruses/</a></li></ul></section>',5),Z=i('<hr class="mt-10 mb-40"><section id="s4"><h2 id="s4t">4. Vaktsiinide vÃ¤ljatÃ¶Ã¶tamise protsess, vaktsiinide ohutus</h2><h3>VÃ¤ljatÃ¶Ã¶tamine</h3><p> Vaktsiinide vÃ¤ljatÃ¶Ã¶tamine algab tavaliselt uurimislaboris, mis vÃµib asuda Ã¼likoolis, meditsiinikeskuses vÃµi vÃ¤ikeses biotehnoloogiaettevÃµttes. Vaktsiini vÃ¤ljatÃ¶Ã¶tamise kÃ¤igus tÃ¶Ã¶tavad teadlased vÃ¤lja erinevaid vaktsiinikandidaate, et testida ja mÃµÃµta nende mÃµju (vÃµi selle puudumist). TÃ¶Ã¶tavate ideede leidmiseks on sageli vaja aastaid uurimistÃ¶Ã¶d. </p><p> Vaktsiini vÃ¤ljatÃ¶Ã¶tamise ajal vÃµivad mitu erinevat teadlast vÃµi uurimisrÃ¼hma tÃ¶Ã¶tada samade eesmÃ¤rkide nimel. TÃ¶Ã¶ edenemist tutvustatakse erinevatel kohtumistel (N: konverentsidel) ja eelretsenseeritavate ajakirjade artiklites. Kui mÃµni tÃ¶Ã¶ tundub paljutÃµotav, vÃµidakse kaasata ka farmaatsiateadlased, et laiendada uurimistÃ¶Ã¶d tootearenduse suunas. </p><h3>Testimine</h3><p> Kui leitakse paljutÃµotav vaktsiinikandidaat, tuleb seda katsetada loomadel. Seda nimetatakse eelkliiniliseks faasiks. KÃµigepealt kasutatakse vÃ¤ikseid loomi, nagu hiired, rotid, kÃ¼Ã¼likud jne. Kui vaktsiinikandidaat avaldab mÃµju vÃ¤ikestele loomadele, tuleb seda tavaliselt tÃµestada suuremate loomade, nÃ¤iteks ahvide puhul. Kui vaktsiin kÃ¤ivitab immuunvastuse, testitakse seda inimkatsetes kolmes etapis (WHO, 2021). </p><p> 1. etapis antakse vaktsiini vÃ¤ikesele arvule vabatahtlikele, et hinnata selle ohutust, veenduda, et see tekitab immuunvastuse ja mÃ¤Ã¤rata Ãµige annus. Ãœldiselt testitakse selles etapis vaktsiine vÃ¤ikeses noorte tervete tÃ¤iskasvanud vabatahtlike rÃ¼hmas. </p><p> 2. etapis antakse vaktsiin juba mitmesajale vabatahtlikule, et hinnata tÃ¤iendavalt selle ohutust ja vÃµimet tekitada immuunvastust. Selles etapis osalejatel on samad omadused (nagu vanus, sugu), kui inimestel, kellele vaktsiin on mÃµeldud. Selles faasis on tavaliselt mitu katset, et hinnata erinevaid vanuserÃ¼hmi (eakad, tÃ¤iskasvanud, lapsed) ja vaktsiini erinevaid koostisi. Tavaliselt kaasatakse ka rÃ¼hm, kes ei saa vaktsiini, et teha kindlaks, kas muutused vaktsineeritute rÃ¼hmas on tingitud vaktsiinist vÃµi on saadud juhuslikult. </p><p> 3. etapis manustatakse vaktsiini tuhandetele vabatahtlikele ja seda vÃµrreldakse sarnase inimeste rÃ¼hmaga, kes ei saanud vaktsiini, kuid said vÃµrdlustoote. Selle eesmÃ¤rk on kindlaks teha, kas vaktsiin on tÃµhus haiguse vastu, mille eest see on loodud kaitsma. Samuti on eesmÃ¤rgiks uurida selle ohutust palju suuremas inimrÃ¼hmas. 3. etapi uuringud viiakse sageli lÃ¤bi mitmes riigis, sh Ã¼he riigi mitmes regioonis, et tagada vaktsiini tÃµhusate tulemuste kehtivus erinevate populatsioonide peal. </p><p> 2. ja 3. etapi uuringute ajal on vabatahtlikud ja uuringut lÃ¤bi viivad teadlased olukorras, kus nad ei tea, millised vabatahtlikud on saanud testitavat vaktsiini vÃµi millised vÃµrdluspreparaati. Seda nimetatakse pimekatseks ja see on vajalik, et tagada tulemuste objektiivsus, st et ei vabatahtlikud ega ka teadlased poleks mÃµjutatud ootustest vaktsiini suhtes ei selle tÃµhususe ega ohutuse mÃµttes. </p><section class="e-card"><h4 class="mt-0">Viide</h4><ul class="text-sm break-all"><li><a href="https://www.who.int/news-room/feature-stories/detail/how-are-vaccines-developed" target="_blank" rel="noopener noreferrer">https://www.who.int/news-room/feature-stories/detail/how-are-vaccines-developed</a></li></ul></section><h3> Autoriseerimine ja jÃ¤lgimine </h3><p> Kui kÃµigi nende kliiniliste uuringute tulemused on kÃ¤tte saadud, on vaja teha rida edasisi samme. Euroopa Ravimiamet ja hiljem iga riigi vastav ametkond vaatavad uuringute andmed hoolikalt lÃ¤bi ja otsustavad, kas anda vaktsiinile kasutusluba. KÃµik katsed peavad olema korrektselt tehtud ja korralikult dokumenteeritud. Enne vaktsiini heakskiitmist peab olema tÃµestatud, et vaktsiin on ohutu ja tÃµhus paljudele inimestele. Vaktsiini ohutuse ja tÃµhususe tase peab seejuures olema Ã¤Ã¤rmiselt kÃµrge. </p><p> Vaktsiinide kasutamise ajal toimub nende tÃ¤iendav ohutuse ja tÃµhususe jÃ¤lgimine. See vÃµimaldab teadlastel jÃ¤lgida vaktsiinide mÃµju ja ohutust isegi siis, kui neid kasutatakse suurel hulgal inimestel ja pika aja jooksul. Neid andmeid kasutatakse vaktsiini kasutamise eeskirjade kohandamiseks. </p><section class="e-card"><h4 class="mt-0">Viide</h4><ul class="text-sm break-all"><li><a href="https://www.worldscientific.com/doi/pdf/10.1142/S2529732521400034" target="_blank" rel="noopener noreferrer">https://www.worldscientific.com/doi/pdf/10.1142/S2529732521400034</a></li></ul></section></section><hr class="mt-10 mb-40">',3),ee={id:"s5"},ae=i('<h2 id="s5t">5. Maskid viiruste ja bakterite vastu</h2><p> Maske kasutatakse tihti kaitseks viiruste ja bakterite eest. Need on muutunud eriti tavaliseks SARS-CoV-2 viiruse eest kaitsmisel. Erinevat tÃ¼Ã¼pi maskide hulgas on <b>kirurgilised nÃ¤omaskid</b> olnud COVID-19 pandeemia ajal kÃµige sagedamini kasutatavateks nÃ¤okateteks. Tavaliselt on need Ã¼helt poolt sinist vÃ¤rvi, mida tuleks hoida vÃ¤liskihina (Joonis 4). Kirurgiliste maskide peamine eesmÃ¤rk on kaitsta patsiente vÃµimaliku kokkupuute eest kandja poolt vÃ¤ljahingatavate bakterite ja viirustega. Maskid takistavad hÃ¤sti koroonaviiruse levikut Ãµhu kaudu, kuid ei ole nii tÃµhusad vahendid kandja enda kaitsmiseks viiruse eest. On leitud nÃ¤iteks, et inimeste poolt hingamisel, rÃ¤Ã¤kimisel ja aevastamisel tekitatud vedelikuosakeste lÃ¤bimÃµÃµt algab 1.6 mikromeetrist ja vÃµib ulatuda kuni paarisaja mikromeetrini </p><p> Et filtreerida sissehingatavat Ãµhku paremini, tuleks kasutada <b>FFP2 vÃµi FFP3 maski</b> (mida sageli nimetatakse ka <b>respiraatoriteks</b>). Sertifitseeritud numeratsioon (FFP1, FPP2, FFP3 (vastavalt standardile EN 149-2001)), nÃ¤itab nende filtreerimise tÃµhusust. FFP2 ja FPP3 filtreerimise tÃµhusus Ãµhus lendlevate (kaasa arvatud viirust sisaldavate) osakeste suhtes on vastavalt 92% ja 98%. MÃµlemal maskil on ka kÃ¼llaltki vÃ¤ike leke kÃ¼lgedelt: vastavalt &lt;8% ja &lt;2%. FFP2 vÃ¤liskihil kasutatakse sageli spetsiaalset polÃ¼meeri. Kui tÃ¶Ã¶keskkonnas (nÃ¤iteks tolmu kaitseks) kasutatavate respiraatorite puhul on lubatud ventiil (mis teeb vÃ¤ljahingamise lihtsamaks), siis SARS-CoV-2 puhul tuleks kasutada ainult klapita respiraatoreid, et filtreerida ka vÃ¤ljahingatava Ãµhku. </p><p> COVID-19 pandeemiaga vÃµeti kasutusele uut tÃ¼Ã¼pi nÃ¤omaskid: <b>filtreeriv mask</b>. Seda tÃ¼Ã¼pi mask on valmistatud mitmekihilisest kangast (Ã¼ks neist peab olema nanokiudfilter, mis tagab bakterite ja kahjuliku peentolmu filtreerimisvÃµime vÃ¤hemalt 90%). See mask Ã¼hendab endas suure filtreerimisvÃµime ja korduvkasutatavuse, kuna seda saab masinas pesta 60 kraadi juures. </p>',4),te={class:"grid gap-3 my-15 md:grid-cols-2 e-card"},se=i('<p class="italic">Joonis 4. Erinevad maskitÃ¼Ã¼bid</p><p><b>Maskide tÃµhusust testitakse</b> pidevalt spetsiaalsetes laborites ehk nn. ekspositsioonikambrites. Nendes uuringutes tÃ¤idab osakeste generaator kambri sama suurte aerosooliosakestega, mille abil viirus tavaliselt levib. JÃ¤rgnvalt mÃµÃµdetakse osakeste kontsentratsiooni maski taga ja vÃµrreldakse kontsentratsiooniga vÃ¤ljaspool seda ehk siis ekspositsioonikambris Ã¼ldiselt. </p><p> Maskikandmise tÃµhusust tÃµendavad kÃµige veenvamalt epidemioloogilised andmed, mis on vÃµetud nÃ¶ pÃ¤ris elust. Lyu ja Wehby (2020) poolt lÃ¤biviidud uurimus nÃ¤itas, et koroonasse nakatumise kasv aeglustus kohe, kui 15 USA osariigis ning Columbia ringkonnas kehtestatid maskikandmise kohustus. Ãœhes uurimuses (Leffler jt. 2020) vaadeldi koroonaga seotud surmajuhtumite statistikat kokku 198 riigis. Selle tulemusena leiti, et nendes riikides, kus oli kas sotsiaalseks normiks kanda maski vÃµi kus ametlikult nÃµuti pandeemia ajal maski kandmist, oli ka surmajuhtumite mÃ¤Ã¤r tunduvalt vÃ¤iksem muudest riikidest. </p><p> Mitmed Facebooki jm sotsiaalmeedia kasutajad on jaganud eksitavaid postitusi nÃ¤omaski pikaajalise kasutamise kohta, mis nende vÃ¤itel pÃµhjustab kehas hapnikuvaegust â€“ hÃ¼poksiat. Samas nÃ¤itavad teadusartiklid ja ekspertide analÃ¼Ã¼sid, et selliseid sÃ¼mptomeid ei esine enamikul inimestel, vÃ¤lja arvatud juhul, kui kasutajal on eelnevalt olnud hingamisteede haigusi, nagu astma vÃµi krooniline obstruktiivne kopsuhaigus. Riide ja kirurgiliste maskide puhul on hÃ¼poksia ja hÃ¼perkapnia (liigse sÃ¼sinikdioksiidi sisaldus vereringes) oht veelgi ebatÃµenÃ¤olisem, kuna need ei liibu nÃ¤o Ã¼mber. Siiski hoiatatakse, et nÃ¤omaski ei tohi kasutada alla kahe aastaste vÃµi hingamisraskustega laste puhul ning trenni tehes. </p><section class="e-card"><h4 class="mt-0">Viited</h4><ul class="text-sm break-all"><li><a href="https://bmcpublichealth.biomedcentral.com/articles/10.1186/s12889-021-10652-9" target="_blank" rel="noopener noreferrer">https://bmcpublichealth.biomedcentral.com/articles/10.1186/s12889-021-10652-9</a></li><li><a href="https://jamanetwork.com/journals/jamainternalmedicine/fullarticle/2774266" target="_blank" rel="noopener noreferrer">https://jamanetwork.com/journals/jamainternalmedicine/fullarticle/2774266</a></li><li><a href="https://www.healthaffairs.org/doi/10.1377/hlthaff.2020.00818" target="_blank" rel="noopener noreferrer">https://www.healthaffairs.org/doi/10.1377/hlthaff.2020.00818</a></li><li><a href="https://www.ajtmh.org/view/journals/tpmd/103/6/article-p2400.xml" target="_blank" rel="noopener noreferrer">https://www.ajtmh.org/view/journals/tpmd/103/6/article-p2400.xml</a></li><li><a href="" target="_blank">https://www.epa.gov/sciencematters/epa-researchers-test-effectiveness-face-masks-disinfection-methods-against-covid-19 </a></li><li><a href="https://journals.asm.org/doi/full/10.1128/mSphere.00637-20" target="_blank" rel="noopener noreferrer">https://journals.asm.org/doi/full/10.1128/mSphere.00637-20</a></li><li><a href="https://pubmed.ncbi.nlm.nih.gov/33626065/" target="_blank" rel="noopener noreferrer">https://pubmed.ncbi.nlm.nih.gov/33626065/</a></li></ul></section>',5),ie=e("div",null,[e("h3",{class:"mt-6 pt-3 mb-10"},"Ã•pilastele edasiseks uurimiseks"),e("ul",{class:"leading-tight"},[e("li",null,[e("a",{href:"https://www.fda.gov/medical-devices/personal-protective-equipment-infection-control/n95-respirators-surgical-masks-face-masks-and-barrier-face-coverings#s3",target:"_blank",rel:"noopener noreferrer"},"N95 Respirators, Surgical Masks, Face Masks, and Barrier Face Coverings")]),e("li",null,[e("a",{href:"https://www.sciencedirect.com/science/article/pii/S2452199X20301481",target:"_blank",rel:"noopener noreferrer"},"An overview of filtration efficiency through the masks: Mechanisms of the aerosols penetration")]),e("li",null,[e("a",{href:"https://www.weforum.org/agenda/2020/10/covid-19-coronavirus-disease-size-compairson-zika-health-air-pollution/",target:"_blank",rel:"noopener noreferrer"},"This is how coronavirus compares to the world's smallest particles")])])],-1),re=e("hr",{class:"mt-10 mb-40"},null,-1),ne={id:"s6"},oe=i('<h2 id="s6t">6. Viirused ja kÃ¤te hÃ¼gieen</h2><h3>KÃ¤te desinfitseerimisvahend vÃµi seep?</h3><p> Meie kÃ¤ed vÃµivad olla nakkuste edasikandumisel kriitiliseks teguriks. PÃµhjalikult kÃ¤tele kandes ja <a href="https://www.cdc.gov/handwashing/when-how-handwashing.html" target="_blank" rel="noopener noreferrer">vÃ¤hemalt 20 sekundit kÃ¼Ã¼rides</a>, peatavad nii alkoholipÃµhised kÃ¤tepuhastusvahendid kui ka seep koroona tÃ¼Ã¼pi viiruse leviku. Nii seep kui alkohol lÃµhuvad viiruse membraani. Seep vÃ¤hendab ka patogeenide kleepumist naha kÃ¼lge, vÃµimaldades patogeenid sealt veega maha pesta. See mitte ainult ei neutraliseeri viirust, vaid ka vÃµimaldab selle kÃ¤telt eemaldamist. Ãœldiselt on hea kÃ¤tehÃ¼gieen lihtne ennetusmeede, mida enamik saab vÃ¤ikese vaevaga teha. Paljud uuringud on nÃ¤idanud kÃ¤tehÃ¼gieeni tÃµhusust nakkuslike patogeenide, sealhulgas koroonaviiruste nagu SARS-CoV-2, edasikandumise Ã¤rahoidmisel. </p><section class="e-card"><h4 class="mt-0">Viide</h4><ul class="text-sm break-all"><li><a href="https://www.uchealth.org/today/why-soap-and-water-work-better-than-hand-sanitizer-to-remove-the-coronavirus/" target="_blank" rel="noopener noreferrer">https://www.uchealth.org/today/why-soap-and-water-work-better-than-hand-sanitizer-to-remove-the-coronavirus/</a></li></ul></section><h3>Koroonaviiruse nÃµrgendamine seebiga</h3><p>Koronaviirused on saanud oma nime viirust Ã¼mbritseva &quot;krooni&quot; jÃ¤rgi, mille moodustavad selle membraanile kinnitunud valgu piigid, mis vastutavad peremeesorganismi nakatamise eest. Membraan on viiruse &quot;kest&quot; ja viiruse nÃµrk koht.</p><p>Seebimolekulidel on hÃ¼drofiilne (vett armastav) &quot;pea&quot; ja hÃ¼drofoobne (vett tÃµrjuv) &quot;saba&quot;. â€œPeaâ€ aitab seebil veega seguneda, samas kui â€œsabaâ€ vÃµib interakteeruda (seguneda) hÃ¼drofoobsete molekulidega, nÃ¤iteks lipiididega (rasvadega).</p><p>Meie Ãµnneks koosneb koroonaviiruse membraan enamasti lipiididest. Neid hoiavad koos molekulidevahelised nÃµrgad keemilised vastasmÃµjud. Seebimolekulide hÃ¼drofoobsed (vett vihkavad) &quot;sabad&quot; vÃµivad katkestada lipiidimolekulide vastasmÃµju koroonaviiruse membraanis (vt Joonis 5).</p><p>Seega hÃ¤irib â€œsabaâ€ membraani lipiidimolekulide vahelist nÃµrka vastasmÃµju, rebides need lahti. Kui viirus lÃµhutakse enne, kui see on peremeesrakku turvaliselt varjunud, ei saa see enam oma nakatavat tÃ¶Ã¶d teha â€“ nagu masin, mille osad on vÃ¤lja kukkunud. SeejÃ¤rel Ã¼mbritsevad seebimolekulid viiruse osi nii, et kÃµik sabad on suunatud sissepoole. Sellist kobarat nimetatakse mitselliks (vt Joonis 6). Seebiosakeste vÃ¤ljapoole suunatud hÃ¼drofiilsed pead vÃµimaldavad mitselli veega kÃ¤telt maha pesta. Ainult veest seega ei piisa.</p>',9),le={class:"grid gap-2 md:grid-cols-2 e-card"},de=e("b",null,"Joonis 5.",-1),ce=e("b",null,"Joonis 6.",-1),me=i('<p>Antud teave kehtib ka teiste Ã¼mbrisega viiruste kohta (gripp, B- ja C-hepatiit ning Ebola), kuna nende Ã¼mbrised koosnevad samuti fosfolipiididest.</p><section class="e-card"><h4 class="mt-0">Allikas</h4><ul class="text-sm break-all"><li><a href="https://www.science.org.au/curious/people-medicine/hand-sanitiser-or-soap-making-informed-choice-covid-19" target="_blank" rel="noopener noreferrer">https://www.science.org.au/curious/people-medicine/hand-sanitiser-or-soap-making-informed-choice-covid-19</a></li></ul></section><h3>KÃ¤te desinfitseerimisvahendi valimine</h3><p>Kui pole kÃ¤epÃ¤rast seepi, soovitab Maailma Tervishoiu Organisatsioon (WHO) alkoholipÃµhiseid kÃ¤tepuhastusvahendeid.</p><p><b>Arvatakse, et alkoholipÃµhised kÃ¤tepuhastusvahendid takistavad mikroobide, sh bakterite ja mÃµnede viiruste, valkude normaalset funktsioneerimist. Suure alkoholisisaldusega kÃ¤tepuhastusvahendid vÃµivad samuti lammutada koroonaviirust Ã¼mbritsevat lipiidkesta.</b> Et kÃ¤tepuhastusvahendid oleksid tÃµhusad, peavad need sisaldama vÃ¤hemalt 60 protsenti alkoholi. Desinfitseerimisvahendis olevad lisandid vÃµivad takistada alkoholi liiga kiiret aurustumist, vÃµimaldades sellel kauem viirust leotada.</p><p>Siiski on alkoholipÃµhiste kÃ¤tepuhastusvahendite kasutamisega seotud ka teatud riskid. Lastel on suurenenud alkoholimÃ¼rgituse oht ja kÃ¤tepuhastusvahendite sagedane kasutamine vÃµib pÃµhjustada antimikroobse resistentsuse. On olemas alternatiivsed alkoholivabad kÃ¤tepuhastusvahendid, kus kÃµige sagedamini kasutatakse bensalkooniumi. Hiljutised uuringud on nÃ¤idanud, et alkoholivaba kÃ¤tepuhastusvahend toimib sama hÃ¤sti ega pÃµhjusta alkoholiga kÃ¤tepuhastusvahendi kasutamisel tuttavat &quot;pÃµletustunnet&quot;.</p><section class="e-card"><h4 class="mt-0">Viited</h4><ul class="text-sm break-all"><li><a href="https://www.sciencedirect.com/science/article/abs/pii/S0048969720340833?via%3Dihub" target="_blank" rel="noopener noreferrer">https://www.sciencedirect.com/science/article/abs/pii/S0048969720340833?via%3Dihub</a></li><li><a href="https://www.journalofhospitalinfection.com/article/S0195-6701(20)30547-8/fulltext#secsectitle0040" target="_blank" rel="noopener noreferrer">https://www.journalofhospitalinfection.com/article/S0195-6701(20)30547-8/fulltext#secsectitle0040</a></li></ul></section>',7),ue=e("hr",{class:"mt-20 mb-40"},null,-1),he={id:"s7"},pe=i('<h2 id="s7t">7. Vaktsiinidega seotud mÃ¼Ã¼did</h2><h3 id="myth-1"><span class="text-rose-400">MÃ¼Ã¼t nr 1:</span> Vaktsiinid pÃµhjustavad autismi</h3><p>Laialt levinud hirm, et vaktsiinid suurendavad lastel autismiriski, sai alguse Briti kirurgi Andrew Wakefieldi 1997. aastal avaldatud uuringust. Artikkel avaldati mainekas meditsiiniajakirjas The Lancet, mis viitas sellele, et leetrite, mumpsi ja punetiste (MMR) vaktsiin vÃµib olla pÃµhjustanud Briti lastel autismi.</p><p>Sellest ajast alates on artikkel tÃ¤ielikult Ã¼mber lÃ¼katud tÃµsiste protseduuriliste vigade, valimi ebapiisavuse (uuriti vaid 12 last), rahaliste huvide konflikti ja eetikareeglite rikkumiste tÃµttu. Andrew Wakefield kaotas oma arstilitsentsi ja artikkel vÃµeti The Lancetist tagasi.</p><p>Ãœkski hilisematest uuringutest ei ole nÃ¤idanud seost vaktsiinide manustamise ja autismi vÃ¤ljakujunemise vahel. Praeguseks on mitmed autismi ja vaktsineerimise vaheliste vÃµimalike seoste uuringud vÃ¤lja selgitanud, et autismi sÃ¼mptomid esinevad lastel juba enne MMR-vaktsiini saamist. Veelgi uuemad uuringud annavad tÃµendeid selle kohta, et autism areneb vÃ¤lja emakas, palju enne lapse sÃ¼ndi vÃµi vaktsineerimist.</p><section class="e-card"><h4 class="mt-0">Viited</h4><ul class="text-sm break-all"><li><a href="https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(97)11096-0/fulltext" target="_blank" rel="noopener noreferrer">https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(97)11096-0/fulltext</a></li><li><a href="https://www.nejm.org/doi/full/10.1056/NEJMoa1307491?query=featured_home" target="_blank" rel="noopener noreferrer">https://www.nejm.org/doi/full/10.1056/NEJMoa1307491?query=featured_home</a></li></ul></section>',6),ve=e("div",null,[e("h3",{class:"mt-6 pt-3 mb-10"},"Edasiseks uurimiseks"),e("ul",{class:"leading-tight"},[e("li",null,[e("a",{href:"https://archive.cdc.gov/#/details?url=https://www.cdc.gov/coronavirus/2019-ncov/vaccines/expect/after.html",target:"_blank",rel:"noopener noreferrer"},"Possible Side Effects After Getting a COVID-19 Vaccine")]),e("li",null,[e("a",{href:"https://www.bbc.com/news/health-55932832",target:"_blank",rel:"noopener noreferrer"},"Study reveals extent of Covid vaccine side-effects")]),e("li",null,[e("a",{href:"https://www.nature.com/articles/d41586-021-00290-x",target:"_blank",rel:"noopener noreferrer"},"COVID vaccines and safety: what the research says")]),e("li",null,[e("a",{href:"https://health.clevelandclinic.org/covid-19-vaccine-side-effects/",target:"_blank",rel:"noopener noreferrer"},"Hereâ€™s What to Know About the COVID-19 Vaccine Side Effects")]),e("li",null,[e("a",{href:"https://www.historyofvaccines.org/content/articles/vaccine-side-effects-and-adverse-events",target:"_blank",rel:"noopener noreferrer"},"Vaccine Side Effects and Adverse Events")]),e("li",null,[e("a",{href:"https://www.bbc.com/news/health-56375307",target:"_blank",rel:"noopener noreferrer"},"Vaccine side effects: My experience of them and what they mean")]),e("li",null,[e("a",{href:"https://vk.ovg.ox.ac.uk/vk/vaccine-side-effects",target:"_blank",rel:"noopener noreferrer"},"Vaccine side effects and adverse reactions")]),e("li",null,[a("ğŸ“º"),e("a",{href:"https://www.youtube.com/watch?v=F6NKbQzo4aE",target:"_blank",rel:"noopener noreferrer"},"Vaccine side effects are actually a good thing")]),e("li",null,[a("ğŸ“º"),e("a",{href:"https://www.youtube.com/watch?v=Atrx1P2EkiQ",target:"_blank",rel:"noopener noreferrer"},"Vaccines and the Immune Response: How Vaccines Work")])])],-1),ke=i('<h3 id="myth-2"><span class="text-rose-400">MÃ¼Ã¼t nr 2:</span> Imikute immuunsÃ¼steem ei talu korraga mitut vaktsiini</h3><p>PÃµhjus, miks lastele antakse vaktsiine noores eas, on see, et neil on kÃµrgeim risk haigestuda vÃµi surra, kui nad haigestuvad nendesse haigustesse. Kuigi vastsÃ¼ndinud on immuunsed mÃµne haiguse (nt tuulerÃµuged) suhtes, kuna neil on emalt saadud antikehad, kestab see immuunsus vaid paar kuud. Pealegi ei saa enamik imikuid oma emadelt difteeria, lÃ¤kakÃ¶ha, lastehalvatuse, teetanuse, B-hepatiidi ega Hib-i vastu kaitsvaid antikehi.</p><p>Et vÃ¤hendada lapsele arstivisiidil tehtavate sÃ¼stide arvu, pakutakse mÃµnda vaktsiini kombineeritud vaktsiinina (Ã¼heks sÃ¼stiks on kombineeritud kaks vÃµi enam erinevat vaktsiini). Kombineeritud vaktsiinid on nÃ¤iteks difteeria-teetanuse-lÃ¤kakÃ¶ha ja leetrite-mumpsi-punetiste vaktsiinid.</p><p>Teadusuuringute tulemused nÃ¤itavad, et mitme vaktsiini samaaegne saamine ei pÃµhjusta terviseprobleeme. Imikute immuunsÃ¼steem on tugevam, kui vÃµiks arvata. Veres leiduvate antikehade arvu pÃµhjal oleks beebil teoreetiliselt vÃµime reageerida palju suuremale arvule vaktsiinidele (jÃ¤Ã¤b ainult kÃ¼simus, kas see on korraga 1000, 10 000 vÃµi 100 000). Isegi kui kÃµik ~10 (olenevalt riiklikust vaktsineerimiskavast) plaanitud vaktsiini manustatakse korraga, kasutaks see vaid murdosa beebi immuunvÃµimest. Tegelikkuses puutuvad imikud iga pÃ¤ev kokku lugematute bakterite ja viirustega ning immuniseerimine on sellega vÃµrreldes tÃ¼hine. Samuti ei ole uuringud nÃ¤idanud, et kokkupuude mitme vaktsiiniga esimese 23 elukuu jooksul oleks seotud suurenenud riskiga nakatuda muudesse infektsioonidesse, mis ei ole vaktsiinide sihtmÃ¤rgiks.</p><section class="e-card"><h4 class="mt-0">Viited</h4><ul class="text-sm break-all"><li><a href="https://www.nejm.org/doi/full/10.1056/NEJMoa1307491?query=featured_home" target="_blank" rel="noopener noreferrer">https://www.nejm.org/doi/full/10.1056/NEJMoa1307491?query=featured_home</a></li><li><a href="https://www.bmj.com/content/364/bmj.l1481/rr-11" target="_blank" rel="noopener noreferrer">https://www.bmj.com/content/364/bmj.l1481/rr-11</a></li><li><a href="https://pubmed.ncbi.nlm.nih.gov/11773551/" target="_blank">https://pubmed.ncbi.nlm.nih.gov/11773551/</a></li></ul></section><h3 id="myth-3"><span class="text-rose-400">MÃ¼Ã¼t nr 3:</span> Loomulikul teel omandatud immuunsus on parem kui vaktsiiniga omandatud immuunsus</h3><p>On tÃµsi, et loomulik nakatumine annab peaaegu alati tugevama immuunsuse haiguse vastu kui vaktsineerimine. Selle lÃ¤henemisviisi ohud kaaluvad siiski Ã¼les suhtelise kasu. Loodusliku nakatumise jÃ¤rgse immuunsuse eest makstavaks hinnaks vÃµib olla tuulerÃµugete vÃµi pneumokokkide pÃµhjustatud kopsupÃµletik, Haemophilus influenzae b (Hib) pÃµhjustatud intellektuaalne puue, ema punetistest pÃµhjustatud sÃ¼nnidefektid, B-hepatiidi viiruse tagajÃ¤rjel saadud maksavÃ¤hk, surm leetrite tÃµttu jne. NÃ¤iteks leetritesse haigestudes on teil vÃµimalus oma sÃ¼mptomite tÃµttu surra 1:500. Seevastu inimeste arv, kellel on MMR-vaktsiini saanud raskeid allergilisi reaktsioone, on alla 1:1000000.</p><p>Sellegipoolest on vÃ¤he vaktsiine, mis kutsuvad esile parema immuunvastuse kui loomulikud infektsioonid. NÃ¤iteks sisaldab inimese papilloomiviiruse (HPV) vaktsiin kÃµrge puhtusastmega spetsiifilist valku, mis annab parema immuunvastuse kui loomulik infektsioon. Teised sarnased nÃ¤ited on teetanuse, Haemophilus influenzae tÃ¼Ã¼p b (Hib) ja pneumokoki vaktsiinid.</p><p>Seoses COVID-19-ga on andmed selles suhtes ebaselged. On nÃ¤idatud, et pÃ¼siv kaitse pÃ¤rast nakatumist on ebatÃµenÃ¤oline. Leiti, et koroonaviirusega patsientidel tekkis oluline â€œimmuunmÃ¤lu&quot; - immuunsÃ¼steemi reaktsioon tellis kÃµigis neljas olulises immuunsÃ¼steemi osas: aktiveerides mÃ¤lu B-rakud, antikehad, mÃ¤lu CD4+ T-rakud ja mÃ¤lu CD8+ T-rakud, kusjuures kaitse hakkas vÃ¤henema poole aasta pÃ¤rast. Samuti on teadlased nÃ¤idanud immuunvastuse suurt erinevust inimeste vahel - antikehade tasemete erinevus vÃµib populatsiooni lÃµikes erineda 200 korda.</p><p>Teised uuringud nÃ¤itasid aga, et Moderna vaktsiini (mRNA) saanud vabatahtlike veres oli rohkem antikehi, kui inimestel, kes olid pÃµdenud COVID-19. Seda asjaolu vÃµib aga muuta haiguse tÃµsidus, kuna haiguse tÃµsiduse ja kestva immuunvastuse vahel on seos â€“ enamikul asÃ¼mptomaatilistel patsientidel oli pÃ¤rast 6-kuulist nakatumist vÃ¤ga vÃ¤he antikehi. Seega on SARS-CoV-2 infektsioonist tekkiv loomulik immuunsus sageli ettearvamatu. Veelgi enam, mRNA vaktsiini poolt esile kutsutud antikehad olid suunatud retseptori sidumisdomeeni (RBD) laiemale hulgale kohtadele kui need, mis tekkisid loomuliku infektsiooniga.</p><section class="e-card"><h4 class="mt-0">Viited</h4><ul class="text-sm break-all"><li><a href="https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(21)00675-9/fulltext" target="_blank" rel="noopener noreferrer">https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(21)00675-9/fulltext</a></li><li><a href="https://science.sciencemag.org/content/371/6529/eabf4063" target="_blank" rel="noopener noreferrer">https://science.sciencemag.org/content/371/6529/eabf4063</a></li><li><a href="https://www.nejm.org/doi/full/10.1056/NEJMc2032195" target="_blank" rel="noopener noreferrer">https://www.nejm.org/doi/full/10.1056/NEJMc2032195</a></li><li><a href="https://www.researchsquare.com/article/rs-612205/v1" target="_blank" rel="noopener noreferrer">https://www.researchsquare.com/article/rs-612205/v1</a></li><li><a href="https://stm.sciencemag.org/content/13/600/eabi9915" target="_blank" rel="noopener noreferrer">https://stm.sciencemag.org/content/13/600/eabi9915</a></li></ul></section><h3 id="myth-4"><span class="text-rose-400">MÃ¼Ã¼t nr 4:</span> Vaktsiinid sisaldavad eluohtlikke toksiine</h3><p>Inimesed tunnevad muret formaldehÃ¼Ã¼di, elavhÃµbeda vÃµi alumiiniumi kasutamise pÃ¤rast vaktsiinides. Ãœhest kÃ¼ljest on tÃµsi, et need kemikaalid on teatud tasemel inimkehale mÃ¼rgised. Teisest kÃ¼ljest on vaktsiinides kasutatu kemikaalide vÃ¤ga vÃ¤ikesi koguseid ja need kogused on vÃ¤iksemad kui toitumisest saadavad vÃµi formaldehÃ¼Ã¼di toodavad meie enda ainevahetussÃ¼steemid kiiremini.</p><p>PÃµhjused, miks teatud elemendid, nÃ¤iteks alumiiniumsoolad, lisatakse vaktsiinidele, on see, et need toimivad adjuvandina, mis tÃ¤hendab, et selle olemasolu suurendab vaktsineerimisel immuunvastust. Samuti sisaldavad alumiiniumsoolasid ainult teatud vaktsiinid, uued COVID-19 vaktsiinid neid nÃ¤iteks ei sisalda. VÃ¤ike osa vaktsiinidest on sisaldanud sÃ¤ilitusainena timerosaali, kuid Ã¼kski lastel kasutatavatest vaktsiinidest ei sisalda seda praegu. Thimerosal sisaldab etÃ¼Ã¼lelavhÃµbedat, mis eritub inimkehast kiiresti, vÃµrreldes bioakumuleeruva metÃ¼Ã¼lelavhÃµbedaga â€“ seega on suur erinevus, mis kujul mÃ¼rgine metall esineb. Sellest hoolimata ei sisalda COVID-19 vaktsiinid toksiine.</p><section class="e-card"><h4 class="mt-0">Viited</h4><ul class="text-sm break-all"><li><a href="https://stm.sciencemag.org/content/13/600/eabi9915" target="_blank" rel="noopener noreferrer">https://stm.sciencemag.org/content/13/600/eabi9915</a></li><li><a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6373706/" target="_blank" rel="noopener noreferrer">https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6373706/</a></li><li><a href="https://www.technologyreview.com/2020/12/09/1013538/what-are-the-ingredients-of-pfizers-covid-19-vaccine/" target="_blank" rel="noopener noreferrer">https://www.technologyreview.com/2020/12/09/1013538/what-are-the-ingredients-of-pfizers-covid-19-vaccine/</a></li></ul></section>',15),fe=e("div",null,[e("h3",{class:"mt-6 pt-3 mb-10"},"Edasiseks uurimiseks"),e("ul",{class:"leading-tight"},[e("li",null,[a("ğŸ“º"),e("a",{href:"https://www.youtube.com/watch?v=Atrx1P2EkiQ",target:"_blank",rel:"noopener noreferrer"},"Vaccines and the Immune Response: How Vaccines Work")]),e("li",null,[e("a",{href:"https://www.cdc.gov/vaccines/vac-gen/additives.htm",target:"_blank",rel:"noopener noreferrer"},"Whatâ€™s in Vaccines?")])])],-1),ge=i('<h3 id="myth-5"><span class="text-rose-400">MÃ¼Ã¼t nr 5:</span> Nakatumiste arvu vÃ¤henemise pÃµhjuseks maailmas on parem hÃ¼gieen ja kanalisatsioon, mitte vaktsiinid.</h3><p>See on osaliselt tÃµsi, et vaktsiinid ei vÃ¤Ã¤ri kogu tunnustust nakkushaiguste esinemissageduse vÃ¤hendamise vÃµi kÃµrvaldamise eest. On nÃ¤idatud, et palju on aidanud ka parem kanalisatsioon, toitumine ja antibiootikumide vÃ¤ljatÃ¶Ã¶tamine. Saastunud vee kaudu levivad sellised nakkused, nagu tÃ¼Ã¼fus ja koolera, mis olid 20. sajandi alguses peamised haiguste ja surma pÃµhjustajad. Paremate sanitaartingimuste tÃµttu on nende esinemine kindlasti oluliselt vÃ¤henenud. Hiljutine Ã¼levaade jÃµudis jÃ¤reldusele, et kÃ¤te pesemine aitab Ã¤ra hoida nakkushaigusi. Veel Ã¼ks hiljutine tÃµend pÃ¤rineb COVID-19 pandeemia ajast, mis nÃ¤itas, et paranenud hÃ¼gieen koos muude ohutusnÃµuetega, on jÃ¤rsult vÃ¤hendanud ka hooajalise gripi esinemissagedust.</p><p>Kui need tegurid aga uuringutes eraldada ja nakkushaiguste esinemissagedust analÃ¼Ã¼sida, ei saa vaktsiinide rolli eitada. Ãœks nÃ¤ide on leetrid Ameerika Ãœhendriikides. Kui 1963. aastal vÃµeti kasutusele esimene leetrite vaktsiin, pÃ¼sis nakatumise mÃ¤Ã¤r ligikaudu 400 000 juhtumi juures aastas. Kuigi hÃ¼gieenilised harjumused ja sanitaartingimused ei muutunud jÃ¤rgmisel kÃ¼mnendil palju, langes leetritesse nakatumise mÃ¤Ã¤r pÃ¤rast vaktsiini kasutuselevÃµttu jÃ¤rsult, 1970. aastaks oli ainult ligikaudu 25 000 juhtu. Teine nÃ¤ide on Hib-tÃµbi. Andmete kohaselt langes selle haiguse esinemissagedus pÃ¤rast vaktsiini kasutuselevÃµttu 20 000-lt 1990. aastal ligikaudu 1500-le 1993. aastal.</p><p>Veel Ã¼ks tÃµend pÃ¤rineb viimastest aastakÃ¼mnetest. HÃ¼gieenis ei ole arenenud maailmas muudatusi toimunud, kÃ¼ll aga on vÃ¤henenud vaktsineerimise mÃ¤Ã¤r. NÃ¼Ã¼d tÃ¤heldatakse mitmetes riikides, nagu Ãœhendkuningriik, USA, Saksamaa, Hispaania jne, Ã¼ha rohkem leetreid ja muid vaktsiinivÃ¤lditavaid haigusi.</p><section class="e-card"><h4 class="mt-0">Viited</h4><ul class="text-sm break-all"><li><a href="https://jptcp.com/index.php/jptcp/article/view/711" target="_blank" rel="noopener noreferrer">https://jptcp.com/index.php/jptcp/article/view/711</a></li><li><a href="https://www.nature.com/articles/d41586-020-01538-8" target="_blank" rel="noopener noreferrer">https://www.nature.com/articles/d41586-020-01538-8</a></li><li><a href="https://www.nature.com/articles/d41586-020-03519-3" target="_blank" rel="noopener noreferrer">https://www.nature.com/articles/d41586-020-03519-3</a></li><li><a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3222407/" target="_blank" rel="noopener noreferrer">https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3222407/</a></li></ul></section><h3 id="myth-6"><span class="text-rose-400">MÃ¼Ã¼t nr 6:</span> Vaktsiinid vÃµivad nakatada inimesi haigusega, mida see pÃ¼Ã¼ab Ã¤ra hoida</h3><p>MÃµned vaktsiinid on elusvaktsiinid, mis sisaldavad elusaid, kuid nÃµrgestatud mikroorganisme/viirusi, mis on endiselt vÃµimelised peremeesorganismis paljunema. Mikroorganismid on nÃµrgestatud, mis tÃ¤hendab, et nad on kaotanud suurema osa oma haigust pÃµhjustavatest vÃµimetest, kuid neil on endiselt olemas immunogeensed omadused. Seega on see alati palju kergem variant kui siis, kui laps nakatub haigust pÃµhjustavasse â€œpÃ¤risâ€ viirusesse. NÃµrgestatud elusvaktsiinideks on leetrite, mumpsi ja punetiste kombineeritud vaktsiin ning rotaviiruse, rÃµugete, tuulerÃµugete ja kollapalaviku vaktsiinid. Enamikul juhtudel on elusvaktsiinidel oluliselt suurem immunogeensus kui inaktiveeritud vaktsiinidel, kuna loomulikku infektsiooni imiteeritakse peaaegu tÃ¤iuslikult, kutsudes esile laiema immunoloogilise vastuse. Kuid nÃµrgenenud immuunsÃ¼steemiga lastele, nÃ¤iteks vÃ¤hiravi saavatele lastele, neid vaktsiine ei eelistata.</p><p>On tÃµsi, et elusvaktsiinid vÃµivad pÃµhjustada kergeid sÃ¼mptomeid, mis sarnanevad selle haigusega, mille eest nad kaitsevad. Vaktsiini saajad kogevad aga organismi immuunvastust vaktsiinile, mitte haigust ennast. On registreeritud ainult Ã¼ks juhtum, kus vaktsiin pÃµhjustas haigust. See oli suukaudne poliomÃ¼eliidi vaktsiin (OPV), mida enam ei kasutata ja mis on praegu asendatud tapetud viiruse vormiga, mida tuntakse inaktiveeritud poliomÃ¼eliidi vaktsiinina (IPV).</p><section class="e-card"><h4 class="mt-0">Viide</h4><ul class="text-sm break-all"><li><a href="https://www.sciencedirect.com/science/article/pii/B9781455710768000090" target="_blank" rel="noopener noreferrer">https://www.sciencedirect.com/science/article/pii/B9781455710768000090</a></li></ul></section><h3 id="myth-7"><span class="text-rose-400">MÃ¼Ã¼t nr 7:</span> Me ei pea enam vaktsineerima, sest nakatumise mÃ¤Ã¤r mitmetesse nakkushaigustesse on paljudes riikides nniikuinii madal</h3><p>TÃ¤nu karjaimmuunsusele ei nÃ¤e paljud inimesed vaktsineerimise jÃ¤rele enam vajadust. Karjaimmuunsus tekib siis, kui suur osa kogukonnast (â€œkariâ€) muutub haiguse suhtes immuunseks, mistÃµttu on haiguse levik inimeselt inimesele ebatÃµenÃ¤oline. Niikaua kui suurem osa inimestest on immuniseeritud mis tahes populatsioonis, on kaitstud ka immuniseerimata vÃ¤hemus. See on oluline, sest teatud osa elanikkonnast â€“ imikud, rasedad naised, eakad ja nÃµrgenenud immuunsÃ¼steemiga inimesed â€“ ei saa mÃµnikord/mÃµndasid vaktsiine. Kui aga paljud inimesed iseennast ega oma lapsi enam ei vaktsineeri, kaob karjaimmuunsus, mis annab vÃµimaluse viirustele ja bakteritele end levitada. Sageli tuuakse mÃµni haigus kaasa rahvusvahelistelt reisidelt. Vaktsineerimata inimesel on sel juhul palju suurem risk haigestuda vÃµi reisimise ajal nakatuda. Seda illustreerib leetrite esinemissageduse tÃµus USA-s viimastel aastatel. Kuni haigused eksisteerivad, on meil oht nakatuda.</p><section class="e-card"><h4 class="mt-0">Viited</h4><ul class="text-sm break-all"><li><a href="https://www.cdc.gov/mmwr/volumes/68/wr/mm6819a4.htm" target="_blank" rel="noopener noreferrer">https://www.cdc.gov/mmwr/volumes/68/wr/mm6819a4.htm</a></li><li><a href="https://bmcpublichealth.biomedcentral.com/articles/10.1186/s12889-021-10652-9" target="_blank" rel="noopener noreferrer">https://bmcpublichealth.biomedcentral.com/articles/10.1186/s12889-021-10652-9</a></li></ul></section>',12),be=e("a",{href:"https://www.who.int/emergencies/diseases/novel-coronavirus-2019/media-resources/science-in-5/episode-8---myth-vs-science",target:"_blank",rel:"noopener noreferrer"}," WHO - Myth vs Science ",-1);function we(h,c){const l=v,d=j,r=k,n=f,m=g;return o(),u("div",V,[t(d,null,{default:s(()=>[t(l,{class:"w-full lg:max-w-xs print:hidden",key:"viruses-bg-et"})]),_:1}),e("section",S,[t(r,{name:"openmoji:scientist-medium-dark-skin-tone",class:"float-right text-[5em]"}),A,I,e("section",M,[D,z,O,C,t(n,{src:"https://evidence.onkel.ee/assets/viruses-01__bacteria-vs-virus.webp",credits:"Source: https://inducoat.com/?attachment_id=24945&lang=en",elevated:!0},{caption:s(()=>[F,a(" Viiruse ja bakteri struktuurierinevused ")]),_:1}),N,t(m,{class:"mb-8"},{default:s(()=>[$,a(" vÃµivad aidata immuunsÃ¼steemil hÃ¤vitada bakteriaalset nakkust, kuid on kasutud viirusnakkuste vastu. "),P,a(" toimivad teisiti kui antibiootikumid ja on praegu tÃµhusad vaid mÃµne viirushaiguse, nÃ¤iteks gripi, herpese, B- ja C-hepatiidi ning HIV-viiruse vastu. Viirusnakkusi vÃµib olla palju raskem tappa kui bakteriaalseid nakkusi, kuna viirus siseneb organismi rakkudesse. "),B,a(" vÃµib nakatunud rakud tappa enne, kui viirus on vÃµimeline paljunema. Viiruse paljunedes aga rakk lÃµhkeb, mis vÃµimaldab viirusel levida teistesse keharakkudesse. ")]),_:1}),T]),E,e("section",R,[H,W,K,Y,t(n,{src:"https://evidence.onkel.ee/assets/viruses-03.webp",credits:"Allikas: https://www.nytimes.com/2020/03/13/health/soap-coronavirus-handwashing-germs.html",elevated:!0},{caption:s(()=>[U,a(" Iga uue antigeeni jaoks peab meie keha looma spetsiifilise antikeha ")]),_:1}),J,L,Q,t(n,{src:"https://evidence.onkel.ee/assets/viruses-04.webp",credits:"Allikas: https://www.who.int/news-room/feature-stories/detail/how-do-vaccines-work",elevated:!0},{caption:s(()=>[G,a(" Antikehade arendamine vaktsineerimise kaudu ")]),_:1}),X]),Z,e("section",ee,[ae,e("div",te,[t(n,{src:"https://evidence.onkel.ee/assets/viruses-06__mask-01.webp"},{caption:s(()=>[a(" Kirurgiline mask ")]),_:1}),t(n,{src:"https://evidence.onkel.ee/assets/viruses-06__mask-02.webp",caption:""},{caption:s(()=>[a(" FFP2 mask (respiraator) ")]),_:1}),t(n,{src:"https://evidence.onkel.ee/assets/viruses-06__mask-03.webp"},{caption:s(()=>[a(" FFP3 mask (respiraator) klapiga ")]),_:1}),t(n,{src:"https://evidence.onkel.ee/assets/viruses-06__mask-04.webp"},{caption:s(()=>[a(" Filteeriv mask ")]),_:1})]),se,t(m,{class:"my-8",theme:"sky-500",icon:"material-symbols:edit-document"},{default:s(()=>[ie]),_:1})]),re,e("section",ne,[oe,e("div",le,[t(n,{src:"https://evidence.onkel.ee/assets/viruses-07.webp",credits:"Allikas: https://www.nytimes.com/2020/03/13/health/soap-coronavirus-handwashing-germs.html"},{caption:s(()=>[de,a(" Seebi molekulid hÃ¤vitamas viirust ")]),_:1}),t(n,{src:"https://evidence.onkel.ee/assets/viruses-08.webp",credits:"Allikas: https://www.nytimes.com/2020/03/13/health/soap-coronavirus-handwashing-germs.html"},{caption:s(()=>[ce,a(" Seebi molekulidest ja viiruse osast koosnev mitsell ")]),_:1})]),me]),ue,e("section",he,[pe,t(m,{class:"my-8",theme:"sky-500",icon:"material-symbols:edit-document"},{default:s(()=>[ve]),_:1}),ke,t(m,{class:"my-8",theme:"sky-500",icon:"material-symbols:edit-document"},{default:s(()=>[fe]),_:1}),ge,t(m,{class:"my-8",theme:"sky-500",icon:"material-symbols:edit-document"},{default:s(()=>[a(" Rohkem COVID-19 mÃ¼Ã¼te ja sellega seotud teadusuuringuid leiate aadressilt: "),be]),_:1})])])])}const _e=b(q,[["render",we]]),ye={},je={class:"flex flex-col items-start lg:flex-row-reverse lg:justify-end xl:gap-10 2xl:gap-20"},xe={class:"e-article",lang:"el",style:{hyphens:"auto"}},qe=e("h1",{class:"mb-0"},"Î™Î¿Î¯",-1),Ve=e("h5",{class:"font-normal uppercase leading-tight"},"Î•Ï€Î¹ÏƒÏ„Î·Î¼Î¿Î½Î¹ÎºÎ­Ï‚ Ï€Î»Î·ÏÎ¿Ï†Î¿ÏÎ¯ÎµÏ‚",-1),Se={id:"s1"},Ae=e("h2",{id:"s1t"},"1. Î™Î¿Î¯ Vs Î²Î±ÎºÏ„Î®ÏÎ¹Î±",-1),Ie=e("p",null,[e("b",null,"Î¤Î± Î²Î±ÎºÏ„Î®ÏÎ¹Î± ÎºÎ±Î¹ Î¿Î¹ Î¹Î¿Î¯ Î¼Ï€Î¿ÏÎ¿ÏÎ½ Î½Î± Ï€ÏÎ¿ÎºÎ±Î»Î­ÏƒÎ¿Ï…Î½ Ï€Î¿Î»Î»Î­Ï‚ ÎºÎ¿Î¹Î½Î­Ï‚ Î»Î¿Î¹Î¼ÏÎ¾ÎµÎ¹Ï‚. Î Î¿Î¹ÎµÏ‚ ÎµÎ¯Î½Î±Î¹ ÏŒÎ¼Ï‰Ï‚ Î¿Î¹ Î´Î¹Î±Ï†Î¿ÏÎ­Ï‚ Î¼ÎµÏ„Î±Î¾Ï Î±Ï…Ï„ÏÎ½ Ï„Ï‰Î½ Î´ÏÎ¿ ÎµÎ¹Î´ÏÎ½ Î¼Î¿Î»Ï…ÏƒÎ¼Î±Ï„Î¹ÎºÏÎ½ Î¿ÏÎ³Î±Î½Î¹ÏƒÎ¼ÏÎ½;")],-1),Me=e("p",null,[a(" Î¤Î± "),e("span",{class:"e-term font-Heading"},"Î²Î±ÎºÏ„Î®ÏÎ¹Î±"),a(" ÎµÎ¯Î½Î±Î¹ Î¼Î¹ÎºÏÎ¿ÏƒÎºÎ¿Ï€Î¹ÎºÎ¿Î¯ Î¼Î¹ÎºÏÎ¿Î¿ÏÎ³Î±Î½Î¹ÏƒÎ¼Î¿Î¯ Ï€Î¿Ï… Î±Ï€Î¿Ï„ÎµÎ»Î¿ÏÎ½Ï„Î±Î¹ Î±Ï€ÏŒ Î­Î½Î± Î¼ÏŒÎ½Î¿ ÎºÏÏ„Ï„Î±ÏÎ¿. Î Î±ÏÎ¿Ï…ÏƒÎ¹Î¬Î¶Î¿Ï…Î½ Î¼ÎµÎ³Î¬Î»Î· Ï€Î¿Î¹ÎºÎ¹Î»Î¯Î± ÎºÎ±Î¹ Î¼Ï€Î¿ÏÎ¿ÏÎ½ Î½Î± Î­Ï‡Î¿Ï…Î½ Ï€Î¿Î»Î»Î¬ ÏƒÏ‡Î®Î¼Î±Ï„Î± ÎºÎ±Î¹ Î´Î¿Î¼Î¹ÎºÎ¬ Ï‡Î±ÏÎ±ÎºÏ„Î·ÏÎ¹ÏƒÏ„Î¹ÎºÎ¬. Î¤Î± Î²Î±ÎºÏ„Î®ÏÎ¹Î± Î¼Ï€Î¿ÏÎ¿ÏÎ½ Î½Î± Î¶Î®ÏƒÎ¿Ï…Î½ ÏƒÏ‡ÎµÎ´ÏŒÎ½ ÏƒÎµ ÎºÎ¬Î¸Îµ Ï€ÎµÏÎ¹Î²Î¬Î»Î»Î¿Î½, ÏƒÏ…Î¼Ï€ÎµÏÎ¹Î»Î±Î¼Î²Î±Î½Î¿Î¼Î­Î½Î¿Ï… Ï„Î¿Ï… Î±Î½Î¸ÏÏÏ€Î¹Î½Î¿Ï… ÏƒÏÎ¼Î±Ï„Î¿Ï‚. ÎœÏŒÎ½Î¿ Î»Î¯Î³Î± Î²Î±ÎºÏ„Î®ÏÎ¹Î± Ï€ÏÎ¿ÎºÎ±Î»Î¿ÏÎ½ Î»Î¿Î¹Î¼ÏÎ¾ÎµÎ¹Ï‚ ÏƒÏ„Î¿Î½ Î¬Î½Î¸ÏÏ‰Ï€Î¿. Î‘Ï…Ï„Î¬ Ï„Î± Î²Î±ÎºÏ„Î®ÏÎ¹Î± Î±Î½Î±Ï†Î­ÏÎ¿Î½Ï„Î±Î¹ Ï‰Ï‚ Ï€Î±Î¸Î¿Î³ÏŒÎ½Î± Î²Î±ÎºÏ„Î®ÏÎ¹Î±. ")],-1),De=e("p",null,[a(" ÎŸÎ¹ "),e("span",{class:"e-term font-Heading"},"Î¹Î¿Î¯"),a(" ÎµÎ¯Î½Î±Î¹ Î­Î½Î±Ï‚ Î¬Î»Î»Î¿Ï‚ Ï„ÏÏ€Î¿Ï‚ Î¼Î¹ÎºÏÎ¿ÏƒÎºÎ¿Ï€Î¹ÎºÏÎ½ Î¼Î¹ÎºÏÎ¿Î¿ÏÎ³Î±Î½Î¹ÏƒÎ¼ÏÎ½, Î¼Î¹ÎºÏÏŒÏ„ÎµÏÎ¿Ï‚ Î±ÎºÏŒÎ¼Î· ÎºÎ±Î¹ Î±Ï€ÏŒ Ï„Î± Î²Î±ÎºÏ„Î®ÏÎ¹Î±. EÎ¯Î½Î±Î¹ Ï€Î¿Î»Ï Î´Î¹Î±Ï†Î¿ÏÎµÏ„Î¹ÎºÎ¿Î¯ Î¼ÎµÏ„Î±Î¾Ï Ï„Î¿Ï…Ï‚ ÎºÎ±Î¹ Î­Ï‡Î¿Ï…Î½ Ï€Î¿Î¹ÎºÎ¯Î»Î± ÏƒÏ‡Î®Î¼Î±Ï„Î± ÎºÎ±Î¹ Ï‡Î±ÏÎ±ÎºÏ„Î·ÏÎ¹ÏƒÏ„Î¹ÎºÎ¬ ÏŒÏ€Ï‰Ï‚ Ï„Î± Î²Î±ÎºÏ„Î®ÏÎ¹Î±. ÎŸÎ¹ Î¹Î¿Î¯ ÎµÎ¯Î½Î±Î¹ Ï€Î±ÏÎ±ÏƒÎ¹Ï„Î¹ÎºÎ¿Î¯, Ï€ÏÎ¬Î³Î¼Î± Ï€Î¿Ï… ÏƒÎ·Î¼Î±Î¯Î½ÎµÎ¹ ÏŒÏ„Î¹ Ï‡ÏÎµÎ¹Î¬Î¶Î¿Î½Ï„Î±Î¹ Î¶Ï‰Î½Ï„Î±Î½Î¬ ÎºÏÏ„Ï„Î±ÏÎ± Î® Î¹ÏƒÏ„Î¿ÏÏ‚ Î³Î¹Î± Î½Î± Î¼Ï€Î¿ÏÎ­ÏƒÎ¿Ï…Î½ Î½Î± Î±Î½Î±Ï€Ï„Ï…Ï‡Î¸Î¿ÏÎ½. ÎŸÎ¹ Î¹Î¿Î¯ Î¼Ï€Î¿ÏÎ¿ÏÎ½ Î½Î± ÎµÎ¹ÏƒÎ²Î¬Î»Î¿Ï…Î½ ÏƒÏ„Î± ÎºÏÏ„Ï„Î±ÏÎ± Ï„Î¿Ï… ÏƒÏÎ¼Î±Ï„ÏŒÏ‚ Î¼Î±Ï‚, Ï‡ÏÎ·ÏƒÎ¹Î¼Î¿Ï€Î¿Î¹ÏÎ½Ï„Î±Ï‚ Ï„Î± ÏƒÏ…ÏƒÏ„Î±Ï„Î¹ÎºÎ¬ Ï„Ï‰Î½ ÎºÏ…Ï„Ï„Î¬ÏÏ‰Î½ Î³Î¹Î± Î½Î± Î±Î½Î±Ï€Ï„Ï…Ï‡Î¸Î¿ÏÎ½ ÎºÎ±Î¹ Î½Î± Ï€Î¿Î»Î»Î±Ï€Î»Î±ÏƒÎ¹Î±ÏƒÏ„Î¿ÏÎ½. ÎœÎµÏÎ¹ÎºÎ¿Î¯ Î¹Î¿Î¯ ÏƒÎºÎ¿Ï„ÏÎ½Î¿Ï…Î½ Î±ÎºÏŒÎ¼Î· ÎºÎ±Î¹ Ï„Î± ÎºÏÏ„Ï„Î±ÏÎ±-Î¾ÎµÎ½Î¹ÏƒÏ„Î­Ï‚ Ï‰Ï‚ Î¼Î­ÏÎ¿Ï‚ Ï„Î¿Ï… ÎºÏÎºÎ»Î¿Ï… Î¶Ï‰Î®Ï‚ Ï„Î¿Ï…Ï‚. ÎŸÎ¹ Î´Î¹Î±Ï†Î¿ÏÎ­Ï‚ Î¼ÎµÏ„Î±Î¾Ï Î¹ÏÎ½ ÎºÎ±Î¹ Î²Î±ÎºÏ„Î·ÏÎ¯Ï‰Î½ Ï†Î±Î¯Î½Î¿Î½Ï„Î±Î¹ ÏƒÏ„Î¿ ÏƒÏ‡Î®Î¼Î± 1 ÎºÎ±Î¹ Î¼Ï€Î¿ÏÎµÎ¯Ï„Îµ Î½Î± Ï„Î± ÎµÎ½Ï„Î¿Ï€Î¯ÏƒÎµÏ„Îµ ÎºÎ±Î¹ ÏƒÏ„Î¿Î½ Ï€Î¯Î½Î±ÎºÎ± 1. ")],-1),ze=e("b",null,"Î£Ï‡Î®Î¼Î± 1.",-1),Oe=i('<table class="mt-20"><caption class="text-left pb-4"><b>Î Î¯Î½Î±ÎºÎ±Ï‚ 1.</b> Î”Î¹Î±Ï†Î¿ÏÎ­Ï‚ Î¹ÏÎ½ ÎºÎ±Î¹ Î²Î±ÎºÏ„Î·ÏÎ¯Ï‰Î½</caption><thead><tr><th></th><th>Î’Î±ÎºÏ„Î®ÏÎ¹Î±</th><th>Î™Î¿Î¯</th></tr></thead><tbody><tr><th class="align-baseline"> Î–Ï‰Î½Ï„Î±Î½ÏŒÏ‚ / ÎœÎ· Î¶Ï‰Î½Ï„Î±Î½ÏŒÏ‚ </th><td><b>Î–Ï‰Î½Ï„Î±Î½ÏŒÏ‚ Î¿ÏÎ³Î±Î½Î¹ÏƒÎ¼ÏŒÏ‚.</b><br>Î¤Î± Î²Î±ÎºÏ„Î®ÏÎ¹Î± ÎµÎ¯Î½Î±Î¹ Î¶Ï‰Î½Ï„Î±Î½Î¿Î¯ Î¿ÏÎ³Î±Î½Î¹ÏƒÎ¼Î¿Î¯ Î¼Îµ Î­Î½Î± Î¼ÏŒÎ½Î¿ ÎºÏÏ„Ï„Î±ÏÎ¿ Ï€Î¿Ï… Î¼Ï€Î¿ÏÎ¿ÏÎ½ Î½Î± Ï€Î±ÏÎ¬Î³Î¿Ï…Î½ ÎµÎ½Î­ÏÎ³ÎµÎ¹Î±, Î½Î± Ï†Ï„Î¹Î¬Ï‡Î½Î¿Ï…Î½ Ï„Î· Î´Î¹ÎºÎ® Ï„Î¿Ï…Ï‚ Ï„ÏÎ¿Ï†Î®, Î½Î± ÎºÎ¹Î½Î¿ÏÎ½Ï„Î±Î¹ ÎºÎ±Î¹ Î½Î± Î±Î½Î±Ï€Î±ÏÎ¬Î³Î¿Î½Ï„Î±Î¹ (ÏƒÏ…Î½Î®Î¸Ï‰Ï‚ Î¼Îµ Î´Ï…Î±Î´Î¹ÎºÎ® ÏƒÏ‡Î¬ÏƒÎ·). Î‘Ï…Ï„ÏŒ ÎµÏ€Î¹Ï„ÏÎ­Ï€ÎµÎ¹ ÏƒÏ„Î± Î²Î±ÎºÏ„Î®ÏÎ¹Î± Î½Î± Î¶Î¿Ï…Î½ ÏƒÎµ Ï€Î¿Î»Î»Î¬ Î¼Î­ÏÎ· -Ï‡ÏÎ¼Î±, Î½ÎµÏÏŒ, Ï†Ï…Ï„Î¬ ÎºÎ±Î¹ Î±Î½Î¸ÏÏÏ€Î¹Î½Î¿ ÏƒÏÎ¼Î±- ÎºÎ±Î¹ Î½Î± ÎµÎ¾Ï…Ï€Î·ÏÎµÏ„Î¿ÏÎ½ Ï€Î¿Î»Î»Î¿ÏÏ‚ ÏƒÎºÎ¿Ï€Î¿ÏÏ‚. Î£Ï„Î± Î²Î±ÎºÏ„Î®ÏÎ¹Î± Ï€ÎµÏÎ¹Î»Î±Î¼Î²Î¬Î½Î¿Î½Ï„Î±Î¹ Ï„ÏŒÏƒÎ¿ Ï€Î±ÏÎ¬ÏƒÎ¹Ï„Î± ÏŒÏƒÎ¿ ÎºÎ±Î¹ Î¼Î· Ï€Î±ÏÎ¬ÏƒÎ¹Ï„Î±. </td><td><b>ÎœÎ· Î¶Ï‰Î½Ï„Î±Î½ÏŒÏ‚.</b><br>ÎŸÎ¹ Î¹Î¿Î¯ Î±Î½Î±Ï€Ï„ÏÏƒÏƒÎ¿Î½Ï„Î±Î¹ ÎºÎ±Î¹ Î±Î½Î±Ï€Î±ÏÎ¬Î³Î¿Î½Ï„Î±Î¹ Î¼ÏŒÎ½Î¿ Î¼Î­ÏƒÎ± ÏƒÏ„Î± ÎºÏÏ„Ï„Î±ÏÎ± Î¾ÎµÎ½Î¹ÏƒÏ„Î­Ï‚ Ï€Î¿Ï… Î¼Î¿Î»ÏÎ½Î¿Ï…Î½. ÎŒÏ„Î±Î½ Î²ÏÎ¯ÏƒÎºÎ¿Î½Ï„Î±Î¹ Î­Î¾Ï‰ Î±Ï€ÏŒ Î±Ï…Ï„Î¬ Ï„Î± Î¶Ï‰Î½Ï„Î±Î½Î¬ ÎºÏÏ„Ï„Î±ÏÎ±, Î¿Î¹ Î¹Î¿Î¯ ÎµÎ¯Î½Î±Î¹ Î±Î´ÏÎ±Î½ÎµÎ¯Ï‚. Î— Â«Î¶Ï‰Î®Â» Ï„Î¿Ï…Ï‚, ÎµÏ€Î¿Î¼Î­Î½Ï‰Ï‚, Î±Ï€Î±Î¹Ï„ÎµÎ¯ Ï„Î·Î½ ÎµÎºÎ¼ÎµÏ„Î¬Î»Î»ÎµÏ…ÏƒÎ· Ï„Ï‰Î½ Î²Î¹Î¿Ï‡Î·Î¼Î¹ÎºÏÎ½ Î´ÏÎ±ÏƒÏ„Î·ÏÎ¹Î¿Ï„Î®Ï„Ï‰Î½ ÎµÎ½ÏŒÏ‚ Î¶Ï‰Î½Ï„Î±Î½Î¿Ï ÎºÏ…Ï„Ï„Î¬ÏÎ¿Ï….<br>ÎŒÎ»Î¿Î¹ Î¿Î¹ Î¹Î¿Î¯ ÎµÎ¯Î½Î±Î¹ ÎµÎ½Î´Î¿ÎºÏ…Ï„Ï„Î±ÏÎ¹ÎºÎ¬ Ï€Î±ÏÎ¬ÏƒÎ¹Ï„Î±. </td></tr><tr><th class="align-baseline">Î‘ÏÎ¹Î¸Î¼ÏŒÏ‚ ÎºÏ…Ï„Ï„Î¬ÏÏ‰Î½</th><td>ÎœÎ¿Î½Î¿ÎºÏÏ„Ï„Î±ÏÎ¿, Î­Î½Î± ÎºÏÏ„Ï„Î±ÏÎ¿</td><td>Î§Ï‰ÏÎ¯Ï‚ ÎºÏÏ„Ï„Î±ÏÎ±, ÏŒÏ‡Î¹ Î¶Ï‰Î½Ï„Î±Î½Î¬</td></tr><tr><th class="align-baseline">Î‘Î½Î±Ï€Î±ÏÎ±Î³Ï‰Î³Î®</th><td>Î”Î¹Î±Î¯ÏÎµÏƒÎ· ÏƒÏ„Î± 2</td><td>Î•Î¹ÏƒÎ²Î¬Î»Î»ÎµÎ¹ ÎºÎ±Î¹ ÎºÎ±Ï„Î±Î»Î±Î¼Î²Î¬Î½ÎµÎ¹ Î­Î½Î± ÎºÏÏ„Ï„Î±ÏÎ¿ Î¾ÎµÎ½Î¹ÏƒÏ„Î®, Î±Î½Î±Î³ÎºÎ¬Î¶Î¿Î½Ï„Î¬Ï‚ Ï„Î¿ Î½Î± Î´Î·Î¼Î¹Î¿Ï…ÏÎ³Î®ÏƒÎµÎ¹ Î±Î½Ï„Î¯Î³ÏÎ±Ï†Î± Ï„Î¿Ï… Ï…Î¹Î¹ÎºÎ¿Ï DNA/RNA. ÎšÎ±Ï„Î±ÏƒÏ„ÏÎ­Ï†ÎµÎ¹ Ï„Î¿ ÎºÏÏ„Ï„Î±ÏÎ¿ Î¾ÎµÎ½Î¹ÏƒÏ„Î® Î±Ï€ÎµÎ»ÎµÏ…Î¸ÎµÏÏÎ½Î¿Î½Ï„Î±Ï‚ Î½Î­Î¿Ï…Ï‚ Î¹Î¿ÏÏ‚</td></tr><tr><th class="align-baseline">ÎœÎ­Î³ÎµÎ¸Î¿Ï‚</th><td>Î¤Î± Î²Î±ÎºÏ„Î®ÏÎ¹Î± ÎµÎ¯Î½Î±Î¹ Ï€Î¿Î»Ï Î¼ÎµÎ³Î±Î»ÏÏ„ÎµÏÎ± ÎºÎ±Î¹ ÎºÏ…Î¼Î±Î¯Î½Î¿Î½Ï„Î±Î¹ Î±Ï€ÏŒ 800 nm Î­Ï‰Ï‚ 1000 nm. Î¤Î± Î²Î±ÎºÏ„Î®ÏÎ¹Î± Î¼Ï€Î¿ÏÎ¿ÏÎ½ Î½Î± ÎµÎ½Ï„Î¿Ï€Î¹ÏƒÏ„Î¿ÏÎ½ Î¼Îµ Ï„Î¿ Ï†Ï‰Ï‚ ÎµÎ½ÏŒÏ‚ Î¼Î¹ÎºÏÎ¿ÏƒÎºÎ¿Ï€Î¯Î¿Ï….</td><td> Î¤Î¿ Î¼Î­Î³ÎµÎ¸Î¿Ï‚ Ï„Ï‰Î½ Î¹ÏÎ½ ÎµÎ¯Î½Î±Î¹ Î±Ï€ÏŒ 20 nm Î­Ï‰Ï‚ 400 nm. ÎŸÎ¹ Î¹Î¿Î¯ ÎµÎ¯Î½Î±Î¹ Î¿ÏÎ±Ï„Î¿Î¯ Î¼ÏŒÎ½Î¿ Î¼Îµ Î·Î»ÎµÎºÏ„ÏÎ¿Î½Î¹ÎºÎ¬ Î¼Î¹ÎºÏÎ¿ÏƒÎºÏŒÏ€Î¹Î±.</td></tr><tr><th class="align-baseline">Î Î»ÎµÎ¿Î½Î­ÎºÏ„Î·Î¼Î±</th><td>ÎŸÏÎ¹ÏƒÎ¼Î­Î½Î± Î²Î±ÎºÏ„Î®ÏÎ¹Î± ÎµÎ¯Î½Î±Î¹ Ï‰Ï†Î­Î»Î¹Î¼Î± (Ï€.Ï‡. Î¿ÏÎ¹ÏƒÎ¼Î­Î½Î± Î²Î±ÎºÏ„Î®ÏÎ¹Î± ÎµÎ¯Î½Î±Î¹ Ï‡ÏÎ®ÏƒÎ¹Î¼Î± ÏƒÏ„Î¿ Î­Î½Ï„ÎµÏÎ¿).</td><td>ÎŸÎ¹ Î¹Î¿Î¯ Î´ÎµÎ½ ÎµÎ¯Î½Î±Î¹ Ï‰Ï†Î­Î»Î¹Î¼Î¿Î¹. ÎŸÎ¹ Î¹Î¿Î¯ Î¼Ï€Î¿ÏÎµÎ¯ Î½Î± ÎµÎ¯Î½Î±Î¹ Ï‡ÏÎ®ÏƒÎ¹Î¼Î¿Î¹ ÏƒÏ„Î· Î³ÎµÎ½ÎµÏ„Î¹ÎºÎ® Î¼Î·Ï‡Î±Î½Î¹ÎºÎ®.</td></tr><tr><th class="align-baseline">Î›Î¿Î¯Î¼Ï‰Î¾Î·</th><td>Î— Î²Î±ÎºÏ„Î·ÏÎ¹Î±ÎºÎ® Î»Î¿Î¯Î¼Ï‰Î¾Î· Ï€ÎµÏÎ¹Î¿ÏÎ¯Î¶ÎµÏ„Î±Î¹ ÏƒÏ…Î½Î®Î¸Ï‰Ï‚ ÏƒÎµ Î­Î½Î± Î¼Î­ÏÎ¿Ï‚ Ï„Î¿Ï… ÏƒÏÎ¼Î±Ï„Î¿Ï‚, ÎºÎ±Î¹ Ï€ÎµÏÎ¹Î³ÏÎ¬Ï†ÎµÏ„Î±Î¹ Ï‰Ï‚ Ï„Î¿Ï€Î¹ÎºÎ® Î¼ÏŒÎ»Ï…Î½ÏƒÎ·. ÎŸÎ¹ Î»Î¿Î¹Î¼ÏÎ¾ÎµÎ¹Ï‚ Î¼Ï€Î¿ÏÎµÎ¯ Î½Î± Ï€ÏÎ¿ÎºÎ»Î·Î¸Î¿ÏÎ½ Î±Ï€ÏŒ Î²Î±ÎºÏ„Î®ÏÎ¹Î± Î® Î±Ï€ÏŒ Ï„Î¿Î¾Î¯Î½ÎµÏ‚ (ÎµÎ½Î´Î¿Ï„Î¿Î¾Î¯Î½ÎµÏ‚) Ï€Î¿Ï… Ï€Î±ÏÎ¬Î³Î¿Î½Ï„Î±Î¹.</td><td>ÎœÎ¹Î± Î¹Î¿Î³ÎµÎ½Î®Ï‚ Î»Î¿Î¯Î¼Ï‰Î¾Î· ÎµÎ¯Î½Î±Î¹ ÏƒÏ…ÏƒÏ„Î·Î¼Î¹ÎºÎ®. ÎŸÎ¹ Î¹Î¿Î¯ Î¼Î¿Î»ÏÎ½Î¿Ï…Î½ Î­Î½Î± ÎºÏÏ„Ï„Î±ÏÎ¿ Î¾ÎµÎ½Î¹ÏƒÏ„Î® ÎºÎ±Î¹ Ï€Î¿Î»Î»Î±Ï€Î»Î±ÏƒÎ¹Î¬Î¶Î¿Î½Ï„Î±Î¹ ÎºÎ±Ï„Î¬ Ï‡Î¹Î»Î¹Î¬Î´ÎµÏ‚, Î±Ï†Î®Î½Î¿Î½Ï„Î±Ï‚ Ï„Î¿ ÎºÏÏ„Ï„Î±ÏÎ¿ Î¾ÎµÎ½Î¹ÏƒÏ„Î® ÎºÎ±Î¹ Î¼Î¿Î»ÏÎ½Î¿Î½Ï„Î±Ï‚ Î¬Î»Î»Î± ÎºÏÏ„Ï„Î±ÏÎ± Ï„Î¿Ï… ÏƒÏÎ¼Î±Ï„Î¿Ï‚.</td></tr><tr><th class="align-baseline">Î‘ÏƒÎ¸Î­Î½ÎµÎ¹Î±</th><td>ÎŸÎ¹ Î²Î±ÎºÏ„Î·ÏÎ¹Î±ÎºÎ­Ï‚ Î±ÏƒÎ¸Î­Î½ÎµÎ¹ÎµÏ‚ Ï€ÎµÏÎ¹Î»Î±Î¼Î²Î¬Î½Î¿Ï…Î½ Ï€Î½ÎµÏ…Î¼Î¿Î½Î¯Î±, Ï†Ï…Î¼Î±Ï„Î¯Ï‰ÏƒÎ·, Ï„Î­Ï„Î±Î½Î¿ ÎºÎ±Î¹ Ï„ÏÎ¿Ï†Î¹ÎºÎ® Î´Î·Î»Î·Ï„Î·ÏÎ¯Î±ÏƒÎ·.</td><td>ÎŸÎ¹ ÏƒÏ…ÏƒÏ„Î·Î¼Î±Ï„Î¹ÎºÎ­Ï‚ Î±ÏƒÎ¸Î­Î½ÎµÎ¹ÎµÏ‚ Ï€Î¿Ï… Ï€ÏÎ¿ÎºÎ±Î»Î¿ÏÎ½Ï„Î±Î¹ Î±Ï€ÏŒ Î¹Î¿Î³ÎµÎ½Î® Î»Î¿Î¯Î¼Ï‰Î¾Î· Ï€ÎµÏÎ¹Î»Î±Î¼Î²Î¬Î½Î¿Ï…Î½ Ï„Î· Î³ÏÎ¯Ï€Î·, Ï„Î·Î½ Î¹Î»Î±ÏÎ¬, Ï„Î·Î½ Ï€Î¿Î»Î¹Î¿Î¼Ï…ÎµÎ»Î¯Ï„Î¹Î´Î±, Ï„Î¿ AIDS ÎºÎ±Î¹ Ï„Î¿ COVID-19.</td></tr><tr><th class="align-baseline">Î˜ÎµÏÎ±Ï€ÎµÎ¯Î±</th><td>Î¤Î± Î±Î½Ï„Î¹Î²Î¹Î¿Ï„Î¹ÎºÎ¬ ÎºÎ±Î¹ Ï„Î± ÎµÎ¼Î²ÏŒÎ»Î¹Î± Ï€ÏÎ¿Î»Î±Î¼Î²Î¬Î½Î¿Ï…Î½ Ï„Î·Î½ Î±ÏƒÎ¸Î­Î½ÎµÎ¹Î±.</td><td>Î¤Î± ÎµÎ¼Î²ÏŒÎ»Î¹Î± ÎµÎ¼Ï€Î¿Î´Î¯Î¶Î¿Ï…Î½ Ï„Î·Î½ ÎµÎ¾Î¬Ï€Î»Ï‰ÏƒÎ· ÎºÎ±Î¹ Ï„Î± Î±Î½Ï„Î¹Î¹Î¹ÎºÎ¬ Ï†Î¬ÏÎ¼Î±ÎºÎ± Î²Î¿Î·Î¸Î¿ÏÎ½ ÏƒÏ„Î·Î½ ÎµÏ€Î¹Î²ÏÎ¬Î´Ï…Î½ÏƒÎ· Ï„Î·Ï‚ Î±Î½Î±Ï€Î±ÏÎ±Î³Ï‰Î³Î®Ï‚, Î±Î»Î»Î¬ Î´ÎµÎ½ Î¼Ï€Î¿ÏÎ¿ÏÎ½ Î½Î± Ï„Î·Î½ ÏƒÏ„Î±Î¼Î±Ï„Î®ÏƒÎ¿Ï…Î½ ÎµÎ½Ï„ÎµÎ»ÏÏ‚.</td></tr></tbody></table>',1),Ce=e("b",null,"Î£Î·Î¼ÎµÎ¯Ï‰ÏƒÎ·! Î¤Î± Î±Î½Ï„Î¹Î²Î¹Î¿Ï„Î¹ÎºÎ¬",-1),Fe=e("b",null,"Î±Î½Ï„Î¹Î¹Î¹ÎºÎ¬ Ï†Î¬ÏÎ¼Î±ÎºÎ±",-1),Ne=e("b",null,"Î±Î½Î¿ÏƒÎ¿Ï€Î¿Î¹Î·Ï„Î¹ÎºÏŒ ÏƒÏÏƒÏ„Î·Î¼Î±",-1),$e=i('<section class="e-card"><h4 class="mt-4">Î‘Î½Î±Ï†Î¿ÏÎ­Ï‚ / Î Î·Î³Î­Ï‚ Î Î»Î·ÏÎ¿Ï†ÏŒÏÎ·ÏƒÎ·Ï‚</h4><ul class="text-sm break-all"><li><a href="https://courses.lumenlearning.com/suny-biology2xmaster/chapter/prevention-and-treatment-of-viral-infections/" rel="noreferrer noopener" target="_blank">https://courses.lumenlearning.com/suny-biology2xmaster/chapter/prevention-and-treatment-of-viral-infections/</a></li><li><a href="https://bodell.mtchs.org/OnlineBio/BIOCD/text/chapter16" rel="noreferrer noopener" target="_blank">https://bodell.mtchs.org/OnlineBio/BIOCD/text/chapter16</a></li><li><a href="http://www.hcrowder.com/disease-reading.html" rel="noreferrer noopener" target="_blank">http://www.hcrowder.com/disease-reading.html</a></li></ul></section>',1),Pe=i('<hr class="mt-10 mb-40"><section id="s2"><h2 id="s2t">2. Î“Î¹Î±Ï„Î¯ Ï„Î± Î±Î½Ï„Î¹Î²Î¹Î¿Ï„Î¹ÎºÎ¬ Î´ÎµÎ½ ÏƒÎºÎ¿Ï„ÏÎ½Î¿Ï…Î½ Ï„Î¿Ï…Ï‚ Î¹Î¿ÏÏ‚;</h2><p> Î¤Î± Î±Î½Ï„Î¹Î²Î¹Î¿Ï„Î¹ÎºÎ¬ Î´ÎµÎ½ Î¼Ï€Î¿ÏÎ¿ÏÎ½ Î½Î± ÏƒÎºÎ¿Ï„ÏÏƒÎ¿Ï…Î½ Ï„Î¿Ï…Ï‚ Î¹Î¿ÏÏ‚ ÎµÏ€ÎµÎ¹Î´Î® Î¿Î¹ Î¹Î¿Î¯ Î­Ï‡Î¿Ï…Î½ Î´Î¹Î±Ï†Î¿ÏÎµÏ„Î¹ÎºÎ­Ï‚ Î´Î¿Î¼Î® ÎºÎ±Î¹ Ï€Î¿Î»Î»Î±Ï€Î»Î±ÏƒÎ¹Î¬Î¶Î¿Î½Ï„Î±Î¹ Î´Î¹Î±Ï†Î¿ÏÎµÏ„Î¹ÎºÎ¬ Î±Ï€ÏŒ Ï„Î± Î²Î±ÎºÏ„Î®ÏÎ¹Î±. Î¤Î± Î±Î½Ï„Î¹Î²Î¹Î¿Ï„Î¹ÎºÎ¬ ÏƒÏ„Î¿Ï‡ÎµÏÎ¿Ï…Î½ Ï„Î¿Î½ Î¼Î·Ï‡Î±Î½Î¹ÏƒÎ¼ÏŒ Î±Î½Î¬Ï€Ï„Ï…Î¾Î·Ï‚ Ï„Ï‰Î½ Î²Î±ÎºÏ„Î·ÏÎ¯Ï‰Î½ (ÏŒÏ‡Î¹ Ï„Ï‰Î½ Î¹ÏÎ½) Î³Î¹Î± Î½Î± ÏƒÎºÎ¿Ï„ÏÏƒÎ¿Ï…Î½ Î® Î½Î± ÎºÎ±Ï„Î±ÏƒÏ„ÎµÎ¯Î»Î¿Ï…Î½ Ï„Î± ÏƒÏ…Î³ÎºÎµÎºÏÎ¹Î¼Î­Î½Î± Î²Î±ÎºÏ„Î®ÏÎ¹Î±. Î•Ï€Î¹Ï€Î»Î­Î¿Î½, Î· Ï…Ï€ÎµÏÎ²Î¿Î»Î¹ÎºÎ® Ï‡ÏÎ®ÏƒÎ· ÎºÎ±Î¹ Î· Î±ÎºÎ±Ï„Î¬Î»Î»Î·Î»Î· ÏƒÏ…Î½Ï„Î±Î³Î¿Î³ÏÎ¬Ï†Î·ÏƒÎ· Î±Î½Ï„Î¹Î²Î¹Î¿Ï„Î¹ÎºÏÎ½ Ï€Î±Î³ÎºÎ¿ÏƒÎ¼Î¯Ï‰Ï‚ Î¿Î´Î·Î³Î¿ÏÎ½ ÏƒÏ„Î¿ Ï€Î±Î³ÎºÏŒÏƒÎ¼Î¹Î¿ Ï…Î³ÎµÎ¹Î¿Î½Î¿Î¼Î¹ÎºÏŒ Î¶Î®Ï„Î·Î¼Î± Ï„Î·Ï‚ Î±Î½Î¸ÎµÎºÏ„Î¹ÎºÏŒÏ„Î·Ï„Î±Ï‚ ÏƒÏ„Î± Î±Î½Ï„Î¹Î²Î¹Î¿Ï„Î¹ÎºÎ¬. Î”ÎµÎ¯Ï„Îµ ÏƒÏ„Î¿Î½ Î Î¯Î½Î±ÎºÎ± 2 ÏƒÎµ Ï€Î¿Î¹ÎµÏ‚ ÏƒÏ…Î½Î¸Î®ÎºÎµÏ‚ Ï„Î± Î±Î½Ï„Î¹Î²Î¹Î¿Ï„Î¹ÎºÎ¬ Î¼Ï€Î¿ÏÎµÎ¯ Î½Î± ÎµÎ¯Î½Î±Î¹ Ï‡ÏÎ®ÏƒÎ¹Î¼Î± (Î£Î·Î¼ÎµÎ¯Ï‰ÏƒÎ·! Î— Î±Ï€ÏŒÏ†Î±ÏƒÎ· Î³Î¹Î± Ï„Î· Ï‡ÏÎ®ÏƒÎ· Ï„Î¿Ï…Ï‚ Î¸Î± Î»Î·Ï†Î¸ÎµÎ¯ Î±Ï€ÏŒ Ï„Î¿Î½ Î³Î¹Î±Ï„ÏÏŒ ÏƒÎ±Ï‚). </p><table class="leading-tight e-card"><caption class="text-left pb-4"><b>Î Î¯Î½Î±ÎºÎ±Ï‚ 2.</b> Î‘Î½Î¬Î³ÎºÎ· Î³Î¹Î± Î±Î½Ï„Î¹Î²Î¹Î¿Ï„Î¹ÎºÎ¬ Î±Ï€ÏŒ ÎºÎ¿Î¹Î½Î­Ï‚ Î»Î¿Î¹Î¼ÏÎ¾ÎµÎ¹Ï‚ Ï„Î¿Ï… Î±Î½Î±Ï€Î½ÎµÏ…ÏƒÏ„Î¹ÎºÎ¿Ï </caption><thead class="border text-center"><tr><th rowspan="2" class="border p-1">Î£Ï…Î½Î®Î¸ÎµÎ¹Ï‚ Î»Î¿Î¹Î¼ÏÎ¾ÎµÎ¹Ï‚ Ï„Î¿Ï… Î±Î½Î±Ï€Î½ÎµÏ…ÏƒÏ„Î¹ÎºÎ¿Ï</th><th colspan="3" class="border p-1">Î£Ï…Î½Î®Î¸Î·Ï‚ Î‘Î¹Ï„Î¯Î±</th><th rowspan="2" class="border p-1">Î§ÏÎµÎ¹Î¬Î¶ÎµÏ„Î±Î¹ Î‘Î½Ï„Î¹Î²Î¹Î¿Ï„Î¹ÎºÏŒ;</th></tr><tr><th class="border p-1">Î™ÏŒÏ‚</th><th class="border p-1">Î™ÏŒÏ‚ Î® Î’Î±ÎºÏ„Î®ÏÎ¹Î¿</th><th class="border p-1">Î’Î±ÎºÏ„Î®ÏÎ¹Î¿</th></tr></thead><tbody class="text-center"><tr><td class="border p-1">ÎšÎ¿Î¹Î½ÏŒ ÎºÏÏ…Î¿Î»ÏŒÎ³Î·Î¼Î± / ÎºÎ±Ï„Î±ÏÏÎ¿Î®</td><td class="border p-1">âˆš</td><td class="border p-1"></td><td class="border p-1"></td><td class="border p-1">ÎŒÏ‡Î¹</td></tr><tr><td class="border p-1">Î Î¿Î½ÏŒÎ»Î±Î¹Î¼Î¿Ï‚</td><td class="border p-1">âˆš</td><td class="border p-1"></td><td class="border p-1"></td><td class="border p-1">ÎŒÏ‡Î¹</td></tr><tr><td class="border p-1">COVID-19</td><td class="border p-1">âˆš</td><td class="border p-1"></td><td class="border p-1"></td><td class="border p-1">ÎŒÏ‡Î¹</td></tr><tr><td class="border p-1">Î“ÏÎ¯Ï€Î·</td><td class="border p-1">âˆš</td><td class="border p-1"></td><td class="border p-1"></td><td class="border p-1">ÎŒÏ‡Î¹</td></tr><tr><td class="border p-1">Î’ÏÎ¿Î³Ï‡Î¯Ï„Î¹Î´Î± / ÎºÏÏÏ‰Î¼Î± ÏƒÏ„Î¿ ÏƒÏ„Î®Î¸Î¿Ï‚<br><span class="text-sm italic">(ÏƒÎµ ÎºÎ±Ï„Î¬ Ï„Î± Î¬Î»Î»Î± Ï…Î³Î¹Î® Ï€Î±Î¹Î´Î¹Î¬ ÎºÎ±Î¹ ÎµÎ½Î®Î»Î¹ÎºÎµÏ‚)</span> *</td><td class="border p-1"></td><td class="border p-1">âˆš</td><td class="border p-1"></td><td class="border p-1">*ÎŒÏ‡Î¹</td></tr><tr><td class="border p-1">Î›Î¿Î¯Î¼Ï‰Î¾Î· Î¼Î­ÏƒÎ¿Ï… Î±Ï…Ï„Î¹Î¿Ï</td><td class="border p-1"></td><td class="border p-1">âˆš</td><td class="border p-1"></td><td class="border p-1">Maybe</td></tr><tr><td class="border p-1">Î›Î¿Î¯Î¼Ï‰Î¾Î· ÎºÏŒÎ»Ï€Î¿Ï…</td><td class="border p-1"></td><td class="border p-1">âˆš</td><td class="border p-1"></td><td class="border p-1">Maybe</td></tr><tr><td class="border p-1">Î£Ï„ÏÎµÏ€Ï„ÏŒÎºÎ¿ÎºÎºÎ¿Ï‚</td><td class="border p-1"></td><td class="border p-1"></td><td class="border p-1">âˆš</td><td class="border p-1">ÎÎ±Î¹</td></tr><tr><td class="border p-1">ÎšÎ¿ÎºÎºÏÏ„Î·Ï‚</td><td class="border p-1"></td><td class="border p-1"></td><td class="border p-1">âˆš</td><td class="border p-1">ÎÎ±Î¹</td></tr></tbody><tfoot class="border text-center"><tr><td colspan="5" class="py-0 px-3"><p class="text-sm italic">* ÎœÎµÎ»Î­Ï„ÎµÏ‚ Î´ÎµÎ¯Ï‡Î½Î¿Ï…Î½ ÏŒÏ„Î¹ ÏƒÎµ Ï…Î³Î¹Î® Ï€Î±Î¹Î´Î¹Î¬ ÎºÎ±Î¹ ÎµÎ½Î®Î»Î¹ÎºÎµÏ‚, Ï„Î± Î±Î½Ï„Î¹Î²Î¹Î¿Ï„Î¹ÎºÎ¬ Î³Î¹Î± Ï„Î· Î²ÏÎ¿Î³Ï‡Î¯Ï„Î¹Î´Î± Î´ÎµÎ½ Î¸Î± Î²Î¿Î·Î¸Î®ÏƒÎ¿Ï…Î½ Ï„Î¿Ï…Ï‚ Î±ÏƒÎ¸ÎµÎ½ÎµÎ¯Ï‚ Î½Î± Î±Î¹ÏƒÎ¸Î±Î½Î¸Î¿ÏÎ½ ÎºÎ±Î»ÏÏ„ÎµÏÎ±.</p><p class="text-xs text-slate-400">Î Î·Î³Î®: https://www.cdc.gov/antibiotic-use/images/VirusOrBacteria-Original-1200by675.jpg</p></td></tr></tfoot></table><section class="e-card"><h4 class="mt-0">Î‘Î½Î±Ï†Î¿ÏÎ­Ï‚ / Î Î·Î³Î­Ï‚ Î Î»Î·ÏÎ¿Ï†ÏŒÏÎ·ÏƒÎ·Ï‚</h4><ul class="text-sm break-all"><li><a href="https://www.drugs.com/article/antibiotics-and-viruses.html" target="_blank" rel="noreferrer noopener">https://www.drugs.com/article/antibiotics-and-viruses.html</a></li><li><a href="https://www.virology.ws/2009/10/19/ten-cool-facts-about-viruses/" target="_blank" rel="noreferrer noopener">https://www.virology.ws/2009/10/19/ten-cool-facts-about-viruses/</a></li></ul></section></section><hr class="mt-10 mb-40">',3),Be={id:"s3"},Te=e("h2",{id:"s3t"},"3. Î ÏÏ‚ Î»ÎµÎ¹Ï„Î¿Ï…ÏÎ³Î¿ÏÎ½ Ï„Î± ÎµÎ¼Î²ÏŒÎ»Î¹Î±",-1),Ee=e("h3",null," Î— Ï†Ï…ÏƒÎ¹ÎºÎ® Î±Î½Ï„Î¯Î´ÏÎ±ÏƒÎ· Ï„Î¿Ï… ÏƒÏÎ¼Î±Ï„Î¿Ï‚ ",-1),Re=e("p",null,[a(" ÎˆÎ½Î± "),e("span",{class:"e-term font-Heading"},"Ï€Î±Î¸Î¿Î³ÏŒÎ½Î¿"),a(" Î¼Ï€Î¿ÏÎµÎ¯ Î½Î± ÎµÎ¯Î½Î±Î¹ Î²Î±ÎºÏ„Î®ÏÎ¹Î¿, Î¹ÏŒÏ‚, Ï€Î±ÏÎ¬ÏƒÎ¹Ï„Î¿ Î® Î¼ÏÎºÎ·Ï„Î±Ï‚ ÎºÎ±Î¹ Î¼Ï€Î¿ÏÎµÎ¯ Î½Î± Ï€ÏÎ¿ÎºÎ±Î»Î­ÏƒÎµÎ¹ Î±ÏƒÎ¸Î­Î½ÎµÎ¹Î± ÏƒÏ„Î¿ ÏƒÏÎ¼Î±. ÎšÎ¬Î¸Îµ Ï€Î±Î¸Î¿Î³ÏŒÎ½Î¿ Î±Ï€Î¿Ï„ÎµÎ»ÎµÎ¯Ï„Î±Î¹ Î±Ï€ÏŒ Ï€Î¿Î»Î»Î¬ Î¼Î¹ÎºÏÏŒÏ„ÎµÏÎ± Ï„Î¼Î®Î¼Î±Ï„Î±, ÏƒÏ…Î½Î®Î¸Ï‰Ï‚ Î¼Î¿Î½Î±Î´Î¹ÎºÎ¬ Î³Î¹Î± Ï„Î¿ ÏƒÏ…Î³ÎºÎµÎºÏÎ¹Î¼Î­Î½Î¿ Ï€Î±Î¸Î¿Î³ÏŒÎ½Î¿ ÎºÎ±Î¹ Ï„Î·Î½ Î±ÏƒÎ¸Î­Î½ÎµÎ¹Î± Ï€Î¿Ï… Ï€ÏÎ¿ÎºÎ±Î»ÎµÎ¯. Î¤Î¿ Ï„Î¼Î®Î¼Î± ÎµÎ½ÏŒÏ‚ Ï€Î±Î¸Î¿Î³ÏŒÎ½Î¿Ï… Ï€Î¿Ï… Ï€ÏÎ¿ÎºÎ±Î»ÎµÎ¯ Ï„Î¿ ÏƒÏ‡Î·Î¼Î±Ï„Î¹ÏƒÎ¼ÏŒ Î±Î½Ï„Î¹ÏƒÏ‰Î¼Î¬Ï„Ï‰Î½ Î¿Î½Î¿Î¼Î¬Î¶ÎµÏ„Î±Î¹ Î±Î½Ï„Î¹Î³ÏŒÎ½Î¿. Î¤Î± Î±Î½Ï„Î¹ÏƒÏÎ¼Î±Ï„Î± Ï€Î¿Ï… Ï€Î±ÏÎ¬Î³Î¿Î½Ï„Î±Î¹ Ï‰Ï‚ Î±Ï€ÏŒÎºÏÎ¹ÏƒÎ· ÏƒÏ„Î¿ Î±Î½Ï„Î¹Î³ÏŒÎ½Î¿ Ï„Î¿Ï… Ï€Î±Î¸Î¿Î³ÏŒÎ½Î¿Ï… ÎµÎ¯Î½Î±Î¹ Î±Ï€Î±ÏÎ±Î¯Ï„Î·Ï„Î± Î³Î¹Î± Ï„Î¿ Î±Î½Î¿ÏƒÎ¿Ï€Î¿Î¹Î·Ï„Î¹ÎºÏŒ ÏƒÏÏƒÏ„Î·Î¼Î±. ÎœÏ€Î¿ÏÎµÎ¯Ï„Îµ Î½Î± Î¸ÎµÏ‰ÏÎ®ÏƒÎµÏ„Îµ Ï„Î± Î±Î½Ï„Î¹ÏƒÏÎ¼Î±Ï„Î± Ï‰Ï‚ Ï„Î¿Ï…Ï‚ ÏƒÏ„ÏÎ±Ï„Î¹ÏÏ„ÎµÏ‚ ÏƒÏ„Î¿ Î±Î¼Ï…Î½Ï„Î¹ÎºÏŒ ÏƒÏÏƒÏ„Î·Î¼Î± Ï„Î¿Ï… ÏƒÏÎ¼Î±Ï„ÏŒÏ‚ ÏƒÎ±Ï‚. ÎˆÏ‡Î¿Ï…Î¼Îµ Ï‡Î¹Î»Î¹Î¬Î´ÎµÏ‚ Î´Î¹Î±Ï†Î¿ÏÎµÏ„Î¹ÎºÎ¬ Î±Î½Ï„Î¹ÏƒÏÎ¼Î±Ï„Î± ÏƒÏ„Î¿ ÏƒÏÎ¼Î± Î¼Î±Ï‚ ÎºÎ±Î¹ Ï„Î¿ ÎºÎ±Î¸Î­Î½Î± ÎµÎ¯Î½Î±Î¹ ÎµÎºÏ€Î±Î¹Î´ÎµÏ…Î¼Î­Î½Î¿ Î½Î± Î±Î½Î±Î³Î½Ï‰ÏÎ¯Î¶ÎµÎ¹ Î­Î½Î± ÏƒÏ…Î³ÎºÎµÎºÏÎ¹Î¼Î­Î½Î¿ Î±Î½Ï„Î¹Î³ÏŒÎ½Î¿. ÎŒÏ„Î±Î½ Ï„Î¿ Î±Î½Î¸ÏÏÏ€Î¹Î½Î¿ ÏƒÏÎ¼Î± ÎµÎºÏ„Î¯Î¸ÎµÏ„Î±Î¹ ÏƒÎµ Î­Î½Î± Î±Î½Ï„Î¹Î³ÏŒÎ½Î¿ Î³Î¹Î± Ï€ÏÏÏ„Î· Ï†Î¿ÏÎ¬, Ï‡ÏÎµÎ¹Î¬Î¶ÎµÏ„Î±Î¹ Ï‡ÏÏŒÎ½Î¿Ï‚ Î³Î¹Î± Î½Î± Î±Î½Ï„Î±Ï€Î¿ÎºÏÎ¹Î¸ÎµÎ¯ Ï„Î¿ Î±Î½Î¿ÏƒÎ¿Ï€Î¿Î¹Î·Ï„Î¹ÎºÏŒ ÏƒÏÏƒÏ„Î·Î¼Î± ÎºÎ±Î¹ Î½Î± Ï€Î±ÏÎ¬Î³ÎµÎ¹ Î±Î½Ï„Î¹ÏƒÏÎ¼Î±Ï„Î± ÎµÎ¹Î´Î¹ÎºÎ¬ Î³Î¹Î± Î±Ï…Ï„ÏŒ Ï„Î¿ Î±Î½Ï„Î¹Î³ÏŒÎ½Î¿ (Î£Ï‡Î®Î¼Î± 2). ")],-1),He=e("p",null," Î¤Î± Î±Î½Ï„Î¹ÏƒÏÎ¼Î±Ï„Î± ÏƒÎµ Î­Î½Î± Ï€Î±Î¸Î¿Î³ÏŒÎ½Î¿ Î³ÎµÎ½Î¹ÎºÎ¬ Î´ÎµÎ½ Ï€ÏÎ¿ÏƒÏ„Î±Ï„ÎµÏÎ¿Ï…Î½ Î±Ï€ÏŒ Î­Î½Î± Î¬Î»Î»Î¿ Ï€Î±Î¸Î¿Î³ÏŒÎ½Î¿, ÎµÎºÏ„ÏŒÏ‚ ÎµÎ¬Î½ Î´ÏÎ¿ Ï€Î±Î¸Î¿Î³ÏŒÎ½Î± ÎµÎ¯Î½Î±Î¹ Ï€Î¿Î»Ï Ï€Î±ÏÏŒÎ¼Î¿Î¹Î± Î¼ÎµÏ„Î±Î¾Ï Ï„Î¿Ï…Ï‚. ÎœÏŒÎ»Î¹Ï‚ Ï€Î±ÏÎ±Ï‡Î¸Î¿ÏÎ½ Ï„Î± ÎµÎ¹Î´Î¹ÎºÎ¬ Î±Î½Ï„Î¹ÏƒÏÎ¼Î±Ï„Î± Î³Î¹Î± ÎºÎ¬Ï€Î¿Î¹Î¿ ÏƒÏ…Î³ÎºÎµÎºÏÎ¹Î¼Î­Î½Î¿ Î±Î½Ï„Î¹Î³ÏŒÎ½Î¿ ÏƒÏ…Î½ÎµÏÎ³Î¬Î¶Î¿Î½Ï„Î±Î¹ Î¼Îµ Ï„Î¿ Ï…Ï€ÏŒÎ»Î¿Î¹Ï€Î¿ Î±Î½Î¿ÏƒÎ¿Ï€Î¿Î¹Î·Ï„Î¹ÎºÏŒ ÏƒÏÏƒÏ„Î·Î¼Î± Î³Î¹Î± Î½Î± ÎºÎ±Ï„Î±ÏƒÏ„ÏÎ­ÏˆÎ¿Ï…Î½ Ï„Î¿ Ï€Î±Î¸Î¿Î³ÏŒÎ½Î¿ ÎºÎ±Î¹ Î½Î± ÏƒÏ„Î±Î¼Î±Ï„Î®ÏƒÎ¿Ï…Î½ Ï„Î· Î½ÏŒÏƒÎ¿. ÎšÎ±Î¸ÏÏ‚ Ï„Î¿ ÏƒÏÎ¼Î± ÏƒÏ„Î·Î½ Î±ÏÏ‡Î¹ÎºÎ® Ï„Î¿Ï… Î±Ï€ÏŒÎºÏÎ¹ÏƒÎ· Ï€Î±ÏÎ¬Î³ÎµÎ¹ Î±Î½Ï„Î¹ÏƒÏÎ¼Î±Ï„Î± ÏƒÎµ Î­Î½Î± Î±Î½Ï„Î¹Î³ÏŒÎ½Î¿, Î´Î·Î¼Î¹Î¿Ï…ÏÎ³ÎµÎ¯ ÎµÏ€Î¯ÏƒÎ·Ï‚ ÎºÏÏ„Ï„Î±ÏÎ± Î¼Î½Î®Î¼Î·Ï‚ Ï„Î± Î¿Ï€Î¿Î¯Î± Ï€Î±ÏÎ±Î¼Î­Î½Î¿Ï…Î½ Î¶Ï‰Î½Ï„Î±Î½Î¬ Î±ÎºÏŒÎ¼Î· ÎºÎ±Î¹ ÏŒÏ„Î±Î½ Ï„Î± Î±Î½Ï„Î¹ÏƒÏÎ¼Î±Ï„Î± Î½Î¹ÎºÎ®ÏƒÎ¿Ï…Î½ Ï„Î¿ Ï€Î±Î¸Î¿Î³ÏŒÎ½Î¿ ÎºÎ±Î¹ Ï„Î± Î¿Ï€Î¿Î¯Î± Î¼Ï€Î¿ÏÎ¿ÏÎ½ Î½Î± Ï€Î±ÏÎ¬Î¾Î¿Ï…Î½ Î±Î½Ï„Î¹ÏƒÏÎ¼Î±Ï„Î± Ï„Î·Î½ ÎµÏ€ÏŒÎ¼ÎµÎ½Î· Ï†Î¿ÏÎ¬ Ï€Î¿Ï… Î¸Î± Ï„Î± Ï‡ÏÎµÎ¹Î±ÏƒÏ„ÎµÎ¯ Î¿ Î¿ÏÎ³Î±Î½Î¹ÏƒÎ¼ÏŒÏ‚. Î‘Ï‚ Ï…Ï€Î¿Î¸Î­ÏƒÎ¿Ï…Î¼Îµ ÏŒÏ„Î¹ Ï„Î¿ ÏƒÏÎ¼Î± ÎµÎºÏ„Î¯Î¸ÎµÏ„Î±Î¹ ÏƒÏ„Î¿ Î¯Î´Î¹Î¿ Ï€Î±Î¸Î¿Î³ÏŒÎ½Î¿ Ï€Î¬Î½Ï‰ Î±Ï€ÏŒ Î¼Î¯Î± Ï†Î¿ÏÎ¬, ÏƒÎµ Î±Ï…Ï„Î® Ï„Î·Î½ Ï€ÎµÏÎ¯Ï€Ï„Ï‰ÏƒÎ· Î· Î±Ï€ÏŒÎºÏÎ¹ÏƒÎ· Î±Î½Ï„Î¹ÏƒÏ‰Î¼Î¬Ï„Ï‰Î½ ÎµÎ¯Î½Î±Î¹ Ï€Î¿Î»Ï Ï€Î¹Î¿ Î³ÏÎ®Î³Î¿ÏÎ· ÎºÎ±Î¹ Ï€Î¹Î¿ Î±Ï€Î¿Ï„ÎµÎ»ÎµÏƒÎ¼Î±Ï„Î¹ÎºÎ® Î±Ï€ÏŒ Ï„Î·Î½ Ï€ÏÏÏ„Î· Ï†Î¿ÏÎ¬ ÎµÏ€ÎµÎ¹Î´Î® Ï„Î± ÎºÏÏ„Ï„Î±ÏÎ± Î¼Î½Î®Î¼Î·Ï‚ ÎµÎ¯Î½Î±Î¹ Î­Ï„Î¿Î¹Î¼Î± Î½Î± Ï€Î±ÏÎ¬Î¾Î¿Ï…Î½ Î±Î½Ï„Î¹ÏƒÏÎ¼Î±Ï„Î± ÎµÎ½Î±Î½Ï„Î¯Î¿Î½ Î±Ï…Ï„Î¿Ï Ï„Î¿Ï… Î±Î½Ï„Î¹Î³ÏŒÎ½Î¿Ï…. Î‘Ï…Ï„ÏŒ ÏƒÎ·Î¼Î±Î¯Î½ÎµÎ¹ ÏŒÏ„Î¹ ÎµÎ¬Î½ Ï„Î¿ Î¬Ï„Î¿Î¼Î¿ ÎµÎºÏ„ÎµÎ¸ÎµÎ¯ ÏƒÎµ Î­Î½Î± ÎµÏ€Î¹ÎºÎ¯Î½Î´Ï…Î½Î¿ Ï€Î±Î¸Î¿Î³ÏŒÎ½Î¿ ÏƒÏ„Î¿ Î¼Î­Î»Î»Î¿Î½, Ï„Î¿ Î±Î½Î¿ÏƒÎ¿Ï€Î¿Î¹Î·Ï„Î¹ÎºÏŒ Ï„Î¿Ï… ÏƒÏÏƒÏ„Î·Î¼Î± Î¸Î± ÎµÎ¯Î½Î±Î¹ ÏƒÎµ Î¸Î­ÏƒÎ· Î½Î± Î±Î½Ï„Î±Ï€Î¿ÎºÏÎ¹Î¸ÎµÎ¯ Î¬Î¼ÎµÏƒÎ±, Ï€ÏÎ¿ÏƒÏ„Î±Ï„ÎµÏÎ¿Î½Ï„Î±Ï‚ Ï„Î¿ Î±Ï€ÏŒ Ï„Î·Î½ Î±ÏƒÎ¸Î­Î½ÎµÎ¹Î±. ",-1),We=e("b",null,"Î£Ï‡Î®Î¼Î± 2.",-1),Ke=e("h3",null,"Î ÏÏ‚ Î²Î¿Î·Î¸Î¿ÏÎ½ Ï„Î± ÎµÎ¼Î²ÏŒÎ»Î¹Î±;",-1),Ye=e("p",null," Î¤Î± ÎµÎ¼Î²ÏŒÎ»Î¹Î± Î¼ÎµÎ¹ÏÎ½Î¿Ï…Î½ Ï„Î¿Î½ ÎºÎ¯Î½Î´Ï…Î½Î¿ ÎµÎ¼Ï†Î¬Î½Î¹ÏƒÎ·Ï‚ Î¼Î¹Î±Ï‚ Î±ÏƒÎ¸Î­Î½ÎµÎ¹Î±Ï‚ ÎºÎ±Î¸ÏÏ‚ ÏƒÏ…Î½ÎµÏÎ³Î¬Î¶Î¿Î½Ï„Î±Î¹ Î¼Îµ Ï„Î¹Ï‚ Ï†Ï…ÏƒÎ¹ÎºÎ­Ï‚ Î¬Î¼Ï…Î½ÎµÏ‚ Ï„Î¿Ï… ÏƒÏÎ¼Î±Ï„ÏŒÏ‚ Î³Î¹Î± Ï„Î·Î½ Î¿Î¹ÎºÎ¿Î´ÏŒÎ¼Î·ÏƒÎ· Ï€ÏÎ¿ÏƒÏ„Î±ÏƒÎ¯Î±Ï‚. ÎŒÏ„Î±Î½ ÎºÎ¬Î½Î¿Ï…Î¼Îµ Î­Î½Î± ÎµÎ¼Î²ÏŒÎ»Î¹Î¿, Ï„Î¿ Î±Î½Î¿ÏƒÎ¿Ï€Î¿Î¹Î·Ï„Î¹ÎºÏŒ Î¼Î±Ï‚ ÏƒÏÏƒÏ„Î·Î¼Î± Î±Î½Ï„Î±Ï€Î¿ÎºÏÎ¯Î½ÎµÏ„Î±Î¹ ÎºÎ±Î¸ÏÏ‚ Ï„Î± ÎµÎ¼Î²ÏŒÎ»Î¹Î± Ï€ÎµÏÎ¹Î­Ï‡Î¿Ï…Î½ ÎµÎ¾Î±ÏƒÎ¸ÎµÎ½Î·Î¼Î­Î½Î± Î® Î±Î½ÎµÎ½ÎµÏÎ³Î¬ Î¼Î­ÏÎ· ÎµÎ½ÏŒÏ‚ ÏƒÏ…Î³ÎºÎµÎºÏÎ¹Î¼Î­Î½Î¿Ï… Î¿ÏÎ³Î±Î½Î¹ÏƒÎ¼Î¿Ï (Î±Î½Ï„Î¹Î³ÏŒÎ½Î±) Ï€Î¿Ï… Ï€Ï…ÏÎ¿Î´Î¿Ï„Î¿ÏÎ½ Î¼Î¹Î± Î±Î½Î¿ÏƒÎ¿Î»Î¿Î³Î¹ÎºÎ® Î±Ï€ÏŒÎºÏÎ¹ÏƒÎ· ÎµÎ½Ï„ÏŒÏ‚ Ï„Î¿Ï… ÏƒÏÎ¼Î±Ï„Î¿Ï‚ Î¼Î±Ï‚ (Î£Ï‡Î®Î¼Î± 3). Î¤Î± Ï€Î¹Î¿ ÏƒÏÎ³Ï‡ÏÎ¿Î½Î± ÎµÎ¼Î²ÏŒÎ»Î¹Î± Î»ÎµÎ¹Ï„Î¿Ï…ÏÎ³Î¿ÏÎ½ Î¼Îµ Î²Î¬ÏƒÎ· ÎºÎ¬Ï€Î¿Î¹Î±Ï‚ Î¼Î¿ÏÏ†Î®Ï‚ Â«ÏƒÏ‡ÎµÎ´Î¯Î¿Ï…Â» Î³Î¹Î± Ï„Î·Î½ Ï€Î±ÏÎ±Î³Ï‰Î³Î® Î±Î½Ï„Î¹Î³ÏŒÎ½Ï‰Î½ ÎºÎ±Î¹ ÏŒÏ‡Î¹ Î¼Îµ Ï„Î¿ Î¯Î´Î¹Î¿ Ï„Î¿ Î±Î½Ï„Î¹Î³ÏŒÎ½Î¿. Î‘Î½ÎµÎ¾Î¬ÏÏ„Î·Ï„Î± Î±Ï€ÏŒ Ï„Î¿ Î±Î½ Ï„Î¿ ÎµÎ¼Î²ÏŒÎ»Î¹Î¿ Î±Ï€Î¿Ï„ÎµÎ»ÎµÎ¯Ï„Î±Î¹ Î±Ï€ÏŒ Ï„Î¿ Î¯Î´Î¹Î¿ Ï„Î¿ Î±Î½Ï„Î¹Î³ÏŒÎ½Î¿ Î® Î±Ï€ÏŒ Ï„Î¿ Â«ÏƒÏ‡Î­Î´Î¹Î¿Â» Î³Î¹Î± Ï„Î·Î½ Ï€Î±ÏÎ±Î³Ï‰Î³Î® Ï„Î¿Ï… Î±Î½Ï„Î¹Î³ÏŒÎ½Î¿Ï…, Î±Ï…Ï„Î® Î· ÎµÎ¾Î±ÏƒÎ¸ÎµÎ½Î·Î¼Î­Î½Î· ÎµÎºÎ´Î¿Ï‡Î® Î´ÎµÎ½ Î¸Î± Ï€ÏÎ¿ÎºÎ±Î»Î­ÏƒÎµÎ¹ Ï„Î·Î½ Î±ÏƒÎ¸Î­Î½ÎµÎ¹Î± ÏƒÏ„Î¿ Î¬Ï„Î¿Î¼Î¿ Ï€Î¿Ï… Î»Î±Î¼Î²Î¬Î½ÎµÎ¹ Ï„Î¿ ÎµÎ¼Î²ÏŒÎ»Î¹Î¿. Î‘Î½Ï„Î¹Î¸Î­Ï„Ï‰Ï‚, Î¸Î± Ï‰Î¸Î®ÏƒÎµÎ¹ Ï„Î¿ Î±Î½Î¿ÏƒÎ¿Ï€Î¿Î¹Î·Ï„Î¹ÎºÏŒ Ï„Î¿Ï… ÏƒÏÏƒÏ„Î·Î¼Î± Î½Î± Î±Î½Ï„Î±Ï€Î¿ÎºÏÎ¹Î¸ÎµÎ¯ Ï€ÎµÏÎ¯Ï€Î¿Ï… ÏŒÏ€Ï‰Ï‚ Î¸Î± ÎµÎ¯Ï‡Îµ Î±Î½Ï„Î¹Î´ÏÎ¬ÏƒÎµÎ¹ ÏƒÏ„Î·Î½ Ï€ÏÏÏ„Î· Ï„Î¿Ï… ÎµÏ€Î±Ï†Î® Î¼Îµ Ï„Î¿ Ï€ÏÎ±Î³Î¼Î±Ï„Î¹ÎºÏŒ Ï€Î±Î¸Î¿Î³ÏŒÎ½Î¿. ",-1),Ue=e("b",null,"Î£Ï‡Î®Î¼Î± 3.",-1),Je=i('<p> Î¤Î± ÎµÎ¼Î²ÏŒÎ»Î¹Î± Î»ÎµÎ¹Ï„Î¿Ï…ÏÎ³Î¿ÏÎ½ ÎµÎºÎ¸Î­Ï„Î¿Î½Ï„Î±Ï‚ Ï„Î± Î»ÎµÏ…ÎºÎ¬ Î±Î¹Î¼Î¿ÏƒÏ†Î±Î¯ÏÎ¹Î± Ï„Î¿Ï… Î¿ÏÎ³Î±Î½Î¹ÏƒÎ¼Î¿Ï ÏƒÏ„Î·Î½ Î¾Î­Î½Î· Ï€ÏÏ‰Ï„ÎµÎÎ½Î· ÎµÎ½ÏŒÏ‚ Î¹Î¿Ï. ÎœÏŒÎ»Î¹Ï‚ Ï„Î¿ ÏƒÏÎ¼Î± ÏƒÎ±Ï‚ ÎºÎ»Î·Î¸ÎµÎ¯ Î½Î± Î±Î½Ï„Î¹Î¼ÎµÏ„Ï‰Ï€Î¯ÏƒÎµÎ¹ Î­Î½Î±Î½ Î¹ÏŒ ÎºÎ±Î¹ Ï€ÏÎ±Î³Î¼Î±Ï„Î¿Ï€Î¿Î¹Î®ÏƒÎµÎ¹ Î¼Î¹Î± Î±Î½Î¿ÏƒÎ¿Î»Î¿Î³Î¹ÎºÎ® Î±Ï€ÏŒÎºÏÎ¹ÏƒÎ· ÏƒÏ„Î¿Î½ Î¹ÏŒ (Î´Î·Î¼Î¹Î¿Ï…ÏÎ³ÏÎ½Ï„Î±Ï‚ Î’ ÎºÎ±Î¹ Î¤ ÎºÏÏ„Ï„Î±ÏÎ±), Â«Î±Ï€Î¿Î¸Î·ÎºÎµÏÎµÎ¹Â» Ï„Î± Î’ ÎºÎ±Î¹ Î¤ ÎºÏÏ„Ï„Î±ÏÎ± Î­Ï„ÏƒÎ¹ ÏÏƒÏ„Îµ Î±Î½ Î¿ Î¯Î´Î¹Î¿Ï‚ Î¹ÏŒÏ‚ Î® Î²Î±ÎºÏ„Î®ÏÎ¹Î¿ Î¼Î¿Î»ÏÎ½ÎµÎ¹ Î¾Î±Î½Î¬ Ï„Î¿ ÏƒÏÎ¼Î±, Ï„Î¿ Î±Î½Î¿ÏƒÎ¿Ï€Î¿Î¹Î·Ï„Î¹ÎºÏŒ ÏƒÏÏƒÏ„Î·Î¼Î± Î½Î± Î¼Ï€Î¿ÏÎµÎ¯ Î½Î± Î±Î½Ï„Î±Ï€Î¿ÎºÏÎ¹Î¸ÎµÎ¯ ÎµÎ¼Ï€Î¿Î´Î¯Î¶Î¿Î½Ï„Î±Ï‚ Ï„Î¿ Ï€Î±Î¸Î¿Î³ÏŒÎ½Î¿ Ï€Î¿Ï… ÏƒÎ±Ï‚ ÎºÎ¬Î½ÎµÎ¹ Î½Î± Î±Î¹ÏƒÎ¸Î±Î½Î¸ÎµÎ¯Ï„Îµ Î¬ÏÏÏ‰ÏƒÏ„Î¿Î¹. Î¤Î± ÎµÎ¼Î²ÏŒÎ»Î¹Î± Â«ÏƒÏ…ÏƒÏ„Î®Î½Î¿Ï…Î½Â» ÏƒÏ„Î¿ ÏƒÏÎ¼Î± Ï„Î¿Î½ Î¹ÏŒ Î­Ï„ÏƒÎ¹ ÏÏƒÏ„Îµ Ï„Î¿ ÏƒÏÎ¼Î± Î½Î± Î¾ÎµÎºÎ¹Î½Î®ÏƒÎµÎ¹ Î½Î± Ï€Î±ÏÎ¬Î³ÎµÎ¹ Î’ ÎºÎ±Î¹ Î¤ ÎºÏÏ„Ï„Î±ÏÎ± Ï‡Ï‰ÏÎ¯Ï‚ Î½Î± Î­Ï‡ÎµÎ¹ Î±ÏÏÏ‰ÏƒÏ„Î®ÏƒÎµÎ¹. </p><h3>Î•Î¼Î²Î¿Î»Î¹Î±ÏƒÎ¼ÏŒÏ‚ ÎºÎ±Î¹ ÏƒÏ…Î½Î±Ï†ÎµÎ¯Ï‚ Ï€ÏÎ¿ÎºÎ»Î®ÏƒÎµÎ¹Ï‚</h3><p> Î¤ÏÏÎ± Î´Î¹Î±Î¸Î­Ï„Î¿Ï…Î¼Îµ ÎµÎ¼Î²ÏŒÎ»Î¹Î± Î³Î¹Î± Ï„Î·Î½ Ï€ÏÏŒÎ»Î·ÏˆÎ· Ï€ÎµÏÎ¹ÏƒÏƒÏŒÏ„ÎµÏÏ‰Î½ Î±Ï€ÏŒ 20 Î±Ï€ÎµÎ¹Î»Î·Ï„Î¹ÎºÏÎ½ Î³Î¹Î± Ï„Î· Î¶Ï‰Î® Î±ÏƒÎ¸ÎµÎ½ÎµÎ¹ÏÎ½, Î²Î¿Î·Î¸ÏÎ½Ï„Î±Ï‚ Ï„Î¿Ï…Ï‚ Î±Î½Î¸ÏÏÏ€Î¿Ï…Ï‚ ÏŒÎ»Ï‰Î½ Ï„Ï‰Î½ Î·Î»Î¹ÎºÎ¹ÏÎ½ Î½Î± Î¶Î®ÏƒÎ¿Ï…Î½ Ï€ÎµÏÎ¹ÏƒÏƒÏŒÏ„ÎµÏÎ¿ Î±Î»Î»Î¬ ÎºÎ±Î¹ Ï€Î¹Î¿ Ï€Î¿Î¹Î¿Ï„Î¹ÎºÎ¬. ÎŸ ÎµÎ¼Î²Î¿Î»Î¹Î±ÏƒÎ¼ÏŒÏ‚ ÏƒÎ®Î¼ÎµÏÎ± Î±Ï€Î¿Ï„ÏÎ­Ï€ÎµÎ¹ 2-3 ÎµÎºÎ±Ï„Î¿Î¼Î¼ÏÏÎ¹Î± Î¸Î±Î½Î¬Ï„Î¿Ï…Ï‚ ÎµÏ„Î·ÏƒÎ¯Ï‰Ï‚ Î±Ï€ÏŒ Î±ÏƒÎ¸Î­Î½ÎµÎ¹ÎµÏ‚ ÏŒÏ€Ï‰Ï‚ Î· Î´Î¹Ï†Î¸ÎµÏÎ¯Ï„Î¹Î´Î±, Î¿ Ï„Î­Ï„Î±Î½Î¿Ï‚, Î¿ ÎºÎ¿ÎºÎºÏÏ„Î·Ï‚, Î· Î³ÏÎ¯Ï€Î· ÎºÎ±Î¹ Î· Î¹Î»Î±ÏÎ¬. </p><p> ÎˆÏ‡Î¿Ï…Î¼Îµ ÎµÎ¼Î²Î¿Î»Î¹Î±ÏƒÎ¼Î¿ÏÏ‚ ÎµÎ½Î¬Î½Ï„Î¹Î± ÏƒÎµ Ï€Î¿Î»Î»Î­Ï‚ ÏƒÎ¿Î²Î±ÏÎ­Ï‚ Î¹Î¿Î³ÎµÎ½ÎµÎ¯Ï‚ Î»Î¿Î¹Î¼ÏÎ¾ÎµÎ¹Ï‚ (Ï€.Ï‡. Î¹Î»Î±ÏÎ¬, Ï€Î±ÏÏ‰Ï„Î¯Ï„Î¹Î´Î±, Î·Ï€Î±Ï„Î¯Ï„Î¹Î´Î± Î‘, Î·Ï€Î±Ï„Î¯Ï„Î¹Î´Î± Î’ ÎºÎ±Î¹ Î¿ÏÎ¹ÏƒÎ¼Î­Î½Î¿Ï…Ï‚ Î¹Î¿ÏÏ‚ â€“ ÏŒÏ€Ï‰Ï‚ Î±Ï…Ï„Î¿Î¯ Ï€Î¿Ï… Ï€ÏÎ¿ÎºÎ±Î»Î¿ÏÎ½ Ï„Î¿ ÎºÎ¿Î¹Î½ÏŒ ÎºÏÏ…Î¿Î»ÏŒÎ³Î·Î¼Î±). Î©ÏƒÏ„ÏŒÏƒÎ¿, Ï„Î¿ Ï€ÏÏŒÎ²Î»Î·Î¼Î± ÏŒÏ„Î¹ Î¼Ï€Î¿ÏÎ¿ÏÎ½ Î½Î± Î¼ÎµÏ„Î±Î»Î»Î±Ï‡Î¸Î¿ÏÎ½ Î±Ï€ÏŒ Ï„Î¿ Î­Î½Î± Î¬Ï„Î¿Î¼Î¿ ÏƒÏ„Î¿ Î¬Î»Î»Î¿ Ï€Î±ÏÎ±Î¼Î­Î½ÎµÎ¹. ÎŒÏ„Î±Î½ Î¿ Î¹ÏŒÏ‚ Î¼ÎµÏ„Î±Î»Î»Î¬ÏƒÏƒÎµÏ„Î±Î¹ Î±Î»Î»Î¬Î¶ÎµÎ¹ Î±ÏÎºÎµÏ„Î¬, Î¼Îµ Î±Ï€Î¿Ï„Î­Î»ÎµÏƒÎ¼Î± Ï„Î¿ Î±Î½Î¿ÏƒÎ¿Ï€Î¿Î¹Î·Ï„Î¹ÎºÏŒ ÏƒÏÏƒÏ„Î·Î¼Î± Î½Î± Î¼Î·Î½ Ï„Î¿Î½ Î±Î½Î±Î³Î½Ï‰ÏÎ¯Î¶ÎµÎ¹ Ï€Î»Î­Î¿Î½. Î¤Î± ÎºÏÏ„Ï„Î±ÏÎ± Ï„Î¿Ï… Î±Î½Î¿ÏƒÎ¿Ï€Î¿Î¹Î·Ï„Î¹ÎºÎ¿Ï Ï€Î¿Ï… Î±Ï€Î¿Î¸Î·ÎºÎµÏÎ¿Î½Ï„Î±Î¹ Î³Î¹Î± Ï„Î· Î±Î½Ï„Î¹Î¼ÎµÏ„ÏÏ€Î¹ÏƒÎ· Ï„Î¿Ï… Î¹Î¿Ï Î´ÎµÎ½ Ï„Î¿ Î±Î½Î±Î³Î½Ï‰ÏÎ¯Î¶Î¿Ï…Î½ Ï€Î»Î­Î¿Î½ Ï‰Ï‚ Ï„Î·Î½ Î¯Î´Î¹Î± Î±ÏƒÎ¸Î­Î½ÎµÎ¹Î± ÎºÎ±Î¹ Î´ÎµÎ½ Î¾Î­ÏÎ¿Ï…Î½ Ï€ÏÏ‚ Î½Î± Ï„Î¿ ÏƒÎºÎ¿Ï„ÏÏƒÎ¿Ï…Î½. Î•Ï†ÏŒÏƒÎ¿Î½ Î¿ Î¹ÏŒÏ‚ Î´ÎµÎ½ Î³Î¯Î½ÎµÏ„Î±Î¹ Î±Î½Ï„Î¹Î»Î·Ï€Ï„ÏŒÏ‚ Î±Ï€ÏŒ Ï„Î¿ Î±Î½Î¿ÏƒÎ¿Ï€Î¿Î¹Î·Ï„Î¹ÎºÏŒ ÏƒÏÏƒÏ„Î·Î¼Î±, Î¼Î¹Î± Î¼ÏŒÎ»Ï…Î½ÏƒÎ· Î±Ï€ÏŒ Ï„Î¿Î½ Î¯Î´Î¹Î¿ Î¹ÏŒ Î¼Ï€Î¿ÏÎµÎ¯ Î½Î± ÏƒÏ…Î¼Î²ÎµÎ¯. ÎŸ ÎµÎ¼Î²Î¿Î»Î¹Î±ÏƒÎ¼ÏŒÏ‚ Î³Î¹Î± Î±Ï…Ï„Î¿ÏÏ‚ Ï„Î¿Ï…Ï‚ Î¹Î¿ÏÏ‚ ÎµÎ¯Î½Î±Î¹ Î´ÏÏƒÎºÎ¿Î»Î¿Ï‚ ÎµÏ€ÎµÎ¹Î´Î® Î­Ï‡Î¿Ï…Î½ Î®Î´Î· Î±Î»Î»Î¬Î¾ÎµÎ¹ Ï„Î· Î¼Î¿ÏÏ†Î® Ï„Î¿Ï…Ï‚ Î¼Î­Ï‡ÏÎ¹ Î½Î± Î±Î½Î±Ï€Ï„Ï…Ï‡Î¸Î¿ÏÎ½ Ï„Î± ÎµÎ¼Î²ÏŒÎ»Î¹Î±. </p><section class="e-card"><h4 class="mt-0">Î‘Î½Î±Ï†Î¿ÏÎ­Ï‚ / Î Î·Î³Î­Ï‚ Î Î»Î·ÏÎ¿Ï†ÏŒÏÎ·ÏƒÎ·Ï‚</h4><ul class="text-sm break-all"><li><a href="https://www.who.int/news-room/feature-stories/detail/how-do-vaccines-work" target="_blank" rel="noreferrer noopener">https://www.who.int/news-room/feature-stories/detail/how-do-vaccines-work</a></li><li><a href="https://www.nytimes.com/interactive/2020/health/pfizer-biontech-covid-19-vaccine.html" target="_blank" rel="noreferrer noopener">https://www.nytimes.com/interactive/2020/health/pfizer-biontech-covid-19-vaccine.html</a></li><li><a href="https://media.nature.com/original/magazine-assets/d41586-021-03552-w/d41586-021-03552-w.pdf" target="_blank" rel="noreferrer noopener">https://media.nature.com/original/magazine-assets/d41586-021-03552-w/d41586-021-03552-w.pdf</a></li><li><a href="https://opentextbc.ca/biology/chapter/12-1-viruses/" target="_blank" rel="noreferrer noopener">https://opentextbc.ca/biology/chapter/12-1-viruses/</a></li></ul></section>',5),Le=i('<hr class="mt-10 mb-40"><section id="s4"><h2 id="s4t">4. Î— Î´Î¹Î±Î´Î¹ÎºÎ±ÏƒÎ¯Î± Î±Î½Î¬Ï€Ï„Ï…Î¾Î·Ï‚ ÎµÎ¼Î²Î¿Î»Î¯Ï‰Î½, Î±ÏƒÏ†Î¬Î»ÎµÎ¹Î± ÎµÎ¼Î²Î¿Î»Î¯Ï‰Î½</h2><h3>Î‘Î½Î¬Ï€Ï„Ï…Î¾Î·</h3><p> Î— Î±Î½Î¬Ï€Ï„Ï…Î¾Î· Ï„Î¿Ï… ÎµÎ¼Î²Î¿Î»Î¯Î¿Ï… Î¾ÎµÎºÎ¹Î½Î¬ ÏƒÏ…Î½Î®Î¸Ï‰Ï‚ ÏƒÎµ Î­Î½Î± ÎµÏÎµÏ…Î½Î·Ï„Î¹ÎºÏŒ ÎµÏÎ³Î±ÏƒÏ„Î®ÏÎ¹Î¿ Î Î±Î½ÎµÏ€Î¹ÏƒÏ„Î·Î¼Î¯Î¿Ï…, Î¹Î±Ï„ÏÎ¹ÎºÎ¿Ï ÎºÎ­Î½Ï„ÏÎ¿Ï… Î® ÏƒÎµ Î¼Î¹Î± Î¼Î¹ÎºÏÎ® ÎµÏ„Î±Î¹ÏÎµÎ¯Î± Î²Î¹Î¿Ï„ÎµÏ‡Î½Î¿Î»Î¿Î³Î¯Î±Ï‚. ÎšÎ±Ï„Î¬ Ï„Î·Î½ Î±Î½Î¬Ï€Ï„Ï…Î¾Î· Ï„Î¿Ï… ÎµÎ¼Î²Î¿Î»Î¯Î¿Ï…, Î¿Î¹ ÎµÏ€Î¹ÏƒÏ„Î®Î¼Î¿Î½ÎµÏ‚ Î±Î½Î±Ï€Ï„ÏÏƒÏƒÎ¿Ï…Î½ Î´Î¹Î±Ï†Î¿ÏÎµÏ„Î¹ÎºÎ¬ Î±Î½Ï„Î¹Î´ÏÎ±ÏƒÏ„Î®ÏÎ¹Î± Î³Î¹Î± Î½Î± Î´Î¿ÎºÎ¹Î¼Î¬ÏƒÎ¿Ï…Î½ ÎºÎ±Î¹ Î½Î± Î¼ÎµÏ„ÏÎ®ÏƒÎ¿Ï…Î½ Ï„Î·Î½ ÎµÏ€Î¯Î´ÏÎ±ÏƒÎ® Ï„Î¿Ï…Ï‚ (Î® Ï„Î·Î½ Î­Î»Î»ÎµÎ¹ÏˆÎ® Ï„Î¿Ï…Ï‚). Î£Ï…Ï‡Î½Î¬ Ï‡ÏÎµÎ¹Î¬Î¶Î¿Î½Ï„Î±Î¹ Ï‡ÏÏŒÎ½Î¹Î± Î­ÏÎµÏ…Î½Î±Ï‚ Î³Î¹Î± Î½Î± Î±Î½Î±Ï€Ï„Ï…Ï‡Î¸Î¿ÏÎ½ Î±Ï€Î¿Ï„ÎµÎ»ÎµÏƒÎ¼Î±Ï„Î¹ÎºÎ­Ï‚ Î¹Î´Î­ÎµÏ‚. </p><p> Î”Î¹Î±Ï†Î¿ÏÎµÏ„Î¹ÎºÎ¿Î¯ ÎµÏ€Î¹ÏƒÏ„Î®Î¼Î¿Î½ÎµÏ‚ Î® ÎµÏÎµÏ…Î½Î·Ï„Î¹ÎºÎ­Ï‚ Î¿Î¼Î¬Î´ÎµÏ‚ Î¼Ï€Î¿ÏÎ¿ÏÎ½ Î½Î± ÏƒÏ…Î½ÎµÏÎ³Î¬Î¶Î¿Î½Ï„Î±Î¹ Ï€Î±ÏÎ¬Î»Î»Î·Î»Î± Î³Î¹Î± Ï„Î·Î½ ÎµÏ€Î¯Ï„ÎµÏ…Î¾Î® ÎºÎ¿Î¹Î½ÏÎ½ ÏƒÏ„ÏŒÏ‡Ï‰Î½ ÎºÎ±Ï„Î¬ Ï„Î·Î½ Î±Î½Î¬Ï€Ï„Ï…Î¾Î· ÎµÎ½ÏŒÏ‚ ÎµÎ¼Î²Î¿Î»Î¯Î¿Ï…. Î— Ï€ÏÏŒÎ¿Î´Î¿Ï‚ Ï„Î·Ï‚ ÎµÏÎ³Î±ÏƒÎ¯Î±Ï‚ Ï€Î±ÏÎ¿Ï…ÏƒÎ¹Î¬Î¶ÎµÏ„Î±Î¹ ÏƒÎµ Î´Î¹Î¬Ï†Î¿ÏÎµÏ‚ ÏƒÏ…Î½Î±Î½Ï„Î®ÏƒÎµÎ¹Ï‚ ÎºÎ±Î¹ Î´Î·Î¼Î¿ÏƒÎ¹ÎµÏÎµÏ„Î±Î¹ ÏƒÎµ Î±Î¾Î¹ÏŒÎ»Î¿Î³Î± ÎµÏ€Î¹ÏƒÏ„Î·Î¼Î¿Î½Î¹ÎºÎ¬ Ï€ÎµÏÎ¹Î¿Î´Î¹ÎºÎ¬. Î•Î¬Î½ ÎºÎ¬Ï€Î¿Î¹Î± Î¼ÎµÎ»Î­Ï„Î· Ï†Î±Î¯Î½ÎµÏ„Î±Î¹ Ï€Î¿Î»Î»Î® Ï…Ï€Î¿ÏƒÏ‡ÏŒÎ¼ÎµÎ½Î·, Î¿Î¹ Ï†Î±ÏÎ¼Î±ÎºÎµÏ…Ï„Î¹ÎºÎ¿Î¯ ÎµÏ€Î¹ÏƒÏ„Î®Î¼Î¿Î½ÎµÏ‚ Î¼Ï€Î¿ÏÎµÎ¯ Î½Î± Ï€ÏÎ¿ÏƒÎµÎ³Î³Î¯ÏƒÎ¿Ï…Î½ ÏŒÏƒÎ¿Ï…Ï‚ ÎµÏÎ³Î¬Î¶Î¿Î½Ï„Î±Î¹ Ï€Î¬Î½Ï‰ ÏƒÎµ Î±Ï…Ï„Î® Î³Î¹Î± Î½Î± ÎµÏ€ÎµÎºÏ„ÎµÎ¯Î½Î¿Ï…Î½ Ï„Î·Î½ Î­ÏÎµÏ…Î½Î¬ Ï„Î¿Ï…Ï‚ Ï€ÏÎ¿Ï‚ Ï„Î·Î½ Î±Î½Î¬Ï€Ï„Ï…Î¾Î· Ï€ÏÎ¿ÏŠÏŒÎ½Ï„Ï‰Î½. </p><h3>Î”Î¿ÎºÎ¹Î¼Î®</h3><p> Î•Î¬Î½ Î²ÏÎµÎ¸ÎµÎ¯ Î­Î½Î± Ï…Ï€Î¿ÏƒÏ‡ÏŒÎ¼ÎµÎ½Î¿ ÎµÎ¼Î²ÏŒÎ»Î¹Î¿, Ï€ÏÎ­Ï€ÎµÎ¹ Î½Î± Î´Î¿ÎºÎ¹Î¼Î±ÏƒÏ„ÎµÎ¯ ÏƒÎµ Î¶ÏÎ±. Î‘Ï…Ï„ÏŒ Î±Ï€Î¿Ï„ÎµÎ»ÎµÎ¯ Ï„Î·Î½ Ï€ÏÎ¿-ÎºÎ»Î¹Î½Î¹ÎºÎ® Ï†Î¬ÏƒÎ· Ï„Î·Ï‚ Î­ÏÎµÏ…Î½Î±Ï‚. Î ÏÏÏ„Î± Ï‡ÏÎ·ÏƒÎ¹Î¼Î¿Ï€Î¿Î¹Î¿ÏÎ½Ï„Î±Î¹ Î¼Î¹ÎºÏÎ¬ Î¶ÏÎ± ÏŒÏ€Ï‰Ï‚ Ï€Î¿Î½Ï„Î¯ÎºÎ¹Î±, Î±ÏÎ¿Ï…ÏÎ±Î¯Î¿Î¹, ÎºÎ¿Ï…Î½Î­Î»Î¹Î± ÎºÎ±Î¹ Î¬Î»Î»Î±. Î•Î¬Î½ Ï„Î¿ Ï…Ï€Î¿ÏˆÎ®Ï†Î¹Î¿ ÎµÎ¼Î²ÏŒÎ»Î¹Î¿ Î­Ï‡ÎµÎ¹ Î±Ï€Î¿Ï„Î­Î»ÎµÏƒÎ¼Î± ÏƒÏ„Î± Î¼Î¹ÎºÏÎ¬ Î¶ÏÎ±, Ï„ÏŒÏ„Îµ ÏƒÏ…Î½Î®Î¸Ï‰Ï‚ Ï€ÎµÏÎ½Î¬Î¼Îµ ÎºÎ±Î¹ ÏƒÎµ Î´Î¿ÎºÎ¹Î¼Î­Ï‚ ÏƒÎµ Î¼ÎµÎ³Î±Î»ÏÏ„ÎµÏÎ± Î¶ÏÎ±, ÏŒÏ€Ï‰Ï‚ Î¿Î¹ Ï€Î¯Î¸Î·ÎºÎ¿Î¹. Î•Î¬Î½ Ï„Î¿ ÎµÎ¼Î²ÏŒÎ»Î¹Î¿ Ï€Ï…ÏÎ¿Î´Î¿Ï„Î®ÏƒÎµÎ¹ Î±Î½Î¿ÏƒÎ¿Î»Î¿Î³Î¹ÎºÎ® Î±Ï€ÏŒÎºÏÎ¹ÏƒÎ· ÎºÎ±Î¹ ÏƒÎµ Î±Ï…Ï„Î¬, Ï„ÏŒÏ„Îµ Î´Î¿ÎºÎ¹Î¼Î¬Î¶ÎµÏ„Î±Î¹ ÏƒÎµ Î±Î½Î¸ÏÏÏ€Î¿Ï…Ï‚ ÏƒÎµ Ï„ÏÎµÎ¹Ï‚ Ï†Î¬ÏƒÎµÎ¹Ï‚ ÎºÎ»Î¹Î½Î¹ÎºÏÎ½ Î´Î¿ÎºÎ¹Î¼ÏÎ½ (WHO, 2021). </p><p> Î£Ï„Î· Î¦Î¬ÏƒÎ· 1, Ï„Î¿ ÎµÎ¼Î²ÏŒÎ»Î¹Î¿ Ï‡Î¿ÏÎ·Î³ÎµÎ¯Ï„Î±Î¹ ÏƒÎµ Î¼ÎµÏÎ¹ÎºÎ¿ÏÏ‚ ÎµÎ¸ÎµÎ»Î¿Î½Ï„Î­Ï‚ Î³Î¹Î± Î½Î± Î±Î¾Î¹Î¿Î»Î¿Î³Î®ÏƒÎ¿Ï…Î½ Ï„Î·Î½ Î±ÏƒÏ†Î¬Î»ÎµÎ¹Î¬ Ï„Î¿Ï…, Î½Î± ÎµÏ€Î¹Î²ÎµÎ²Î±Î¹ÏÏƒÎ¿Ï…Î½ ÏŒÏ„Î¹ Î´Î·Î¼Î¹Î¿Ï…ÏÎ³ÎµÎ¯ Î±Î½Î¿ÏƒÎ¿Î±Ï€ÏŒÎºÏÎ¹ÏƒÎ· ÎºÎ±Î¹ Î½Î± ÎºÎ±Î¸Î¿ÏÎ¯ÏƒÎ¿Ï…Î½ Ï„Î· ÏƒÏ‰ÏƒÏ„Î® Î´Î¿ÏƒÎ¿Î»Î¿Î³Î¯Î±. Î“ÎµÎ½Î¹ÎºÎ¬, ÏƒÎµ Î±Ï…Ï„Î® Ï„Î· Ï†Î¬ÏƒÎ·, Ï„Î± ÎµÎ¼Î²ÏŒÎ»Î¹Î± Î´Î¿ÎºÎ¹Î¼Î¬Î¶Î¿Î½Ï„Î±Î¹ ÏƒÎµ Î¼Î¹Î± Î¼Î¹ÎºÏÎ® Î¿Î¼Î¬Î´Î± Î½ÎµÎ±ÏÏÎ½, Ï…Î³Î¹ÏÎ½ ÎµÎ½Î·Î»Î¯ÎºÏ‰Î½ ÎµÎ¸ÎµÎ»Î¿Î½Ï„ÏÎ½. </p><p> Î£Ï„Î· Ï†Î¬ÏƒÎ· 2, Ï„Î¿ ÎµÎ¼Î²ÏŒÎ»Î¹Î¿ Ï‡Î¿ÏÎ·Î³ÎµÎ¯Ï„Î±Î¹ ÏƒÎµ Î±ÏÎºÎµÏ„Î­Ï‚ ÎµÎºÎ±Ï„Î¿Î½Ï„Î¬Î´ÎµÏ‚ ÎµÎ¸ÎµÎ»Î¿Î½Ï„Î­Ï‚ Î³Î¹Î± Î½Î± Î±Î¾Î¹Î¿Î»Î¿Î³Î·Î¸ÎµÎ¯ Ï€ÎµÏÎ±Î¹Ï„Î­ÏÏ‰ Î· Î±ÏƒÏ†Î¬Î»ÎµÎ¹Î¬ Ï„Î¿Ï… ÎºÎ±Î¹ Î· Î¹ÎºÎ±Î½ÏŒÏ„Î·Ï„Î¬ Ï„Î¿Ï… Î½Î± Î´Î·Î¼Î¹Î¿Ï…ÏÎ³Î®ÏƒÎµÎ¹ Î±Î½Î¿ÏƒÎ¿Î»Î¿Î³Î¹ÎºÎ® Î±Ï€ÏŒÎºÏÎ¹ÏƒÎ·. ÎŸÎ¹ ÏƒÏ…Î¼Î¼ÎµÏ„Î­Ï‡Î¿Î½Ï„ÎµÏ‚ ÏƒÎµ Î±Ï…Ï„Î® Ï„Î· Ï†Î¬ÏƒÎ· Î­Ï‡Î¿Ï…Î½ Ï„Î± Î¯Î´Î¹Î± Ï‡Î±ÏÎ±ÎºÏ„Î·ÏÎ¹ÏƒÏ„Î¹ÎºÎ¬ (ÏŒÏ€Ï‰Ï‚ Î·Î»Î¹ÎºÎ¯Î± ÎºÎ±Î¹ Ï†ÏÎ»Î¿) Î¼Îµ ÎµÎºÎµÎ¯Î½Î¿Ï…Ï‚ Î³Î¹Î± Ï„Î¿Ï…Ï‚ Î¿Ï€Î¿Î¯Î¿Ï…Ï‚ Ï€ÏÎ¿Î¿ÏÎ¯Î¶ÎµÏ„Î±Î¹ Ï„Î¿ ÎµÎ¼Î²ÏŒÎ»Î¹Î¿. Î¥Ï€Î¬ÏÏ‡Î¿Ï…Î½ ÏƒÏ…Î½Î®Î¸Ï‰Ï‚ Ï€Î¿Î»Î»Î±Ï€Î»Î­Ï‚ Î´Î¿ÎºÎ¹Î¼Î­Ï‚ ÏƒÎµ Î±Ï…Ï„Î® Ï„Î· Ï†Î¬ÏƒÎ· Î³Î¹Î± Ï„Î·Î½ Î±Î¾Î¹Î¿Î»ÏŒÎ³Î·ÏƒÎ· Î´Î¹Î±Ï†ÏŒÏÏ‰Î½ Î·Î»Î¹ÎºÎ¹Î±ÎºÏÎ½ Î¿Î¼Î¬Î´Ï‰Î½ (Ï€.Ï‡. Î·Î»Î¹ÎºÎ¹Ï‰Î¼Î­Î½Î¿Î¹, ÎµÎ½Î®Î»Î¹ÎºÎµÏ‚, Ï€Î±Î¹Î´Î¹Î¬) ÎºÎ±Î¹ Î´Î¹Î±Ï†Î¿ÏÎµÏ„Î¹ÎºÎ¬ ÏƒÎºÎµÏ…Î¬ÏƒÎ¼Î±Ï„Î± ÎµÎ¼Î²Î¿Î»Î¯Ï‰Î½. Î•Ï€Î¯ÏƒÎ·Ï‚, Î¼Î¹Î± Î¿Î¼Î¬Î´Î± ÎµÎ»Î­Î³Ï‡Î¿Ï… Î´ÎµÎ½ ÎºÎ¬Î½ÎµÎ¹ Ï„Î¿ ÎµÎ¼Î²ÏŒÎ»Î¹Î¿ ÏÏƒÏ„Îµ Î½Î± Î´Î¹Î±Ï†Î±Î½ÎµÎ¯ ÎµÎ¬Î½ Î¿Î¹ Î±Î»Î»Î±Î³Î­Ï‚ ÏƒÏ„Î·Î½ ÎµÎ¼Î²Î¿Î»Î¹Î±ÏƒÎ¼Î­Î½Î· Î¿Î¼Î¬Î´Î± Î±Ï€Î¿Î´Î¯Î´Î¿Î½Ï„Î±Î¹ ÏƒÏ„Î¿ ÎµÎ¼Î²ÏŒÎ»Î¹Î¿ Î® Î­Ï‡Î¿Ï…Î½ ÏƒÏ…Î¼Î²ÎµÎ¯ Ï„Ï…Ï‡Î±Î¯Î±. </p><p> Î£Ï„Î· Ï†Î¬ÏƒÎ· 3 Ï„Î¿ ÎµÎ¼Î²ÏŒÎ»Î¹Î¿ Ï‡Î¿ÏÎ·Î³ÎµÎ¯Ï„Î±Î¹ ÏƒÎµ Ï‡Î¹Î»Î¹Î¬Î´ÎµÏ‚ ÎµÎ¸ÎµÎ»Î¿Î½Ï„Î­Ï‚, Î¿Î¹ Î¿Ï€Î¿Î¯Î¿Î¹ ÎµÎ»Î­Î³Ï‡Î¿Î½Ï„Î±Î¹ Ï„Î±Ï…Ï„ÏŒÏ‡ÏÎ¿Î½Î± Î¼Îµ Î¼Î¹Î± Ï€Î±ÏÏŒÎ¼Î¿Î¹Î± Î¿Î¼Î¬Î´Î± Î±Î½Î¸ÏÏÏ€Ï‰Î½ Ï€Î¿Ï… Î´ÎµÎ½ Î­ÎºÎ±Î½Î±Î½ Ï„Î¿ ÎµÎ¼Î²ÏŒÎ»Î¹Î¿ Î±Î»Î»Î¬ Î­Î»Î±Î²Î±Î½ Î­Î½Î± ÏƒÏ…Î³ÎºÏÎ¯ÏƒÎ¹Î¼Î¿ Ï€ÏÎ¿ÏŠÏŒÎ½. Î‘Ï…Ï„Î® Î· Ï†Î¬ÏƒÎ· ÏƒÏ„Î¿Ï‡ÎµÏÎµÎ¹ Î½Î± ÎºÎ±Î¸Î¿ÏÎ¯ÏƒÎµÎ¹ ÎµÎ¬Î½ Ï„Î¿ ÎµÎ¼Î²ÏŒÎ»Î¹Î¿ ÎµÎ¯Î½Î±Î¹ Î±Ï€Î¿Ï„ÎµÎ»ÎµÏƒÎ¼Î±Ï„Î¹ÎºÏŒ Î­Î½Î±Î½Ï„Î¹ Ï„Î·Ï‚ Î±ÏƒÎ¸Î­Î½ÎµÎ¹Î±Ï‚ Î³Î¹Î± Ï„Î·Î½ Î¿Ï€Î¿Î¯Î± Î­Ï‡ÎµÎ¹ ÏƒÏ‡ÎµÎ´Î¹Î±ÏƒÏ„ÎµÎ¯ Î½Î± Ï€ÏÎ¿ÏƒÏ„Î±Ï„ÎµÏÎµÎ¹. Î•Ï€Î¯ÏƒÎ·Ï‚, ÏƒÏ„Î¿Ï‡ÎµÏÎµÎ¹ Î½Î± Î¼ÎµÎ»ÎµÏ„Î®ÏƒÎµÎ¹ Ï„Î·Î½ Î±ÏƒÏ†Î¬Î»ÎµÎ¹Î¬ Ï„Î¿Ï… ÏƒÎµ Ï€Î¿Î»Ï Î¼ÎµÎ³Î±Î»ÏÏ„ÎµÏÎ· Î¿Î¼Î¬Î´Î± Î±Î½Î¸ÏÏÏ€Ï‰Î½. ÎŸÎ¹ Î´Î¿ÎºÎ¹Î¼Î­Ï‚ Ï„Î·Ï‚ Ï†Î¬ÏƒÎ·Ï‚ 3 Î´Î¹ÎµÎ¾Î¬Î³Î¿Î½Ï„Î±Î¹ ÏƒÏ…Ï‡Î½Î¬ ÏƒÎµ Ï€Î¿Î»Î»Î­Ï‚ Ï‡ÏÏÎµÏ‚ ÎºÎ±Î¹ Ï€ÎµÏÎ¹Î¿Ï‡Î­Ï‚ ÎµÎ½Ï„ÏŒÏ‚ Î¼Î¹Î±Ï‚ Ï‡ÏÏÎ±Ï‚ Î³Î¹Î± Î½Î± Î´Î¹Î±ÏƒÏ†Î±Î»Î¹ÏƒÏ„ÎµÎ¯ ÏŒÏ„Î¹ Ï„Î± ÎµÏ…ÏÎ®Î¼Î±Ï„Î± Ï„Î·Ï‚ Î±Ï€ÏŒÎ´Î¿ÏƒÎ·Ï‚ Ï„Î¿Ï… ÎµÎ¼Î²Î¿Î»Î¯Î¿Ï… Ï€ÏÎ¿ÎºÏÏ€Ï„Î¿Ï…Î½ Î±Ï€ÏŒ Ï€Î¿Î»Î»Î¿ÏÏ‚ Î´Î¹Î±Ï†Î¿ÏÎµÏ„Î¹ÎºÎ¿ÏÏ‚ Ï€Î»Î·Î¸Ï…ÏƒÎ¼Î¿ÏÏ‚. </p><p> ÎšÎ±Ï„Î¬ Ï„Î· Î´Î¹Î¬ÏÎºÎµÎ¹Î± Ï„Ï‰Î½ Î´Î¿ÎºÎ¹Î¼ÏÎ½ Ï„Î·Ï‚ Ï†Î¬ÏƒÎ·Ï‚ 2 ÎºÎ±Î¹ 3, Î¿Î¹ ÎµÎ¸ÎµÎ»Î¿Î½Ï„Î­Ï‚ ÎºÎ±Î¹ Î¿Î¹ ÎµÏ€Î¹ÏƒÏ„Î®Î¼Î¿Î½ÎµÏ‚ Ï€Î¿Ï… Î´Î¹ÎµÎ¾Î¬Î³Î¿Ï…Î½ Ï„Î· Î¼ÎµÎ»Î­Ï„Î· Î´ÎµÎ½ Î³Î½Ï‰ÏÎ¯Î¶Î¿Ï…Î½ Ï€Î¿Î¹Î¿Î¹ ÎµÎ¸ÎµÎ»Î¿Î½Ï„Î­Ï‚ Î­Ï‡Î¿Ï…Î½ Î»Î¬Î²ÎµÎ¹ Ï„Î¿ Ï…Ï€ÏŒ Î´Î¿ÎºÎ¹Î¼Î® ÎµÎ¼Î²ÏŒÎ»Î¹Î¿ Î® Ï„Î¿ ÏƒÏ…Î³ÎºÏÎ¯ÏƒÎ¹Î¼Î¿ Ï€ÏÎ¿ÏŠÏŒÎ½. Î‘Ï…Ï„ÏŒ Î¿Î½Î¿Î¼Î¬Î¶ÎµÏ„Î±Î¹ Â«Ï„Ï…Ï†Î»ÏŒÏ„Î·Ï„Î±Â» ÎºÎ±Î¹ ÎµÎ¯Î½Î±Î¹ Î±Ï€Î±ÏÎ±Î¯Ï„Î·Ï„Î¿ Î³Î¹Î± Î½Î± Î´Î¹Î±ÏƒÏ†Î±Î»Î¹ÏƒÏ„ÎµÎ¯ ÏŒÏ„Î¹ Î¿ÏÏ„Îµ Î¿Î¹ ÎµÎ¸ÎµÎ»Î¿Î½Ï„Î­Ï‚ Î¿ÏÏ„Îµ Î¿Î¹ ÎµÏ€Î¹ÏƒÏ„Î®Î¼Î¿Î½ÎµÏ‚ ÎµÏ€Î·ÏÎµÎ¬Î¶Î¿Î½Ï„Î±Î¹ ÏƒÏ„Î·Î½ Î±Î¾Î¹Î¿Î»ÏŒÎ³Î·ÏƒÎ· Ï„Î·Ï‚ Î±Ï€Î¿Ï„ÎµÎ»ÎµÏƒÎ¼Î±Ï„Î¹ÎºÏŒÏ„Î·Ï„Î±Ï‚ Î® Ï„Î·Ï‚ Î±ÏƒÏ†Î¬Î»ÎµÎ¹Î±Ï‚ Î³Î½Ï‰ÏÎ¯Î¶Î¿Î½Ï„Î±Ï‚ Ï€Î¿Î¹Î¿Ï‚ Ï€Î®ÏÎµ Ï€Î¿Î¹Î¿ Ï€ÏÎ¿ÏŠÏŒÎ½. </p><section class="e-card"><h4 class="mt-0">Î‘Î½Î±Ï†Î¿ÏÎ­Ï‚ / Î Î·Î³Î­Ï‚ Î Î»Î·ÏÎ¿Ï†ÏŒÏÎ·ÏƒÎ·Ï‚</h4><ul class="text-sm break-all"><li><a href="https://www.who.int/news-room/feature-stories/detail/how-are-vaccines-developed" target="_blank" rel="noopener noreferrer">https://www.who.int/news-room/feature-stories/detail/how-are-vaccines-developed</a></li></ul></section><h3>Î•Î¾Î¿Ï…ÏƒÎ¹Î¿Î´ÏŒÏ„Î·ÏƒÎ· ÎºÎ±Î¹ Ï€Î±ÏÎ±ÎºÎ¿Î»Î¿ÏÎ¸Î·ÏƒÎ·</h3><p> ÎŒÏ„Î±Î½ Ï„Î± Î±Ï€Î¿Ï„ÎµÎ»Î­ÏƒÎ¼Î±Ï„Î± ÏŒÎ»Ï‰Î½ Î±Ï…Ï„ÏÎ½ Ï„Ï‰Î½ ÎºÎ»Î¹Î½Î¹ÎºÏÎ½ Î´Î¿ÎºÎ¹Î¼ÏÎ½ ÎµÎ¯Î½Î±Î¹ Î´Î¹Î±Î¸Î­ÏƒÎ¹Î¼Î± Î±ÎºÎ¿Î»Î¿Ï…Î¸ÎµÎ¯ Î¼Î¹Î± ÏƒÎµÎ¹ÏÎ¬ Î±Ï€ÏŒ Î¬Î»Î»ÎµÏ‚ ÎµÎ½Î­ÏÎ³ÎµÎ¹ÎµÏ‚. Î‘Î¾Î¹Ï‰Î¼Î±Ï„Î¿ÏÏ‡Î¿Î¹ Ï„Î¿Ï… Î•Ï…ÏÏ‰Ï€Î±ÏŠÎºÎ¿Ï ÎŸÏÎ³Î±Î½Î¹ÏƒÎ¼Î¿Ï Î¦Î±ÏÎ¼Î¬ÎºÏ‰Î½ ÎºÎ±Î¹ Î±ÏÎ³ÏŒÏ„ÎµÏÎ± ÎºÎ¬Î¸Îµ Ï‡ÏÏÎ±Ï‚ Î¾ÎµÏ‡Ï‰ÏÎ¹ÏƒÏ„Î¬ ÎµÎ¾ÎµÏ„Î¬Î¶Î¿Ï…Î½ Ï€ÏÎ¿ÏƒÎµÎºÏ„Î¹ÎºÎ¬ Ï„Î± Î´ÎµÎ´Î¿Î¼Î­Î½Î± Ï„Î·Ï‚ Î¼ÎµÎ»Î­Ï„Î·Ï‚ ÎºÎ±Î¹ Î±Ï€Î¿Ï†Î±ÏƒÎ¯Î¶Î¿Ï…Î½ ÎµÎ¬Î½ Î¸Î± ÎµÎ³ÎºÏÎ¯Î½Î¿Ï…Î½ Ï„Î¿ ÎµÎ¼Î²ÏŒÎ»Î¹Î¿. ÎŒÎ»ÎµÏ‚ Î¿Î¹ Î´Î¿ÎºÎ¹Î¼Î­Ï‚ Ï€ÏÎ­Ï€ÎµÎ¹ Î½Î± Î³Î¯Î½Î¿Î½Ï„Î±Î¹ ÏƒÏ‰ÏƒÏ„Î¬ ÎºÎ±Î¹ Î½Î± ÎµÎ¯Î½Î±Î¹ ÎºÎ±Î»Î¬ Ï„ÎµÎºÎ¼Î·ÏÎ¹Ï‰Î¼Î­Î½ÎµÏ‚. ÎˆÎ½Î± ÎµÎ¼Î²ÏŒÎ»Î¹Î¿ Ï€ÏÎ­Ï€ÎµÎ¹ Î½Î± Î±Ï€Î¿Î´ÎµÎ¹Ï‡Î¸ÎµÎ¯ Î±ÏƒÏ†Î±Î»Î­Ï‚ ÎºÎ±Î¹ Î±Ï€Î¿Ï„ÎµÎ»ÎµÏƒÎ¼Î±Ï„Î¹ÎºÏŒ ÏƒÎµ Î­Î½Î±Î½ ÎµÏ…ÏÏ Ï€Î»Î·Î¸Ï…ÏƒÎ¼ÏŒ Ï€ÏÎ¹Î½ ÎµÎ³ÎºÏÎ¹Î¸ÎµÎ¯. ÎŸ Ï€Î®Ï‡Î·Ï‚ Î³Î¹Î± Ï„Î·Î½ Î±ÏƒÏ†Î¬Î»ÎµÎ¹Î± ÎºÎ±Î¹ Ï„Î·Î½ Î±Ï€Î¿Ï„ÎµÎ»ÎµÏƒÎ¼Î±Ï„Î¹ÎºÏŒÏ„Î·Ï„Î± Ï„Î¿Ï… ÎµÎ¼Î²Î¿Î»Î¯Î¿Ï… ÎµÎ¯Î½Î±Î¹ ÎµÎ¾Î±Î¹ÏÎµÏ„Î¹ÎºÎ¬ Ï…ÏˆÎ·Î»ÏŒÏ‚. Î‘Ï…Ï„ÏŒÏ‚ Ï€ÎµÏÎ¹Î»Î±Î¼Î²Î¬Î½ÎµÎ¹ Î±Î¾Î¹Î¿Î»Î¿Î³Î®ÏƒÎµÎ¹Ï‚ Ï„Î·Ï‚ Î±Ï€Î¿Ï„ÎµÎ»ÎµÏƒÎ¼Î±Ï„Î¹ÎºÏŒÏ„Î·Ï„Î±Ï‚ ÎºÎ±Î¹ Ï„Î·Ï‚ Î±ÏƒÏ†Î¬Î»ÎµÎ¹Î±Ï‚ Ï€ÏÎ¿ÎºÎµÎ¹Î¼Î­Î½Î¿Ï… Î½Î± Î´Î¿Î¸ÎµÎ¯ Î­Î³ÎºÏÎ¹ÏƒÎ· Î±Ï€ÏŒ Î´Î¹Î¬Ï†Î¿ÏÎ¿Ï…Ï‚ ÏÏ…Î¸Î¼Î¹ÏƒÏ„Î¹ÎºÎ¿ÏÏ‚ ÎºÎ±Î¹ Ï€Î¿Î»Î¹Ï„Î¹ÎºÎ¿ÏÏ‚ Î¿ÏÎ³Î±Î½Î¹ÏƒÎ¼Î¿ÏÏ‚ Î´Î·Î¼ÏŒÏƒÎ¹Î±Ï‚ Ï…Î³ÎµÎ¯Î±Ï‚. </p><p> Î ÎµÏÎ±Î¹Ï„Î­ÏÏ‰ Ï€Î±ÏÎ±ÎºÎ¿Î»Î¿ÏÎ¸Î·ÏƒÎ· Ï„Î·Ï‚ Î±ÏƒÏ†Î¬Î»ÎµÎ¹Î±Ï‚ ÎºÎ±Î¹ Ï„Î·Ï‚ Î±Ï€Î¿Ï„ÎµÎ»ÎµÏƒÎ¼Î±Ï„Î¹ÎºÏŒÏ„Î·Ï„Î±Ï‚ Ï€ÏÎ±Î³Î¼Î±Ï„Î¿Ï€Î¿Î¹ÎµÎ¯Ï„Î±Î¹ ÎºÎ±Ï„Î¬ Ï„Î· Ï‡ÏÎ®ÏƒÎ· Ï„Ï‰Î½ ÎµÎ¼Î²Î¿Î»Î¯Ï‰Î½. Î‘Ï…Ï„ÏŒ Î´Î¯Î½ÎµÎ¹ Ï„Î· Î´Ï…Î½Î±Ï„ÏŒÏ„Î·Ï„Î± ÏƒÏ„Î¿Ï…Ï‚ ÎµÏ€Î¹ÏƒÏ„Î®Î¼Î¿Î½ÎµÏ‚ Î½Î± Ï€Î±ÏÎ±ÎºÎ¿Î»Î¿Ï…Î¸Î¿ÏÎ½ Ï„Î· Î´ÏÎ¬ÏƒÎ· ÎºÎ±Î¹ Ï„Î·Î½ Î±ÏƒÏ†Î¬Î»ÎµÎ¹Î± Ï„Î¿Ï… ÎµÎ¼Î²Î¿Î»Î¯Î¿Ï…, Î±ÎºÏŒÎ¼Î· ÎºÎ±Î¹ ÏŒÏ„Î±Î½ Ï‡ÏÎ·ÏƒÎ¹Î¼Î¿Ï€Î¿Î¹ÎµÎ¯Ï„Î±Î¹ ÏƒÎµ Ï€Î¿Î»Î»Î¿ÏÏ‚ Î±Î½Î¸ÏÏÏ€Î¿Ï…Ï‚ Î³Î¹Î± Î¼ÎµÎ³Î¬Î»Î¿ Ï‡ÏÎ¿Î½Î¹ÎºÏŒ Î´Î¹Î¬ÏƒÏ„Î·Î¼Î±. Î‘Ï…Ï„Î¬ Ï„Î± Î´ÎµÎ´Î¿Î¼Î­Î½Î± Ï‡ÏÎ·ÏƒÎ¹Î¼Î¿Ï€Î¿Î¹Î¿ÏÎ½Ï„Î±Î¹ Î³Î¹Î± Ï„Î·Î½ Ï€ÏÎ¿ÏƒÎ±ÏÎ¼Î¿Î³Î® Ï„Ï‰Î½ Ï€Î¿Î»Î¹Ï„Î¹ÎºÏÎ½ Î³Î¹Î± Ï„Î· Ï‡ÏÎ®ÏƒÎ· Ï„Î¿Ï… ÎµÎ¼Î²Î¿Î»Î¯Î¿Ï…. </p><section class="e-card"><h4 class="mt-0">Î‘Î½Î±Ï†Î¿ÏÎ­Ï‚ / Î Î·Î³Î­Ï‚ Î Î»Î·ÏÎ¿Ï†ÏŒÏÎ·ÏƒÎ·Ï‚</h4><ul class="text-sm break-all"><li><a href="https://www.worldscientific.com/doi/pdf/10.1142/S2529732521400034" target="_blank" rel="noreferrer noopener">https://www.worldscientific.com/doi/pdf/10.1142/S2529732521400034</a></li></ul></section></section><hr class="mt-10 mb-40">',3),Qe={id:"s5"},Ge=e("h2",{id:"s5t"},"5. ÎœÎ¬ÏƒÎºÎµÏ‚ ÎºÎ±Ï„Î¬ Î¹ÏÎ½ ÎºÎ±Î¹ Î²Î±ÎºÏ„Î·ÏÎ¯Ï‰Î½",-1),Xe=e("p",null," ÎŸÎ¹ Î¼Î¬ÏƒÎºÎµÏ‚ Ï‡ÏÎ·ÏƒÎ¹Î¼Î¿Ï€Î¿Î¹Î¿ÏÎ½Ï„Î±Î¹ ÏƒÏ…Ï‡Î½Î¬ Î³Î¹Î± Ï„Î·Î½ Ï€ÏÎ¿ÏƒÏ„Î±ÏƒÎ¯Î± Î±Ï€ÏŒ Î¹Î¿ÏÏ‚ ÎºÎ±Î¹ Î²Î±ÎºÏ„Î®ÏÎ¹Î±. Î•Î¯Ï‡Î±Î½ Î´Î¹Î±Î´Î¿Î¸ÎµÎ¯ ÎµÏ…ÏÎ­Ï‰Ï‚ Î³Î¹Î± Ï„Î·Î½ Ï€ÏÎ¿ÏƒÏ„Î±ÏƒÎ¯Î± Î±Ï€ÏŒ Ï„Î¿Î½ Î¹ÏŒ SARS-CoV-2. ÎœÎµÏ„Î±Î¾Ï Ï„Ï‰Î½ Î´Î¹Î±Ï†Î¿ÏÎµÏ„Î¹ÎºÏÎ½ Ï„ÏÏ€Ï‰Î½ Î¼Î¬ÏƒÎºÎ±Ï‚ Î¿Î¹ Ï‡ÎµÎ¹ÏÎ¿Ï…ÏÎ³Î¹ÎºÎ­Ï‚ Î¼Î¬ÏƒÎºÎµÏ‚ Ï€ÏÎ¿ÏƒÏÏ€Î¿Ï… Î®Ï„Î±Î½ Î±Ï€ÏŒ Ï„Î± Ï€Î¹Î¿ ÏƒÏ…Ï‡Î½Î¬ Ï‡ÏÎ·ÏƒÎ¹Î¼Î¿Ï€Î¿Î¹Î¿ÏÎ¼ÎµÎ½Î± ÎºÎ±Î»ÏÎ¼Î¼Î±Ï„Î± Ï€ÏÎ¿ÏƒÏÏ€Î¿Ï… ÎºÎ±Ï„Î¬ Ï„Î·Î½ Ï€Î±Î½Î´Î·Î¼Î¯Î± Ï„Î¿Ï… COVID-19. Î¤Ï…Ï€Î¹ÎºÎ¬, Î­Ï‡Î¿Ï…Î½ Î¼Ï€Î»Îµ Ï‡ÏÏÎ¼Î± ÏƒÏ„Î· Î¼Î¯Î± Ï€Î»ÎµÏ…ÏÎ¬, Î· Î¿Ï€Î¿Î¯Î± Ï€ÏÎ­Ï€ÎµÎ¹ Î½Î± Ï‡ÏÎ·ÏƒÎ¹Î¼Î¿Ï€Î¿Î¹ÎµÎ¯Ï„Î±Î¹ Ï‰Ï‚ ÎµÎ¾Ï‰Ï„ÎµÏÎ¹ÎºÏŒ ÏƒÏ„ÏÏÎ¼Î± (ÎµÎ¹ÎºÏŒÎ½Î± 4). ÎŸ ÎºÏÏÎ¹Î¿Ï‚ ÏƒÏ„ÏŒÏ‡Î¿Ï‚ Ï„Î·Ï‚ Ï‡ÎµÎ¹ÏÎ¿Ï…ÏÎ³Î¹ÎºÎ®Ï‚ Î¼Î¬ÏƒÎºÎ±Ï‚ ÎµÎ¯Î½Î±Î¹ Î· Ï€ÏÎ¿ÏƒÏ„Î±ÏƒÎ¯Î± Ï„Ï‰Î½ Î±ÏƒÎ¸ÎµÎ½ÏÎ½ Î±Ï€ÏŒ Ï„Î·Î½ Ï€Î¹Î¸Î±Î½Î® ÎµÏ€Î±Ï†Î® Î¼Îµ Î²Î±ÎºÏ„Î®ÏÎ¹Î± ÎºÎ±Î¹ Î¹Î¿ÏÏ‚ Ï€Î¿Ï… ÎµÎºÏ€Î½Î­ÎµÎ¹ Î±Ï…Ï„ÏŒÏ‚ Ï€Î¿Ï… Ï†Î¿ÏÎ¬ÎµÎ¹ Ï„Î· Î¼Î¬ÏƒÎºÎ±. ÎˆÏ„ÏƒÎ¹, Î±Ï€Î¿Ï„ÏÎ­Ï€Î¿Ï…Î½ Î±Ï€Î¿Ï„ÎµÎ»ÎµÏƒÎ¼Î±Ï„Î¹ÎºÎ¬ Ï„Î·Î½ ÎµÎ¾Î¬Ï€Î»Ï‰ÏƒÎ· Ï„Î¿Ï… ÎºÎ¿ÏÎ¿Î½Î¿ÏŠÎ¿Ï Î¼Î­ÏƒÏ‰ Ï„Î¿Ï… Î±Î­ÏÎ±, ÏŒÎ¼Ï‰Ï‚ ÎµÎ¯Î½Î±Î¹ Î»Î¹Î³ÏŒÏ„ÎµÏÎ¿ Î±Ï€Î¿Ï„ÎµÎ»ÎµÏƒÎ¼Î±Ï„Î¹ÎºÎ­Ï‚ Î³Î¹Î± Ï„Î·Î½ Ï€ÏÎ¿ÏƒÏ„Î±ÏƒÎ¯Î± Î±Ï…Ï„Î¿Ï Ï€Î¿Ï… Ï†Î¿ÏÎ¬ÎµÎ¹ Ï„Î· Î¼Î¬ÏƒÎºÎ±. ",-1),Ze=e("p",null," ÎŸÎ¹ Î¼Î¬ÏƒÎºÎµÏ‚ FFP2 Î® FFP3 (Ï€Î¿Ï… ÏƒÏ…Ï‡Î½Î¬ Î¿Î½Î¿Î¼Î¬Î¶Î¿Î½Ï„Î±Î¹ Î±Î½Î±Ï€Î½ÎµÏ…ÏƒÏ„Î®ÏÎµÏ‚) Î¸Î± Ï€ÏÎ­Ï€ÎµÎ¹ Î½Î± Ï‡ÏÎ·ÏƒÎ¹Î¼Î¿Ï€Î¿Î¹Î¿ÏÎ½Ï„Î±Î¹ Î³Î¹Î± Ï„Î¿ Ï†Î¹Î»Ï„ÏÎ¬ÏÎ¹ÏƒÎ¼Î± ÎºÎ±Î¹ Ï„Î·Î½ ÎºÎ±Î»ÏÏ„ÎµÏÎ· ÎµÎ¹ÏƒÏ€Î½Î¿Î® Î±Î­ÏÎ±. Î¤Î¿ ÏƒÏÏƒÏ„Î·Î¼Î± Î±ÏÎ¯Î¸Î¼Î·ÏƒÎ·Ï‚ (FFP1, FPP2, FFP3) Ï…Ï€Î¿Î´ÎµÎ¹ÎºÎ½ÏÎµÎ¹ Ï„Î·Î½ Î±Ï€Î¿Ï„ÎµÎ»ÎµÏƒÎ¼Î±Ï„Î¹ÎºÏŒÏ„Î·Ï„Î± Ï†Î¹Î»Ï„ÏÎ±ÏÎ¯ÏƒÎ¼Î±Ï„Î¿Ï‚ Î±Ï…Ï„ÏÎ½ Ï„Ï‰Î½ ÏƒÏ…ÏƒÎºÎµÏ…ÏÎ½ (Î¼Îµ Ï€Î¹ÏƒÏ„Î¿Ï€Î¿Î¯Î·ÏƒÎ· ÏŒÏ„Î¹ Ï€Î»Î·ÏÎ¿ÏÎ½ Ï„Î¿ Ï€ÏÏŒÏ„Ï…Ï€Î¿ EN 149-2001). ÎŸÎ¹ Î¼Î¬ÏƒÎºÎµÏ‚ FFP2 ÎºÎ±Î¹ FPP3 Î­Ï‡Î¿Ï…Î½ Î±Ï€ÏŒÎ´Î¿ÏƒÎ· Ï†Î¹Î»Ï„ÏÎ±ÏÎ¯ÏƒÎ¼Î±Ï„Î¿Ï‚ Î³Î¹Î± Ï„Î± Î±Î¹Ï‰ÏÎ¿ÏÎ¼ÎµÎ½Î± ÏƒÏ‰Î¼Î±Ï„Î¯Î´Î¹Î± (ÏƒÏ…Î¼Ï€ÎµÏÎ¹Î»Î±Î¼Î²Î±Î½Î¿Î¼Î­Î½Ï‰Î½ ÎµÎºÎµÎ¯Î½Ï‰Î½ Ï€Î¿Ï… Ï€ÎµÏÎ¹Î­Ï‡Î¿Ï…Î½ Ï„Î¿Î½ Î¹ÏŒ) 92% ÎºÎ±Î¹ 98%, Î±Î½Ï„Î¯ÏƒÏ„Î¿Î¹Ï‡Î±. ÎšÎ±Î¹ Î¿Î¹ Î´ÏÎ¿ Ï„ÏÏ€Î¿Î¹ Î¼Î¬ÏƒÎºÎ±Ï‚ Î­Ï‡Î¿Ï…Î½ ÎµÏ€Î¯ÏƒÎ·Ï‚ Î¼Î¹ÎºÏÎ® Î´Î¹Î±ÏÏÎ¿Î® Ï€ÏÎ¿Ï‚ Ï„Î± Î¼Î­ÏƒÎ±: <8% ÎºÎ±Î¹ <2%, Î±Î½Ï„Î¯ÏƒÏ„Î¿Î¹Ï‡Î±. Î£Ï„Î· Î¼Î¬ÏƒÎºÎ± FFP2, Ï‡ÏÎ·ÏƒÎ¹Î¼Î¿Ï€Î¿Î¹ÎµÎ¯Ï„Î±Î¹ ÏƒÏ…Ï‡Î½Î¬ ÎµÎ¹Î´Î¹ÎºÏŒ ÎºÎ±Î¿Ï…Ï„ÏƒÎ¿ÏÎº ÏƒÏ„Î¿ ÎµÎ¾Ï‰Ï„ÎµÏÎ¹ÎºÏŒ ÏƒÏ„ÏÏÎ¼Î± Ï„Î¿Ï… Î±Î½Î±Ï€Î½ÎµÏ…ÏƒÏ„Î®ÏÎ±. Î‘Î½ ÎºÎ±Î¹ ÏƒÎµ ÎµÏ€Î±Î³Î³ÎµÎ»Î¼Î±Ï„Î¹ÎºÎ¬ Ï€ÎµÏÎ¹Î²Î¬Î»Î»Î¿Î½Ï„Î± Î­Ï‡ÎµÎ¹ ÎµÏ€Î¹Ï„ÏÎ±Ï€ÎµÎ¯ Î¼Î¹Î± Î²Î±Î»Î²Î¯Î´Î± (Ï€Î¿Ï… Î´Î¹ÎµÏ…ÎºÎ¿Î»ÏÎ½ÎµÎ¹ Ï„Î·Î½ ÎµÎºÏ€Î½Î¿Î®), ÏƒÏ„Î·Î½ Ï€ÎµÏÎ¯Ï€Ï„Ï‰ÏƒÎ· Ï„Î¿Ï… SARS-CoV-2, Î¸Î± Ï€ÏÎ­Ï€ÎµÎ¹ Î½Î± Ï‡ÏÎ·ÏƒÎ¹Î¼Î¿Ï€Î¿Î¹Î¿ÏÎ½Ï„Î±Î¹ Î¼ÏŒÎ½Î¿ Î±Î½Î±Ï€Î½ÎµÏ…ÏƒÏ„Î®ÏÎµÏ‚ Ï‡Ï‰ÏÎ¯Ï‚ Î²Î±Î»Î²Î¯Î´ÎµÏ‚ Î³Î¹Î± Î½Î± Ï†Î¹Î»Ï„ÏÎ¬ÏÎ¿Ï…Î½ ÎºÎ±Î¹ Ï„Î¿Î½ ÎµÎºÏ€Î½ÎµÏŒÎ¼ÎµÎ½Î¿ Î±Î­ÏÎ±. ",-1),ea=e("p",null," ÎœÎµ Ï„Î·Î½ Ï€Î±Î½Î´Î·Î¼Î¯Î± COVID-19, ÎµÎ¹ÏƒÎ®Ï‡Î¸Î· Î¼Î¹Î± Î½Î­Î± Î¼Î¬ÏƒÎºÎ± Ï€ÏÎ¿ÏƒÏÏ€Î¿Ï…: Î· Î¼Î¬ÏƒÎºÎ± Ï†Î¹Î»Ï„ÏÎ±ÏÎ¯ÏƒÎ¼Î±Ï„Î¿Ï‚. Î‘Ï…Ï„ÏŒÏ‚ Î¿ Ï„ÏÏ€Î¿Ï‚ Î¼Î¬ÏƒÎºÎ±Ï‚ ÎµÎ¯Î½Î±Î¹ ÎºÎ±Ï„Î±ÏƒÎºÎµÏ…Î±ÏƒÎ¼Î­Î½Î¿Ï‚ Î±Ï€ÏŒ Ï€Î¿Î»Ï…ÏƒÏ„ÏÏ‰Î¼Î±Ï„Î¹ÎºÏŒ ÏÏ†Î±ÏƒÎ¼Î± (Ï„Î¿ Î­Î½Î± ÏƒÏ„ÏÏÎ¼Î± Ï€ÏÎ­Ï€ÎµÎ¹ Î½Î± ÎµÎ¯Î½Î±Î¹ Ï†Î¯Î»Ï„ÏÎ¿ Î½Î±Î½Î¿ÏŠÎ½ÏÎ½ Ï€Î¿Ï… ÎµÎ³Î³Ï…Î¬Ï„Î±Î¹ Î¹ÎºÎ±Î½ÏŒÏ„Î·Ï„Î± Ï†Î¹Î»Ï„ÏÎ±ÏÎ¯ÏƒÎ¼Î±Ï„Î¿Ï‚ Î²Î±ÎºÏ„Î·ÏÎ¹Î±ÎºÎ®Ï‚ ÎºÎ±Î¹ ÎµÏ€Î¹Î²Î»Î±Î²Î¿ÏÏ‚ Î»ÎµÏ€Ï„Î®Ï‚ ÏƒÎºÏŒÎ½Î·Ï‚ Ï„Î¿Ï…Î»Î¬Ï‡Î¹ÏƒÏ„Î¿Î½ 90%). Î‘Ï…Ï„Î® Î· Î¼Î¬ÏƒÎºÎ± ÏƒÏ…Î½Î´Ï…Î¬Î¶ÎµÎ¹ Ï…ÏˆÎ·Î»Î® Î¹ÎºÎ±Î½ÏŒÏ„Î·Ï„Î± Ï†Î¹Î»Ï„ÏÎ±ÏÎ¯ÏƒÎ¼Î±Ï„Î¿Ï‚ Î¼Îµ Î´Ï…Î½Î±Ï„ÏŒÏ„Î·Ï„Î± ÎµÏ€Î±Î½Î±Ï‡ÏÎ·ÏƒÎ¹Î¼Î¿Ï€Î¿Î¯Î·ÏƒÎ·Ï‚ ÎºÎ±Î¸ÏÏ‚ Î¼Ï€Î¿ÏÎµÎ¯ Î½Î± Ï€Î»Ï…Î¸ÎµÎ¯ ÏƒÏ„Î¿ Ï€Î»Ï…Î½Ï„Î®ÏÎ¹Î¿ ÏƒÏ„Î¿Ï…Ï‚ 60 Î²Î±Î¸Î¼Î¿ÏÏ‚. ",-1),aa={class:"grid gap-3 my-15 md:grid-cols-2 e-card"},ta=i('<p class="mt-3 mb-8 text-sm text-center"><i><b>Î•Î¹ÎºÏŒÎ½Î± 1.</b> Î”Î¹Î±Ï†Î¿ÏÎµÏ„Î¹ÎºÎ¿Î¯ Ï„ÏÏ€Î¿Î¹ Î¼Î¬ÏƒÎºÎ±Ï‚</i></p><p> Î— Î±Ï€Î¿Ï„ÎµÎ»ÎµÏƒÎ¼Î±Ï„Î¹ÎºÏŒÏ„Î·Ï„Î± Ï„Ï‰Î½ Î¼Î±ÏƒÎºÏÎ½ Î­Ï‡ÎµÎ¹ Î´Î¿ÎºÎ¹Î¼Î±ÏƒÏ„ÎµÎ¯ ÏƒÎµ ÎµÎ¹Î´Î¹ÎºÎ¬ ÎµÏÎ³Î±ÏƒÏ„Î®ÏÎ¹Î± (Ï€.Ï‡. ÏƒÎµ Î¸Î¬Î»Î±Î¼Î¿ Î­ÎºÎ¸ÎµÏƒÎ·Ï‚). Î£Îµ Î±Ï…Ï„Î­Ï‚ Ï„Î¹Ï‚ Î¼ÎµÎ»Î­Ï„ÎµÏ‚ Î¼Î¯Î± Î³ÎµÎ½Î½Î®Ï„ÏÎ¹Î± ÏƒÏ‰Î¼Î±Ï„Î¹Î´Î¯Ï‰Î½ Î­Ï‡ÎµÎ¹ ÎµÏ€Î¹Î¼Î¿Î»Ï…Î½Î¸ÎµÎ¯ Î¼Îµ Ï„Î¿Î½ Î¹ÏŒ. Î£Ï„Î· ÏƒÏ…Î½Î­Ï‡ÎµÎ¹Î±, Î±Î½ÎµÎ¼Î¹ÏƒÏ„Î®ÏÎµÏ‚ Ï€Î¯ÏƒÏ‰ Î±Ï€ÏŒ Ï„Î· Î³ÎµÎ½Î½Î®Ï„ÏÎ¹Î± ÏƒÏ‰Î¼Î±Ï„Î¹Î´Î¯Ï‰Î½ Î³ÎµÎ¼Î¯Î¶Î¿Ï…Î½ Ï„Î¿Î½ Î¸Î¬Î»Î±Î¼Î¿ Î­ÎºÎ¸ÎµÏƒÎ·Ï‚ Î¼Îµ Î¼Î¹ÎºÏÎ¬ ÏƒÏ‰Î¼Î±Ï„Î¯Î´Î¹Î±, Ï€Î±ÏÏŒÎ¼Î¿Î¹Î± Î¼Îµ Ï„Î± Î±ÎµÏÎ¿Î»ÏÎ¼Î±Ï„Î± Ï€Î¿Ï… Ï€ÏÎ¿ÎºÏÏ€Ï„Î¿Ï…Î½ Î±Ï€ÏŒ Ï„Î·Î½ Î±Î½Î±Ï€Î½Î¿Î® Ï†Î¿ÏÎ­Ï‰Î½ Ï„Î¿Ï… Î¹Î¿Ï. ÎšÎ±Ï„ÏŒÏ€Î¹Î½ Î¼ÎµÏ„ÏÎ¹Î­Ï„Î±Î¹ Î· ÏƒÏ…Î³ÎºÎ­Î½Ï„ÏÏ‰ÏƒÎ· ÏƒÏ‰Î¼Î±Ï„Î¹Î´Î¯Ï‰Î½ Ï€Î¬Î½Ï‰ ÏƒÏ„Î¹Ï‚ Î¼Î¬ÏƒÎºÎµÏ‚ ÎºÎ±Î¹ ÏƒÏ…Î³ÎºÏÎ¯Î½ÎµÏ„Î±Î¹ Î¼Îµ Ï„Î· ÏƒÏ…Î³ÎºÎ­Î½Ï„ÏÏ‰ÏƒÎ· ÏƒÏ„Î· Î³ÎµÎ½Î¹ÎºÎ® Î±Ï„Î¼ÏŒÏƒÏ†Î±Î¹ÏÎ± Ï„Î¿Ï… Î¸Î±Î»Î¬Î¼Î¿Ï… Î­ÎºÎ¸ÎµÏƒÎ·Ï‚. </p><p> Î©ÏƒÏ„ÏŒÏƒÎ¿, Ï„Î± Î¹ÏƒÏ‡Ï…ÏÏŒÏ„ÎµÏÎ± ÏƒÏ„Î¿Î¹Ï‡ÎµÎ¯Î± Î³Î¹Î± Ï„Î·Î½ Î±Ï€Î¿Ï„ÎµÎ»ÎµÏƒÎ¼Î±Ï„Î¹ÎºÏŒÏ„Î·Ï„Î± Ï„Î·Ï‚ Î¼Î¬ÏƒÎºÎ±Ï‚ Î²Î±ÏƒÎ¯Î¶Î¿Î½Ï„Î±Î¹ ÏƒÎµ ÎµÏ€Î¹Î´Î·Î¼Î¹Î¿Î»Î¿Î³Î¹ÎºÎ¬ Î´ÎµÎ´Î¿Î¼Î­Î½Î± Î±Ï€ÏŒ Ï€ÏÎ±Î³Î¼Î±Ï„Î¹ÎºÎ­Ï‚ ÎºÎ±Ï„Î±ÏƒÏ„Î¬ÏƒÎµÎ¹Ï‚. Î“Î¹Î± Ï€Î±ÏÎ¬Î´ÎµÎ¹Î³Î¼Î±, Î¿ Î·Î¼ÎµÏÎ®ÏƒÎ¹Î¿Ï‚ ÏÏ…Î¸Î¼ÏŒÏ‚ Î±Î½Î¬Ï€Ï„Ï…Î¾Î·Ï‚ Ï„Î¿Ï… COVID-19 ÎµÏ€Î¹Î²ÏÎ±Î´ÏÎ½Î¸Î·ÎºÎµ Î¼ÎµÏ„Î¬ Î±Ï€ÏŒ Ï„Î· Ï‡ÏÎ®ÏƒÎ· Ï„Î·Ï‚ Î¼Î¬ÏƒÎºÎ±Ï‚ ÏƒÎµ 15 Ï€Î¿Î»Î¹Ï„ÎµÎ¯ÎµÏ‚ ÎºÎ±Î¹ Ï„Î·Î½ Î ÎµÏÎ¹Ï†Î­ÏÎµÎ¹Î± Ï„Î·Ï‚ ÎšÎ¿Î»Î¿ÏÎ¼Ï€Î¹Î± ÏƒÏ„Î¹Ï‚ Î—Î Î‘. ÎœÎ¹Î± Î¬Î»Î»Î· Î¼ÎµÎ»Î­Ï„Î· ÎµÎ¾Î­Ï„Î±ÏƒÎµ Ï„Î¿Ï…Ï‚ Î¸Î±Î½Î¬Ï„Î¿Ï…Ï‚ Î±Ï€ÏŒ ÎºÎ¿ÏÎ¿Î½Î¿ÏŠÏŒ ÏƒÎµ 198 Ï‡ÏÏÎµÏ‚ ÎºÎ±Î¹ Î´Î¹Î±Ï€Î¯ÏƒÏ„Ï‰ÏƒÎµ ÏŒÏ„Î¹ ÎµÎºÎµÎ¯Î½Î¿Î¹ Î¼Îµ Ï€Î¿Î»Î¹Ï„Î¹ÏƒÏ„Î¹ÎºÎ¿ÏÏ‚ ÎºÎ±Î½ÏŒÎ½ÎµÏ‚ Î® ÎºÏ…Î²ÎµÏÎ½Î·Ï„Î¹ÎºÎ­Ï‚ Ï€Î¿Î»Î¹Ï„Î¹ÎºÎ­Ï‚ Ï€Î¿Ï… ÎµÏ…Î½Î¿Î¿ÏÏƒÎ±Î½ Ï„Î· Ï‡ÏÎ®ÏƒÎ· Î¼Î¬ÏƒÎºÎ±Ï‚ ÎµÎ¯Ï‡Î±Î½ Ï‡Î±Î¼Î·Î»ÏŒÏ„ÎµÏÎ± Ï€Î¿ÏƒÎ¿ÏƒÏ„Î¬ Î¸Î±Î½Î¬Ï„Ï‰Î½. </p><p> Î Î¿Î»Î»Î¿Î¯ Ï‡ÏÎ®ÏƒÏ„ÎµÏ‚ Ï„Î¿Ï… Facebook ÎºÎ±Î¹ Ï„Ï‰Î½ Î¼Î­ÏƒÏ‰Î½ ÎºÎ¿Î¹Î½Ï‰Î½Î¹ÎºÎ®Ï‚ Î´Î¹ÎºÏ„ÏÏ‰ÏƒÎ·Ï‚ Î­Ï‡Î¿Ï…Î½ ÎºÎ¿Î¹Î½Î¿Ï€Î¿Î¹Î®ÏƒÎµÎ¹ Ï€Î±ÏÎ±Ï€Î»Î±Î½Î·Ï„Î¹ÎºÎ­Ï‚ Î±Î½Î±ÏÏ„Î®ÏƒÎµÎ¹Ï‚ ÏƒÏ‡ÎµÏ„Î¹ÎºÎ¬ Î¼Îµ Ï„Î¿ ÏŒÏ„Î¹ Î· Ï€Î±ÏÎ±Ï„ÎµÏ„Î±Î¼Î­Î½Î· Ï‡ÏÎ®ÏƒÎ· Î¼Î¬ÏƒÎºÎ±Ï‚ Ï€ÏÎ¿ÏƒÏÏ€Î¿Ï… Ï€ÏÎ¿ÎºÎ±Î»ÎµÎ¯ Î±Î½ÎµÏ€Î¬ÏÎºÎµÎ¹Î± Î¿Î¾Ï…Î³ÏŒÎ½Î¿Ï… ÏƒÏ„Î¿ ÏƒÏÎ¼Î± - Ï…Ï€Î¿Î¾Î¯Î±. Î©ÏƒÏ„ÏŒÏƒÎ¿, ÎµÏÎµÏ…Î½Î·Ï„Î¹ÎºÎ¬ Î¬ÏÎ¸ÏÎ± ÎºÎ±Î¹ ÎµÎ¹Î´Î¹ÎºÎ¿Î¯ Ï€ÏÎ¿Ï„ÎµÎ¯Î½Î¿Ï…Î½ ÏŒÏ„Î¹ Ï„Î­Ï„Î¿Î¹Î± ÏƒÏ…Î¼Ï€Ï„ÏÎ¼Î±Ï„Î± ÎµÎ¯Î½Î±Î¹ Î±Ï€Î¯Î¸Î±Î½Î¿ Î½Î± ÎµÎ¼Ï†Î±Î½Î¹ÏƒÏ„Î¿ÏÎ½, ÎµÎºÏ„ÏŒÏ‚ ÎµÎ¬Î½ Î¿ Ï‡ÏÎ®ÏƒÏ„Î·Ï‚ Î­Ï‡ÎµÎ¹ Ï€ÏÎ¿Ï‹Ï€Î¬ÏÏ‡Î¿Ï…ÏƒÎµÏ‚ Î±Î½Î±Ï€Î½ÎµÏ…ÏƒÏ„Î¹ÎºÎ­Ï‚ Î±ÏƒÎ¸Î­Î½ÎµÎ¹ÎµÏ‚ ÏŒÏ€Ï‰Ï‚ Ï„Î¿ Î¬ÏƒÎ¸Î¼Î± Î® Ï‡ÏÏŒÎ½Î¹Î± Î±Ï€Î¿Ï†ÏÎ±ÎºÏ„Î¹ÎºÎ® Ï€Î½ÎµÏ…Î¼Î¿Î½Î¿Ï€Î¬Î¸ÎµÎ¹Î± (COPD). ÎŸ ÎºÎ¯Î½Î´Ï…Î½Î¿Ï‚ Ï…Ï€Î¿Î¾Î¯Î±Ï‚ ÎºÎ±Î¹ Ï…Ï€ÎµÏÎºÎ±Ï€Î½Î¯Î±Ï‚ (Î´Î·Î». Î· ÏÏ€Î±ÏÎ¾Î· Ï…Ï€ÎµÏÎ²Î¿Î»Î¹ÎºÎ¿Ï Î´Î¹Î¿Î¾ÎµÎ¹Î´Î¯Î¿Ï… Ï„Î¿Ï… Î¬Î½Î¸ÏÎ±ÎºÎ± ÏƒÏ„Î¿ Î±Î¯Î¼Î±) ÎµÎ¯Î½Î±Î¹ Î±Ï€Î¯Î¸Î±Î½Î¿ Î½Î± ÎµÎ¼Ï†Î±Î½Î¹ÏƒÏ„ÎµÎ¯ Î¼Îµ Ï…Ï†Î±ÏƒÎ¼Î¬Ï„Î¹Î½ÎµÏ‚ ÎºÎ±Î¹ Ï‡ÎµÎ¹ÏÎ¿Ï…ÏÎ³Î¹ÎºÎ­Ï‚ Î¼Î¬ÏƒÎºÎµÏ‚, ÎºÎ±Î¸ÏÏ‚ Î´ÎµÎ½ ÎµÏ†Î±ÏÎ¼ÏŒÎ¶Î¿Ï…Î½ ÏƒÏ†Î¹Ï‡Ï„Î¬. Î©ÏƒÏ„ÏŒÏƒÎ¿, ÎµÏ€Î¹ÏƒÎ·Î¼Î±Î¯Î½ÎµÏ„Î±Î¹ ÏŒÏ„Î¹ Î´ÎµÎ½ Ï€ÏÎ­Ï€ÎµÎ¹ Î½Î± Ï„Î¿Ï€Î¿Î¸ÎµÏ„Î¿ÏÎ½Ï„Î±Î¹ Î¼Î¬ÏƒÎºÎµÏ‚ Ï€ÏÎ¿ÏƒÏÏ€Î¿Ï… ÏƒÎµ Î¼Î¹ÎºÏÎ¬ Ï€Î±Î¹Î´Î¹Î¬ ÎºÎ¬Ï„Ï‰ Ï„Ï‰Î½ Î´ÏÎ¿ ÎµÏ„ÏÎ½, ÏƒÎµ Î¬Ï„Î¿Î¼Î± Î¼Îµ Î´Ï…ÏƒÎºÎ¿Î»Î¯Î± ÏƒÏ„Î·Î½ Î±Î½Î±Ï€Î½Î¿Î® Î® ÏŒÏ„Î±Î½ Î±Î¸Î»Î¿ÏÎ½Ï„Î±Î¹. </p><section class="e-card"><h4 class="mt-0">Î‘Î½Î±Ï†Î¿ÏÎ­Ï‚ / Î Î·Î³Î­Ï‚ Î Î»Î·ÏÎ¿Ï†ÏŒÏÎ·ÏƒÎ·Ï‚</h4><ul class="text-sm break-all"><li><a href="https://bmcpublichealth.biomedcentral.com/articles/10.1186/s12889-021-10652-9" target="_blank" rel="noopener noreferrer">https://bmcpublichealth.biomedcentral.com/articles/10.1186/s12889-021-10652-9</a></li><li><a href="https://jamanetwork.com/journals/jamainternalmedicine/fullarticle/2774266" target="_blank" rel="noopener noreferrer">https://jamanetwork.com/journals/jamainternalmedicine/fullarticle/2774266</a></li><li><a href="https://www.healthaffairs.org/doi/10.1377/hlthaff.2020.00818" target="_blank" rel="noopener noreferrer">https://www.healthaffairs.org/doi/10.1377/hlthaff.2020.00818</a></li><li><a href="https://www.ajtmh.org/view/journals/tpmd/103/6/article-p2400.xml" target="_blank" rel="noopener noreferrer">https://www.ajtmh.org/view/journals/tpmd/103/6/article-p2400.xml</a></li><li><a href="" target="_blank" rel="noopener noreferrer">https://www.epa.gov/sciencematters/epa-researchers-test-effectiveness-face-masks-disinfection-methods-against-covid-19 </a></li><li><a href="https://journals.asm.org/doi/full/10.1128/mSphere.00637-20" target="_blank" rel="noopener noreferrer">https://journals.asm.org/doi/full/10.1128/mSphere.00637-20</a></li><li><a href="https://pubmed.ncbi.nlm.nih.gov/33626065/" target="_blank" rel="noopener noreferrer">https://pubmed.ncbi.nlm.nih.gov/33626065/</a></li><li><a href="https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0247414" target="_blank" rel="noopener noreferrer">https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0247414</a></li></ul></section>',5),sa=e("div",null,[e("h3",{class:"mt-6 pt-3 mb-10"},"Î“Î¹Î± Ï€ÎµÏÎ¹ÏƒÏƒÏŒÏ„ÎµÏÎ· Î¼ÎµÎ»Î­Ï„Î·"),e("ul",{class:"leading-tight break-all"},[e("li",null,[e("a",{href:"https://youtu.be/npXP5wqNzaI?t=205",target:"_blank",rel:"noopener noreferrer"},"https://youtu.be/npXP5wqNzaI?t=205"),a(" ÎµÏ€ÎµÎ¾Î®Î³Î·ÏƒÎ· Ï„Ï‰Î½ Ï€ÎµÏÎ¹ÏƒÏƒÏŒÏ„ÎµÏÏ‰Î½ Î¼ÏÎ¸Ï‰Î½, Ï€Î±ÏÎ¿Ï…ÏƒÎ¯Î± Ï€Î¹Î¸Î±Î½Î®Ï‚ Ï…Ï€Î¿Î¾Î¯Î±Ï‚ 3:24 - 6:39")]),e("li",null,[e("a",{href:"https://drive.google.com/file/d/1rbdXeVTKT8oFFWyV0XZ00ewjdngvsuHF/view?usp=share_link",target:"_blank",rel:"noopener noreferrer"},"https://drive.google.com/file/d/1rbdXeVTKT8oFFWyV0XZ00ewjdngvsuHF/view?usp=share_link"),a(" â€“ Î±Ï€Î¿Ï„ÎµÎ»ÎµÏƒÎ¼Î±Ï„Î¹ÎºÏŒÏ„Î·Ï„Î± Î¼Î¬ÏƒÎºÎ±Ï‚ Ï‰Ï‚ Ï€ÏÏÏ‚ Ï„Î¿ Ï†Î¹Î»Ï„ÏÎ¬ÏÎ¹ÏƒÎ¼Î±")]),e("li",null,[e("a",{href:"https://drive.google.com/file/d/1oNy89fCcFjaBuicacmlH1xiGHGsr--Is/view?usp=share_link",target:"_blank",rel:"noopener noreferrer"},"https://drive.google.com/file/d/1oNy89fCcFjaBuicacmlH1xiGHGsr--Is/view?usp=share_link"),a(" â€“ Î±Ï€Î¿Ï„ÎµÎ»ÎµÏƒÎ¼Î±Ï„Î¹ÎºÏŒÏ„Î·Ï„Î± Î¼Î¬ÏƒÎºÎ±Ï‚ Ï‰Ï‚ Ï€ÏÏÏ‚ Ï„Î·Î½ Ï€ÏÎ¿ÏƒÏ„Î±ÏƒÎ¯Î± Î±Ï€ÏŒ Î±ÏÏÏÏƒÏ„Î¹ÎµÏ‚")]),e("li",null,[e("a",{href:"https://www.fda.gov/medical-devices/personal-protective-equipment-infection-control/n95-respirators-surgical-masks-face-masks-and-barrier-face-coverings#s3",target:"_blank",rel:"noopener noreferrer"},"N95 Respirators, Surgical Masks, Face Masks, and Barrier Face Coverings")]),e("li",null,[e("a",{href:"https://www.sciencedirect.com/science/article/pii/S2452199X20301481",target:"_blank",rel:"noopener noreferrer"},"An overview of filtration efficiency through the masks: Mechanisms of the aerosols penetration")]),e("li",null,[e("a",{href:"https://www.weforum.org/agenda/2020/10/covid-19-coronavirus-disease-size-compairson-zika-health-air-pollution/",target:"_blank",rel:"noopener noreferrer"},"This is how coronavirus compares to the world's smallest particles")])])],-1),ia=e("hr",{class:"mt-10 mb-40"},null,-1),ra={id:"s6"},na=i('<h2 id="s6t">6. Î™Î¿Î¯ ÎºÎ±Î¹ Ï…Î³Î¹ÎµÎ¹Î½Î® Ï‡ÎµÏÎ¹ÏÎ½</h2><h3>Î‘Ï€Î¿Î»Ï…Î¼Î±Î½Ï„Î¹ÎºÏŒ Ï‡ÎµÏÎ¹ÏÎ½ Î® ÏƒÎ±Ï€Î¿ÏÎ½Î¹;</h3><p> Î¤Î± Ï‡Î­ÏÎ¹Î± Î¼Î±Ï‚ Î¼Ï€Î¿ÏÎ¿ÏÎ½ Î½Î± Î±Ï€Î¿Ï„ÎµÎ»Î­ÏƒÎ¿Ï…Î½ ÎºÏÎ¯ÏƒÎ¹Î¼Î¿ Ï€Î±ÏÎ¬Î³Î¿Î½Ï„Î± ÏƒÏ„Î· Î¼ÎµÏ„Î¬Î´Î¿ÏƒÎ· Î»Î¿Î¹Î¼ÏÎ¾ÎµÏ‰Î½. ÎŒÏ„Î±Î½ ÎµÏ†Î±ÏÎ¼ÏŒÎ¶Î¿Î½Ï„Î±Î¹ ÏƒÏ‡Î¿Î»Î±ÏƒÏ„Î¹ÎºÎ¬ ÏƒÏ„Î± Ï‡Î­ÏÎ¹Î± ÎºÎ±Î¹ Ï„ÏÎ¯Î²Î¿Î½Ï„Î±Î¹ Î³Î¹Î± Ï„Î¿Ï…Î»Î¬Ï‡Î¹ÏƒÏ„Î¿Î½ 20 Î´ÎµÏ…Ï„ÎµÏÏŒÎ»ÎµÏ€Ï„Î±, Ï„Î± Î±Ï€Î¿Î»Ï…Î¼Î±Î½Ï„Î¹ÎºÎ¬ Ï‡ÎµÏÎ¹ÏÎ½ ÎºÎ±Î¹ Ï„Î¿ ÏƒÎ±Ï€Î¿ÏÎ½Î¹ Î¼Îµ Î²Î¬ÏƒÎ· Ï„Î¿ Î±Î»ÎºÎ¿ÏŒÎ» Î¸Î± ÏƒÎºÎ¿Ï„ÏÏƒÎ¿Ï…Î½ Ï„Î¿Î½ ÎºÎ¿ÏÎ¿Î½Î¿ÏŠÏŒ. Î•Ï€Î¹Ï€Î»Î­Î¿Î½, Ï„Î¿ ÏƒÎ±Ï€Î¿ÏÎ½Î¹ Î´Î¹Î±Ï„Î±ÏÎ¬ÏƒÏƒÎµÎ¹ Ï„Î¿Î½ ÎºÎ¿Î»Î»ÏÎ´Î· Î´ÎµÏƒÎ¼ÏŒ Î¼ÎµÏ„Î±Î¾Ï Ï„Ï‰Î½ Ï€Î±Î¸Î¿Î³ÏŒÎ½Ï‰Î½ ÎºÎ±Î¹ Ï„Î¿Ï… Î´Î­ÏÎ¼Î±Ï„ÏŒÏ‚ ÏƒÎ±Ï‚, ÎµÏ€Î¹Ï„ÏÎ­Ï€Î¿Î½Ï„Î±Ï‚ ÏƒÏ„Î± Ï€Î±Î¸Î¿Î³ÏŒÎ½Î± Î½Î± Î³Î»Î¹ÏƒÏ„ÏÎ®ÏƒÎ¿Ï…Î½ Î±Î¼Î­ÏƒÏ‰Ï‚ Î¼Î±ÎºÏÎ¹Î¬ Î±Ï€ÏŒ Ï„Î± Ï‡Î­ÏÎ¹Î± ÏƒÎ±Ï‚. ÎœÎµ Ï„Î¿ ÏƒÏ‡Î¿Î»Î±ÏƒÏ„Î¹ÎºÏŒ Ï€Î»ÏÏƒÎ¹Î¼Î¿, ÏŒÏ‡Î¹ Î¼ÏŒÎ½Î¿ ÎµÎ¾Î¿Ï…Î´ÎµÏ„ÎµÏÏÎ½ÎµÏ„Îµ Ï„Î¿Î½ Î¹ÏŒ, Î±Î»Î»Î¬ Ï„Î¿Î½ Î±Ï€Î¿Î¼Î±ÎºÏÏÎ½ÎµÏ„Îµ ÎºÎ±Î¹ Î±Ï€ÏŒ Ï„Î± Ï‡Î­ÏÎ¹Î± ÏƒÎ±Ï‚. Î— Ï€ÏÎ±ÎºÏ„Î¹ÎºÎ® Ï„Î·Ï‚ ÎºÎ±Î»Î®Ï‚ Ï…Î³Î¹ÎµÎ¹Î½Î®Ï‚ Ï„Ï‰Î½ Ï‡ÎµÏÎ¹ÏÎ½ ÎµÎ¯Î½Î±Î¹ Î¼Î¹Î± Î±Ï€Î»Î® Ï€ÏÎ¿Î»Î·Ï€Ï„Î¹ÎºÎ® ÏƒÏ„ÏÎ±Ï„Î·Î³Î¹ÎºÎ® Ï€Î¿Ï… Î¼Ï€Î¿ÏÎ¿ÏÎ½ ÎµÏÎºÎ¿Î»Î± Î½Î± Î±ÎºÎ¿Î»Î¿Ï…Î¸Î®ÏƒÎ¿Ï…Î½ Î¿Î¹ Ï€ÎµÏÎ¹ÏƒÏƒÏŒÏ„ÎµÏÎ¿Î¹ Î¬Î½Î¸ÏÏ‰Ï€Î¿Î¹ ÎºÎ±Î¹ Ï€Î¿Î»Î»Î­Ï‚ Î¼ÎµÎ»Î­Ï„ÎµÏ‚ Î­Ï‡Î¿Ï…Î½ Î±Ï€Î¿Î´ÎµÎ¯Î¾ÎµÎ¹ Ï„Î·Î½ Î±Ï€Î¿Ï„ÎµÎ»ÎµÏƒÎ¼Î±Ï„Î¹ÎºÏŒÏ„Î·Ï„Î± Ï„Î·Ï‚ Ï…Î³Î¹ÎµÎ¹Î½Î®Ï‚ Ï„Ï‰Î½ Ï‡ÎµÏÎ¹ÏÎ½ ÏƒÏ„Î·Î½ Ï€ÏÏŒÎ»Î·ÏˆÎ· Ï„Î·Ï‚ Î¼ÎµÏ„Î¬Î´Î¿ÏƒÎ·Ï‚ Î¼Î¿Î»Ï…ÏƒÎ¼Î±Ï„Î¹ÎºÏÎ½ Ï€Î±Î¸Î¿Î³ÏŒÎ½Ï‰Î½, ÏƒÏ…Î¼Ï€ÎµÏÎ¹Î»Î±Î¼Î²Î±Î½Î¿Î¼Î­Î½Ï‰Î½ Ï„Î¿Ï… ÎºÎ¿ÏÎ¿Î½Î¿ÏŠÎ¿Ï… ÏŒÏ€Ï‰Ï‚ Î¿ SARS-CoV-2. </p><section class="e-card"><h4 class="mt-0">Î‘Î½Î±Ï†Î¿ÏÎ­Ï‚ / Î Î·Î³Î­Ï‚ Î Î»Î·ÏÎ¿Ï†ÏŒÏÎ·ÏƒÎ·Ï‚</h4><ul class="text-sm break-all"><li><a href="https://www.uchealth.org/today/why-soap-and-water-work-better-than-hand-sanitizer-to-remove-the-coronavirus/" target="_blank" rel="noopener noreferrer">https://www.uchealth.org/today/why-soap-and-water-work-better-than-hand-sanitizer-to-remove-the-coronavirus/</a></li></ul></section><h3>Î‘Ï€Î¿Î´Ï…Î½Î¬Î¼Ï‰ÏƒÎ· Ï„Î¿Ï… ÎºÎ¿ÏÎ¿Î½Î¿ÏŠÎ¿Ï Î¼Îµ ÏƒÎ±Ï€Î¿ÏÎ½Î¹</h3><p> ÎŸÎ¹ ÎºÎ¿ÏÎ¿Î½Î¿ÏŠÎ¿Î¯ Ï€Î±Î¯ÏÎ½Î¿Ï…Î½ Ï„Î¿ ÏŒÎ½Î¿Î¼Î¬ Ï„Î¿Ï…Ï‚ Î±Ï€ÏŒ Ï„Î·Î½ Â«ÎºÎ¿ÏÏÎ½Î±Â» Ï€Î¿Ï… Ï€ÎµÏÎ¹Î²Î¬Î»Î»ÎµÎ¹ Ï„Î¿Î½ Î¹ÏŒ - Î±Î¹Ï‡Î¼Î­Ï‚ Ï€ÏÏ‰Ï„ÎµÎÎ½Î·Ï‚ Ï€Î¿Ï… ÎµÎ¯Î½Î±Î¹ ÎµÎ½ÏƒÏ‰Î¼Î±Ï„Ï‰Î¼Î­Î½ÎµÏ‚ ÏƒÏ„Î·Î½ ÎµÏ€Î¹Ï†Î¬Î½ÎµÎ¹Î¬ Ï„Î¿Ï…Ï‚. ÎŸÎ¹ Î±Î¹Ï‡Î¼Î­Ï‚, Î¿Î¹ Î¿Ï€Î¿Î¯ÎµÏ‚ ÎµÎ¯Î½Î±Î¹ Ï…Ï€ÎµÏÎ¸Ï…Î½ÎµÏ‚ Î³Î¹Î± Ï„Î· Î¼ÏŒÎ»Ï…Î½ÏƒÎ· Ï„Î¿Ï… Î¾ÎµÎ½Î¹ÏƒÏ„Î®, Î³Î±Î½Ï„Î¶ÏÎ½Î¿Ï…Î½ ÏƒÎµ Î¼Î¹Î± Î¼ÎµÎ¼Î²ÏÎ¬Î½Î·. Î— Î¼ÎµÎ¼Î²ÏÎ¬Î½Î· ÎµÎ¯Î½Î±Î¹ Ï„Î¿ Â«ÎºÎ­Î»Ï…Ï†Î¿Ï‚Â» Ï„Î¿Ï… Î¹Î¿Ï, Î±Î»Î»Î¬ ÎºÎ±Î¹ Ï„Î¿ Î±Î´ÏÎ½Î±Î¼Î¿ ÏƒÎ·Î¼ÎµÎ¯Î¿ Ï„Î¿Ï… Î¹Î¿Ï. </p><p> Î¤Î± Î¼ÏŒÏÎ¹Î± Ï„Î¿Ï… ÏƒÎ±Ï€Î¿Ï…Î½Î¹Î¿Ï Î­Ï‡Î¿Ï…Î½ Î´ÏÎ¿ Ï‡Î·Î¼Î¹ÎºÎ¬ Î´Î¹Î±ÎºÏÎ¹Ï„Î¬ Î¼Î­ÏÎ·: Î­Î½Î± Ï…Î´ÏÏŒÏ†Î¹Î»Î¿ (Ï€Î¿Ï… Î±Î³Î±Ï€Î¬ Ï„Î¿ Î½ÎµÏÏŒ) Â«ÎºÎµÏ†Î¬Î»Î¹Â» ÎºÎ±Î¹ Î¼Î¹Î± Ï…Î´ÏÏŒÏ†Î¿Î²Î· (Ï€Î¿Ï… Î¼Î¹ÏƒÎµÎ¯ Ï„Î¿ Î½ÎµÏÏŒ) Â«Î¿Ï…ÏÎ¬Â». Î¤Î¿ ÎºÎµÏ†Î¬Î»Î¹ Î²Î¿Î·Î¸Î¬ Ï„Î¿ ÏƒÎ±Ï€Î¿ÏÎ½Î¹ Î½Î± Î±Î½Î±Î¼Î¹Ï‡Î¸ÎµÎ¯ Î¼Îµ Ï„Î¿ Î½ÎµÏÏŒ, ÎµÎ½Ï Î· Î¿Ï…ÏÎ¬ Î¼Ï€Î¿ÏÎµÎ¯ Î½Î± Î±Î»Î»Î·Î»ÎµÏ€Î¹Î´ÏÎ¬ÏƒÎµÎ¹ Î¼Îµ Î¬Î»Î»Î± Ï…Î´ÏÏŒÏ†Î¿Î²Î± Î¼ÏŒÏÎ¹Î± ÏŒÏ€Ï‰Ï‚ Ï„Î± Î»Î¹Ï€Î¯Î´Î¹Î±. </p><p> Î•Ï…Ï„Ï…Ï‡ÏÏ‚, Î· Î¼ÎµÎ¼Î²ÏÎ¬Î½Î· Ï„Î¿Ï… ÎºÎ¿ÏÎ¿Î½Î¿ÏŠÎ¿Ï Î±Ï€Î¿Ï„ÎµÎ»ÎµÎ¯Ï„Î±Î¹ ÎºÏ…ÏÎ¯Ï‰Ï‚ Î±Ï€ÏŒ Î¼ÏŒÏÎ¹Î± Î»Î¹Ï€Î¹Î´Î¯Ï‰Î½. Î”Î¹Î±Ï„Î·ÏÎµÎ¯Ï„Î±Î¹ Ï‡Î¬ÏÎ· ÏƒÎµ Î±ÏƒÎ¸ÎµÎ½ÎµÎ¯Ï‚ Ï‡Î·Î¼Î¹ÎºÎ­Ï‚ Î±Î»Î»Î·Î»ÎµÏ€Î¹Î´ÏÎ¬ÏƒÎµÎ¹Ï‚ Î¼ÎµÏ„Î±Î¾Ï Î¼ÎµÎ¼Î¿Î½Ï‰Î¼Î­Î½Ï‰Î½ Î¼Î¿ÏÎ¯Ï‰Î½. ÎŸÎ¹ Ï…Î´ÏÏŒÏ†Î¿Î²ÎµÏ‚ (Ï€Î¿Ï… Î¼Î¹ÏƒÎ¿ÏÎ½ Ï„Î¿ Î½ÎµÏÏŒ) Â«Î¿Ï…ÏÎ­Ï‚Â» Ï„Ï‰Î½ Î¼Î¿ÏÎ¯Ï‰Î½ Ï„Î¿Ï… ÏƒÎ±Ï€Î¿Ï…Î½Î¹Î¿Ï Î¼Ï€Î¿ÏÎ¿ÏÎ½ Î½Î± ÏƒÏ€Î¬ÏƒÎ¿Ï…Î½ Ï„Î¹Ï‚ Î±Î»Î»Î·Î»ÎµÏ€Î¹Î´ÏÎ¬ÏƒÎµÎ¹Ï‚ Î¼ÎµÏ„Î±Î¾Ï Ï„Ï‰Î½ Î¼Î¿ÏÎ¯Ï‰Î½ Î»Î¹Ï€Î¹Î´Î¯Ï‰Î½ ÏƒÏ„Î· Î¼ÎµÎ¼Î²ÏÎ¬Î½Î· Ï„Î¿Ï… ÎºÎ¿ÏÎ¿Î½Î¿ÏŠÎ¿Ï (Î²Î». Î£Ï‡Î®Î¼Î± 5). </p><p> Î— Î¿Ï…ÏÎ¬ Ï„Î¿Ï… ÏƒÎ±Ï€Î¿Ï…Î½Î¹Î¿Ï Î¼Ï€Î¿ÏÎµÎ¯ Î½Î± Î´Î¹Î±Ï„Î±ÏÎ¬Î¾ÎµÎ¹ Ï„Î¹Ï‚ Î±Î´ÏÎ½Î±Î¼ÎµÏ‚ Î±Î»Î»Î·Î»ÎµÏ€Î¹Î´ÏÎ¬ÏƒÎµÎ¹Ï‚ Î¼ÎµÏ„Î±Î¾Ï Ï„Ï‰Î½ Î¼Î¿ÏÎ¯Ï‰Î½ Ï„Ï‰Î½ Î»Î¹Ï€Î¹Î´Î¯Ï‰Î½ ÏƒÏ„Î· Î¼ÎµÎ¼Î²ÏÎ¬Î½Î·, ÏƒÏ‡Î¯Î¶Î¿Î½Ï„Î¬Ï‚ Ï„Î·Î½. Î‘Ï‚ Ï…Ï€Î¿Î¸Î­ÏƒÎ¿Ï…Î¼Îµ ÏŒÏ„Î¹ Î¿ Î¹ÏŒÏ‚ Î­Ï‡ÎµÎ¹ Î´Î¹Î±ÏƒÏ€Î±ÏƒÏ„ÎµÎ¯ Ï€ÏÎ¹Î½ Ï€ÏÎ¿ÏƒÏ„Î±Ï„ÎµÏ…Ï„ÎµÎ¯ Î¼Îµ Î±ÏƒÏ†Î¬Î»ÎµÎ¹Î± ÏƒÎµ Î­Î½Î± ÎºÏÏ„Ï„Î±ÏÎ¿ Î¾ÎµÎ½Î¹ÏƒÏ„Î®. Î£Îµ Î±Ï…Ï„Î®Î½ Ï„Î·Î½ Ï€ÎµÏÎ¯Ï€Ï„Ï‰ÏƒÎ·, Î´ÎµÎ½ Î¸Î± ÎµÎ¯Î½Î±Î¹ Ï€Î»Î­Î¿Î½ ÏƒÎµ Î¸Î­ÏƒÎ· Î½Î± ÎºÎ¬Î½ÎµÎ¹ Ï„Î· Î¼Î¿Î»Ï…ÏƒÎ¼Î±Ï„Î¹ÎºÎ® Ï„Î¿Ï… Î´Î¿Ï…Î»ÎµÎ¹Î¬. Î£Ï„Î· ÏƒÏ…Î½Î­Ï‡ÎµÎ¹Î±, Ï„Î± Î¼ÏŒÏÎ¹Î± Ï„Î¿Ï… ÏƒÎ±Ï€Î¿Ï…Î½Î¹Î¿Ï Ï€ÎµÏÎ¹Î²Î¬Î»Î»Î¿Ï…Î½ Î¸ÏÎ±ÏÏƒÎ¼Î±Ï„Î± Î¹Î¿Ï Î¼Îµ ÏŒÎ»ÎµÏ‚ Ï„Î¹Ï‚ Î¿Ï…ÏÎ­Ï‚ ÏƒÏ„ÏÎ±Î¼Î¼Î­Î½ÎµÏ‚ Ï€ÏÎ¿Ï‚ Ï„Î± Î¼Î­ÏƒÎ±. Î‘Ï…Ï„ÏŒ Ï„Î¿ ÏƒÏÎ¼Ï€Î»ÎµÎ³Î¼Î± Î¿Î½Î¿Î¼Î¬Î¶ÎµÏ„Î±Î¹ Î¼Î¹ÎºÎºÏÎ»Î¹Î¿ (Î²Î». Î£Ï‡Î®Î¼Î± 6). ÎŸÎ¹ Ï…Î´ÏÏŒÏ†Î¹Î»ÎµÏ‚ ÎºÎµÏ†Î±Î»Î­Ï‚ Ï€Î¿Ï… ÎºÎ¿Î¹Ï„Î¿ÏÎ½ Ï€ÏÎ¿Ï‚ Ï„Î± Î­Î¾Ï‰ ÎµÏ€Î¹Ï„ÏÎ­Ï€Î¿Ï…Î½ ÏƒÏ„Î¿ Î¼Î¹ÎºÎºÏÎ»Î¹Î¿ Î½Î± Î¾ÎµÏ€Î»Ï…Î¸ÎµÎ¯ ÏƒÏ„Î·Î½ Î±Ï€Î¿Ï‡Î­Ï„ÎµÏ…ÏƒÎ· Î¼Îµ Î½ÎµÏÏŒ. Î¤Î¿ Î½ÎµÏÏŒ, Ï‡Ï‰ÏÎ¯Ï‚ Ï„Î¿ ÏƒÎ±Ï€Î¿ÏÎ½Î¹, Î´ÎµÎ½ Î¸Î± Î¼Ï€Î¿ÏÎ¿ÏÏƒÎµ Î½Î± ÎºÎ¬Î½ÎµÎ¹ ÎºÎ¬Ï„Î¹ Ï„Î­Ï„Î¿Î¹Î¿. </p>',9),oa={class:"grid gap-2 md:grid-cols-2 e-card"},la=e("b",null,"Î£Ï‡Î®Î¼Î± 5.",-1),da=e("b",null,"Î£Ï‡Î®Î¼Î± 6.",-1),ca=i('<p> ÎŸÎ¹ Ï€Î»Î·ÏÎ¿Ï†Î¿ÏÎ¯ÎµÏ‚ Ï€Î¿Ï… Î´Î¯Î½Î¿Î½Ï„Î±Î¹ Î¹ÏƒÏ‡ÏÎ¿Ï…Î½ ÎµÏ€Î¯ÏƒÎ·Ï‚ ÎºÎ±Î¹ Î³Î¹Î± Î¬Î»Î»Î¿Ï…Ï‚ Î¹Î¿ÏÏ‚ Î¼Îµ Ï€ÎµÏÎ¯Î²Î»Î·Î¼Î± (Ï€.Ï‡. Î³ÏÎ¯Ï€Î·, Î·Ï€Î±Ï„Î¯Ï„Î¹Î´Î± Î’ ÎºÎ±Î¹ C ÎºÎ±Î¹ Î½ÏŒÏƒÎ¿Ï‚ Ï„Î¿Ï… Î¹Î¿Ï ÎˆÎ¼Ï€Î¿Î»Î±), ÎºÎ±Î¸ÏÏ‚ Î¿Î¹ Ï†Î¬ÎºÎµÎ»Î¿Î¯ Ï„Î¿Ï…Ï‚ Î±Ï€Î¿Ï„ÎµÎ»Î¿ÏÎ½Ï„Î±Î¹ Î±Ï€ÏŒ Ï†Ï‰ÏƒÏ†Î¿Î»Î¹Ï€Î¯Î´Î¹Î±. </p><section class="e-card"><h4 class="mt-0">Î‘Î½Î±Ï†Î¿ÏÎ­Ï‚ / Î Î·Î³Î­Ï‚ Î Î»Î·ÏÎ¿Ï†ÏŒÏÎ·ÏƒÎ·Ï‚</h4><ul class="text-sm break-all"><li><a href="https://www.science.org.au/curious/people-medicine/hand-sanitiser-or-soap-making-informed-choice-covid-19" target="_blank" rel="noopener noreferrer">https://www.science.org.au/curious/people-medicine/hand-sanitiser-or-soap-making-informed-choice-covid-19</a></li></ul></section><h3>Î•Ï€Î¹Î»Î­Î³Î¿Î½Ï„Î±Ï‚ Î±Ï€Î¿Î»Ï…Î¼Î±Î½Ï„Î¹ÎºÏŒ Ï‡ÎµÏÎ¹ÏÎ½</h3><p> ÎŸ Î Î±Î³ÎºÏŒÏƒÎ¼Î¹Î¿Ï‚ ÎŸÏÎ³Î±Î½Î¹ÏƒÎ¼ÏŒÏ‚ Î¥Î³ÎµÎ¯Î±Ï‚ (WHO) ÏƒÏ…Î½Î¹ÏƒÏ„Î¬ Î±Î½Ï„Î¹ÏƒÎ·Ï€Ï„Î¹ÎºÏŒ Ï‡ÎµÏÎ¹ÏÎ½ Î¼Îµ Î²Î¬ÏƒÎ· Ï„Î¿ Î¿Î¹Î½ÏŒÏ€Î½ÎµÏ…Î¼Î± ÎµÎ¬Î½ Î´ÎµÎ½ Î­Ï‡ÎµÏ„Îµ ÏƒÎ±Ï€Î¿ÏÎ½Î¹ Ï‡ÎµÏÎ¹ÏÎ½. </p><p><b>Î¤Î± Î±Î½Ï„Î¹ÏƒÎ·Ï€Ï„Î¹ÎºÎ¬ Ï‡ÎµÏÎ¹ÏÎ½ Î¼Îµ Î²Î¬ÏƒÎ· Ï„Î¿ Î±Î»ÎºÎ¿ÏŒÎ» Ï€Î¹ÏƒÏ„ÎµÏÎµÏ„Î±Î¹ ÏŒÏ„Î¹ Î»ÎµÎ¹Ï„Î¿Ï…ÏÎ³Î¿ÏÎ½ ÎµÎ¼Ï€Î¿Î´Î¯Î¶Î¿Î½Ï„Î±Ï‚ Ï„Î¹Ï‚ Ï€ÏÏ‰Ï„ÎµÎÎ½ÎµÏ‚ Ï„Ï‰Î½ Î¼Î¹ÎºÏÎ¿Î²Î¯Ï‰Î½ - ÏƒÏ…Î¼Ï€ÎµÏÎ¹Î»Î±Î¼Î²Î±Î½Î¿Î¼Î­Î½Ï‰Î½ Ï„Ï‰Î½ Î²Î±ÎºÏ„Î·ÏÎ¯Ï‰Î½ ÎºÎ±Î¹ Î¿ÏÎ¹ÏƒÎ¼Î­Î½Ï‰Î½ Î¹ÏÎ½ - Î½Î± Î»ÎµÎ¹Ï„Î¿Ï…ÏÎ³Î®ÏƒÎ¿Ï…Î½ ÎºÎ±Î½Î¿Î½Î¹ÎºÎ¬.</b> Î¤Î± Î±Î½Ï„Î¹ÏƒÎ·Ï€Ï„Î¹ÎºÎ¬ Ï‡ÎµÏÎ¹ÏÎ½ Î¼Îµ Ï…ÏˆÎ·Î»Î® Ï€ÎµÏÎ¹ÎµÎºÏ„Î¹ÎºÏŒÏ„Î·Ï„Î± ÏƒÎµ Î±Î»ÎºÎ¿ÏŒÎ» Î¼Ï€Î¿ÏÎ¿ÏÎ½ ÎµÏ€Î¯ÏƒÎ·Ï‚ Î½Î± ÎµÏ€Î·ÏÎµÎ¬ÏƒÎ¿Ï…Î½ Ï„Î¿ Î»Î¹Ï€Î¹Î´Î¹ÎºÏŒ Ï€ÎµÏÎ¯Î²Î»Î·Î¼Î± Ï€Î¿Ï… Ï€ÎµÏÎ¹Î²Î¬Î»Î»ÎµÎ¹ Ï„Î¿Î½ ÎºÎ¿ÏÎ¿Î½Î¿ÏŠÏŒ. Î“Î¹Î± Î½Î± ÎµÎ¯Î½Î±Î¹ Î±Ï€Î¿Ï„ÎµÎ»ÎµÏƒÎ¼Î±Ï„Î¹ÎºÎ¬, Ï„Î± Î±Î½Ï„Î¹ÏƒÎ·Ï€Ï„Î¹ÎºÎ¬ Ï‡ÎµÏÎ¹ÏÎ½ Ï€ÏÎ­Ï€ÎµÎ¹ Î½Î± Ï€ÎµÏÎ¹Î­Ï‡Î¿Ï…Î½ Ï„Î¿Ï…Î»Î¬Ï‡Î¹ÏƒÏ„Î¿Î½ 60% Î±Î»ÎºÎ¿ÏŒÎ». Î¤Î± Ï€ÏÏŒÏƒÎ¸ÎµÏ„Î± ÏƒÏ„Î¿ Î±Î½Ï„Î¹ÏƒÎ·Ï€Ï„Î¹ÎºÏŒ Î¼Ï€Î¿ÏÎ¿ÏÎ½ Î½Î± ÎµÎ¼Ï€Î¿Î´Î¯ÏƒÎ¿Ï…Î½ Ï„Î¿ Î±Î»ÎºÎ¿ÏŒÎ» Î½Î± ÎµÎ¾Î±Ï„Î¼Î¹ÏƒÏ„ÎµÎ¯ Ï€Î¿Î»Ï Î³ÏÎ®Î³Î¿ÏÎ±, ÎºÎ¬Î½Î¿Î½Ï„Î±Ï‚ Ï„Î¿Î½ Î¹ÏŒ Î½Î± ÎµÎ¼Ï€Î¿Ï„Î¹ÏƒÏ„ÎµÎ¯ Î³Î¹Î± Î¼ÎµÎ³Î±Î»ÏÏ„ÎµÏÎ¿ Ï‡ÏÎ¿Î½Î¹ÎºÏŒ Î´Î¹Î¬ÏƒÏ„Î·Î¼Î±. </p><p> Î©ÏƒÏ„ÏŒÏƒÎ¿, Ï…Ï€Î¬ÏÏ‡Î¿Ï…Î½ ÎµÏ€Î¯ÏƒÎ·Ï‚ Î¿ÏÎ¹ÏƒÎ¼Î­Î½Î¿Î¹ ÎºÎ¯Î½Î´Ï…Î½Î¿Î¹ Ï€Î¿Ï… ÏƒÏ‡ÎµÏ„Î¯Î¶Î¿Î½Ï„Î±Î¹ Î¼Îµ Ï„Î· Ï‡ÏÎ®ÏƒÎ· Î±Î½Ï„Î¹ÏƒÎ·Ï€Ï„Î¹ÎºÏÎ½ Î¼Îµ Î²Î¬ÏƒÎ· Ï„Î¿ Î±Î»ÎºÎ¿ÏŒÎ». Î¥Ï€Î¬ÏÏ‡ÎµÎ¹ Î±Ï…Î¾Î·Î¼Î­Î½Î¿Ï‚ ÎºÎ¯Î½Î´Ï…Î½Î¿Ï‚ Î´Î·Î»Î·Ï„Î·ÏÎ¯Î±ÏƒÎ·Ï‚ Î±Ï€ÏŒ Î±Î»ÎºÎ¿ÏŒÎ» Î³Î¹Î± Ï„Î± Ï€Î±Î¹Î´Î¹Î¬ ÎºÎ±Î¹ Î· ÏƒÏ…Ï‡Î½Î® Ï„Î¿Ï…Ï‚ Ï‡ÏÎ®ÏƒÎ· Î¸Î± Î¼Ï€Î¿ÏÎ¿ÏÏƒÎµ Î½Î± Î¿Î´Î·Î³Î®ÏƒÎµÎ¹ ÏƒÎµ Î¼Î¹ÎºÏÎ¿Î²Î¹Î±ÎºÎ® Î±Î½Ï„Î¿Ï‡Î®. Î¥Ï€Î¬ÏÏ‡Î¿Ï…Î½ ÎµÎ½Î±Î»Î»Î±ÎºÏ„Î¹ÎºÎ¬ Î±Î½Ï„Î¹ÏƒÎ·Ï€Ï„Î¹ÎºÎ¬ Ï‡ÎµÏÎ¹ÏÎ½ Ï‡Ï‰ÏÎ¯Ï‚ Î±Î»ÎºÎ¿ÏŒÎ», ÏŒÏ€Î¿Ï… Ï‡ÏÎ·ÏƒÎ¹Î¼Î¿Ï€Î¿Î¹ÎµÎ¯Ï„Î±Î¹ ÏƒÏ‡ÎµÏ„Î¹ÎºÎ¬ ÏƒÏ…Ï‡Î½Î¬ Ï„Î¿ Î²ÎµÎ½Î¶Î±Î»ÎºÏŒÎ½Î¹Î¿. Î ÏÏŒÏƒÏ†Î±Ï„ÎµÏ‚ Î¼ÎµÎ»Î­Ï„ÎµÏ‚ Î­Ï‡Î¿Ï…Î½ Î´ÎµÎ¯Î¾ÎµÎ¹ ÏŒÏ„Î¹ Ï„Î¿ Î±Ï€Î¿Î»Ï…Î¼Î±Î½Ï„Î¹ÎºÏŒ Ï‡ÎµÏÎ¹ÏÎ½ Ï‡Ï‰ÏÎ¯Ï‚ Î±Î»ÎºÎ¿ÏŒÎ» Î»ÎµÎ¹Ï„Î¿Ï…ÏÎ³ÎµÎ¯ ÎµÎ¾Î¯ÏƒÎ¿Ï… ÎºÎ±Î»Î¬ ÎºÎ±Î¹ Î´ÎµÎ½ Ï€ÏÎ¿ÎºÎ±Î»ÎµÎ¯ Ï„Î¿ Î³Î½Ï‰ÏƒÏ„ÏŒ Î±Î¯ÏƒÎ¸Î·Î¼Î± Â«ÎµÎ³ÎºÎ±ÏÎ¼Î±Ï„Î¿Ï‚Â» Ï€Î¿Ï… Ï€ÏÎ¿ÎºÎ±Î»ÎµÎ¯Ï„Î±Î¹ Î±Ï€ÏŒ Ï„Î· Ï‡ÏÎ®ÏƒÎ· Î±Ï€Î¿Î»Ï…Î¼Î±Î½Ï„Î¹ÎºÎ¿Ï Ï‡ÎµÏÎ¹ÏÎ½ Î¼Îµ Î±Î»ÎºÎ¿ÏŒÎ». </p><section class="e-card"><h4 class="mt-0">Î‘Î½Î±Ï†Î¿ÏÎ­Ï‚ / Î Î·Î³Î­Ï‚ Î Î»Î·ÏÎ¿Ï†ÏŒÏÎ·ÏƒÎ·Ï‚</h4><ul class="text-sm break-all"><li><a href="https://www.sciencedirect.com/science/article/abs/pii/S0048969720340833?via%3Dihub" target="_blank" rel="noopener noreferrer">https://www.sciencedirect.com/science/article/abs/pii/S0048969720340833?via%3Dihub</a></li><li><a href="https://www.journalofhospitalinfection.com/article/S0195-6701(20)30547-8/fulltext#secsectitle0040" target="_blank" rel="noopener noreferrer">https://www.journalofhospitalinfection.com/article/S0195-6701(20)30547-8/fulltext#secsectitle0040</a></li></ul></section>',7),ma=e("hr",{class:"mt-10 mb-40"},null,-1),ua={id:"s7"},ha=i('<h2 id="s7t" class="mt-40 text-5xl">7. ÎŸÎ¹ Î¼ÏÎ¸Î¿Î¹ Î³Î¹Î± Ï„Î± ÎµÎ¼Î²ÏŒÎ»Î¹Î±</h2><h3><span class="text-rose-400">ÎœÏÎ¸Î¿Ï‚ 1:</span> Î¤Î± ÎµÎ¼Î²ÏŒÎ»Î¹Î± Ï€ÏÎ¿ÎºÎ±Î»Î¿ÏÎ½ Î±Ï…Ï„Î¹ÏƒÎ¼ÏŒ/ÏƒÎ¿Î²Î±ÏÎ­Ï‚ Ï€Î±ÏÎµÎ½Î­ÏÎ³ÎµÎ¹ÎµÏ‚ </h3><p> ÎŸ Ï†ÏŒÎ²Î¿Ï‚ ÏŒÏ„Î¹ Ï„Î± ÎµÎ¼Î²ÏŒÎ»Î¹Î± Î±Ï…Î¾Î¬Î½Î¿Ï…Î½ Ï„Î¿Î½ ÎºÎ¯Î½Î´Ï…Î½Î¿ Î±Ï…Ï„Î¹ÏƒÎ¼Î¿Ï Ï€ÏÎ¿Î®Î»Î¸Îµ Î±Ï€ÏŒ Î¼Î¯Î± Î¼ÎµÎ»Î­Ï„Î· Ï„Î¿Ï… 1997 Î· Î¿Ï€Î¿Î¯Î± Î´Î·Î¼Î¿ÏƒÎ¹ÎµÏÏ„Î·ÎºÎµ Î±Ï€ÏŒ Ï„Î¿Î½ Andrew Wakefield, Î­Î½Î±Î½ Î’ÏÎµÏ„Î±Î½ÏŒ Ï‡ÎµÎ¹ÏÎ¿ÏÏÎ³Î¿. Î£Ï…Î³ÎºÎµÎºÏÎ¹Î¼Î­Î½Î±, Î· Î¼ÎµÎ»Î­Ï„Î· Î´Î·Î¼Î¿ÏƒÎ¹ÎµÏÎ¸Î·ÎºÎµ ÏƒÏ„Î¿ The Lancet, Î­Î½Î± Î¹Î±Ï„ÏÎ¹ÎºÏŒ Ï€ÎµÏÎ¹Î¿Î´Î¹ÎºÏŒ, ÎºÎ±Î¹ Î¹ÏƒÏ‡Ï…ÏÎ¹Î¶ÏŒÏ„Î±Î½ ÏŒÏ„Î¹ Ï„Î¿ ÎµÎ¼Î²ÏŒÎ»Î¹Î¿ Î¹Î»Î±ÏÎ¬Ï‚, Ï€Î±ÏÏ‰Ï„Î¯Î´Î¹Î´Î±Ï‚ ÎºÎ±Î¹ ÎµÏÏ…Î¸ÏÎ¬Ï‚ (MMR) Î±ÏÎ¾Î·ÏƒÎµ Ï„Î·Î½ ÎµÎ¼Ï†Î¬Î½Î¹ÏƒÎ· Î±Ï…Ï„Î¹ÏƒÎ¼Î¿Ï ÏƒÎµ Ï€Î¿Î»Î»Î¬ Ï€Î±Î¹Î´Î¹Î¬ ÏƒÏ„Î· Î’ÏÎµÏ„Î±Î½Î¯Î±. </p><p> ÎˆÎºÏ„Î¿Ï„Îµ, Î· Î¼ÎµÎ»Î­Ï„Î· Î±Ï…Ï„Î® Î­Ï‡ÎµÎ¹ Î±Ï€Î±Î¾Î¹Ï‰Î¸ÎµÎ¯ Ï€Î»Î®ÏÏ‰Ï‚ Î»ÏŒÎ³Ï‰ ÏƒÎ¿Î²Î±ÏÏÎ½ Î´Î¹Î±Î´Î¹ÎºÎ±ÏƒÏ„Î¹ÎºÏÎ½ Ï€ÎµÎ¹ÏÎ±Î¼Î±Ï„Î¹ÎºÏÎ½ ÏƒÏ†Î±Î»Î¼Î¬Ï„Ï‰Î½ Ï€Î¿Ï… ÎµÎ½Ï„Î¿Ï€Î¯ÏƒÏ„Î·ÎºÎ±Î½. Î£Ï…Î³ÎºÎµÎºÏÎ¹Î¼Î­Î½Î± Î¿Î¹ ÏƒÏ…Î¼Î¼ÎµÏ„Î­Ï‡Î¿Î½Ï„ÎµÏ‚ ÏƒÏ„Î· Î¼ÎµÎ»Î­Ï„Î· Î®Ï„Î±Î½ Î¼ÏŒÎ½Î¿ 12. Î•Ï€Î¹Ï€Î»Î­Î¿Î½, Î±Ï€Î¿ÎºÎ±Î»ÏÏ†Î¸Î·ÎºÎ±Î½ ÏƒÏ…Î³ÎºÏÎ¿ÏÏƒÎµÎ¹Ï‚ Î¿Î¹ÎºÎ¿Î½Î¿Î¼Î¹ÎºÏÎ½ ÏƒÏ…Î¼Ï†ÎµÏÏŒÎ½Ï„Ï‰Î½ ÎºÎ±Î¹ Î·Î¸Î¹ÎºÎ­Ï‚ Ï€Î±ÏÎ±Î²Î¬ÏƒÎµÎ¹Ï‚. Î©Ï‚ Î±Ï€Î¿Ï„Î­Î»ÎµÏƒÎ¼Î±, Î¿ Andrew Wakefield Î­Ï‡Î±ÏƒÎµ Ï„Î·Î½ Î¹Î±Ï„ÏÎ¹ÎºÎ® Ï„Î¿Ï… Î¬Î´ÎµÎ¹Î± ÎºÎ±Î¹ Î· Î¼ÎµÎ»Î­Ï„Î· Ï€Î¿Ï… Î´Î·Î¼Î¿ÏƒÎ¹ÎµÏÎ¸Î·ÎºÎµ Î±Î½Î±ÎºÎ»Î®Î¸Î·ÎºÎµ Î±Ï€ÏŒ Ï„Î¿ Ï€ÎµÏÎ¹Î¿Î´Î¹ÎºÏŒ. </p><p> Î£Î®Î¼ÎµÏÎ±, Ï…Ï€Î¬ÏÏ‡Î¿Ï…Î½ Î±ÏÎºÎµÏ„Î­Ï‚ Î¼ÎµÎ»Î­Ï„ÎµÏ‚ Ï€Î¿Ï… Î­Ï‡Î¿Ï…Î½ ÎµÎ½Ï„Î¿Ï€Î¯ÏƒÎµÎ¹ ÏƒÏ…Î¼Ï€Ï„ÏÎ¼Î±Ï„Î± Ï„Î¿Ï… Î±Ï…Ï„Î¹ÏƒÎ¼Î¿Ï ÏƒÎµ Ï€Î±Î¹Î´Î¹Î¬ Ï€Î¿Î»Ï Ï€ÏÎ¹Î½ Î»Î¬Î²Î¿Ï…Î½ Ï„Î¿ ÎµÎ¼Î²ÏŒÎ»Î¹Î¿ MMR ÎºÎ±Î¹ Î±Ï…Ï„Î­Ï‚ Î±Ï€Î¿Ï„ÎµÎ»Î¿ÏÎ½ ÏƒÏ„Î¿Î¹Ï‡ÎµÎ¯Î± ÎµÎ½Î¬Î½Ï„Î¹Î± ÏƒÏ„Î¿Î½ Î¼ÏÎ¸Î¿ Ï€Î¿Ï… ÏƒÏ…ÏƒÏ‡ÎµÏ„Î¯Î¶ÎµÎ¹ Ï„Î¿Î½ ÎµÎ¼Î²Î¿Î»Î¹Î±ÏƒÎ¼ÏŒ Î¼Îµ Ï„Î¿Î½ Î±Ï…Ï„Î¹ÏƒÎ¼ÏŒ. Î•Ï€Î¹Ï€Î»Î­Î¿Î½, Ï€ÏÏŒÏƒÏ†Î±Ï„Î· Î­ÏÎµÏ…Î½Î± Î±Î½Î±Ï†Î­ÏÎµÎ¹ ÏƒÏ„Î¿Î¹Ï‡ÎµÎ¯Î± Ï€Î¿Ï… Ï…Ï€Î¿ÏƒÏ„Î·ÏÎ¯Î¶Î¿Ï…Î½ ÏŒÏ„Î¹ Î¿ Î±Ï…Ï„Î¹ÏƒÎ¼ÏŒÏ‚ Î±Î½Î±Ï€Ï„ÏÏƒÏƒÎµÏ„Î±Î¹ ÏƒÏ„Î· Î¼Î®Ï„ÏÎ±, Î´Î·Î»Î±Î´Î® Ï€Î¿Î»Ï Ï€ÏÎ¹Î½ Î³ÎµÎ½Î½Î·Î¸ÎµÎ¯ Î­Î½Î± Î¼Ï‰ÏÏŒ ÎºÎ±Î¹ Î¾ÎµÎºÎ¹Î½Î®ÏƒÎµÎ¹ Î½Î± ÎºÎ¬Î½ÎµÎ¹ ÎµÎ¼Î²ÏŒÎ»Î¹Î±. ÎšÎ±Î¼Î¯Î± Î±Ï€ÏŒ Ï„Î¹Ï‚ Ï„ÎµÎ»ÎµÏ…Ï„Î±Î¯ÎµÏ‚ Î¼ÎµÎ»Î­Ï„ÎµÏ‚ Î´ÎµÎ½ Î­Ï‡ÎµÎ¹ Î±Î½Î±Ï†Î­ÏÎµÎ¹ ÎºÎ¬Ï€Î¿Î¹Î¿Ï… ÎµÎ¯Î´Î¿Ï…Ï‚ ÏƒÏ…ÏƒÏ‡Î­Ï„Î¹ÏƒÎ·Ï‚ Î¼ÎµÏ„Î±Î¾Ï Î¿Ï€Î¿Î¹Î¿Ï…Î´Î®Ï€Î¿Ï„Îµ ÎµÎ¼Î²Î¿Î»Î¯Î¿Ï… ÎºÎ±Î¹ Ï„Î·Î½ ÎµÎ¼Ï†Î¬Î½Î¹ÏƒÎ· ÏƒÏ…Î¼Ï€Ï„Ï‰Î¼Î¬Ï„Ï‰Î½ Î±Ï…Ï„Î¹ÏƒÎ¼Î¿Ï. </p><section class="e-card"><h4 class="mt-0">Î‘Î½Î±Ï†Î¿ÏÎ­Ï‚ / Î Î·Î³Î­Ï‚ Î Î»Î·ÏÎ¿Ï†ÏŒÏÎ·ÏƒÎ·Ï‚</h4><ul class="text-sm break-all"><li><a href="https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(97)11096-0/fulltext" target="_blank" rel="noopener noreferrer">https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(97)11096-0/fulltext</a></li><li><a href="https://www.nejm.org/doi/full/10.1056/NEJMoa1307491?query=featured_home" target="_blank" rel="noopener noreferrer">https://www.nejm.org/doi/full/10.1056/NEJMoa1307491?query=featured_home</a></li></ul></section>',6),pa=e("div",null,[e("h3",{class:"mt-6 pt-3 mb-10"},"Î“Î¹Î± Ï€ÎµÏÎ¹ÏƒÏƒÏŒÏ„ÎµÏÎ· Î­ÏÎµÏ…Î½Î±"),e("ul",{class:"leading-tight"},[e("li",null,[e("a",{href:"https://archive.cdc.gov/#/details?url=https://www.cdc.gov/coronavirus/2019-ncov/vaccines/expect/after.html",target:"_blank",rel:"noopener noreferrer"},"Possible Side Effects After Getting a COVID-19 Vaccine")]),e("li",null,[e("a",{href:"https://www.bbc.com/news/health-55932832",target:"_blank",rel:"noopener noreferrer"},"Study reveals extent of Covid vaccine side-effects")]),e("li",null,[e("a",{href:"https://www.nature.com/articles/d41586-021-00290-x",target:"_blank",rel:"noopener noreferrer"},"COVID vaccines and safety: what the research says")]),e("li",null,[e("a",{href:"https://health.clevelandclinic.org/covid-19-vaccine-side-effects/",target:"_blank",rel:"noopener noreferrer"},"Hereâ€™s What to Know About the COVID-19 Vaccine Side Effects")]),e("li",null,[e("a",{href:"https://www.historyofvaccines.org/content/articles/vaccine-side-effects-and-adverse-events",target:"_blank",rel:"noopener noreferrer"},"Vaccine Side Effects and Adverse Events")]),e("li",null,[e("a",{href:"https://www.bbc.com/news/health-56375307",target:"_blank",rel:"noopener noreferrer"},"Vaccine side effects: My experience of them and what they mean")]),e("li",null,[e("a",{href:"https://vk.ovg.ox.ac.uk/vk/vaccine-side-effects",target:"_blank",rel:"noopener noreferrer"},"Vaccine side effects and adverse reactions")]),e("li",null,[a("ğŸ“º"),e("a",{href:"https://www.youtube.com/watch?v=F6NKbQzo4aE",target:"_blank",rel:"noopener noreferrer"},"Vaccine side effects are actually a good thing")]),e("li",null,[a("ğŸ“º"),e("a",{href:"https://www.youtube.com/watch?v=Atrx1P2EkiQ",target:"_blank",rel:"noopener noreferrer"},"Vaccines and the Immune Response: How Vaccines Work")])])],-1),va=i('<h3><span class="text-rose-400">ÎœÏÎ¸Î¿Ï‚ 2:</span> Î¤Î¿ Î±Î½Î¿ÏƒÎ¿Ï€Î¿Î¹Î·Ï„Î¹ÎºÏŒ ÏƒÏÏƒÏ„Î·Î¼Î± Ï„Ï‰Î½ Î²ÏÎµÏ†ÏÎ½ Î´ÎµÎ½ Î¼Ï€Î¿ÏÎµÎ¯ Î½Î± Ï‡ÎµÎ¹ÏÎ¹ÏƒÏ„ÎµÎ¯ Ï€Î¿Î»Î»Î±Ï€Î»Î¬ ÎµÎ¼Î²ÏŒÎ»Î¹Î± </h3><p> Î¤Î± Ï€Î±Î¹Î´Î¹Î¬ ÎµÎ¼Î²Î¿Î»Î¹Î¬Î¶Î¿Î½Ï„Î±Î¹ ÏƒÎµ Î½ÎµÎ±ÏÎ® Î·Î»Î¹ÎºÎ¯Î± ÎµÏ€ÎµÎ¹Î´Î® Î´Î¹Î±Ï„ÏÎ­Ï‡Î¿Ï…Î½ Î¼ÎµÎ³Î±Î»ÏÏ„ÎµÏÎ¿ ÎºÎ¯Î½Î´Ï…Î½Î¿ Î½Î± Î±ÏÏÏ‰ÏƒÏ„Î®ÏƒÎ¿Ï…Î½ ÏƒÎ¿Î²Î±ÏÎ¬ Î® Î½Î± Ï€ÎµÎ¸Î¬Î½Î¿Ï…Î½ ÎµÎ¬Î½ ÎºÎ¿Î»Î»Î®ÏƒÎ¿Ï…Î½ ÎºÎ¬Ï€Î¿Î¹ÎµÏ‚ Î±ÏƒÎ¸Î­Î½ÎµÎ¹ÎµÏ‚. </p><p> Î¤Î± Î½ÎµÎ¿Î³Î­Î½Î½Î·Ï„Î± Î­Ï‡Î¿Ï…Î½ Î±Î½Î¿ÏƒÎ¯Î± ÏƒÎµ Î¿ÏÎ¹ÏƒÎ¼Î­Î½ÎµÏ‚ Î±ÏƒÎ¸Î­Î½ÎµÎ¹ÎµÏ‚ (Ï€.Ï‡. Î±Î½ÎµÎ¼Î¿Î²Î»Î¿Î³Î¹Î¬) ÎµÏ€ÎµÎ¹Î´Î® Î»Î±Î¼Î²Î¬Î½Î¿Ï…Î½ Î±Î½Ï„Î¹ÏƒÏÎ¼Î±Ï„Î± Î±Ï€ÏŒ Ï„Î¹Ï‚ Î¼Î·Ï„Î­ÏÎµÏ‚ Ï„Î¿Ï…Ï‚ ÎºÎ±Ï„Î¬ Ï„Î· Î´Î¹Î¬ÏÎºÎµÎ¹Î± Ï„Î·Ï‚ ÎºÏÎ·ÏƒÎ·Ï‚. Î©ÏƒÏ„ÏŒÏƒÎ¿, Î· Î±Î½Î¿ÏƒÎ¯Î± Î±Ï…Ï„Î® Î´Î¹Î±ÏÎºÎµÎ¯ Î¼ÏŒÎ½Î¿ Î³Î¹Î± Î¼ÎµÏÎ¹ÎºÎ¿ÏÏ‚ Î¼Î®Î½ÎµÏ‚. </p><p> ÎŒÎ¼Ï‰Ï‚ Ï„Î± Ï€ÎµÏÎ¹ÏƒÏƒÏŒÏ„ÎµÏÎ± Î²ÏÎ­Ï†Î· Î´ÎµÎ½ Î­Ï‡Î¿Ï…Î½ Î±Î½Ï„Î¹ÏƒÏÎ¼Î±Ï„Î± ÏƒÎµ Î±ÏƒÎ¸Î­Î½ÎµÎ¹ÎµÏ‚ ÏŒÏ€Ï‰Ï‚ Î· Î´Î¹Ï†Î¸ÎµÏÎ¯ÏÎ¹Î´Î± (diphtheria), Î¿ ÎºÎ¿ÎºÎºÏÏ„Î·Ï‚ (whooping cough), Î· Ï€Î¿Î»Î¹Î¿Î¼Ï…ÎµÎ»Î¯Ï„Î¹Î´Î± (polio), Î¿ Ï„Î­Ï„Î±Î½Î¿Ï‚ (tetanus), Î· Î·Ï€Î±Ï„Î¯Ï„Î¹Î´Î± Î’ Î® ÏƒÏ„Î¿Î½ Î¹ÏŒ Hib. </p><p> Î“Î¹Î± Î½Î± Î¼ÎµÎ¹Ï‰Î¸ÎµÎ¯ Î¿ Î±ÏÎ¹Î¸Î¼ÏŒÏ‚ Ï„Ï‰Î½ ÎµÎ¼Î²Î¿Î»Î¯Ï‰Î½ Ï€Î¿Ï… Î»Î±Î¼Î²Î¬Î½ÎµÎ¹ Î­Î½Î± Ï€Î±Î¹Î´Î¯ ÎºÎ±Ï„Î¬ Ï„Î·Î½ ÎµÏ€Î¯ÏƒÎºÎµÏˆÎ® Ï„Î¿Ï… ÏƒÏ„Î¿Î½ Î³Î¹Î±Ï„ÏÏŒ, Î¿ÏÎ¹ÏƒÎ¼Î­Î½Î± ÎµÎ¼Î²ÏŒÎ»Î¹Î± Ï€ÏÎ¿ÏƒÏ†Î­ÏÎ¿Î½Ï„Î±Î¹ Ï‰Ï‚ ÏƒÏ…Î½Î´Ï…Î±ÏƒÎ¼ÏŒÏ‚ (ÏƒÏ…Î½Î´Ï…Î¬Î¶Î¿Î½Ï„Î±Î¹ Î´ÏÎ¿ Î® Ï€ÎµÏÎ¹ÏƒÏƒÏŒÏ„ÎµÏÎ± Î´Î¹Î±Ï†Î¿ÏÎµÏ„Î¹ÎºÎ¬ ÎµÎ¼Î²ÏŒÎ»Î¹Î± ÏƒÎµ Î­Î½Î±). Î Î±ÏÎ±Î´ÎµÎ¯Î³Î¼Î±Ï„Î± Ï„Î­Ï„Î¿Î¹Ï‰Î½ ÎµÎ¼Î²Î¿Î»Î¯Ï‰Î½ ÎµÎ¯Î½Î±Î¹ Ï„Î¿ ÎµÎ¼Î²ÏŒÎ»Î¹Î¿ Ï„Î·Ï‚ Î´Î¹Ï†Î¸ÎµÏÎ¯Ï„Î¹Î´Î±Ï‚, Ï„Î¿Ï… Ï„ÎµÏ„Î¬Î½Î¿Ï…, Ï„Î¿Ï… ÎºÎ¿ÎºÎºÏÏ„Î· (DTap), Ï„Î·Ï‚ Î™Î»Î±ÏÎ¬Ï‚, Î Î±ÏÏ‰Ï„Î¯Ï„Î¹Î´Î±Ï‚ Î±Î»Î»Î¬ ÎºÎ±Î¹ Ï„Î·Ï‚ Î•ÏÏ…Î¸ÏÎ¬Ï‚ (MMR). </p><p> Î•Ï€Î¹ÏƒÏ„Î·Î¼Î¿Î½Î¹ÎºÎ¬ Î´ÎµÎ´Î¿Î¼Î­Î½Î± Î´ÎµÎ¯Ï‡Î½Î¿Ï…Î½ ÏŒÏ„Î¹ Î· Ï„Î±Ï…Ï„ÏŒÏ‡ÏÎ¿Î½Î· Î»Î®ÏˆÎ· Ï€Î¿Î»Î»ÏÎ½ ÎµÎ¼Î²Î¿Î»Î¯Ï‰Î½ Î´ÎµÎ½ Ï€ÏÎ¿ÎºÎ±Î»ÎµÎ¯ ÎºÎ±Î½Î­Î½Î± Ï€ÏÏŒÎ²Î»Î·Î¼Î± Ï…Î³ÎµÎ¯Î±Ï‚. Î¤Î¿ Î±Î½Î¿ÏƒÎ¿Ï€Î¿Î¹Î·Ï„Î¹ÎºÏŒ ÏƒÏÏƒÏ„Î·Î¼Î± Ï„Ï‰Î½ Î²ÏÎµÏ†ÏÎ½ ÎµÎ¯Î½Î±Î¹ Ï€Î¹Î¿ Î±Î½Î¸ÎµÎºÏ„Î¹ÎºÏŒ Î±Ï€ÏŒ ÏŒÏƒÎ¿ Ï€Î¹ÏƒÏ„ÎµÏÎ¿Ï…Î½ Î¼ÎµÏÎ¹ÎºÎ¿Î¯. ÎœÎ¬Î»Î¹ÏƒÏ„Î± Î¼Îµ Î²Î¬ÏƒÎ· Ï„Î¿Î½ Î±ÏÎ¹Î¸Î¼ÏŒ Ï„Ï‰Î½ Î±Î½Ï„Î¹ÏƒÏ‰Î¼Î¬Ï„Ï‰Î½ Ï€Î¿Ï… Ï…Ï€Î¬ÏÏ‡Î¿Ï…Î½ ÏƒÏ„Î¿ Î±Î¯Î¼Î±, Î¸ÎµÏ‰ÏÎ·Ï„Î¹ÎºÎ¬ Î­Î½Î± Î²ÏÎ­Ï†Î¿Ï‚ Î¸Î± ÎµÎ¯Ï‡Îµ Ï„Î·Î½ Î¹ÎºÎ±Î½ÏŒÏ„Î·Ï„Î± Î½Î± Î±Î½Ï„Î±Ï€Î¿ÎºÏÎ¹Î¸ÎµÎ¯ ÏƒÎµ Ï€Î¿Î»Ï Î¼ÎµÎ³Î±Î»ÏÏ„ÎµÏÎ¿ Î±ÏÎ¹Î¸Î¼ÏŒ ÎµÎ¼Î²Î¿Î»Î¯Ï‰Î½ (Ï„Î¿ ÎµÏÏÏ„Î·Î¼Î± ÎµÎ¯Î½Î±Î¹ ÎµÎ¬Î½ Î¸Î± Ï€ÏÎ­Ï€ÎµÎ¹ Î½Î± Î±Î½Ï„Î±Ï€Î¿ÎºÏÎ¹Î¸ÎµÎ¯ ÏƒÎµ 1000, 10000 Î® 100000 Ï„Î±Ï…Ï„ÏŒÏ‡ÏÎ¿Î½Î±). </p><p> Î‘ÎºÏŒÎ¼Î· ÎºÎ±Î¹ Î±Î½ ÏŒÎ»Î± Ï„Î± Ï€ÏÎ¿Î³ÏÎ±Î¼Î¼Î±Ï„Î¹ÏƒÎ¼Î­Î½Î± ÎµÎ¼Î²ÏŒÎ»Î¹Î± (Î²Î¬ÏƒÎµÎ¹ Ï„Î¿Ï… ÎµÎ¸Î½Î¹ÎºÎ¿Ï ÏƒÏ‡ÎµÎ´Î¯Î¿Ï… ÎµÎ¼Î²Î¿Î»Î¹Î±ÏƒÎ¼Î¿Ï) Î³Î¯Î½Î¿Î½Ï„Î±Î½ Ï„Î±Ï…Ï„ÏŒÏ‡ÏÎ¿Î½Î±, Î¸Î± ÎµÏ€Î¹Î²Î¬ÏÏ…Î½Î±Î½ Î¼ÏŒÎ½Î¿ Î­Î½Î± Î¼Î¹ÎºÏÏŒ Î¼Î­ÏÎ¿Ï‚ Ï„Î¿Ï… Î±Î½Î¿ÏƒÎ¿Ï€Î¿Î¹Î·Ï„Î¹ÎºÎ¿Ï ÏƒÏ…ÏƒÏ„Î®Î¼Î±Ï„Î¿Ï‚ ÎµÎ½ÏŒÏ‚ Î²ÏÎ­Ï†Î¿Ï…Ï‚. </p><p> Î£Ï„Î·Î½ Ï€ÏÎ±Î³Î¼Î±Ï„Î¹ÎºÏŒÏ„Î·Ï„Î±, Ï„Î± Î²ÏÎ­Ï†Î· ÎµÎºÏ„Î¯Î¸ÎµÎ½Ï„Î±Î¹ ÏƒÎµ Î±Î½Î±ÏÎ¯Î¸Î¼Î·Ï„Î± Î²Î±ÎºÏ„Î®ÏÎ¹Î± ÎºÎ±Î¹ Î¹Î¿ÏÏ‚ ÎºÎ±Î¸Î·Î¼ÎµÏÎ¹Î½Î¬, ÎºÎ±Î¹ Î· ÎµÏ€Î¹Î²Î¬ÏÏ…Î½ÏƒÎ· Î±Ï€ÏŒ Ï„Î¿Ï…Ï‚ ÎµÎ¼Î²Î¿Î»Î¹Î±ÏƒÎ¼Î¿ÏÏ‚ ÎµÎ¯Î½Î±Î¹ Î±Î¼ÎµÎ»Î·Ï„Î­Î± ÏƒÎµ ÏƒÏÎ³ÎºÏÎ¹ÏƒÎ· Î¼Îµ Î±Ï…Ï„Î¬. Î•Ï€Î¹Ï€Î»Î­Î¿Î½, Î­ÏÎµÏ…Î½ÎµÏ‚ Î±Ï€Î¿ÎºÎ±Î»ÏÏ€Ï„Î¿Ï…Î½ ÏŒÏ„Î¹ Î· Î­ÎºÎ¸ÎµÏƒÎ· ÏƒÎµ Ï€Î¿Î»Î»Î±Ï€Î»Î¬ ÎµÎ¼Î²ÏŒÎ»Î¹Î± ÎºÎ±Ï„Î¬ Ï„Î¿Ï…Ï‚ Ï€ÏÏÏ„Î¿Ï…Ï‚ 23 Î¼Î®Î½ÎµÏ‚ Î¶Ï‰Î®Ï‚ Ï„Î¿Ï…Ï‚ ÏƒÏ…ÏƒÏ‡ÎµÏ„Î¯Î¶ÎµÏ„Î±Î¹ Î¼Îµ Ï„Î¿Î½ Î±Ï…Î¾Î·Î¼Î­Î½Î¿ ÎºÎ¯Î½Î´Ï…Î½Î¿ Ï€Î±ÏÎ¿Ï…ÏƒÎ¯Î±ÏƒÎ·Ï‚ Î»Î¿Î¹Î¼ÏÎ¾ÎµÏ‰Î½ Ï€Î¿Ï… Î´ÎµÎ½ ÏƒÏ„Î¿Ï‡ÎµÏÎ¿Î½Ï„Î±Î¹ Î±Ï€ÏŒ Ï„Î± ÎµÎ¼Î²ÏŒÎ»Î¹Î± Î±Ï…Ï„Î¬. </p><section class="e-card"><h4 class="mt-0">Î‘Î½Î±Ï†Î¿ÏÎ­Ï‚ / Î Î·Î³Î­Ï‚ Î Î»Î·ÏÎ¿Ï†ÏŒÏÎ·ÏƒÎ·Ï‚</h4><ul class="text-sm break-all"><li><a href="https://www.nejm.org/doi/full/10.1056/NEJMoa1307491?query=featured_home" target="_blank" rel="noopener noreferrer">https://www.nejm.org/doi/full/10.1056/NEJMoa1307491?query=featured_home</a></li><li><a href="https://www.bmj.com/content/364/bmj.l1481/rr-11" target="_blank" rel="noopener noreferrer">https://www.bmj.com/content/364/bmj.l1481/rr-11</a></li><li><a href="https://pubmed.ncbi.nlm.nih.gov/11773551/" target="_blank" rel="noopener noreferrer">https://pubmed.ncbi.nlm.nih.gov/11773551/</a></li></ul></section><h3><span class="text-rose-400">ÎœÏÎ¸Î¿Ï‚ 3:</span> Î— Î±Î½Î¿ÏƒÎ¯Î± Ï€Î¿Ï… Î±Ï€Î¿ÎºÏ„Î¬ ÎºÎ¬Ï€Î¿Î¹Î¿Ï‚ Ï€Î¿Ï… Î½Î¿ÏƒÎµÎ¯ ÎµÎ¯Î½Î±Î¹ ÎºÎ±Î»ÏÏ„ÎµÏÎ· Î±Ï€ÏŒ Ï„Î·Î½ Î±Î½Î¿ÏƒÎ¯Î± Ï€Î¿Ï… Î±Ï€Î¿ÎºÏ„Î¬ ÎµÎºÎµÎ¯Î½Î¿Ï‚ Ï€Î¿Ï… ÎµÎ¼Î²Î¿Î»Î¹Î¬Î¶ÎµÏ„Î±Î¹</h3><p> Î¤Î¿ Î³ÎµÎ³Î¿Î½ÏŒÏ‚ ÏŒÏ„Î¹ Î· Ï†Ï…ÏƒÎ¹ÎºÎ® Î»Î¿Î¯Î¼Ï‰Î¾Î· Ï€ÏÎ¿ÎºÎ±Î»ÎµÎ¯ Î¹ÏƒÏ‡Ï…ÏÏŒÏ„ÎµÏÎ· Î±Î½Î¿ÏƒÎ¯Î± Î­Î½Î±Î½Ï„Î¹ Ï„Î·Ï‚ Î±ÏƒÎ¸Î­Î½ÎµÎ¹Î±Ï‚ Î±Ï€ÏŒ Ï„Î¿Î½ ÎµÎ¼Î²Î¿Î»Î¹Î±ÏƒÎ¼ÏŒ ÎµÎ¯Î½Î±Î¹ Î±Î»Î·Î¸Î®Ï‚. Î©ÏƒÏ„ÏŒÏƒÎ¿, Î¿Î¹ ÎºÎ¯Î½Î´Ï…Î½Î¿Î¹ Î±Ï…Ï„Î®Ï‚ Ï„Î·Ï‚ Ï€ÏÎ¿ÏƒÎ­Î³Î³Î¹ÏƒÎ·Ï‚ Ï…Ï€ÎµÏÎ²Î±Î¯Î½Î¿Ï…Î½ ÎºÎ±Ï„Î¬ Ï€Î¿Î»Ï Ï„Î± ÏƒÏ‡ÎµÏ„Î¹ÎºÎ¬ Î¿Ï†Î­Î»Î·. </p><p> Î¤Î¿ Ï„Î¯Î¼Î·Î¼Î± Î¼ÎµÏ„Î¬ Î±Ï€ÏŒ Î¼Î¯Î± Ï†Ï…ÏƒÎ¹ÎºÎ® Î¼ÏŒÎ»Ï…Î½ÏƒÎ· Î±Î½ÎµÎ¼Î¿Î²Î»Î¿Î³Î¹Î¬Ï‚ Î¼Ï€Î¿ÏÎµÎ¯ Î½Î± Ï€ÎµÏÎ¹Î»Î±Î¼Î²Î¬Î½ÎµÎ¹ Î¼Î­Ï‡ÏÎ¹ ÎºÎ±Î¹ Ï€Î½ÎµÏ…Î¼Î¿Î½Î¯Î± Ï€Î¿Ï… Ï€ÏÎ¿ÎºÎ»Î®Î¸Î·ÎºÎµ Î±Ï€ÏŒ Î±Î½ÎµÎ¼Î¿Î²Î»Î¿Î³Î¹Î¬ Î® Ï€Î½ÎµÏ…Î¼Î¿Î½Î¹ÏŒÎºÎ¿ÎºÎ¿. Î†Î»Î»Î± Ï€Î±ÏÎ±Î´ÎµÎ¯Î³Î¼Î±Ï„Î± ÎµÏ€Î¹Ï€Ï„ÏÏƒÎµÏ‰Î½ Î±Ï€ÏŒ Ï†Ï…ÏƒÎ¹ÎºÎ® Î¼ÏŒÎ»Ï…Î½ÏƒÎ· ÎµÎ¯Î½Î±Î¹ Î· Î´Î¹Î±Î½Î¿Î·Ï„Î¹ÎºÎ® Î±Î½Î±Ï€Î·ÏÎ¯Î± Î¼ÎµÏ„Î¬ Î±Ï€ÏŒ Î½ÏŒÏƒÎ·ÏƒÎ· Ï€Î¿Ï… Ï€ÏÎ¿ÎºÎ±Î»ÎµÎ¯ Î¿ Î¹ÏŒÏ‚ Hib, Î³ÎµÎ½ÎµÏ„Î¹ÎºÎ­Ï‚ Î±Î½Ï‰Î¼Î±Î»Î¯ÎµÏ‚ Î¼ÎµÏ„Î¬ Î±Ï€ÏŒ ÎµÏÏ…Î¸ÏÎ¬, ÎºÎ±ÏÎºÎ¯Î½Î¿ Ï„Î¿Ï… Î®Ï€Î±Ï„Î¿Ï‚ Î¼ÎµÏ„Î¬ Î±Ï€ÏŒ Ï„Î¿Î½ Î¹ÏŒ Ï„Î·Ï‚ Î·Ï€Î±Ï„Î¯Ï„Î¹Î´Î±Ï‚ Î’ Î® Î¼Î­Ï‡ÏÎ¹ ÎºÎ±Î¹ Î¸Î¬Î½Î±Ï„Î¿ Î¼ÎµÏ„Î¬ Î±Ï€ÏŒ Ï„Î·Î½ Î±ÏƒÎ¸Î­Î½ÎµÎ¹Î± Î¹Î»Î±ÏÎ¬Ï‚. </p><p> Î Î¹Î¿ ÏƒÏ…Î³ÎºÎµÎºÏÎ¹Î¼Î­Î½Î± ÎµÎ¬Î½ ÎºÎ¬Ï€Î¿Î¹Î¿Ï‚ Î¸ÎµÎ»Î®ÏƒÎµÎ¹ Î½Î± Î±Ï€Î¿ÎºÏ„Î®ÏƒÎµÎ¹ Î±Î½Î¿ÏƒÎ¯Î± ÏƒÏ„Î·Î½ Î¹Î»Î±ÏÎ¬ Î¼ÎµÏ„Î¬ Î±Ï€ÏŒ Ï†Ï…ÏƒÎ¹ÎºÎ® Î½ÏŒÏƒÎ·ÏƒÎ·, Î¸Î± Î±Î½Ï„Î¹Î¼ÎµÏ„ÏÏ€Î¹Î¶Îµ 1 ÏƒÏ„Î¹Ï‚ 500 Ï€Î¹Î¸Î±Î½ÏŒÏ„Î·Ï„ÎµÏ‚ Î¸Î±Î½Î¬Ï„Î¿Ï… Î±Ï€ÏŒ Ï„Î± ÏƒÏ…Î¼Ï€Ï„ÏÎ¼Î±Ï„Î¬ Ï„Î·Ï‚. </p><p> Î‘Î½Ï„Î¯Î¸ÎµÏ„Î±, Î¿ Î±ÏÎ¹Î¸Î¼ÏŒÏ‚ Ï„Ï‰Î½ Î±Ï„ÏŒÎ¼Ï‰Î½ Ï€Î¿Ï… ÎµÎ¯Ï‡Î±Î½ ÏƒÎ¿Î²Î±ÏÎ­Ï‚ Î±Î»Î»ÎµÏÎ³Î¹ÎºÎ­Ï‚ Î±Î½Ï„Î¹Î´ÏÎ¬ÏƒÎµÎ¹Ï‚ Î±Ï€ÏŒ Î­Î½Î± ÎµÎ¼Î²ÏŒÎ»Î¹Î¿ MMR Î³Î¹Î± Ï„Î·Î½ Î™Î»Î±ÏÎ¬-Î Î±ÏÏ‰Ï„Î¯Ï„Î¹Î´Î±-Î•ÏÏ…Î¸ÏÎ¬, ÎµÎ¯Î½Î±Î¹ Î¼Î¹ÎºÏÏŒÏ„ÎµÏÎ¿Ï‚ Î±Ï€ÏŒ 1 ÏƒÎµ 1.000.000.000. </p><p> Î©ÏƒÏ„ÏŒÏƒÎ¿, Ï…Ï€Î¬ÏÏ‡Î¿Ï…Î½ Î¼ÎµÏÎ¹ÎºÎ¬ ÎµÎ¼Î²ÏŒÎ»Î¹Î± Ï€Î¿Ï… Ï€ÏÎ¿ÎºÎ±Î»Î¿ÏÎ½ ÎºÎ±Î»ÏÏ„ÎµÏÎ· Î±Î½Î¿ÏƒÎ¿Î»Î¿Î³Î¹ÎºÎ® Î±Ï€ÏŒÎºÏÎ¹ÏƒÎ· Î±Ï€ÏŒ ÏŒÏ„Î¹ Î· Ï†Ï…ÏƒÎ¹ÎºÎ® Î½ÏŒÏƒÎ·ÏƒÎ·. Î“Î¹Î± Ï€Î±ÏÎ¬Î´ÎµÎ¹Î³Î¼Î±, Ï„Î¿ ÎµÎ¼Î²ÏŒÎ»Î¹Î¿ Î³Î¹Î± Ï„Î¿Î½ Î¹ÏŒ Ï„Ï‰Î½ Î±Î½Î¸ÏÏÏ€Î¹Î½Ï‰Î½ Î¸Î·Î»Ï‰Î¼Î¬Ï„Ï‰Î½ (HPV) Ï€ÎµÏÎ¹Î­Ï‡ÎµÎ¹ Ï…ÏˆÎ·Î»Î® ÎºÎ±Î¸Î±ÏÏŒÏ„Î·Ï„Î± Ï„Î·Ï‚ ÏƒÏ…Î³ÎºÎµÎºÏÎ¹Î¼Î­Î½Î·Ï‚ Ï€ÏÏ‰Ï„ÎµÎÎ½Î·Ï‚, Ï€Î¿Ï… Î¿Î´Î·Î³ÎµÎ¯ ÏƒÎµ ÎºÎ±Î»ÏÏ„ÎµÏÎ· Î±Î½Î¿ÏƒÎ¿Î»Î¿Î³Î¹ÎºÎ® Î±Ï€ÏŒÎºÏÎ¹ÏƒÎ· Î±ÎºÏŒÎ¼Î± ÎºÎ±Î¹ Î±Ï€ÏŒ Ï„Î· Ï†Ï…ÏƒÎ¹ÎºÎ® Î½ÏŒÏƒÎ·ÏƒÎ·. Î†Î»Î»Î± Ï€Î±ÏÎ±Î´ÎµÎ¯Î³Î¼Î±Ï„Î± Ï€ÎµÏÎ¹Î»Î±Î¼Î²Î¬Î½Î¿Ï…Î½ Ï„Î¿ ÎµÎ¼Î²ÏŒÎ»Î¹Î¿ ÎºÎ±Ï„Î¬ Ï„Î¿Ï… Ï„ÎµÏ„Î¬Î½Î¿Ï…, Ï„Î¿Ï… Î¹Î¿Ï Hib, ÎºÎ±Î¹ Ï„Î¿Ï… Ï€Î½ÎµÏ…Î¼Î¿Î½Î¹ÏŒÎºÎ¿ÎºÎºÎ¿Ï…. ÎŒÏƒÎ¿Î½ Î±Ï†Î¿ÏÎ¬ Ï„Î¿Î½ COVID-19, Î´ÎµÎ½ Î­Ï‡ÎµÎ¹ Î´Î¹ÎµÏ…ÎºÏÎ¹Î½Î¹ÏƒÏ„ÎµÎ¯ Î±ÎºÏŒÎ¼Î·. ÎˆÏ‡ÎµÎ¹ Î±Ï€Î¿Î´ÎµÎ¹Ï‡Î¸ÎµÎ¯ ÏŒÎ¼Ï‰Ï‚ ÏŒÏ„Î¹ Î· Î¼ÏŒÎ½Î¹Î¼Î· Ï€ÏÎ¿ÏƒÏ„Î±ÏƒÎ¯Î± Î¼ÎµÏ„Î¬ Ï„Î· Î½ÏŒÏƒÎ·ÏƒÎ· ÎµÎ¯Î½Î±Î¹ Î±Ï€Î¯Î¸Î±Î½Î·. </p><p> Î Î±ÏÏŒÎ»Î¿ Ï€Î¿Ï… Î¿Î¹ Î±ÏƒÎ¸ÎµÎ½ÎµÎ¯Ï‚ Î¼Îµ ÎºÎ¿ÏÎ¿Î½Î¿ÏŠÏŒ Î±Ï€Î­ÎºÏ„Î·ÏƒÎ±Î½ Â«ÏƒÎ·Î¼Î±Î½Ï„Î¹ÎºÎ® Î±Î½Î¿ÏƒÎ¿Î»Î¿Î³Î¹ÎºÎ® Î¼Î½Î®Î¼Î·Â» Ï€Î¿Ï… Ï€ÎµÏÎ¹Î»Î¬Î¼Î²Î±Î½Îµ ÎºÎ±Î¹ Ï„Î± Ï„Î­ÏƒÏƒÎµÏÎ± ÏƒÎ·Î¼Î±Î½Ï„Î¹ÎºÎ¬ Î¼Î­ÏÎ· Ï„Î¿Ï… Î±Î½Î¿ÏƒÎ¿Ï€Î¿Î¹Î·Ï„Î¹ÎºÎ¿Ï ÏƒÏ…ÏƒÏ„Î®Î¼Î±Ï„Î¿Ï‚, ÎºÏÏ„Ï„Î±ÏÎ± Î¼Î½Î®Î¼Î·Ï‚ Î’, Î±Î½Ï„Î¹ÏƒÏÎ¼Î±Ï„Î±, ÎºÏÏ„Ï„Î±ÏÎ± Î¼Î½Î®Î¼Î·Ï‚ CD4+Î¤Î±, ÎºÏÏ„Ï„Î±ÏÎ± Î¼Î½Î®Î¼Î·Ï‚ CD8+Î¤, Î· Ï€ÏÎ¿ÏƒÏ„Î±ÏƒÎ¯Î± Î¬ÏÏ‡Î¹ÏƒÎµ Î½Î± Î¼ÎµÎ¹ÏÎ½ÎµÏ„Î±Î¹ Î¼ÎµÏ„Î¬ Î±Ï€ÏŒ Î¼Î¹ÏƒÏŒ Ï‡ÏÏŒÎ½Î¿ Î® ÎºÎ±Î¹ Î»Î¹Î³ÏŒÏ„ÎµÏÎ¿. Î•Ï€Î¯ÏƒÎ·Ï‚, Î¿Î¹ ÎµÏ€Î¹ÏƒÏ„Î®Î¼Î¿Î½ÎµÏ‚ Î­Ï‡Î¿Ï…Î½ Î´ÎµÎ¯Î¾ÎµÎ¹ Î­Î½Î± Â«Ï„ÎµÏÎ¬ÏƒÏ„Î¹Î¿ Î´Ï…Î½Î±Î¼Î¹ÎºÏŒ ÎµÏÏÎ¿Ï‚Â» ÏƒÏ„Î·Î½ Î±Î½Î¿ÏƒÎ¿Î»Î¿Î³Î¹ÎºÎ® Î±Ï€ÏŒÎºÏÎ¹ÏƒÎ· Î¼ÎµÏ„Î±Î¾Ï Ï„Ï‰Î½ Î±Ï„ÏŒÎ¼Ï‰Î½, Î¼Îµ 200Ï€Î»Î¬ÏƒÎ¹Î± Î´Î¹Î±Ï†Î¿ÏÎ¬ ÏƒÏ„Î± ÎµÏ€Î¯Ï€ÎµÎ´Î± Î±Î½Ï„Î¹ÏƒÏ‰Î¼Î¬Ï„Ï‰Î½. </p><p> Î†Î»Î»ÎµÏ‚ Î¼ÎµÎ»Î­Ï„ÎµÏ‚ Î­Ï‡Î¿Ï…Î½ Î´ÎµÎ¯Î¾ÎµÎ¹ ÏŒÏ„Î¹ ÎµÎ¸ÎµÎ»Î¿Î½Ï„Î­Ï‚ Ï€Î¿Ï… Î­Î»Î±Î²Î±Î½ Ï„Î¿ ÎµÎ¼Î²ÏŒÎ»Î¹Î¿ Moderna (mRNA), Î±Ï€Î­ÎºÏ„Î·ÏƒÎ±Î½ Ï€ÎµÏÎ¹ÏƒÏƒÏŒÏ„ÎµÏÎ± Î±Î½Ï„Î¹ÏƒÏÎ¼Î±Ï„Î± â€“ Î­Î½Î±Ï‚ Î´ÎµÎ¯ÎºÏ„Î·Ï‚ Î±Î½Î¿ÏƒÎ¿Î»Î¿Î³Î¹ÎºÎ®Ï‚ Î±Ï€ÏŒÎºÏÎ¹ÏƒÎ·Ï‚ â€“ ÏƒÏ„Î¿ Î±Î¯Î¼Î± Ï„Î¿Ï…Ï‚ Î±Ï€ÏŒ Ï„Î¿Ï…Ï‚ Î±Î½Î¸ÏÏÏ€Î¿Ï…Ï‚ Ï€Î¿Ï… Î½ÏŒÏƒÎ·ÏƒÎ±Î½ Î¼Îµ Ï„Î¿Î½ Î¹ÏŒ COVID-19. Î©ÏƒÏ„ÏŒÏƒÎ¿, Î±Ï…Ï„ÏŒ Ï„Î¿ Î³ÎµÎ³Î¿Î½ÏŒÏ‚ Î¼Ï€Î¿ÏÎµÎ¯ Î½Î± Ï„ÏÎ¿Ï€Î¿Ï€Î¿Î¹Î·Î¸ÎµÎ¯ Î±Ï€ÏŒ Ï„Î· ÏƒÎ¿Î²Î±ÏÏŒÏ„Î·Ï„Î± Ï„Î·Ï‚ Î½ÏŒÏƒÎ¿Ï… ÎºÎ±Î¸ÏÏ‚ Ï…Ï€Î¬ÏÏ‡ÎµÎ¹ ÏƒÏ…ÏƒÏ‡Î­Ï„Î¹ÏƒÎ· Î¼ÎµÏ„Î±Î¾Ï Î±Ï…Ï„Î®Ï‚ ÎºÎ±Î¹ Ï„Î·Ï‚ Î´Î¹Î±ÏÎºÎ¿ÏÏ‚ Î±Î½Î¿ÏƒÎ¿Î»Î¿Î³Î¹ÎºÎ®Ï‚ Î±Ï€ÏŒÎºÏÎ¹ÏƒÎ·Ï‚. Î£Ï…Î³ÎºÎµÎºÏÎ¹Î¼Î­Î½Î±, Î¿Î¹ Ï€ÎµÏÎ¹ÏƒÏƒÏŒÏ„ÎµÏÎ¿Î¹ ÏƒÏ…Î¼Ï€Ï„Ï‰Î¼Î±Ï„Î¹ÎºÎ¿Î¯ Î±ÏƒÎ¸ÎµÎ½ÎµÎ¯Ï‚ ÎµÎ¯Ï‡Î±Î½ Ï€Î¿Î»Ï Î»Î¯Î³Î± Î±Î½Ï„Î¹ÏƒÏÎ¼Î±Ï„Î± Î¼ÎµÏ„Î¬ Î±Ï€ÏŒ Î­Î¾Î¹ Î¼Î®Î½ÎµÏ‚ Î¼ÏŒÎ»Ï…Î½ÏƒÎ·Ï‚. </p><p> Î‘Ï€ÏŒ Ï„Î± Ï€Î¹Î¿ Ï€Î¬Î½Ï‰ ÏƒÏ…Î¼Ï€ÎµÏÎ±Î¯Î½Î¿Ï…Î¼Îµ ÏŒÏ„Î¹ Î· Ï†Ï…ÏƒÎ¹ÎºÎ® Î±Î½Î¿ÏƒÎ¯Î± Ï€Î¿Ï… Î´Î·Î¼Î¹Î¿Ï…ÏÎ³ÎµÎ¯Ï„Î±Î¹ Î±Ï€ÏŒ Î¼Î¯Î± Î¼ÏŒÎ»Ï…Î½ÏƒÎ· SARS-CoV-2 ÎµÎ¯Î½Î±Î¹ ÏƒÏ…Ï‡Î½Î¬ Î±Ï€ÏÏŒÎ²Î»ÎµÏ€Ï„Î·. Î•Ï€Î¹Ï€Î»Î­Î¿Î½, Ï„Î± Î±Î½Ï„Î¹ÏƒÏÎ¼Î±Ï„Î± Ï€Î¿Ï… Î±Î½Î±Ï€Ï„ÏÏƒÏƒÎ¿Î½Ï„Î±Î¹ Î¼Î­ÏƒÏ‰ ÎµÎ½ÏŒÏ‚ ÎµÎ¼Î²Î¿Î»Î¯Î¿Ï… mRNA ÏƒÏ„Î¿Ï‡ÎµÏÎ¿Ï…Î½ Î­Î½Î± ÎµÏ…ÏÏÏ„ÎµÏÎ¿ Ï†Î¬ÏƒÎ¼Î± Î¸Î­ÏƒÎµÏ‰Î½ ÏƒÏ„Î¿Î½ Ï„Î¿Î¼Î­Î± Î´Î­ÏƒÎ¼ÎµÏ…ÏƒÎ·Ï‚ Ï…Ï€Î¿Î´Î¿Ï‡Î­Ï‰Î½ (RBD) Î±Ï€ÏŒ ÎµÎºÎµÎ¯Î½Î± Ï€Î¿Ï… Ï€ÏÎ¿ÎºÎ±Î»Î¿ÏÎ½Ï„Î±Î¹ Î±Ï€ÏŒ Ï†Ï…ÏƒÎ¹ÎºÎ® Î¼ÏŒÎ»Ï…Î½ÏƒÎ·. </p><section class="e-card"><h4 class="mt-0">Î‘Î½Î±Ï†Î¿ÏÎ­Ï‚ / Î Î·Î³Î­Ï‚ Î Î»Î·ÏÎ¿Ï†ÏŒÏÎ·ÏƒÎ·Ï‚</h4><ul class="text-sm break-all"><li><a href="https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(21)00675-9/fulltext" target="_blank" rel="noopener noreferrer">https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(21)00675-9/fulltext</a></li><li><a href="https://science.sciencemag.org/content/371/6529/eabf4063" target="_blank" rel="noopener noreferrer">https://science.sciencemag.org/content/371/6529/eabf4063</a></li><li><a href="https://www.nejm.org/doi/full/10.1056/NEJMc2032195" target="_blank" rel="noopener noreferrer">https://www.nejm.org/doi/full/10.1056/NEJMc2032195</a></li><li><a href="https://www.researchsquare.com/article/rs-612205/v1" target="_blank" rel="noopener noreferrer">https://www.researchsquare.com/article/rs-612205/v1</a></li><li><a href="https://stm.sciencemag.org/content/13/600/eabi9915" target="_blank" rel="noopener noreferrer">https://stm.sciencemag.org/content/13/600/eabi9915</a></li></ul></section><h3><span class="text-rose-400">ÎœÏÎ¸Î¿Ï‚ 4:</span> Î¤Î± ÎµÎ¼Î²ÏŒÎ»Î¹Î± Ï€ÎµÏÎ¹Î­Ï‡Î¿Ï…Î½ Î¿Ï…ÏƒÎ¯ÎµÏ‚ Î±Ï€ÎµÎ¹Î»Î·Ï„Î¹ÎºÎ­Ï‚ Î³Î¹Î± Ï„Î·Î½ Î±Î½Î¸ÏÏÏ€Î¹Î½Î· Î¶Ï‰Î®</h3><p> Î Î¿Î»Î»Î¿Î¯ Î¬Î½Î¸ÏÏ‰Ï€Î¿Î¹ Î±Î½Î·ÏƒÏ…Ï‡Î¿ÏÎ½ Î³Î¹Î± Ï„Î·Î½ Ï€ÎµÏÎ¹ÎµÎºÏ„Î¹ÎºÏŒÏ„Î·Ï„Î± Î¿Ï…ÏƒÎ¹ÏÎ½ ÏŒÏ€Ï‰Ï‚ Î· Ï†Î¿ÏÎ¼Î±Î»Î´ÎµÎ°Î´Î·, Î¿ Ï…Î´ÏÎ¬ÏÎ³Ï…ÏÎ¿Ï‚ Î® Ï„Î¿ Î±Î»Î¿Ï…Î¼Î¯Î½Î¹Î¿ Î¼Î­ÏƒÎ± ÏƒÏ„Î± ÎµÎ¼Î²ÏŒÎ»Î¹Î±. Î‘Ï…Ï„Î­Ï‚ Î¿Î¹ Ï‡Î·Î¼Î¹ÎºÎ­Ï‚ Î¿Ï…ÏƒÎ¯ÎµÏ‚ ÎµÎ¯Î½Î±Î¹ Ï„Î¿Î¾Î¹ÎºÎ­Ï‚ Î³Î¹Î± Ï„Î¿Î½ Î±Î½Î¸ÏÏÏ€Î¹Î½Î¿ Î¿ÏÎ³Î±Î½Î¹ÏƒÎ¼ÏŒ Î¼ÏŒÎ½Î¿ ÏƒÎµ Ï€Î¿Î»Ï Î¼ÎµÎ³Î¬Î»ÎµÏ‚ ÏƒÏ…Î³ÎºÎµÎ½Ï„ÏÏÏƒÎµÎ¹Ï‚. ÎŸÎ¹ Ï€Î¿ÏƒÏŒÏ„Î·Ï„ÎµÏ‚ Ï€Î¿Ï… Ï€ÎµÏÎ¹Î­Ï‡Î¿Î½Ï„Î±Î¹ ÏƒÏ„Î± ÎµÎ¼Î²ÏŒÎ»Î¹Î± ÎµÎ¯Î½Î±Î¹ ÏƒÎµ ÎµÎ»Î¬Ï‡Î¹ÏƒÏ„ÎµÏ‚ Ï€Î¿ÏƒÏŒÏ„Î·Ï„ÎµÏ‚, Î¼Î¹ÎºÏÏŒÏ„ÎµÏÎµÏ‚ ÎºÎ±Î¹ Î±Ï€ÏŒ Ï„Î¹Ï‚ Ï€Î¿ÏƒÏŒÏ„Î·Ï„ÎµÏ‚ Ï€Î¿Ï… Î»Î±Î¼Î²Î¬Î½Î¿Ï…Î¼Îµ Î±ÎºÏŒÎ¼Î± ÎºÎ±Î¹ Î±Ï€ÏŒ Ï„Î· Î´Î¹Î±Ï„ÏÎ¿Ï†Î® Î¼Î±Ï‚. ÎœÎ¬Î»Î¹ÏƒÏ„Î± Î· Î¿Ï…ÏƒÎ¯Î± Ï„Î·Ï‚ Ï†Î¿ÏÎ¼Î±Î»Î´ÎµÎ°Î´Î·Ï‚ Ï€Î±ÏÎ¬Î³ÎµÏ„Î±Î¹ ÏƒÎµ Ï…ÏˆÎ·Î»ÏŒÏ„ÎµÏÎµÏ‚ ÏƒÏ…Î³ÎºÎµÎ½Ï„ÏÏÏƒÎµÎ¹Ï‚ Î±ÎºÏŒÎ¼Î± ÎºÎ±Î¹ Î±Ï€ÏŒ Ï„Î¿Î½ Î¯Î´Î¹Î¿ Ï„Î¿Î½ Î¼ÎµÏ„Î±Î²Î¿Î»Î¹ÏƒÎ¼ÏŒ Î¼Î±Ï‚. </p><p> ÎŸÏÎ¹ÏƒÎ¼Î­Î½Î± Ï‡Î·Î¼Î¹ÎºÎ¬ ÏƒÏ„Î¿Î¹Ï‡ÎµÎ¯Î± ÏŒÏ€Ï‰Ï‚ ÎµÎ¯Î½Î±Î¹ Ï„Î± Î¬Î»Î±Ï„Î± Î±Î»Î¿Ï…Î¼Î¹Î½Î¯Î¿Ï… (aluminium salts) Ï€ÏÎ¿ÏƒÏ„Î¯Î¸ÎµÎ½Ï„Î±Î¹ ÏƒÏ„Î± ÎµÎ¼Î²ÏŒÎ»Î¹Î± ÎºÎ±Î¸ÏÏ‚ Î»ÎµÎ¹Ï„Î¿Ï…ÏÎ³Î¿ÏÎ½ Ï‰Ï‚ Î±Î½Î¿ÏƒÎ¿ÎµÎ½Î¹ÏƒÏ‡Ï…Ï„Î¹ÎºÎ¬. Î‘Ï…Ï„ÏŒ ÏƒÎ·Î¼Î±Î¯Î½ÎµÎ¹ Ï€Ï‰Ï‚ Î· Ï€Î±ÏÎ¿Ï…ÏƒÎ¯Î± Ï„Î¿Ï…Ï‚ ÏƒÏ„Î± ÎµÎ¼Î²ÏŒÎ»Î¹Î± ÎµÎ½Î¹ÏƒÏ‡ÏÎµÎ¹ Ï„Î·Î½ Î±Î½Î¿ÏƒÎ¿Î»Î¿Î³Î¹ÎºÎ® Î±Ï€ÏŒÎºÏÎ¹ÏƒÎ· ÏŒÏ„Î±Î½ ÎºÎ¬Ï€Î¿Î¹Î¿Ï‚ ÎµÎ¼Î²Î¿Î»Î¹Î¬Î¶ÎµÏ„Î±Î¹. Î Î±ÏÏŒÎ»Î± Î±Ï…Ï„Î¬, Î¼ÏŒÎ½Î¿ ÏƒÏ…Î³ÎºÎµÎºÏÎ¹Î¼Î­Î½Î± ÎµÎ¼Î²ÏŒÎ»Î¹Î± Ï€ÎµÏÎ¹Î­Ï‡Î¿Ï…Î½ Î¬Î»Î±Ï„Î± Î±Î»Î¿Ï…Î¼Î¹Î½Î¯Î¿Ï…. Î“Î¹Î± Ï€Î±ÏÎ¬Î´ÎµÎ¹Î³Î¼Î± Ï„Î± Ï€ÏÏŒÏƒÏ†Î±Ï„Î± ÎµÎ¼Î²ÏŒÎ»Î¹Î± Î³Î¹Î± Ï„Î¿Î½ Î¹ÏŒ COVID-19 Î´ÎµÎ½ Ï€ÎµÏÎ¹Î­Ï‡Î¿Ï…Î½ Î¬Î»Î±Ï„Î± Î±Î»Î¿Ï…Î¼Î¹Î½Î¯Î¿Ï…. </p><p> ÎœÎµÏÎ¹ÎºÎ¬ ÎµÎ¼Î²ÏŒÎ»Î¹Î± ÎµÏ€Î¯ÏƒÎ·Ï‚ ÎµÎ¼Ï€ÎµÏÎ¹Î­Ï‡Î¿Ï…Î½ Ï„Î·Î½ Î¸Î¹Î¼ÎµÏÎ¿ÏƒÎ¬Î»Î·(thimerosal) Ï‰Ï‚ ÏƒÏ…Î½Ï„Î·ÏÎ·Ï„Î¹ÎºÏŒ. Î©ÏƒÏ„ÏŒÏƒÎ¿, ÎºÎ±Î½Î­Î½Î± Î±Ï€ÏŒ Ï„Î± ÎµÎ¼Î²ÏŒÎ»Î¹Î± Ï€Î¿Ï… ÎºÎ¬Î½Î¿Ï…Î½ Ï„Î± Ï€Î±Î¹Î´Î¹Î¬ Î´ÎµÎ½ Ï€ÎµÏÎ¹Î­Ï‡ÎµÎ¹ Ï„Î¿ ÏƒÏ…Î³ÎºÎµÎºÏÎ¹Î¼Î­Î½Î¿ ÏƒÏ…Î½Ï„Î·ÏÎ·Ï„Î¹ÎºÏŒ. Î— Î¸Î¹Î¼ÎµÏÎ¿ÏƒÎ¬Î»Î· Ï€ÎµÏÎ¹Î­Ï‡ÎµÎ¹ Î±Î¹Î¸Ï…Î»Ï…Î´ÏÎ¬ÏÎ³Ï…ÏÎ¿ (ethylmercury), Î¿ Î¿Ï€Î¿Î¯Î¿Ï‚ Î±Ï€Î¿Î¼Î±ÎºÏÏÎ½ÎµÏ„Î±Î¹ Î³ÏÎ®Î³Î¿ÏÎ± Î±Ï€ÏŒ Ï„Î¿Î½ Î±Î½Î¸ÏÏÏ€Î¹Î½Î¿ Î¿ÏÎ³Î±Î½Î¹ÏƒÎ¼ÏŒ ÏƒÎµ ÏƒÏÎ³ÎºÏÎ¹ÏƒÎ· Î¼Îµ Ï„Î¿Î½ Î¼ÎµÎ¸Ï…Î»Ï…Î´ÏÎ¬ÏÎ³Ï…ÏÎ¿ (methylmercury) Î¿ Î¿Ï€Î¿Î¯Î¿Ï‚ Î²Î¹Î¿ÏƒÏ…ÏƒÏƒÏ‰ÏÎµÏÎµÏ„Î±Î¹, ÏƒÏ…Î½ÎµÏ€ÏÏ‚ Ï…Ï€Î¬ÏÏ‡ÎµÎ¹ Î´Î¹Î±Ï†Î¿ÏÎ¬ ÏƒÏ„Î·Î½ Ï„Î¿Î¾Î¹ÎºÏŒÏ„Î·Ï„Î± Ï€Î¿Ï… Ï€ÏÎ¿ÎºÎ±Î»ÎµÎ¯Ï„Î±Î¹ ÏƒÏ„Î¿Î½ Î±Î½Î¸ÏÏÏ€Î¹Î½Î¿ Î¿ÏÎ³Î±Î½Î¹ÏƒÎ¼ÏŒ Î±Î½Î¬Î»Î¿Î³Î± Î¼Îµ Ï„Î· Î¼Î¿ÏÏ†Î® Ï„Î¿Ï… Î¼ÎµÏ„Î¬Î»Î»Î¿Ï…. Î¤Î± ÎµÎ¼Î²ÏŒÎ»Î¹Î± Î³Î¹Î± Ï„Î¿Î½ Î¹ÏŒ COVID-19 Î´ÎµÎ½ Ï€ÎµÏÎ¹Î­Ï‡Î¿Ï…Î½ Ï„Î¿Î¾Î¹ÎºÎ¬ Î¼Î­Ï„Î±Î»Î»Î±. </p><section class="e-card"><h4 class="mt-0">Î‘Î½Î±Ï†Î¿ÏÎ­Ï‚ / Î Î·Î³Î­Ï‚ Î Î»Î·ÏÎ¿Ï†ÏŒÏÎ·ÏƒÎ·Ï‚</h4><ul class="text-sm break-all"><li><a href="https://stm.sciencemag.org/content/13/600/eabi9915" target="_blank" rel="noopener noreferrer">https://stm.sciencemag.org/content/13/600/eabi9915</a></li><li><a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6373706/" target="_blank" rel="noopener noreferrer">https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6373706/</a></li><li><a href="https://www.technologyreview.com/2020/12/09/1013538/what-are-the-ingredients-of-pfizers-covid-19-vaccine/" target="_blank" rel="noopener noreferrer">https://www.technologyreview.com/2020/12/09/1013538/what-are-the-ingredients-of-pfizers-covid-19-vaccine/</a></li></ul></section>',24),ka=e("div",null,[e("h3",{class:"mt-6 pt-3 mb-10"},"Î“Î¹Î± Ï€ÎµÏÎ¹ÏƒÏƒÏŒÏ„ÎµÏÎ· Î¼ÎµÎ»Î­Ï„Î·"),e("ul",{class:"leading-tight"},[e("li",null,[a("ğŸ“º"),e("a",{href:"https://www.youtube.com/watch?v=Atrx1P2EkiQ",target:"_blank",rel:"noopener noreferrer"},"Vaccines and the Immune Response: How Vaccines Work")]),e("li",null,[e("a",{href:"https://www.cdc.gov/vaccines/vac-gen/additives.htm",target:"_blank",rel:"noopener noreferrer"},"Whatâ€™s in Vaccines?")])])],-1),fa=i('<h3><span class="text-rose-400">ÎœÏÎ¸Î¿Ï‚ 5:</span> Î— ÎºÎ±Î»ÏÏ„ÎµÏÎ· Ï…Î³Î¹ÎµÎ¹Î½Î® ÎºÎ±Î¹ Î±Ï€Î¿Î»ÏÎ¼Î±Î½ÏƒÎ· Î¼Ï€Î¿ÏÎ¿ÏÎ½ Î½Î± Î¼ÎµÎ¹ÏÏƒÎ¿Ï…Î½ Ï„Î¹Ï‚ Î»Î¿Î¹Î¼ÏÎ¾ÎµÎ¹Ï‚ ÎºÎ±Î¹ ÏŒÏ‡Î¹ Ï„Î± ÎµÎ¼Î²ÏŒÎ»Î¹Î±</h3><p> Î— Î±Î»Î®Î¸ÎµÎ¹Î± ÎµÎ¯Î½Î±Î¹ ÏŒÏ„Î¹ Î· Ï‡Î¿ÏÎ®Î³Î·ÏƒÎ· ÎµÎ¼Î²Î¿Î»Î¯Ï‰Î½ Î´ÎµÎ½ Î¸Î± Î­Ï€ÏÎµÏ€Îµ Î½Î± Î»Î±Î¼Î²Î¬Î½ÎµÎ¹ ÏŒÎ»Î± Ï„Î± ÎµÏÏƒÎ·Î¼Î± Î³Î¹Î± Ï„Î· Î¼ÎµÎ¯Ï‰ÏƒÎ· Î® ÎµÎ¾Î¬Î»ÎµÎ¹ÏˆÎ· Ï„Î¿Ï… Ï€Î¿ÏƒÎ¿ÏƒÏ„Î¿Ï Ï„Ï‰Î½ Î¼Î¿Î»Ï…ÏƒÎ¼Î±Ï„Î¹ÎºÏÎ½ Î±ÏƒÎ¸ÎµÎ½ÎµÎ¹ÏÎ½. ÎˆÏ‡ÎµÎ¹ Î±Ï€Î¿Î´ÎµÎ¹Ï‡Î¸ÎµÎ¯ ÏŒÏ„Î¹ Î· ÎºÎ±Î»ÏÏ„ÎµÏÎ· Ï…Î³Î¹ÎµÎ¹Î½Î®, Î· Î´Î¹Î±Ï„ÏÎ¿Ï†Î® ÎºÎ±Î¹ Î· Î±Î½Î¬Ï€Ï„Ï…Î¾Î· Î±Î½Ï„Î¹Î²Î¹Î¿Ï„Î¹ÎºÏÎ½ Î­Ï‡Î¿Ï…Î½ ÎµÏ€Î¯ÏƒÎ·Ï‚ ÏƒÏ…Î¼Î²Î¬Î»ÎµÎ¹ ÏƒÏ„Î·Î½ ÎµÎ¾Î¬Î»ÎµÎ¹ÏˆÎ· ÎµÎ½ÏŒÏ‚ Ï€Î¿ÏƒÎ¿ÏƒÏ„Î¿Ï Ï„Ï‰Î½ Î¼Î¿Î»Ï…ÏƒÎ¼Î±Ï„Î¹ÎºÏÎ½ Î±ÏƒÎ¸ÎµÎ½ÎµÎ¹ÏÎ½. Î›Î¿Î¹Î¼ÏÎ¾ÎµÎ¹Ï‚ ÏŒÏ€Ï‰Ï‚ Î¿ Ï„ÏÏ†Î¿Ï‚ ÎºÎ±Î¹ Î· Ï‡Î¿Î»Î­ÏÎ± Ï€Î¿Ï… Î¼ÎµÏ„Î±Î´Î¯Î´Î¿Î½Ï„Î±Î¹ Î±Ï€ÏŒ Î¼Î¿Î»Ï…ÏƒÎ¼Î­Î½Î¿ Î½ÎµÏÏŒ, ÎºÎ±Î¹ Î¼Î¬Î»Î¹ÏƒÏ„Î± Î±Ï€Î¿Ï„ÎµÎ»Î¿ÏÏƒÎ±Î½ Î¼Î¯Î± ÎºÏÏÎ¹Î± Î±Î¹Ï„Î¯Î± Î±ÏƒÎ¸ÎµÎ½ÎµÎ¹ÏÎ½ ÎºÎ±Î¹ Î¸Î±Î½Î¬Ï„Î¿Ï… ÏƒÏ„Î¹Ï‚ Î±ÏÏ‡Î­Ï‚ Ï„Î¿Ï…Ï‚ 20Î¿Ï Î±Î¹ÏÎ½Î±, Î­Ï‡Î¿Ï…Î½ Î¼ÎµÎ¹Ï‰Î¸ÎµÎ¯ Î´ÏÎ±Î¼Î±Ï„Î¹ÎºÎ¬ Î»ÏŒÎ³Ï‰ Ï„Î·Ï‚ ÎºÎ±Î»ÏÏ„ÎµÏÎ·Ï‚ Ï…Î³Î¹ÎµÎ¹Î½Î®Ï‚. ÎœÎ¯Î± Ï€ÏÏŒÏƒÏ†Î±Ï„Î· Î±Î½Î±ÏƒÎºÏŒÏ€Î·ÏƒÎ· ÎºÎ±Ï„Î­Î»Î·Î¾Îµ ÏƒÏ„Î¿ ÏƒÏ…Î¼Ï€Î­ÏÎ±ÏƒÎ¼Î± ÏŒÏ„Î¹ Ï„Î¿ Ï€Î»ÏÏƒÎ¹Î¼Î¿ Ï„Ï‰Î½ Ï‡ÎµÏÎ¹ÏÎ½ Î±Ï€Î¿Ï„ÏÎ­Ï€ÎµÎ¹ Ï„Î¹Ï‚ Î¼Î¿Î»Ï…ÏƒÎ¼Î±Ï„Î¹ÎºÎ­Ï‚ Î±ÏƒÎ¸Î­Î½ÎµÎ¹ÎµÏ‚. ÎˆÎ½Î± Î¬Î»Î»Î¿ Ï€ÏÏŒÏƒÏ†Î±Ï„Î¿ ÏƒÏ„Î¿Î¹Ï‡ÎµÎ¯Î¿ Ï€ÏÎ¿Î­ÏÏ‡ÎµÏ„Î±Î¹ Î±Ï€ÏŒ Ï„Î¿ lockdown Î³Î¹Î± Ï„Î¿Î½ COVID-19 ÎºÎ±Î¹ Ï„Î·Î½ Ï€Î±ÏÎ¬Î»Î»Î·Î»Î· Î²ÎµÎ»Ï„Î¯Ï‰ÏƒÎ· Ï„Î·Ï‚ Ï…Î³Î¹ÎµÎ¹Î½Î®Ï‚ Î· Î¿Ï€Î¿Î¯Î± Î¼ÎµÎ¯Ï‰ÏƒÎµ Î´ÏÎ±Î¼Î±Ï„Î¹ÎºÎ¬ Ï„Î± Ï€Î¿ÏƒÎ¿ÏƒÏ„Î¬ ÎµÏ€Î¿Ï‡Î¹ÎºÎ®Ï‚ Î³ÏÎ¯Ï€Î·Ï‚. </p><p> Î©ÏƒÏ„ÏŒÏƒÎ¿, ÏŒÏ„Î±Î½ Î±Ï…Ï„Î¿Î¯ Î¿Î¹ Ï€Î±ÏÎ¬Î³Î¿Î½Ï„ÎµÏ‚ Î±Ï€Î¿Î¼Î¿Î½Ï‰Î¸Î¿ÏÎ½ ÎºÎ±Î¹ Î±Î½Î±Î»Ï…Î¸Î¿ÏÎ½ Ï„Î± Ï€Î¿ÏƒÎ¿ÏƒÏ„Î¬ Ï„Ï‰Î½ Î¼Î¿Î»Ï…ÏƒÎ¼Î±Ï„Î¹ÎºÏÎ½ Î±ÏƒÎ¸ÎµÎ½ÎµÎ¹ÏÎ½, Ï„ÏŒÏ„Îµ Î¿ ÏÏŒÎ»Î¿Ï‚ Ï„Ï‰Î½ ÎµÎ¼Î²Î¿Î»Î¯Ï‰Î½ Î´ÎµÎ½ Î¼Ï€Î¿ÏÎµÎ¯ Î½Î± Î±Î¼Ï†Î¹ÏƒÎ²Î·Ï„Î·Î¸ÎµÎ¯. ÎˆÎ½Î± ÏƒÏ‡ÎµÏ„Î¹ÎºÏŒ Ï€Î±ÏÎ¬Î´ÎµÎ¹Î³Î¼Î± Î±Ï€Î¿Ï„ÎµÎ»ÎµÎ¯ Ï„Î¿ ÎµÎ¼Î²ÏŒÎ»Î¹Î¿ Ï„Î·Ï‚ Î¹Î»Î±ÏÎ¬Ï‚ ÏƒÏ„Î¹Ï‚ Î—Î½Ï‰Î¼Î­Î½ÎµÏ‚ Î Î¿Î»Î¹Ï„ÎµÎ¯ÎµÏ‚ Î‘Î¼ÎµÏÎ¹ÎºÎ®Ï‚. Î£Ï…Î³ÎºÎµÎºÏÎ¹Î¼Î­Î½Î±, ÏŒÏ„Î±Î½ ÎµÎ¹ÏƒÎ®Ï‡Î¸Î· Ï„Î¿ Ï€ÏÏÏ„Î¿ ÎµÎ¼Î²ÏŒÎ»Î¹Î¿ Î¹Î»Î±ÏÎ¬Ï‚ Ï„Î¿ 1963, Ï„Î± Ï€Î¿ÏƒÎ¿ÏƒÏ„Î¬ Î¼ÏŒÎ»Ï…Î½ÏƒÎ·Ï‚ Î®Ï„Î±Î½ ÏƒÏ„Î±Î¸ÎµÏÎ¬ ÏƒÎµ Ï€ÎµÏÎ¯Ï€Î¿Ï… 40000 Ï€ÎµÏÎ¹Ï€Ï„ÏÏƒÎµÎ¹Ï‚ ÎµÏ„Î·ÏƒÎ¯Ï‰Ï‚. Î•ÎºÎµÎ¯ Î´Î·Î»Î±Î´Î® Ï€Î¿Ï… Î¿Î¹ ÎºÎ±Î½ÏŒÎ½ÎµÏ‚ Ï…Î³Î¹ÎµÎ¹Î½Î®Ï‚ ÎºÎ±Î¹ Î±Ï€Î¿Î»ÏÎ¼Î±Î½ÏƒÎ·Ï‚ Î´ÎµÎ½ Î¬Î»Î»Î±Î¾Î±Î½ ÎºÎ±Î¹ Ï€Î¿Î»Î»Î¬ Î³Î¹Î± Ï€Î¬Î½Ï‰ Î±Ï€ÏŒ Î¼Î¯Î± Î´ÎµÎºÎ±ÎµÏ„Î¯Î± Î· ÎµÎ¹ÏƒÎ±Î³Ï‰Î³Î® Ï„Î¿Ï… ÎµÎ¼Î²Î¿Î»Î¯Î¿Ï… Î¼ÎµÎ¯Ï‰ÏƒÎµ ÏƒÎ·Î¼Î±Î½Ï„Î¹ÎºÎ¬ Ï„Î¿ Ï€Î¿ÏƒÎ¿ÏƒÏ„ÏŒ Ï„Ï‰Î½ Î¼Î¿Î»ÏÎ½ÏƒÎµÏ‰Î½ Î±Ï€ÏŒ Î¹Î»Î±ÏÎ¬ ÏƒÎµ Ï€ÎµÏÎ¯Ï€Î¿Ï… 25.000 Ï€ÎµÏÎ¹Ï€Ï„ÏÏƒÎµÎ¹Ï‚ Î¼Î­Ï‡ÏÎ¹ Ï„Î¿ 1970. </p><p> Î‘ÎºÏŒÎ¼Î· Î­Î½Î± Ï€Î±ÏÎ¬Î´ÎµÎ¹Î³Î¼Î± ÎµÎ¯Î½Î±Î¹ Î· Î½ÏŒÏƒÎ¿Ï‚ Hib. Î£ÏÎ¼Ï†Ï‰Î½Î± Î¼Îµ ÏƒÏ„Î¿Î¹Ï‡ÎµÎ¯Î± Ï„Î¿Ï… CDC, Î¿Î¹ Î¼Î¿Î»ÏÎ½ÏƒÎµÎ¹Ï‚ Î±Ï€ÏŒ Î±Ï…Ï„Î® Ï„Î·Î½ Î±ÏƒÎ¸Î­Î½ÎµÎ¹Î± Î¼ÎµÎ¹ÏÎ¸Î·ÎºÎ±Î½ Î±Ï€ÏŒ 20.000 ÏƒÎµ 1.500 Î¼Î­ÏƒÎ± ÏƒÎµ 3 Ï‡ÏÏŒÎ½Î¹Î± (Î±Ï€ÏŒ Ï„Î¿ 1990 Î¼Î­Ï‡ÏÎ¹ Ï„Î¿ 1993), Î¼ÎµÏ„Î¬ Ï„Î·Î½ ÎµÎ¹ÏƒÎ±Î³Ï‰Î³Î® Ï„Î¿Ï… ÎµÎ¼Î²Î¿Î»Î¯Î¿Ï…. </p><p> Î¤Î­Î»Î¿Ï‚, Î±ÎºÏŒÎ¼Î· Î­Î½Î± Ï€ÏÏŒÏƒÏ†Î±Ï„Î¿ ÏƒÏ„Î¿Î¹Ï‡ÎµÎ¯Î¿ ÎµÎ¯Î½Î±Î¹ ÏŒÏ„Î¹ Ï€Î±ÏÏŒÎ»Î¿ Ï€Î¿Ï… Î´ÎµÎ½ Î­Î³Î¹Î½Î±Î½ Î´ÏÎ±Î¼Î±Ï„Î¹ÎºÎ­Ï‚ Î±Î»Î»Î±Î³Î­Ï‚ ÏƒÏ„Î¿Ï…Ï‚ ÎºÎ±Î½ÏŒÎ½ÎµÏ‚ Ï…Î³Î¹ÎµÎ¹Î½Î®Ï‚ ÏƒÏ„Î¿Î½ Î±Î½ÎµÏ€Ï„Ï…Î³Î¼Î­Î½Î¿ ÎºÏŒÏƒÎ¼Î¿, Î­Î³Î¹Î½Îµ Î¼ÎµÎ¯Ï‰ÏƒÎ· Ï„Ï‰Î½ ÎµÎ¼Î²Î¿Î»Î¹Î±ÏƒÎ¼ÏÎ½. Î‘Ï…Ï„Î® Ï„Î· ÏƒÏ„Î¹Î³Î¼Î® Î±ÏÎºÎµÏ„Î­Ï‚ Ï‡ÏÏÎµÏ‚ ÏŒÏ€Ï‰Ï‚ Î· Î’ÏÎµÏ„Î±Î½Î¯Î±, Î¿Î¹ Î—Î½Ï‰Î¼Î­Î½ÎµÏ‚ Î Î¿Î»Î¹Ï„ÎµÎ¯ÎµÏ‚ Î‘Î¼ÎµÏÎ¹ÎºÎ®Ï‚, Î· Î“ÎµÏÎ¼Î±Î½Î¯Î±, Î· Î™ÏƒÏ€Î±Î½Î¯Î± Îº.Î¬., Î²Î»Î­Ï€Î¿Ï…Î½ Ï„Î± Ï€Î¿ÏƒÎ¿ÏƒÏ„Î¬ Î¼ÏŒÎ»Ï…Î½ÏƒÎ·Ï‚ Î±Ï€ÏŒ Ï„Î·Î½ Î¹Î»Î±ÏÎ¬ ÎºÎ±Î¹ Î±Ï€ÏŒ Î¬Î»Î»ÎµÏ‚ Î±ÏƒÎ¸Î­Î½ÎµÎ¹ÎµÏ‚ Ï€Î¿Ï… Î¸Î± Î¼Ï€Î¿ÏÎ¿ÏÏƒÎ±Î½ Î½Î± ÎµÎ¼Ï€Î¿Î´Î¹ÏƒÏ„Î¿ÏÎ½ Î¼Î­ÏƒÏ‰ ÎµÎ¼Î²Î¿Î»Î¹Î±ÏƒÎ¼Î¿Ï Î½Î± Î±Ï…Î¾Î¬Î½Î¿Î½Ï„Î±Î¹. </p><section class="e-card"><h4 class="mt-0">Î‘Î½Î±Ï†Î¿ÏÎ­Ï‚ / Î Î·Î³Î­Ï‚ Î Î»Î·ÏÎ¿Ï†ÏŒÏÎ·ÏƒÎ·Ï‚</h4><ul class="text-sm break-all"><li><a href="https://jptcp.com/index.php/jptcp/article/view/711" target="_blank" rel="noopener noreferrer">https://jptcp.com/index.php/jptcp/article/view/711</a></li><li><a href="https://www.nature.com/articles/d41586-020-01538-8" target="_blank" rel="noopener noreferrer">https://www.nature.com/articles/d41586-020-01538-8</a></li><li><a href="https://www.nature.com/articles/d41586-020-03519-3" target="_blank" rel="noopener noreferrer">https://www.nature.com/articles/d41586-020-03519-3</a></li><li><a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3222407/" target="_blank" rel="noopener noreferrer">https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3222407/</a></li></ul></section><h3><span class="text-rose-400">ÎœÏÎ¸Î¿Ï‚ 6:</span> Î¤Î± ÎµÎ¼Î²ÏŒÎ»Î¹Î± Î¼Ï€Î¿ÏÎ¿ÏÎ½ Î½Î± Î¼Î¿Î»ÏÎ½Î¿Ï…Î½ Ï„Î¿ Ï€Î±Î¹Î´Î¯ Î¼Îµ Ï„Î·Î½ Î±ÏƒÎ¸Î­Î½ÎµÎ¹Î± Ï„Î·Î½ Î¿Ï€Î¿Î¯Î± Ï€ÏÎ¿ÏƒÏ€Î±Î¸ÎµÎ¯ Î½Î± ÎµÎ¼Ï€Î¿Î´Î¯ÏƒÎµÎ¹</h3><p> ÎœÎµÏÎ¹ÎºÎ¬ Î±Ï€ÏŒ Ï„Î± ÎµÎ¼Î²ÏŒÎ»Î¹Î± Ï€ÎµÏÎ¹Î­Ï‡Î¿Ï…Î½ Î¶Ï‰Î½Ï„Î±Î½Î¿ÏÏ‚ ÎµÎ¾Î±ÏƒÎ¸ÎµÎ½Î·Î¼Î­Î½Î¿Ï…Ï‚ Î¼Î¹ÎºÏÎ¿Î¿ÏÎ³Î±Î½Î¹ÏƒÎ¼Î¿ÏÏ‚/Î¹Î¿ÏÏ‚ Î¿Î¹ Î¿Ï€Î¿Î¯Î¿Î¹ ÎµÎ¾Î±ÎºÎ¿Î»Î¿Ï…Î¸Î¿ÏÎ½ Î½Î± ÎµÎ¯Î½Î±Î¹ Î¹ÎºÎ±Î½Î¿Î¯ Î½Î± Î±Î½Î±Ï€Î±ÏÎ±Ï‡Î¸Î¿ÏÎ½ ÏƒÏ„Î¿Î½ Î¾ÎµÎ½Î¹ÏƒÏ„Î® (ÏƒÏ„Î¿Î½ ÎµÎ¼Î²Î¿Î»Î¹Î±ÏƒÎ¼Î­Î½Î¿). ÎŸÎ¹ Î¼Î¹ÎºÏÎ¿Î¿ÏÎ³Î±Î½Î¹ÏƒÎ¼Î¿Î¯ ÎµÎ¯Î½Î±Î¹ Â«Î±Ï€Î¿Î´Ï…Î½Î±Î¼Ï‰Î¼Î­Î½Î¿Î¹Â», Ï€Î¿Ï… ÏƒÎ·Î¼Î±Î¯Î½ÎµÎ¹ ÏŒÏ„Î¹ Î­Ï‡Î¿Ï…Î½ Ï‡Î¬ÏƒÎµÎ¹ Ï„Î¿ Î¼ÎµÎ³Î±Î»ÏÏ„ÎµÏÎ¿ Î¼Î­ÏÎ¿Ï‚ Ï„Î·Ï‚ Î¹ÎºÎ±Î½ÏŒÏ„Î·Ï„Î¬Ï‚ Ï„Î¿Ï…Ï‚ Î½Î± Ï€ÏÎ¿ÎºÎ±Î»Î¿ÏÎ½ Î±ÏƒÎ¸Î­Î½ÎµÎ¹ÎµÏ‚, Î±Î»Î»Î¬ ÎµÎ¾Î±ÎºÎ¿Î»Î¿Ï…Î¸Î¿ÏÎ½ Î½Î± Î´Î¹Î±Î¸Î­Ï„Î¿Ï…Î½ Î±Î½Î¿ÏƒÎ¿Î³Î¿Î½Î¹ÎºÎ­Ï‚ (immunogenic) Î¹Î´Î¹ÏŒÏ„Î·Ï„ÎµÏ‚. ÎˆÏ„ÏƒÎ¹ Î· Î¼ÏŒÎ»Ï…Î½ÏƒÎ· Î±Ï€ÏŒ Î­Î½Î± ÎµÎ¼Î²ÏŒÎ»Î¹Î¿ ÎµÎ¯Î½Î±Î¹ Ï€Î¿Î»Ï Î»Î¹Î³ÏŒÏ„ÎµÏÎ¿ ÏƒÎ¿Î²Î±ÏÎ® ÏƒÎµ ÏƒÏ‡Î­ÏƒÎ· Î¼Îµ Ï„Î· Î¼ÏŒÎ»Ï…Î½ÏƒÎ· Î±Ï€ÏŒ Ï„Î¿Î½ Î¯Î´Î¹Î¿ Ï„Î¿Î½ Î¹ÏŒ Ï€Î¿Ï… Ï€ÏÎ¿ÎºÎ±Î»ÎµÎ¯ Ï„Î·Î½ Î±ÏƒÎ¸Î­Î½ÎµÎ¹Î±. Î¤Î± Â«Î¶Ï‰Î½Ï„Î±Î½Î¬Â» ÎµÎ¾Î±ÏƒÎ¸ÎµÎ½Î·Î¼Î­Î½Î± ÎµÎ¼Î²ÏŒÎ»Î¹Î± ÎµÎ¯Î½Î±Î¹ Î±Ï…Ï„Î¬ Ï„Î·Ï‚ Î¹Î»Î±ÏÎ¬Ï‚-Ï€Î±ÏÏ‰Ï„Î¯Ï„Î¹Î´Î±Ï‚-ÎµÏÏ…Î¸ÏÎ¬Ï‚(MMR), Ï„Î¿Ï… ÏÎ¿Ï„Î±ÏŠÎ¿Ï (rotavirus), Ï„Î·Ï‚ ÎµÏ…Î»Î¿Î³Î¹Î¬Ï‚, Ï„Î·Ï‚ Î±Î½ÎµÎ¼Î¿Î²Î»Î¿Î³Î¹Î¬Ï‚ ÎºÎ±Î¹ Ï„Î¿Ï… ÎºÎ¯Ï„ÏÎ¹Î½Î¿Ï… Ï€Ï…ÏÎµÏ„Î¿Ï. Î£Ï„Î¹Ï‚ Ï€ÎµÏÎ¹ÏƒÏƒÏŒÏ„ÎµÏÎµÏ‚ Ï€ÎµÏÎ¹Ï€Ï„ÏÏƒÎµÎ¹Ï‚, Ï„Î± Â«Î¶Ï‰Î½Ï„Î±Î½Î¬Â» ÎµÎ¼Î²ÏŒÎ»Î¹Î± Î´ÎµÎ¯Ï‡Î½Î¿Ï…Î½ ÏƒÎ·Î¼Î±Î½Ï„Î¹ÎºÎ¬ Ï…ÏˆÎ·Î»ÏŒÏ„ÎµÏÎ· Î±Î½Î¿ÏƒÎ¿Î³Î¿Î½Î¹ÎºÏŒÏ„Î·Ï„Î± Î±Ï€ÏŒ Ï„Î± Î±Î´ÏÎ±Î½Î¿Ï€Î¿Î¹Î·Î¼Î­Î½Î± ÎµÎ¼Î²ÏŒÎ»Î¹Î±, ÎºÎ±Î¸ÏÏ‚ Î¼Î¹Î¼Î¿ÏÎ½Ï„Î±Î¹ ÏƒÏ‡ÎµÎ´ÏŒÎ½ Ï„Î­Î»ÎµÎ¹Î± Ï„Î· Ï†Ï…ÏƒÎ¹ÎºÎ® Î¼ÏŒÎ»Ï…Î½ÏƒÎ· Ï€ÏÎ¿ÎºÎ±Î»ÏÎ½Ï„Î±Ï‚ Î­Î½Î± Ï€Î¹Î¿ Î¿Î»Î¿ÎºÎ»Î·ÏÏ‰Î¼Î­Î½Î¿ Ï†Î¬ÏƒÎ¼Î± Î±Î½Î¿ÏƒÎ¿Î»Î¿Î³Î¹ÎºÏÎ½ Î±Ï€Î¿ÎºÏÎ¯ÏƒÎµÏ‰Î½. Î©ÏƒÏ„ÏŒÏƒÎ¿, Î±Ï…Ï„Î¬ Ï„Î± ÎµÎ¼Î²ÏŒÎ»Î¹Î± Î´ÎµÎ½ ÏƒÏ…ÏƒÏ„Î®Î½Î¿Î½Ï„Î±Î¹ Î³Î¹Î± Ï€Î±Î¹Î´Î¹Î¬ Î¼Îµ ÎµÎ¾Î±ÏƒÎ¸ÎµÎ½Î·Î¼Î­Î½Î¿ Î±Î½Î¿ÏƒÎ¿Ï€Î¿Î¹Î·Ï„Î¹ÎºÏŒ ÏƒÏÏƒÏ„Î·Î¼Î±, ÏŒÏ€Ï‰Ï‚ Î³Î¹Î± Ï€Î±ÏÎ¬Î´ÎµÎ¹Î³Î¼Î± Î±Ï…Ï„Î¬ Ï€Î¿Ï… Ï…Ï€Î¿Î²Î¬Î»Î»Î¿Î½Ï„Î±Î¹ ÏƒÎµ Î¸ÎµÏÎ±Ï€ÎµÎ¯Î± Î³Î¹Î± ÎºÎ±ÏÎºÎ¯Î½Î¿. </p><p> Î•Ï€Î¯ÏƒÎ·Ï‚, Ï„Î± Â«Î¶Ï‰Î½Ï„Î±Î½Î¬Â» ÎµÎ¼Î²ÏŒÎ»Î¹Î± Î¼Ï€Î¿ÏÎ¿ÏÎ½ Ï€ÏÎ¬Î³Î¼Î±Ï„Î¹ Î½Î± Ï€ÏÎ¿ÎºÎ±Î»Î­ÏƒÎ¿Ï…Î½ Î®Ï€Î¹Î± ÏƒÏ…Î¼Ï€Ï„ÏÎ¼Î±Ï„Î± Ï€Î¿Ï… Î¼Î¿Î¹Î¬Î¶Î¿Ï…Î½ Î¼Îµ Ï„Î·Î½ Î±ÏƒÎ¸Î­Î½ÎµÎ¹Î± Î±Ï€ÏŒ Ï„Î·Î½ Î¿Ï€Î¿Î¯Î± Ï„Î¿Ï…Ï‚ Ï€ÏÎ¿ÏƒÏ„Î±Ï„ÎµÏÎ¿Ï…Î½. Î©ÏƒÏ„ÏŒÏƒÎ¿, Î¿Î¹ Î»Î®Ï€Ï„ÎµÏ‚ Ï„Î¿Ï… ÎµÎ¼Î²Î¿Î»Î¯Î¿Ï… Î²Î¹ÏÎ½Î¿Ï…Î½ Ï„Î·Î½ Î±Î½Î¿ÏƒÎ¿Î»Î¿Î³Î¹ÎºÎ® Î±Ï€ÏŒÎºÏÎ¹ÏƒÎ· Ï„Î¿Ï… Î¿ÏÎ³Î±Î½Î¹ÏƒÎ¼Î¿Ï ÏƒÏ„Î¿ ÎµÎ¼Î²ÏŒÎ»Î¹Î¿ ÎºÎ±Î¹ ÏŒÏ‡Î¹ Ï„Î·Î½ Î¯Î´Î¹Î± Ï„Î·Î½ Î±ÏƒÎ¸Î­Î½ÎµÎ¹Î±. Î¥Ï€Î¬ÏÏ‡ÎµÎ¹ Î¼ÏŒÎ½Î¿ Î¼Î¯Î± ÎºÎ±Ï„Î±Î³ÎµÎ³ÏÎ±Î¼Î¼Î­Î½Î· Ï€ÎµÏÎ¯Ï€Ï„Ï‰ÏƒÎ· ÎºÎ±Ï„Î¬ Ï„Î·Î½ Î¿Ï€Î¿Î¯Î± Î­Î½Î± ÎµÎ¼Î²ÏŒÎ»Î¹Î¿ Î±Ï€Î¿Î´ÎµÎ¯Ï‡Î¸Î·ÎºÎµ ÏŒÏ„Î¹ Ï€ÏÎ¿ÎºÎ±Î»ÎµÎ¯ Ï„Î·Î½ Î±ÏƒÎ¸Î­Î½ÎµÎ¹Î±. Î‘Ï…Ï„ÏŒ Î®Ï„Î±Î½ Ï„Î¿ Î±Ï€ÏŒ Ï„Î¿Ï… ÏƒÏ„ÏŒÎ¼Î±Ï„Î¿Ï‚ ÎµÎ¼Î²ÏŒÎ»Î¹Î¿ Ï„Î·Ï‚ Ï€Î¿Î»Î¹Î¿Î¼Ï…ÎµÎ»Î¯Ï„Î¹Î´Î±Ï‚ (POV) Ï„Î¿ Î¿Ï€Î¿Î¯Î¿ Î´ÎµÎ½ Ï‡ÏÎ·ÏƒÎ¹Î¼Î¿Ï€Î¿Î¹ÎµÎ¯Ï„Î±Î¹ Ï€Î»Î­Î¿Î½ ÎºÎ±Î¹ Î­Ï‡ÎµÎ¹ Î±Î½Ï„Î¹ÎºÎ±Ï„Î±ÏƒÏ„Î±Î¸ÎµÎ¯ Ï€ÏÎ¿Ï‚ Ï„Î¿ Ï€Î±ÏÏŒÎ½ Î¼Îµ Î¼Î¯Î± Î¼Î¿ÏÏ†Î® Î½ÎµÎºÏÎ¿Ï Î¹Î¿Ï, Î³Î½Ï‰ÏƒÏ„Î® Ï‰Ï‚ Î±Î´ÏÎ±Î½Î¿Ï€Î¿Î¹Î·Î¼Î­Î½Î¿ ÎµÎ¼Î²ÏŒÎ»Î¹Î¿ Ï€Î¿Î»Î¹Î¿Î¼Ï…ÎµÎ»Î¯Ï„Î¹Î´Î±Ï‚ (IPV). </p><section class="e-card"><h4 class="mt-0">Î‘Î½Î±Ï†Î¿ÏÎ­Ï‚ / Î Î·Î³Î­Ï‚ Î Î»Î·ÏÎ¿Ï†ÏŒÏÎ·ÏƒÎ·Ï‚</h4><ul class="text-sm break-all"><li><a href="https://www.sciencedirect.com/science/article/pii/B9781455710768000090" target="_blank" rel="noopener noreferrer">https://www.sciencedirect.com/science/article/pii/B9781455710768000090</a></li></ul></section><h3><span class="text-rose-400">ÎœÏÎ¸Î¿Ï‚ 7:</span> Î”ÎµÎ½ ÎµÎ¯Î½Î±Î¹ Î±Ï€Î±ÏÎ±Î¯Ï„Î·Ï„Î¿ Î½Î± ÎµÎ¼Î²Î¿Î»Î¹Î±ÏƒÏ„Î¿ÏÎ¼Îµ Î»ÏŒÎ³Ï‰ Ï„Î¿Ï… ÏŒÏ„Î¹ Ï€Î¿Î»Î»Î­Ï‚ Ï‡ÏÏÎµÏ‚ Î­Ï‡Î¿Ï…Î½ Ï‡Î±Î¼Î·Î»Î¬ Ï€Î¿ÏƒÎ¿ÏƒÏ„Î¬ Î¼Î¿Î»ÏÎ½ÏƒÎµÏ‰Î½</h3><p> Î— Â«Î±Î½Î¿ÏƒÎ¯Î± Ï„Î·Ï‚ Î±Î³Î­Î»Î·Ï‚Â» ÎµÎ¼Ï†Î±Î½Î¯Î¶ÎµÏ„Î±Î¹ ÏŒÏ„Î±Î½ Î­Î½Î± Î¼ÎµÎ³Î¬Î»Î¿ Î¼Î­ÏÎ¿Ï‚ Î¼Î¯Î±Ï‚ ÎºÎ¿Î¹Î½ÏŒÏ„Î·Ï„Î±Ï‚ (Î· Î±Î³Î­Î»Î·) Î±Ï€Î¿ÎºÏ„Î¬ Î±Î½Î¿ÏƒÎ¯Î± ÏƒÎµ Î¼Î¯Î± Î±ÏƒÎ¸Î­Î½ÎµÎ¹Î±, ÎºÎ±Î¸Î¹ÏƒÏ„ÏÎ½Ï„Î±Ï‚ Î±Ï€Î¯Î¸Î±Î½Î· Ï„Î·Î½ ÎµÎ¾Î¬Ï€Î»Ï‰ÏƒÎ· Ï„Î·Ï‚ Î±ÏƒÎ¸Î­Î½ÎµÎ¹Î±Ï‚ Î±Ï€ÏŒ Î¬Ï„Î¿Î¼Î¿ ÏƒÎµ Î¬Ï„Î¿Î¼Î¿. Î§Î¬ÏÎ· ÏƒÏ„Î·Î½ Â«Î±Î½Î¿ÏƒÎ¯Î± Ï„Î·Ï‚ Î±Î³Î­Î»Î·Ï‚Â», Ï€Î¿Î»Î»Î¿Î¯ Î¬Î½Î¸ÏÏ‰Ï€Î¿Î¹ Î´ÎµÎ½ Î²Î»Î­Ï€Î¿Ï…Î½ Ï„Î·Î½ Î±Î½Î¬Î³ÎºÎ· ÎµÎ¼Î²Î¿Î»Î¹Î±ÏƒÎ¼Î¿Ï. Î•Î¬Î½ Î· Ï€Î»ÎµÎ¹Î¿ÏˆÎ·Ï†Î¯Î± Ï„Ï‰Î½ Î±Î½Î¸ÏÏÏ€Ï‰Î½ ÎµÎ¯Î½Î±Î¹ Î±Î½Î¿ÏƒÎ¿Ï€Î¿Î¹Î·Î¼Î­Î½Î·, Î· Î¼Î· Î±Î½Î¿ÏƒÎ¿Ï€Î¿Î¹Î·Î¼Î­Î½Î· Î¼ÎµÎ¹Î¿Î½ÏŒÏ„Î·Ï„Î± Î¸Î± Ï€ÏÎ¿ÏƒÏ„Î±Ï„ÎµÏÎµÏ„Î±Î¹ ÎµÏ€Î¯ÏƒÎ·Ï‚. Î‘Ï…Ï„ÏŒ ÎµÎ¯Î½Î±Î¹ ÏƒÎ·Î¼Î±Î½Ï„Î¹ÎºÏŒ Î´Î¹ÏŒÏ„Î¹ Ï…Ï€Î¬ÏÏ‡ÎµÎ¹ Î­Î½Î± Î¼Î­ÏÎ¿Ï‚ Ï„Î¿Ï… Ï€Î»Î·Î¸Ï…ÏƒÎ¼Î¿Ï, Ï„Î± Î²ÏÎ­Ï†Î·, ÎµÎ³ÎºÏ…Î¼Î¿Î½Î¿ÏÏƒÎµÏ‚, Î·Î»Î¹ÎºÎ¹Ï‰Î¼Î­Î½Î¿Î¹ ÎºÎ±Î¹ Î¬Ï„Î¿Î¼Î± Î¼Îµ ÎµÎ¾Î±ÏƒÎ¸ÎµÎ½Î·Î¼Î­Î½Î¿ Î±Î½Î¿ÏƒÎ¿Ï€Î¿Î¹Î·Ï„Î¹ÎºÏŒ ÏƒÏÏƒÏ„Î·Î¼Î± Ï€Î¿Ï… Î¼ÎµÏÎ¹ÎºÎ­Ï‚ Ï†Î¿ÏÎ­Ï‚ Î´ÎµÎ½ Î¼Ï€Î¿ÏÎµÎ¯ Î½Î± Î»Î¬Î²ÎµÎ¹ ÎµÎ¼Î²ÏŒÎ»Î¹Î±. Î©ÏƒÏ„ÏŒÏƒÎ¿, Î±Ï‚ Ï…Ï€Î¿Î¸Î­ÏƒÎ¿Ï…Î¼Îµ ÏŒÏ„Î¹ Ï€Î¿Î»Î»Î¿Î¯ Î¬Î½Î¸ÏÏ‰Ï€Î¿Î¹ Î´ÎµÎ½ ÎµÎ¼Î²Î¿Î»Î¹Î¬Î¶Î¿Î½Ï„Î±Î¹ Î¿ÏÏ„Îµ Î¿Î¹ Î¯Î´Î¹Î¿Î¹ Î¿ÏÏ„Îµ ÎºÎ±Î¹ Ï„Î± Ï€Î±Î¹Î´Î¹Î¬ Ï„Î¿Ï…Ï‚. Î£Îµ Î±Ï…Ï„Î® Ï„Î·Î½ Ï€ÎµÏÎ¯Ï€Ï„Ï‰ÏƒÎ·, Î· Â«Î±Î½Î¿ÏƒÎ¯Î± Ï„Î·Ï‚ Î±Î³Î­Î»Î·Ï‚Â» ÎµÎ¾Î±Ï†Î±Î½Î¯Î¶ÎµÏ„Î±Î¹, Î±Î½Î¿Î¯Î³Î¿Î½Ï„Î±Ï‚ ÎµÏ…ÎºÎ±Î¹ÏÎ¯ÎµÏ‚ ÏƒÎµ Î¹Î¿ÏÏ‚ ÎºÎ±Î¹ Î²Î±ÎºÏ„Î®ÏÎ¹Î± Î½Î± ÎµÎ³ÎºÎ±Ï„Î±ÏƒÏ„Î±Î¸Î¿ÏÎ½ ÎºÎ±Î¹ Î½Î± ÎµÎ¾Î±Ï€Î»Ï‰Î¸Î¿ÏÎ½. ÎœÎµ Ï„ÏŒÏƒÎ¿Ï…Ï‚ Ï€Î¿Î»Î»Î¿ÏÏ‚ Î±Î½Î¸ÏÏÏ€Î¿Ï…Ï‚ Î¼Îµ Î±Î½Î¿ÏƒÎ¯Î± Î¼Î¯Î± Î¼Î¿Î»Ï…ÏƒÎ¼Î±Ï„Î¹ÎºÎ® Î±ÏƒÎ¸Î­Î½ÎµÎ¹Î± Î´ÎµÎ½ Î¸Î± Î­Ï‡ÎµÎ¹ Ï€Î¿Ï„Î­ Ï„Î·Î½ ÎµÏ…ÎºÎ±Î¹ÏÎ¯Î± Î½Î± ÎµÎ³ÎºÎ±Ï„Î±ÏƒÏ„Î±Î¸ÎµÎ¯ ÎºÎ±Î¹ Î½Î± ÎµÎ¾Î±Ï€Î»Ï‰Î¸ÎµÎ¯. </p><p> Î•Ï€Î¹Ï€Î»Î­Î¿Î½, Î¿Î¹ Î´Î¹ÎµÎ¸Î½ÎµÎ¯Ï‚ Î¼ÎµÏ„Î±ÎºÎ¹Î½Î®ÏƒÎµÎ¹Ï‚ ÏƒÏ…Ï‡Î½Î¬ Î¼ÎµÏ„Î±Ï†Î­ÏÎ¿Ï…Î½ Î¼Î¯Î± Î±ÏƒÎ¸Î­Î½ÎµÎ¹Î± Î±Ï€ÏŒ Ï„Î¿ ÎµÎ¾Ï‰Ï„ÎµÏÎ¹ÎºÏŒ Î¼Î­ÏƒÎ± ÏƒÎµ Î¼Î¹Î± Ï‡ÏÏÎ±, ÎµÎ½Ï Î­Î½Î± Î¼Î· ÎµÎ¼Î²Î¿Î»Î¹Î±ÏƒÎ¼Î­Î½Î¿ Î¬Ï„Î¿Î¼Î¿ Î´Î¹Î±Ï„ÏÎ­Ï‡ÎµÎ¹ Ï€Î¿Î»Ï Î¼ÎµÎ³Î±Î»ÏÏ„ÎµÏÎ¿ ÎºÎ¯Î½Î´Ï…Î½Î¿ Î½Î± Î±ÏÏÏ‰ÏƒÏ„Î®ÏƒÎµÎ¹ Î® Î½Î± Î¼Î¿Î»Ï…Î½Î¸ÎµÎ¯ ÎµÎ½Ï Ï„Î±Î¾Î¹Î´ÎµÏÎµÎ¹. Î— Î±Ï…Î¾Î·Î¼Î­Î½Î· ÏƒÏ…Ï‡Î½ÏŒÏ„Î·Ï„Î± Ï„Î·Ï‚ Î¹Î»Î±ÏÎ¬Ï‚ Ï„Î¿ ÎºÎ±Ï„Î±Î´ÎµÎ¹ÎºÎ½ÏÎµÎ¹ Î±Ï…Ï„ÏŒ ÏƒÏ„Î¹Ï‚ Î—Î½Ï‰Î¼Î­Î½ÎµÏ‚ Î Î¿Î»Î¹Ï„ÎµÎ¯ÎµÏ‚ Î‘Î¼ÎµÏÎ¹ÎºÎ®Ï‚ Ï„Î± Ï„ÎµÎ»ÎµÏ…Ï„Î±Î¯Î± Ï‡ÏÏŒÎ½Î¹Î±. ÎŒÏƒÎ¿ Ï…Ï€Î¬ÏÏ‡ÎµÎ¹ Î· Î±ÏƒÎ¸Î­Î½ÎµÎ¹Î±, Ï„ÏŒÏ„Îµ Ï…Ï€Î¬ÏÏ‡ÎµÎ¹ ÎºÎ±Î¹ Î¿ ÎºÎ¯Î½Î´Ï…Î½Î¿Ï‚ Î½Î± Î¼Î¿Î»Ï…Î½Î¸Î¿ÏÎ¼Îµ. </p><section class="e-card"><h4 class="mt-0">Î‘Î½Î±Ï†Î¿ÏÎ­Ï‚ / Î Î·Î³Î­Ï‚ Î Î»Î·ÏÎ¿Ï†ÏŒÏÎ·ÏƒÎ·Ï‚</h4><ul class="text-sm break-all"><li><a href="https://www.cdc.gov/mmwr/volumes/68/wr/mm6819a4.htm" target="_blank" rel="noopener noreferrer">https://www.cdc.gov/mmwr/volumes/68/wr/mm6819a4.htm</a></li><li><a href="https://bmcpublichealth.biomedcentral.com/articles/10.1186/s12889-021-10652-9" target="_blank" rel="noopener noreferrer">https://bmcpublichealth.biomedcentral.com/articles/10.1186/s12889-021-10652-9</a></li></ul></section>',14),ga=e("a",{href:"https://www.who.int/emergencies/diseases/novel-coronavirus-2019/media-resources/science-in-5/episode-8---myth-vs-science",target:"_blank",rel:"noopener noreferrer"}," WHO - Myth vs Science ",-1);function ba(h,c){const l=v,d=k,r=f,n=g;return o(),u("div",je,[t(l,{class:"w-full lg:max-w-xs print:hidden"}),e("section",xe,[t(d,{name:"openmoji:scientist-medium-dark-skin-tone",class:"float-right text-[5em]"}),qe,Ve,e("section",Se,[Ae,Ie,Me,De,t(r,{src:"https://evidence.onkel.ee/assets/viruses-01__bacteria-vs-virus.webp",credits:"Î Î·Î³Î®: https://inducoat.com/?attachment_id=24945&lang=en",elevated:!0},{caption:s(()=>[ze,a(" Î”Î¿Î¼Î¹ÎºÎ­Ï‚ Î´Î¹Î±Ï†Î¿ÏÎ­Ï‚ Î¹ÏÎ½ ÎºÎ±Î¹ Î²Î±ÎºÏ„Î·ÏÎ¯Ï‰Î½ ")]),_:1}),Oe,t(n,{class:"mb-8"},{default:s(()=>[Ce,a(" Î¼Ï€Î¿ÏÎ¿ÏÎ½ Î½Î± Î²Î¿Î·Î¸Î®ÏƒÎ¿Ï…Î½ Ï„Î¿ Î±Î½Î¿ÏƒÎ¿Ï€Î¿Î¹Î·Ï„Î¹ÎºÏŒ ÏƒÏÏƒÏ„Î·Î¼Î± Î½Î± ÎµÎ¾Î¿Î½Ï„ÏÏƒÎµÎ¹ Ï„Î¹Ï‚ Î²Î±ÎºÏ„Î·ÏÎ¹Î±ÎºÎ­Ï‚ Î»Î¿Î¹Î¼ÏÎ¾ÎµÎ¹Ï‚, Î±Î»Î»Î¬ Î´ÎµÎ½ Î¼Ï€Î¿ÏÎ¿ÏÎ½ Î½Î± Ï‡ÏÎ·ÏƒÎ¹Î¼Î¿Ï€Î¿Î¹Î·Î¸Î¿ÏÎ½ Î­Î½Î±Î½Ï„Î¹ Ï„Ï‰Î½ Î¹Î¿Î³ÎµÎ½ÏÎ½ Î»Î¿Î¹Î¼ÏÎ¾ÎµÏ‰Î½. Î¤Î± "),Fe,a(" Î´ÏÎ¿Ï…Î½ Î´Î¹Î±Ï†Î¿ÏÎµÏ„Î¹ÎºÎ¬ Î±Ï€ÏŒ Ï„Î± Î±Î½Ï„Î¹Î²Î¹Î¿Ï„Î¹ÎºÎ¬ ÎºÎ±Î¹ ÎµÏ€Î¯ Ï„Î¿Ï… Ï€Î±ÏÏŒÎ½Ï„Î¿Ï‚ ÎµÎ¯Î½Î±Î¹ Î±Ï€Î¿Ï„ÎµÎ»ÎµÏƒÎ¼Î±Ï„Î¹ÎºÎ¬ Î¼ÏŒÎ½Î¿ Î­Î½Î±Î½Ï„Î¹ Î¿ÏÎ¹ÏƒÎ¼Î­Î½Ï‰Î½ Î¹Î¿Î³ÎµÎ½ÏÎ½ Î±ÏƒÎ¸ÎµÎ½ÎµÎ¹ÏÎ½, ÏŒÏ€Ï‰Ï‚ Î· Î³ÏÎ¯Ï€Î·, Î¿ Î­ÏÏ€Î·Ï‚, Î· Î·Ï€Î±Ï„Î¯Ï„Î¹Î´Î± Î’ ÎºÎ±Î¹ C ÎºÎ±Î¹ Î¿ HIV. ÎŸÎ¹ Î¹Î¿Î³ÎµÎ½ÎµÎ¯Ï‚ Î»Î¿Î¹Î¼ÏÎ¾ÎµÎ¹Ï‚ Î¼Ï€Î¿ÏÎµÎ¯ Î½Î± ÎµÎ¯Î½Î±Î¹ Ï€Î¿Î»Ï Ï€Î¹Î¿ Î´ÏÏƒÎºÎ¿Î»Î¿ Î½Î± Î±Î½Ï„Î¹Î¼ÎµÏ„Ï‰Ï€Î¹ÏƒÎ¸Î¿ÏÎ½, ÎµÏ€ÎµÎ¹Î´Î® Î¿ Î¹ÏŒÏ‚ ÎµÎ¹ÏƒÏ‡Ï‰ÏÎµÎ¯ ÏƒÏ„Î± Î±Î½Î¸ÏÏÏ€Î¹Î½Î± ÎºÏÏ„Ï„Î±ÏÎ±. Î¤Î¿ "),Ne,a(" Î¼Ï€Î¿ÏÎµÎ¯ Î¼ÎµÏÎ¹ÎºÎ­Ï‚ Ï†Î¿ÏÎ­Ï‚ Î½Î± ÏƒÎºÎ¿Ï„ÏÏƒÎµÎ¹ Ï„Î± Î¼Î¿Î»Ï…ÏƒÎ¼Î­Î½Î± ÎºÏÏ„Ï„Î±ÏÎ± Ï€ÏÎ¹Î½ Î¼Ï€Î¿ÏÎ­ÏƒÎµÎ¹ Î½Î± Î±Î½Î±Ï€Î±ÏÎ±Ï‡Î¸ÎµÎ¯ Î¿ Î¹ÏŒÏ‚. Î©ÏƒÏ„ÏŒÏƒÎ¿, ÎºÎ±Î¸ÏÏ‚ Î¿ Î¹ÏŒÏ‚ Î±Î½Î±Ï€Î±ÏÎ¬Î³ÎµÏ„Î±Î¹, ÏƒÏ…Ï‡Î½Î¬ ÏƒÎºÎ¿Ï„ÏÎ½ÎµÎ¹ Ï„Î¿ Î¼Î¿Î»Ï…ÏƒÎ¼Î­Î½Î¿ ÎºÏÏ„Ï„Î±ÏÎ¿ Ï„ÎµÎ¼Î±Ï‡Î¯Î¶Î¿Î½Ï„Î±Ï‚ Ï„Î¿ ÎºÎ±Î¹ Î´Î¹Î±ÏƒÎºÎ¿ÏÏ€Î¯Î¶Î¿Î½Ï„Î±Ï‚ Ï„Î¿, Î³ÎµÎ³Î¿Î½ÏŒÏ‚ Ï€Î¿Ï… ÎµÏ€Î¹Ï„ÏÎ­Ï€ÎµÎ¹ ÏƒÏ„Î¿Î½ Î¹ÏŒ Î½Î± ÎµÎ¾Î±Ï€Î»Ï‰Î¸ÎµÎ¯ ÎºÎ±Î¹ ÏƒÎµ Î¬Î»Î»Î± ÎºÏÏ„Ï„Î±ÏÎ± Ï„Î¿Ï… ÏƒÏÎ¼Î±Ï„Î¿Ï‚. ")]),_:1}),$e]),Pe,e("section",Be,[Te,Ee,Re,He,t(r,{src:"https://evidence.onkel.ee/assets/viruses-03.webp",credits:"Î Î·Î³Î®: https://www.nytimes.com/2020/03/13/health/soap-coronavirus-handwashing-germs.html",elevated:!0},{caption:s(()=>[We,a(" Î“Î¹Î± ÎºÎ¬Î¸Îµ Î½Î­Î¿ Î±Î½Ï„Î¹Î³ÏŒÎ½Î¿, Ï„Î¿ ÏƒÏÎ¼Î± Î¼Î±Ï‚ Ï‡ÏÎµÎ¹Î¬Î¶ÎµÏ„Î±Î¹ Î½Î± Î´Î·Î¼Î¹Î¿Ï…ÏÎ³Î®ÏƒÎµÎ¹ Î­Î½Î± ÏƒÏ…Î³ÎºÎµÎºÏÎ¹Î¼Î­Î½Î¿ Î±Î½Ï„Î¯ÏƒÏ‰Î¼Î± ")]),_:1}),Ke,Ye,t(r,{src:"https://evidence.onkel.ee/assets/viruses-04.webp",credits:"Î Î·Î³Î®: https://www.who.int/news-room/feature-stories/detail/how-do-vaccines-work",elevated:!0},{caption:s(()=>[Ue,a(" Î‘Î½Î¬Ï€Ï„Ï…Î¾Î· Î±Î½Ï„Î¹ÏƒÏ‰Î¼Î¬Ï„Ï‰Î½ Î¼Î­ÏƒÏ‰ ÎµÎ¼Î²Î¿Î»Î¹Î±ÏƒÎ¼Î¿Ï ")]),_:1}),Je]),Le,e("section",Qe,[Ge,Xe,Ze,ea,e("div",aa,[t(r,{src:"https://evidence.onkel.ee/assets/viruses-06__mask-01.webp"},{caption:s(()=>[a(" Î§ÎµÎ¹ÏÎ¿Ï…ÏÎ³Î¹ÎºÎ® Î¼Î¬ÏƒÎºÎ± ")]),_:1}),t(r,{src:"https://evidence.onkel.ee/assets/viruses-06__mask-02.webp",caption:""},{caption:s(()=>[a(" ÎœÎ¬ÏƒÎºÎ± FFP2 (Î±Î½Î±Ï€Î½ÎµÏ…ÏƒÏ„Î¹ÎºÎ® ÏƒÏ…ÏƒÎºÎµÏ…Î®) ")]),_:1}),t(r,{src:"https://evidence.onkel.ee/assets/viruses-06__mask-03.webp"},{caption:s(()=>[a(" ÎœÎ¬ÏƒÎºÎ± FFP3 (Î±Î½Î±Ï€Î½ÎµÏ…ÏƒÏ„Î¹ÎºÎ® ÏƒÏ…ÏƒÎºÎµÏ…Î®) Î¼Îµ Î²Î±Î»Î²Î¯Î´Î± ")]),_:1}),t(r,{src:"https://evidence.onkel.ee/assets/viruses-06__mask-04.webp"},{caption:s(()=>[a(" ÎœÎ¬ÏƒÎºÎ± Ï†Î¹Î»Ï„ÏÎ±ÏÎ¯ÏƒÎ¼Î±Ï„Î¿Ï‚ ")]),_:1})]),ta,t(n,{class:"my-8",theme:"sky-500",icon:"material-symbols:edit-document"},{default:s(()=>[sa]),_:1})]),ia,e("section",ra,[na,e("div",oa,[t(r,{src:"https://evidence.onkel.ee/assets/viruses-07.webp",credits:"Î Î·Î³Î®: https://www.nytimes.com/2020/03/13/health/soap-coronavirus-handwashing-germs.html"},{caption:s(()=>[la,a(" Soap molecules destroying the virus ")]),_:1}),t(r,{src:"https://evidence.onkel.ee/assets/viruses-08.webp",credits:"Î Î·Î³Î®: https://www.nytimes.com/2020/03/13/health/soap-coronavirus-handwashing-germs.html"},{caption:s(()=>[da,a(" Micelle consisting of soap molecules and virus fragment ")]),_:1})]),ca]),ma,e("section",ua,[ha,t(n,{class:"my-8",theme:"sky-500",icon:"material-symbols:edit-document"},{default:s(()=>[pa]),_:1}),va,t(n,{class:"my-8",theme:"sky-500",icon:"material-symbols:edit-document"},{default:s(()=>[ka]),_:1}),fa]),t(n,{class:"my-8",theme:"sky-500",icon:"material-symbols:edit-document"},{default:s(()=>[a(" Î†Î»Î»Î¿Î¹ Î¼ÏÎ¸Î¿Î¹ ÏƒÏ‡ÎµÏ„Î¹ÎºÎ¬ Î¼Îµ Ï„Î¿Î½ Î¹ÏŒ COVID-19 ÎºÎ±Î¹ Î¬Î»Î»ÎµÏ‚ ÎµÏ€Î¹ÏƒÏ„Î·Î¼Î¿Î½Î¹ÎºÎ­Ï‚ Ï€Î»Î·ÏÎ¿Ï†Î¿ÏÎ¯ÎµÏ‚ Î¼Ï€Î¿ÏÎµÎ¯Ï„Îµ Î½Î± Î²ÏÎµÎ¯Ï„Îµ ÏƒÎµ Î±Ï…Ï„ÏŒ Ï„Î¿Î½ ÏƒÏÎ½Î´ÎµÏƒÎ¼Î¿: "),ga]),_:1})])])}const wa=b(ye,[["render",ba]]),_a={},ya={class:"flex flex-col items-start lg:flex-row-reverse lg:justify-end xl:gap-10 2xl:gap-20"},ja={class:"e-article",lang:"pt",style:{hyphens:"auto"}},xa=e("h1",{class:"mb-0"},"VÃ­rus",-1),qa=e("h5",{class:"font-normal uppercase leading-tight"},"INFORMAÃ‡ÃƒO CIENTÃFICA",-1),Va={id:"s1"},Sa=e("h2",{id:"s1t"},"1. VÃ­rus versus bactÃ©rias",-1),Aa=e("p",{class:"font-bold"}," BactÃ©rias e vÃ­rus podem causar muitas infeÃ§Ãµes comuns. Mas quais sÃ£o as diferenÃ§as entre estes dois tipos de organismos infeciosos? ",-1),Ia=e("p",null,[e("span",{class:"e-term font-Heading"},"BactÃ©rias"),a(" sÃ£o pequenos microrganismos que sÃ£o compostos por uma Ãºnica cÃ©lula. As bactÃ©rias sÃ£o microorganismos minÃºsculos constituÃ­dos por uma Ãºnica cÃ©lula. SÃ£o muito diversas e podem ter muitas formas e caracterÃ­sticas estruturais. As bactÃ©rias podem viver em quase todos os ambientes possÃ­veis, incluindo dentro ou sobre o corpo humano. Apenas um pequeno nÃºmero de bactÃ©rias causa infecÃ§Ãµes nos seres humanos. Estas bactÃ©rias sÃ£o designadas por bactÃ©rias patogÃ©nicas. ")],-1),Ma=e("p",null,[a(" Os "),e("span",{class:"e-term font-Heading"},"virus"),a(" sÃ£o outro tipo de microorganismo minÃºsculo, ainda mais pequeno do que as bactÃ©rias. Tal como as bactÃ©rias, sÃ£o muito diversos e tÃªm uma diversidade de formas e caracterÃ­sticas. Os vÃ­rus sÃ£o parasitas. Isto significa que necessitam de cÃ©lulas ou tecidos vivos para se desenvolverem. Os vÃ­rus podem invadir as cÃ©lulas do seu corpo, utilizando os componentes das suas cÃ©lulas para crescer e multiplicar-se. Alguns vÃ­rus chegam mesmo a matar as cÃ©lulas hospedeiras como parte do seu ciclo de vida. As diferenÃ§as entre vÃ­rus e bactÃ©rias podem ser vistas na figura 1 e encontradas na tabela 1. ")],-1),Da=e("b",null,"Figura 1.",-1),za=i('<table class="mt-20"><caption class="text-left pb-4"><b>Tabela 1.</b> DiferenÃ§as entre bactÃ©rias e vÃ­rus</caption><thead><tr><th></th><th>BactÃ©ria</th><th>VÃ­rus</th></tr></thead><tbody><tr><th class="align-baseline"> Viver </th><td><b>Organismo vivo.</b><br>As bactÃ©rias sÃ£o organismos vivos com uma Ãºnica cÃ©lula que pode gerar energia, fazer os seus prÃ³prios alimentos, mover-se e reproduzir-se (tipicamente por fissÃ£o binÃ¡ria). Isto permite que as bactÃ©rias vivam em muitos lugares â€“ solo, Ã¡gua, plantas e o corpo humano e servem muitos propÃ³sitos. <br> As bactÃ©rias incluem parasitas e nÃ£o parasitas. </td><td><b>Sem vida.</b><br> Os vÃ­rus sÃ³ crescem e reproduzem-se dentro das cÃ©lulas hospedeiras que infetam. Quando encontrados fora destas cÃ©lulas vivas, os vÃ­rus estÃ£o adormecidos. A sua &quot;vida&quot;, portanto, requer o sequestro das atividades bioquÃ­micas de uma cÃ©lula viva. <br> Todos os vÃ­rus sÃ£o parasitas intracelulares. </td></tr><tr><th class="align-baseline">NÃºmero de cÃ©lulas</th><td>Unicelular, uma cÃ©lula</td><td>Sem cÃ©lulas, nÃ£o vive</td></tr><tr><th class="align-baseline">ReproduÃ§Ã£o</th><td>Divide-se em 2</td><td>Invade uma cÃ©lula hospedeira e toma conta da cÃ©lula fazendo com que faÃ§a cÃ³pias do ADN/RNA viral. DestrÃ³i a cÃ©lula hospedeira libertando novos vÃ­rus</td></tr><tr><th class="align-baseline">Tamanho</th><td>As bactÃ©rias sÃ£o muito maiores, variando de 800 nm a 1000 nm. As bactÃ©rias podem ser vistas sob um microscÃ³pio leve.</td><td>O tamanho dos vÃ­rus Ã© entre 20 nm a 400 nm. Os vÃ­rus sÃ³ sÃ£o visÃ­veis ao microscÃ³pio electrÃ³nico</td></tr><tr><th class="align-baseline">BenefÃ­cios</th><td>Algumas bactÃ©rias sÃ£o benÃ©ficas, por exemplo, certas bactÃ©rias sÃ£o necessÃ¡rias no intestino.</td><td>Os vÃ­rus nÃ£o sÃ£o benÃ©ficos. VÃ­rus podem ser Ãºteis na engenharia genÃ©tica.</td></tr><tr><th class="align-baseline">InfeÃ§Ã£o</th><td>A infeÃ§Ã£o bacteriana Ã© geralmente confinada a uma parte do corpo, descrita como uma infeÃ§Ã£o localizada. As infeÃ§Ãµes podem ser causadas por bactÃ©rias ou por toxinas (endotoxinas) produzidas.</td><td>Uma infeÃ§Ã£o viral Ã© sistÃ©mica. Os vÃ­rus infetam uma cÃ©lula hospedeira e multiplicam-se aos milhares, deixando a cÃ©lula hospedeira e infetando outras cÃ©lulas do corpo.</td></tr><tr><th class="align-baseline">DoenÃ§a</th><td>As doenÃ§as bacterianas incluem pneumonia, tuberculose, tÃ©tano e intoxicaÃ§Ã£o alimentar.</td><td>As doenÃ§as sistÃ©micas causadas por infeÃ§Ãµes virais incluem a gripe, o sarampo, a poliomielite, a SIDA e o COVID-19.</td></tr><tr><th class="align-baseline">Tratamento</th><td>AntibiÃ³ticos e vacinas previnem a doenÃ§a.</td><td>As vacinas previnem a propagaÃ§Ã£o e os medicamentos antivirais ajudam a retardar a reproduÃ§Ã£o, mas nÃ£o podem detÃª-lo completamente.</td></tr></tbody></table>',1),Oa=i(`<section class="e-card"><h4 class="mt-4">ReferÃªncias</h4><ul class="text-sm break-all"><li><a href="https://courses.lumenlearning.com/suny-biology2xmaster/chapter/prevention-and-treatment-of-viral-infections/">https://courses.lumenlearning.com/suny-biology2xmaster/chapter/prevention-and-treatment-of-viral-infections/</a></li><li><a href="https://bodell.mtchs.org/OnlineBio/BIOCD/text/chapter16">https://bodell.mtchs.org/OnlineBio/BIOCD/text/chapter16</a></li><li><a href="
                            http://www.hcrowder.com/disease-reading.html"> http://www.hcrowder.com/disease-reading.html</a></li></ul></section>`,1),Ca=i('<hr class="mt-10 mb-40"><section id="s2"><h2 id="s2t">2. Porque Ã© que os antibiÃ³ticos nÃ£o matam os vÃ­rus?</h2><p> Os antibiÃ³ticos visam a maquinaria de crescimento em bactÃ©rias (nÃ£o vÃ­rus) para matar ou inibir essas bactÃ©rias em particular. Os antibiÃ³ticos nÃ£o podem matar vÃ­rus porque os vÃ­rus tÃªm estruturas diferentes e replicam-se de forma diferente das bactÃ©rias. AlÃ©m disso, o uso excessivo e a prescriÃ§Ã£o inadequada de antibiÃ³ticos em todo o mundo estÃ£o a levar ao problema global de saÃºde da <a href="https://www.drugs.com/article/antibiotic-resistance.html" target="_blank" rel="noopener noreferrer">resistÃªncia aos antibiÃ³ticos</a>. Consulte o quadro 2 em que condiÃ§Ãµes os antibiÃ³ticos podem ser Ãºteis (NB! A decisÃ£o sobre a sua utilizaÃ§Ã£o serÃ¡ tomada pelo seu mÃ©dico). </p><table class="leading-tight e-card"><caption class="text-left pb-4"><b>Tabela 2.</b> Necessidade de antibiÃ³ticos por infeÃ§Ãµes respiratÃ³rias comuns </caption><thead class="border text-center"><tr><th rowspan="2" class="border p-1">Common respiÂ­ratory infections</th><th colspan="3" class="border p-1">Common cause</th><th rowspan="2" class="border p-1">Are<br>antiÂ­biotics needed</th></tr><tr><th class="border p-1">Virus</th><th class="border p-1">Virus or bacteria</th><th class="border p-1">Bacteria</th></tr></thead><tbody class="text-center"><tr><td class="border p-1">Common cold / runny nose</td><td class="border p-1">Yes</td><td class="border p-1"></td><td class="border p-1"></td><td class="border p-1">No</td></tr><tr><td class="border p-1">Sore throat (except strep)</td><td class="border p-1">Yes</td><td class="border p-1"></td><td class="border p-1"></td><td class="border p-1">No</td></tr><tr><td class="border p-1">COVID-19</td><td class="border p-1">Yes</td><td class="border p-1"></td><td class="border p-1"></td><td class="border p-1">No</td></tr><tr><td class="border p-1">Flu</td><td class="border p-1">Yes</td><td class="border p-1"></td><td class="border p-1"></td><td class="border p-1">No</td></tr><tr><td class="border p-1">Bronchitis / chest cold<br><span class="text-sm italic">(in otherwise healthy children and adults)</span> *</td><td class="border p-1"></td><td class="border p-1">Yes</td><td class="border p-1"></td><td class="border p-1">No *</td></tr><tr><td class="border p-1">Middle ear infection</td><td class="border p-1"></td><td class="border p-1">Yes</td><td class="border p-1"></td><td class="border p-1">Maybe</td></tr><tr><td class="border p-1">Sinus infection</td><td class="border p-1"></td><td class="border p-1">Yes</td><td class="border p-1"></td><td class="border p-1">Maybe</td></tr><tr><td class="border p-1">Strep throat</td><td class="border p-1"></td><td class="border p-1"></td><td class="border p-1">Yes</td><td class="border p-1">Yes</td></tr><tr><td class="border p-1">Whooping couch</td><td class="border p-1"></td><td class="border p-1"></td><td class="border p-1">Yes</td><td class="border p-1">Yes</td></tr></tbody><tfoot class="border text-center"><tr><td colspan="5" class="py-0 px-3"><p class="text-sm italic">* Studies shows that in otherwise healthy children and adults, antibiotics for bronchitis won&#39;t help patients feel better.</p><p class="text-xs text-slate-400">Fonte: https://www.cdc.gov/antibiotic-use/images/VirusOrBacteria-Original-1200by675.jpg</p></td></tr></tfoot></table><section class="e-card"><h4 class="mt-0">ReferÃªncia</h4><ul class="text-sm break-all"><li><a href="https://www.drugs.com/article/antibiotics-and-viruses.html" target="_blank" rel="noopener noreferrer">https://www.drugs.com/article/antibiotics-and-viruses.html</a></li><li><a href="https://www.virology.ws/2009/10/19/ten-cool-facts-about-viruses/" target="_blank" rel="noopener noreferrer">https://www.virology.ws/2009/10/19/ten-cool-facts-about-viruses/</a></li></ul></section></section><hr class="mt-10 mb-40">',3),Fa={id:"s3"},Na=e("h2",{id:"s3t"},"3. Como funcionam as vacinas",-1),$a=e("h3",null,"A resposta natural do corpo",-1),Pa=e("p",null,[a(" Um "),e("span",{class:"e-term font-Heading"},"agente patogÃ©nico"),a(" Ã© uma bactÃ©ria, vÃ­rus, parasita ou fungo que pode causar doenÃ§as dentro do corpo. Cada agente patogÃ©nico Ã© composto por vÃ¡rias subpartes, geralmente Ãºnicas a esse agente patogÃ©nico especÃ­fico e Ã  doenÃ§a que causa. A subparte de um agente patogÃ©nico que causa a formaÃ§Ã£o de anticorpos Ã© chamada de antigÃ©nio. Os anticorpos produzidos em resposta ao antigÃ©nio do agente patogÃ©nico sÃ£o essenciais para o sistema imunitÃ¡rio. Pode considerar os anticorpos como soldados no sistema de defesa do seu corpo. Cada anticorpo, ou soldado, no nosso sistema, Ã© treinado para reconhecer um antigÃ©nio especÃ­fico. Temos milhares de anticorpos diferentes nos nossos corpos. Quando o corpo humano Ã© exposto a um antigÃ©nio pela primeira vez, leva tempo para o sistema imunolÃ³gico responder e produzir anticorpos especÃ­ficos desse antigÃ©nio (Fig. 2). ")],-1),Ba=e("p",null," Os anticorpos de um agente patogÃ©nico geralmente nÃ£o protegem contra outro agente patogÃ©nico, exceto quando dois agentes patogÃ©nicos sÃ£o muito semelhantes uns aos outros, como primos. Uma vez produzidos os anticorpos especÃ­ficos do antigÃ©nio, trabalham com o resto do sistema imunitÃ¡rio para destruir o agente patogÃ©nico e parar a doenÃ§a. Uma vez que o corpo produz anticorpos na sua resposta primÃ¡ria a um antÃ­geno, tambÃ©m cria cÃ©lulas de memÃ³ria produtoras de anticorpos, que permanecem vivas mesmo apÃ³s os anticorpos derrotarem o agente patogÃ©nico. Suponha que o corpo seja exposto ao mesmo agente patogÃ©nico mais de uma vez. Nesse caso, a resposta do anticorpo Ã© muito mais rÃ¡pida e eficaz do que a primeira vez, porque as cÃ©lulas de memÃ³ria estÃ£o prontas para bombear anticorpos contra esse antigÃ©nio. Isto significa que se a pessoa for exposta a um agente patogÃ©nico perigoso no futuro, o seu sistema imunolÃ³gico serÃ¡ capaz de responder imediatamente, protegendo contra doenÃ§as. ",-1),Ta=e("b",null,"Figura 2.",-1),Ea=e("h3",null,"Como as vacinas ajudam?",-1),Ra=e("p",null," As vacinas reduzem os riscos de obter uma doenÃ§a trabalhando com as defesas naturais do seu corpo para construir proteÃ§Ã£o. Quando se recebe uma vacina, o seu sistema imunolÃ³gico responde. ",-1),Ha=e("p",null," As vacinas contÃªm partes enfraquecidas ou inativas de um determinado organismo (antÃ­geno) que desencadeia uma resposta imune dentro do corpo (Fig. 3). As vacinas mais recentes contÃªm a planta para produzir antigÃ©nios em vez do prÃ³prio antigÃ©nio. Independentemente de a vacina ser constituÃ­da pelo prÃ³prio antigÃ©nio ou pela planta para que o corpo produza o antigÃ©nio, esta versÃ£o enfraquecida nÃ£o causarÃ¡ a doenÃ§a na pessoa que recebe a vacina. No entanto, vai levar o seu sistema imunolÃ³gico a responder tanto quanto teria na sua primeira reaÃ§Ã£o ao agente patogÃ©nico real. ",-1),Wa=e("b",null,"Figura 3.",-1),Ka=i('<p> As vacinas funcionam expondo os seus glÃ³bulos brancos Ã  proteÃ­na estranha de um vÃ­rus. Depois de o corpo ter encontrado um vÃ­rus e ter dado uma resposta imunitÃ¡ria (produzindo cÃ©lulas B e T) ao vÃ­rus, guarda as cÃ©lulas B e T para que, se o mesmo vÃ­rus ou bactÃ©ria voltar a infetar o corpo, o sistema imunitÃ¡rio possa encenar uma guerra total, impedindo que o agente patogÃ©nico volte a fazer-nos sentir doentes. As vacinas apresentam o vÃ­rus ao organismo para que este possa poupar as cÃ©lulas B e T sem nunca ficar doente. </p><h3>ImunizaÃ§Ã£o e desafios relacionados</h3><p> Temos agora vacinas para prevenir mais de 20 doenÃ§as que ameaÃ§am a vida, ajudando pessoas de todas as idades a viverem vidas mais longas e saudÃ¡veis. Atualmente, a imunizaÃ§Ã£o previne 2 a 3 milhÃµes de mortes por ano de doenÃ§as como difteria, tÃ©tano, pertÃºssis/tosse convulsa, gripe e sarampo. </p><p> Temos vacinaÃ§Ã£o contra muitas infeÃ§Ãµes virais graves (sarampo, papeira, hepatite A, hepatite B e alguns vÃ­rus â€“ como aqueles que causam a constipaÃ§Ã£o comum). Ainda assim, o problema continua a ser que podem mudar de uma pessoa para outra. Quando o vÃ­rus sofre mutaÃ§Ãµes, muda o suficiente para que o sistema imunolÃ³gico jÃ¡ nÃ£o o reconheÃ§a. As cÃ©lulas imunitÃ¡rias armazenadas para matar o vÃ­rus, jÃ¡ nÃ£o o reconhecem como a mesma doenÃ§a e nÃ£o sabem como matÃ¡-lo. Ã‰ assim que uma infeÃ§Ã£o com o mesmo vÃ­rus pode continuar a esquivar-se do sistema imunitÃ¡rio. A vacinaÃ§Ã£o para estes vÃ­rus Ã© difÃ­cil porque jÃ¡ mudaram o seu formato atÃ© ao momento em que as vacinas sÃ£o desenvolvidas. </p><section class="e-card"><h4 class="mt-0">ReferÃªncias</h4><ul class="text-sm break-all"><li><a href="https://www.who.int/news-room/feature-stories/detail/how-do-vaccines-work" target="_blank" rel="noopener noreferrer">https://www.who.int/news-room/feature-stories/detail/how-do-vaccines-work</a></li><li><a href="https://www.nytimes.com/interactive/2020/health/pfizer-biontech-covid-19-vaccine.html" target="_blank" rel="noopener noreferrer">https://www.nytimes.com/interactive/2020/health/pfizer-biontech-covid-19-vaccine.html</a></li><li><a href="https://media.nature.com/original/magazine-assets/d41586-021-03552-w/d41586-021-03552-w.pdf" target="_blank" rel="noopener noreferrer">https://media.nature.com/original/magazine-assets/d41586-021-03552-w/d41586-021-03552-w.pdf</a></li><li><a href="https://opentextbc.ca/biology/chapter/12-1-viruses/" target="_blank" rel="noopener noreferrer">https://opentextbc.ca/biology/chapter/12-1-viruses/</a></li></ul></section>',5),Ya=i('<hr class="mt-10 mb-40"><section id="s4"><h2 id="s4t">4. Processo de desenvolvimento de vacinas, seguranÃ§a das vacinas</h2><h3>Desenvolvimento</h3><p> O desenvolvimento da vacina comeÃ§a normalmente num laboratÃ³rio de investigaÃ§Ã£o localizado numa universidade, num centro mÃ©dico ou numa pequena empresa de biotecnologia. Durante o desenvolvimento da vacina, os cientistas desenvolvem diferentes reagentes para testar e medir o seu efeito (ou falta dele). Muitas vezes sÃ£o necessÃ¡rios anos de investigaÃ§Ã£o para encontrar ideias que funcionem. </p><p> Diferentes cientistas ou grupos de investigaÃ§Ã£o podem trabalhar para os mesmos objetivos durante o desenvolvimento da vacina. O progresso do trabalho Ã© apresentado em diferentes reuniÃµes e artigos publicados em revistas cientÃ­ficas, revistos pelos pares. Se algum trabalho parecer promissor, os cientistas farmacÃªuticos podem contactar os que estÃ£o a trabalhar nele para expandir a sua investigaÃ§Ã£o para o desenvolvimento de fÃ¡rmacos. </p><h3>Ensaios/testes</h3><p> Se for encontrada uma vacina candidata promissora, tem de ser testada em animais. Esta Ã© a chamada fase prÃ©-clÃ­nica. Primeiro sÃ£o usados pequenos animais como ratos, coelhos e outros. Se a vacina candidata afetar pequenos animais, normalmente o efeito tem de ser comprovado em animais maiores, como macacos. Se a vacina desencadear uma resposta imunitÃ¡ria, Ã© testada em trÃªs fases de ensaios clÃ­nicos em seres humanos (OMS, 2021). </p><p> Na fase 1, a vacina Ã© inoculada em alguns voluntÃ¡rios para avaliar a sua seguranÃ§a, confirmar que gera uma resposta imune, e determinar a dose adequada. Geralmente, nesta fase, as vacinas sÃ£o testadas num pequeno grupo de jovens voluntÃ¡rios adultos saudÃ¡veis. </p><p> Na fase 2, a vacina Ã© dada a vÃ¡rias centenas de voluntÃ¡rios para avaliar a sua seguranÃ§a e capacidade para gerar uma resposta imune. Os participantes nesta fase tÃªm as mesmas caracterÃ­sticas (como a idade e o sexo) que aqueles para os quais a vacina se destina. Geralmente existem mÃºltiplos ensaios nesta fase para avaliar vÃ¡rias faixas etÃ¡rias (idosos, adultos, crianÃ§as) e diferentes formulaÃ§Ãµes de vacinas. AlÃ©m disso, um grupo que nÃ£o recebe a vacina Ã© geralmente incluÃ­do para determinar se as alteraÃ§Ãµes no grupo vacinado sÃ£o atribuÃ­das Ã  vacina ou se ocorreram por acaso. </p><p> Na fase 3, a vacina Ã© administrada a milhares de voluntÃ¡rios â€“ comparada com um grupo semelhante de pessoas que nÃ£o receberam a vacina mas receberam um produto de comparaÃ§Ã£o. Isto visa determinar se a vacina Ã© eficaz contra a doenÃ§a que se destina a proteger. AlÃ©m disso, pretende estudar a sua seguranÃ§a num grupo muito maior de pessoas. Os ensaios de fase 3 sÃ£o frequentemente realizados em paÃ­ses e vÃ¡rios locais dentro dos paÃ­ses, para garantir que os resultados do desempenho da vacina se aplicam a populaÃ§Ãµes diferentes. </p><p> Durante os ensaios de fase 2 e 3, os voluntÃ¡rios e os cientistas que conduzem o estudo sÃ£o impedidos de saber quais os voluntÃ¡rios que receberam a vacina em teste ou o produto de comparaÃ§Ã£o. A isto chama-se â€œensaio cegoâ€ e Ã© necessÃ¡rio para garantir que nem os voluntÃ¡rios nem os cientistas sejam influenciados na sua avaliaÃ§Ã£o de eficÃ¡cia ou seguranÃ§a por saberem quem recebeu qual produto. </p><section class="e-card"><h4 class="mt-0">ReferÃªncias</h4><ul class="text-sm break-all"><li><a href="https://www.who.int/news-room/feature-stories/detail/how-are-vaccines-developed" target="_blank" rel="noopener noreferrer">https://www.who.int/news-room/feature-stories/detail/how-are-vaccines-developed</a></li></ul></section><h3>AutorizaÃ§Ã£o e monitorizaÃ§Ã£o</h3><p> Quando os resultados de todos estes ensaios clÃ­nicos estÃ£o disponÃ­veis, Ã© necessÃ¡ria uma sÃ©rie de passos. Os funcionÃ¡rios da AgÃªncia Europeia de Medicamentos e, mais tarde, em cada paÃ­s, analisam de perto os dados do estudo e decidem se autorizam a vacina. Todos os ensaios tÃªm de ser correctamente realizados e bem documentados. Antes de ser aprovada, uma vacina tem de ser comprovadamente segura e eficaz numa populaÃ§Ã£o alargada. A fasquia para a seguranÃ§a e eficÃ¡cia das vacinas Ã© excecionalmente elevada. Isto inclui anÃ¡lises de eficÃ¡cia e seguranÃ§a para aprovaÃ§Ãµes regulamentares e polÃ­ticas de saÃºde pÃºblica. </p><p> Durante a utilizaÃ§Ã£o das vacinas, Ã© efectuada uma monitorizaÃ§Ã£o adicional da seguranÃ§a e da eficÃ¡cia. Isto permite aos cientistas acompanhar o impacto e a seguranÃ§a das vacinas, mesmo quando estas sÃ£o utilizadas em muitas pessoas durante um longo perÃ­odo de tempo. Estes dados sÃ£o utilizados para ajustar as polÃ­ticas de utilizaÃ§Ã£o das vacinas. </p><section class="e-card"><h4 class="mt-0">ReferÃªncias</h4><ul class="text-sm break-all"><li><a href="https://www.worldscientific.com/doi/pdf/10.1142/S2529732521400034" target="_blank" rel="noopener noreferrer">https://www.worldscientific.com/doi/pdf/10.1142/S2529732521400034</a></li></ul></section></section><hr class="mt-10 mb-40">',3),Ua={id:"s5"},Ja=e("h2",{id:"s5t"},"5. MÃ¡scaras contra vÃ­rus e bactÃ©rias",-1),La=e("p",null," As mÃ¡scaras sÃ£o frequentemente usadas para proteger contra vÃ­rus e bactÃ©rias. Elas espalharam-se no sentido de proteÃ§Ã£o contra o vÃ­rus SARS-CoV-2. Entre os diferentes tipos de mÃ¡scaras, as mÃ¡scaras cirÃºrgicas estÃ£o entre as coberturas faciais mais usadas na pandemia de COVID-19. Normalmente, sÃ£o de cor azul de um lado, que deve ser mantido como uma camada externa (Fig. 4). O principal objetivo das mÃ¡scaras cirÃºrgicas Ã© proteger os doentes de um potencial contato com bactÃ©rias e vÃ­rus exalados por quem usa a mÃ¡scara. Portanto, eles impedem a propagaÃ§Ã£o do coronavÃ­rus pelo ar, mas sÃ£o meios menos eficazes para proteger o portador do vÃ­rus. ",-1),Qa=e("p",null," As mÃ¡scaras FFP2 ou FFP3 (frequentemente designadas por respiradores) devem ser utilizadas para filtrar e inalar melhor o ar. O sistema de numeraÃ§Ã£o (FFP1, FPP2, FFP3) indica a eficiÃªncia de filtragem destes dispositivos (certificados como cumprindo a norma EN 149-2001). FFP2 e FPP3 tÃªm uma eficiÃªncia de filtragem de partÃ­culas transportadas pelo ar (incluindo as que contÃªm o vÃ­rus) de 92% e 98%, respetivamente. Ambas as mÃ¡scaras tÃªm tambÃ©m uma pequena fuga para o interior: <8% e <2%, respetivamente. Na FFP2, Ã© frequentemente utilizada borracha especial na camada exterior da mÃ¡scara. Se, em ambientes profissionais, foi permitida uma vÃ¡lvula (que facilita a expiraÃ§Ã£o), no caso do SARS-CoV-2, apenas devem ser utilizados respiradores sem vÃ¡lvula para filtrar tambÃ©m o ar expirado. ",-1),Ga=e("p",null," Com a pandemia de COVID-19, foi introduzida uma nova mÃ¡scara facial: a mÃ¡scara filtrante. Este tipo de mÃ¡scara Ã© feito de tecido multicamadas (uma delas tem de ser um filtro de nanofibras que garante uma capacidade de filtragem de bactÃ©rias e poeiras finas nocivas de, pelo menos, 90%). Esta mÃ¡scara combina uma elevada capacidade de filtragem com a possibilidade de reutilizaÃ§Ã£o, uma vez que pode ser lavada na mÃ¡quina a 60 graus. ",-1),Xa={class:"grid gap-3 my-15 md:grid-cols-2 e-card"},Za=i('<p><i><b>Figura 4.</b> Diferentes tipos de mÃ¡scaras</i></p><p> A eficÃ¡cia das mÃ¡scaras foi testada em laboratÃ³rios especiais, por exemplo, na cÃ¢mara de exposiÃ§Ã£o. Nesses estudos, um transportador de vÃ­rus. Subsequentemente, as concentraÃ§Ãµes de partÃ­culas por detrÃ¡s do gerador de partÃ­culas enchem a cÃ¢mara de exposiÃ§Ã£o com pequenas partÃ­culas; Ã  semelhanÃ§a dos aerossÃ³is, as mÃ¡scaras sÃ£o medidas e comparadas com a concentraÃ§Ã£o na atmosfera geral da cÃ¢mara de exposiÃ§Ã£o. </p><p> No entanto, as evidÃªncias mais fortes baseiam-se em dados epidemiolÃ³gicos de situaÃ§Ãµes da vida real. Por exemplo, a taxa de crescimento diÃ¡ria do COVID-19 estÃ¡ a abrandar apÃ³s imosiÃ§Ã£o de mÃ¡scaras em 15 estados e no distrito de Columbia nos EUA. Um outro estudo analisou as mortes de coronavÃ­rus em 198 paÃ­ses e concluiu que os paÃ­ses com normas culturais ou polÃ­ticas governamentais que favorecem o uso de mÃ¡scaras tinham taxas de mortalidade mais baixas. </p><p> Muitos utilizadores do Facebook e das redes sociais tÃªm partilhado publicaÃ§Ãµes enganosas sobre a utilizaÃ§Ã£o prolongada de mÃ¡scaras faciais que provocam uma deficiÃªncia de oxigÃ©nio no corpo - hipoxia. No entanto, artigos de investigaÃ§Ã£o e especialistas sugerem que Ã© pouco provÃ¡vel que esses sintomas ocorram na maioria das pessoas, a menos que o utilizador tenha doenÃ§as respiratÃ³rias prÃ©-existentes, como asma ou doenÃ§a pulmonar obstrutiva crÃ³nica (DPOC). O risco de hipoxia e hipercapnia (excesso de diÃ³xido de carbono na corrente sanguÃ­nea) Ã© improvÃ¡vel com as mÃ¡scaras de tecido e cirÃºrgicas, uma vez que nÃ£o sÃ£o justas. No entanto, alerta-se para o facto de as mÃ¡scaras faciais nÃ£o deverem ser colocadas em crianÃ§as com menos de dois anos de idade, em pessoas com dificuldades respiratÃ³rias ou durante a prÃ¡tica de exercÃ­cio fÃ­sico. </p><section class="e-card"><h4 class="mt-0">ReferÃªncias</h4><ul class="text-sm break-all"><li><a href="https://bmcpublichealth.biomedcentral.com/articles/10.1186/s12889-021-10652-9" target="_blank" rel="noopener noreferrer">https://bmcpublichealth.biomedcentral.com/articles/10.1186/s12889-021-10652-9</a></li><li><a href="https://jamanetwork.com/journals/jamainternalmedicine/fullarticle/2774266" target="_blank" rel="noopener noreferrer">https://jamanetwork.com/journals/jamainternalmedicine/fullarticle/2774266</a></li><li><a href="https://www.healthaffairs.org/doi/10.1377/hlthaff.2020.00818" target="_blank" rel="noopener noreferrer">https://www.healthaffairs.org/doi/10.1377/hlthaff.2020.00818</a></li><li><a href="https://www.ajtmh.org/view/journals/tpmd/103/6/article-p2400.xml" target="_blank" rel="noopener noreferrer">https://www.ajtmh.org/view/journals/tpmd/103/6/article-p2400.xml</a></li><li><a href="https://www.epa.gov/sciencematters/epa-researchers-test-effectiveness-face-masks-disinfection-methods-against-covid-19" target="_blank" rel="noopener noreferrer">https://www.epa.gov/sciencematters/epa-researchers-test-effectiveness-face-masks-disinfection-methods-against-covid-19</a></li><li><a href="https://journals.asm.org/doi/full/10.1128/mSphere.00637-20" target="_blank" rel="noopener noreferrer">https://journals.asm.org/doi/full/10.1128/mSphere.00637-20</a></li><li><a href="https://pubmed.ncbi.nlm.nih.gov/33626065/" target="_blank" rel="noopener noreferrer">https://pubmed.ncbi.nlm.nih.gov/33626065/</a></li></ul></section>',5),et=e("div",null,[e("h3",{class:"mt-6 pt-3 mb-10"},"Para mais estudo"),e("ul",{class:"leading-tight break-all"},[e("li",null,[e("a",{href:"https://www.fda.gov/medical-devices/personal-protective-equipment-infection-control/n95-respirators-surgical-masks-face-masks-and-barrier-face-coverings#s3",target:"_blank",rel:"noopener noreferrer"},"N95 Respirators, Surgical Masks, Face Masks, and Barrier Face Coverings")]),e("li",null,[e("a",{href:"https://www.sciencedirect.com/science/article/pii/S2452199X20301481",target:"_blank"},"An overview of filtration efficiency through the masks: Mechanisms of the aerosols penetration")]),e("li",null,[e("a",{href:"https://www.weforum.org/agenda/2020/10/covid-19-coronavirus-disease-size-compairson-zika-health-air-pollution/",target:"_blank",rel:"noopener noreferrer"},"This is how coronavirus compares to the world's smallest particles")])])],-1),at=e("hr",{class:"mt-10 mb-40"},null,-1),tt={id:"s6"},st=i('<h2 id="s6t">6. VÃ­rus e higiene das mÃ£os</h2><h3>Desinfetante para as mÃ£os ou sabonete?</h3><p> As nossas mÃ£os podem ser um elemento crÃ­tico na transmissÃ£o de infeÃ§Ãµes. Quando aplicados nas mÃ£os cuidadosamente e esfregados durante pelo menos 20 segundos, os desinfectantes para as mÃ£os Ã  base de Ã¡lcool e o sabÃ£o travam o coronavÃ­rus. No entanto, o sabÃ£o rompe a ligaÃ§Ã£o entre os agentes patogÃ©nicos e a sua pele, permitindo que os agentes patogÃ©nicos deslizem imediatamente. NÃ£o sÃ³ estÃ¡ a neutralizar o vÃ­rus, como tambÃ©m o estÃ¡ a eliminar fisicamente das suas mÃ£os. A prÃ¡tica de uma boa higiene das mÃ£os Ã© uma estratÃ©gia preventiva simples que a maioria das pessoas pode facilmente adotar, e muitos estudos demonstraram a eficÃ¡cia da higiene das mÃ£os na prevenÃ§Ã£o da transmissÃ£o de agentes patogÃ©nicos infecciosos, incluindo coronavÃ­rus como o SARS-CoV-2. </p><section class="e-card"><h4 class="mt-0">ReferÃªncias</h4><ul class="text-sm break-all"><li><a href="https://www.uchealth.org/today/why-soap-and-water-work-better-than-hand-sanitizer-to-remove-the-coronavirus/" target="_blank" rel="noopener noreferrer">https://www.uchealth.org/today/why-soap-and-water-work-better-than-hand-sanitizer-to-remove-the-coronavirus/</a></li></ul></section><h3>Enfraquecer o corona vÃ­rus com sabÃ£o</h3><p> Os coronavÃ­rus recebem o seu nome da &quot;coroa&quot; que rodeia o vÃ­rus - os picos de proteÃ­nas incorporados na sua superfÃ­cie. Os picos, responsÃ¡veis pela infeÃ§Ã£o do hospedeiro, estÃ£o ancorados numa membrana. A membrana Ã© o &quot;invÃ³lucro&quot; do vÃ­rus e o seu ponto fraco. </p><p> As molÃ©culas de sabÃ£o tÃªm duas partes quimicamente distintas: uma &quot;cabeÃ§a&quot; hidrofÃ­lica (que adora Ã¡gua) e uma &quot;cauda&quot; hidrofÃ³bica (que odeia Ã¡gua). A cabeÃ§a ajuda o sabÃ£o a misturar-se com a Ã¡gua, enquanto a cauda pode interagir com outras molÃ©culas hidrofÃ³bicas, como os lÃ­pidos. </p><p> Felizmente, a membrana do coronavÃ­rus Ã© constituÃ­da principalmente por molÃ©culas de lÃ­pidos. Estas sÃ£o mantidas juntas por interacÃ§Ãµes quÃ­micas fracas entre molÃ©culas individuais. As &quot;caudas&quot; hidrofÃ³bicas (que odeiam a Ã¡gua) das molÃ©culas de sabÃ£o podem quebrar as interacÃ§Ãµes entre as molÃ©culas lipÃ­dicas na membrana do coronavÃ­rus (ver Fig. 5). </p><p> A â€œcaudaâ€ do sabÃ£o pode romper as interacÃ§Ãµes fracas entre as molÃ©culas lipÃ­dicas da membrana, rasgando-a. Suponhamos que o vÃ­rus se fragmenta antes de ser abrigado em seguranÃ§a numa cÃ©lula hospedeira. Nesse caso, o vÃ­rus deixa de ser capaz de fazer o seu trabalho infecioso - como uma mÃ¡quina cujas peÃ§as se desintegram. As molÃ©culas de sabÃ£o envolvem entÃ£o os fragmentos de vÃ­rus com todas as caudas viradas para o interior. Este aglomerado Ã© designado por micela (ver Fig. 6). As cabeÃ§as hidrofÃ­licas voltadas para o exterior permitem que a micela seja levada pela Ã¡gua. A Ã¡gua, por si sÃ³, nÃ£o Ã© suficiente. </p>',9),it={class:"grid gap-2 md:grid-cols-2 e-card"},rt=e("b",null,"Figura 5.",-1),nt=e("b",null,"Figura 6.",-1),ot=i('<p> A informaÃ§Ã£o dada tambÃ©m Ã© vÃ¡lida para os outros vÃ­rus envolvidos (Gripe, Hepatite B e C e DoenÃ§a do VÃ­rus do Ã‰bola) uma vez que na sua estrutura tambÃ©m tÃªm fosfolÃ­pidos. </p><section class="e-card"><h4 class="mt-0">ReferÃªncia</h4><ul class="text-sm break-all"><li><a href="https://www.science.org.au/curious/people-medicine/hand-sanitiser-or-soap-making-informed-choice-covid-19" target="_blank" rel="noopener noreferrer">https://www.science.org.au/curious/people-medicine/hand-sanitiser-or-soap-making-informed-choice-covid-19</a></li></ul></section><h3>Escolher desinfetante para as mÃ£os</h3><p> A OrganizaÃ§Ã£o Mundial de SaÃºde (OMS) recomenda desinfetantes Ã  base de Ã¡lcool se nÃ£o tiver sabÃ£o Ã  mÃ£o. </p><p><b>Acredita-se que os desinfetantes para as mÃ£os Ã  base de Ã¡lcool funcionem impedindo que as proteÃ­nas dos micrÃ³bios â€“ incluindo bactÃ©rias e alguns vÃ­rus â€“ funcionem normalmente. Desinfetantes para as mÃ£os com alto teor de Ã¡lcool tambÃ©m podem interferir na camada lipÃ­dica que envolve o coronavÃ­rus.</b> Para serem eficazes, os desinfetantes para as mÃ£os devem conter pelo menos 60% de Ã¡lcool. Os aditivos no desinfetante podem impedir que o Ã¡lcool evapore muito rÃ¡pido, permitindo que o vÃ­rus fique encharcado por mais tempo. </p><p> No entanto, existem tambÃ©m certos riscos relacionados com a utilizaÃ§Ã£o de desinfetantes manuais Ã  base de Ã¡lcool. Existe um aumento do risco de intoxicaÃ§Ã£o alcoÃ³lica para as crianÃ§as, e o uso frequente de desinfetantes manuais pode resultar em resistÃªncia antimicrobiana. Existem desinfetantes manuais alternativos sem Ã¡lcool, onde o benzalcÃ³nio Ã© mais utilizado. Estudos recentes indicaram que o desinfetante manual sem Ã¡lcool funciona tÃ£o bem e nÃ£o causa a sensaÃ§Ã£o familiar de &quot;queimadura&quot; conhecida pelo uso de desinfetante de mÃ£os alcoÃ³licas. </p><section class="e-card"><h4 class="mt-0">ReferÃªncias</h4><ul class="text-sm break-all"><li><a href="https://www.sciencedirect.com/science/article/abs/pii/S0048969720340833?via%3Dihub" target="_blank" rel="noopener noreferrer">https://www.sciencedirect.com/science/article/abs/pii/S0048969720340833?via%3Dihub</a></li><li><a href="https://www.journalofhospitalinfection.com/article/S0195-6701(20)30547-8/fulltext#secsectitle0040" target="_blank" rel="noopener noreferrer">https://www.journalofhospitalinfection.com/article/S0195-6701(20)30547-8/fulltext#secsectitle0040</a></li></ul></section>',7),lt=e("hr",{class:"mt-10 mb-40"},null,-1),dt={id:"s7"},ct=i('<h2 id="s7t" class="mt-40 text-5xl">7. Mitos da Vacina</h2><h3><span class="text-rose-400">Mito 1:</span> As vacinas causam autismo/efeitos secundÃ¡rios graves.</h3><p> O medo generalizado de que as vacinas aumentam o risco de autismo teve origem num estudo de 1997 publicado por Andrew Wakefield, um cirurgiÃ£o britÃ¢nico. O artigo foi publicado na The Lancet, uma prestigiada revista mÃ©dica, sugerindo que a vacina contra o sarampo, a papeira e a rubÃ©ola (MMR) aumentava o autismo nas crianÃ§as britÃ¢nicas. </p><p> Desde entÃ£o, o artigo foi completamente desacreditado devido a erros processuais graves, ao facto de o estudo ter contado com apenas 12 participantes, a conflitos de interesses financeiros nÃ£o revelados e a violaÃ§Ãµes Ã©ticas. Andrew Wakefield perdeu a sua licenÃ§a mÃ©dica e o artigo foi retirado da revista The Lancet. </p><p> Atualmente, contra a teoria da ligaÃ§Ã£o entre autismo e vacinaÃ§Ã£o, vÃ¡rios estudos identificaram sintomas de autismo em crianÃ§as muito antes de estas receberem a vacina MMR. AlÃ©m disso, investigaÃ§Ãµes recentes fornecem provas de que o autismo se desenvolve no Ãºtero, muito antes de um bebÃ© nascer ou receber vacinas. Nenhum dos Ãºltimos estudos relatou uma ligaÃ§Ã£o entre qualquer vacina e a probabilidade de desenvolver autismo. </p><section class="e-card"><h4 class="mt-0">ReferÃªncias</h4><ul class="text-sm break-all"><li><a href="https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(97)11096-0/fulltext" target="_blank" rel="noopener noreferrer">https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(97)11096-0/fulltext</a></li><li><a href="https://www.nejm.org/doi/full/10.1056/NEJMoa1307491?query=featured_home" target="_blank" rel="noopener noreferrer">https://www.nejm.org/doi/full/10.1056/NEJMoa1307491?query=featured_home</a></li></ul></section>',6),mt=e("div",null,[e("h3",{class:"mt-6 pt-3 mb-10"},"Para mais estudo"),e("ul",{class:"leading-tight"},[e("li",null,[e("a",{href:"https://archive.cdc.gov/#/details?url=https://www.cdc.gov/coronavirus/2019-ncov/vaccines/expect/after.html",target:"_blank",rel:"noopener noreferrer"},"Possible Side Effects After Getting a COVID-19 Vaccine")]),e("li",null,[e("a",{href:"https://www.bbc.com/news/health-55932832",target:"_blank",rel:"noopener noreferrer"},"Study reveals extent of Covid vaccine side-effects")]),e("li",null,[e("a",{href:"https://www.nature.com/articles/d41586-021-00290-x",target:"_blank"},"COVID vaccines and safety: what the research says")]),e("li",null,[e("a",{href:"https://health.clevelandclinic.org/covid-19-vaccine-side-effects/",target:"_blank",rel:"noopener noreferrer"},"Hereâ€™s What to Know About the COVID-19 Vaccine Side Effects")]),e("li",null,[e("a",{href:"https://www.historyofvaccines.org/content/articles/vaccine-side-effects-and-adverse-events",target:"_blank",rel:"noopener noreferrer"},"Vaccine Side Effects and Adverse Events")]),e("li",null,[e("a",{href:"https://www.bbc.com/news/health-56375307",target:"_blank"},"Vaccine side effects: My experience of them and what they mean")]),e("li",null,[e("a",{href:"https://vk.ovg.ox.ac.uk/vk/vaccine-side-effects",target:"_blank",rel:"noopener noreferrer"},"Vaccine side effects and adverse reactions")]),e("li",null,[a("ğŸ“º"),e("a",{href:"https://www.youtube.com/watch?v=F6NKbQzo4aE",target:"_blank",rel:"noopener noreferrer"},"Vaccine side effects are actually a good thing")]),e("li",null,[a("ğŸ“º"),e("a",{href:"https://www.youtube.com/watch?v=Atrx1P2EkiQ",target:"_blank",rel:"noopener noreferrer"},"Vaccines and the Immune Response: How Vaccines Work")])])],-1),ut=i('<h3><span class="text-rose-400">Mito 2:</span> Os sistemas imunolÃ³gicos infantis nÃ£o conseguem lidar com vÃ¡rias vacinas</h3><p> As crianÃ§as recebem vacinas em tenra idade porque correm o maior risco de adoecer ou morrer se contraÃ­rem estas doenÃ§as. Mesmo os recÃ©m-nascidos sÃ£o imunes a algumas doenÃ§as (por exemplo, varicela) porque recebem anticorpos das mÃ£es; esta imunidade dura apenas alguns meses. AlÃ©m disso, a maioria dos bebÃ©s nÃ£o obtÃ©m anticorpos protetores contra difteria, tosse convulsa, poliomielite, tÃ©tano, hepatite B ou Hib das suas mÃ£es. </p><p> Para reduzir o nÃºmero de vacinas que uma crianÃ§a recebe numa visita ao mÃ©dico, algumas vacinas sÃ£o oferecidas como uma combinaÃ§Ã£o (duas ou mais vacinas diferentes foram combinadas numa Ãºnica injeÃ§Ã£o). Exemplos de vacinas combinadas sÃ£o difteria-tÃ©tano-pertussis (DTap) e o sarampo-papeira-rubÃ©ola (MMR). </p><p> Dados cientÃ­ficos demonstram que a administraÃ§Ã£o de vÃ¡rias vacinas em simultÃ¢neo nÃ£o causa quaisquer problemas de saÃºde. O sistema imunolÃ³gico infantil Ã© mais resistente do que se possa pensar. Com base no nÃºmero de anticorpos presentes no sangue, um bebÃ© teria, teoricamente a capacidade de responder a um nÃºmero muito maior de vacinas do que as que sÃ£o administradas (a questÃ£o que se coloca Ã© se sÃ£o 1.000, 10.000 ou 100.000 de uma sÃ³ vez). Mesmo que todas as cerca de 10 (dependendo do plano nacional de vacinaÃ§Ã£o) vacinas programadas fossem administradas de uma sÃ³ vez, isso utilizaria apenas uma fraÃ§Ã£o da capacidade imunitÃ¡ria de um bebÃ©. Na realidade, os bebÃ©s estÃ£o expostos a inÃºmeras bactÃ©rias e vÃ­rus todos os dias, e as imunizaÃ§Ãµes sÃ£o insignificantes em comparaÃ§Ã£o. AlÃ©m disso, os estudos nÃ£o demonstraram que a exposiÃ§Ã£o a mÃºltiplas vacinas durante os primeiros 23 meses de vida estaria associada a um risco acrescido de infecÃ§Ãµes nÃ£o visadas pelas vacinas. </p><section class="e-card"><h4 class="mt-0">ReferÃªncias</h4><ul class="text-sm break-all"><li><a href="https://www.nejm.org/doi/full/10.1056/NEJMoa1307491?query=featured_home" target="_blank" rel="noopener noreferrer">https://www.nejm.org/doi/full/10.1056/NEJMoa1307491?query=featured_home</a></li><li><a href="https://www.bmj.com/content/364/bmj.l1481/rr-11" target="_blank" rel="noopener noreferrer">https://www.bmj.com/content/364/bmj.l1481/rr-11</a></li><li><a href="https://pubmed.ncbi.nlm.nih.gov/11773551/" target="_blank" rel="noopener noreferrer">https://pubmed.ncbi.nlm.nih.gov/11773551/</a></li></ul></section><h3><span class="text-rose-400">Mito 3:</span> A imunidade adquirida atravÃ©s de uma doenÃ§a Ã© melhor do que a imunidade adquirida atravÃ©s da vacinaÃ§Ã£o</h3><p> Ã‰ verdade que a infeÃ§Ã£o natural resulta quase sempre numa imunidade mais forte Ã  doenÃ§a do que uma vacinaÃ§Ã£o. No entanto, os perigos desta abordagem superam em muito os benefÃ­cios relativos. O preÃ§o da imunidade apÃ³s a infeÃ§Ã£o natural pode ser pneumonia de varicela ou pneumococcus, incapacidade intelectual de Haemophilus influenzae tipo b (Hib), defeitos congÃ©nitos de rubÃ©ola, cancro do fÃ­gado devido ao vÃ­rus da hepatite B, morte por sarampo, etc. Se quisesse ganhar imunidade ao sarampo, por exemplo, ao contrair a doenÃ§a, enfrentaria uma em cada 500 hipÃ³teses de morte devido aos seus sintomas. Em contraste, o nÃºmero de pessoas que tiveram reaÃ§Ãµes alÃ©rgicas severas de uma vacina MMR Ã© inferior a um em um milhÃ£o. </p><p> No entanto, poucas vacinas induzem uma melhor resposta imunolÃ³gica do que a infeÃ§Ã£o natural. Por exemplo, a vacina do papilomavÃ­rus humano (HPV) contÃ©m uma alta pureza da proteÃ­na especÃ­fica, conduzindo a uma melhor resposta imunolÃ³gica do que a infeÃ§Ã£o natural. Outros exemplos incluem o tÃ©tano, o haemophilus influenzae tipo b (Hib) e a vacina pneumocÃ³cica. </p><p> No que diz respeito ao COVID-19, tem de ser esclarecido. Foi demonstrado que a proteÃ§Ã£o permanente apÃ³s a infeÃ§Ã£o Ã© improvÃ¡vel. Apesar de os doentes com coronavÃ­rus terem adquirido uma &quot;memÃ³ria imunitÃ¡ria substancial&quot; que envolveu as quatro partes significativas do sistema imunitÃ¡rio: cÃ©lulas B da memÃ³ria, anticorpos, cÃ©lulas CD4+ T de memÃ³ria e cÃ©lulas CD8+ T de memÃ³ria, a proteÃ§Ã£o comeÃ§ou a reduzir apÃ³s meio ano. AlÃ©m disso, os cientistas mostraram uma &quot;gama dinÃ¢mica massiva&quot; na resposta imunitÃ¡ria entre indivÃ­duos, com uma diferenÃ§a de 200 vezes nos nÃ­veis de anticorpos. </p><p> Outros estudos mostraram que os voluntÃ¡rios que receberam a vacina Moderna (mRNA) tinham mais anticorpos - um marcador de resposta imune - no sangue do que as pessoas que estavam doentes com COVID-19. No entanto, este facto pode ser modificado pela gravidade da doenÃ§a, uma vez que existe uma correlaÃ§Ã£o entre a gravidade da doenÃ§a e a resposta imunolÃ³gica duradoura â€“ a maioria dos pacientes assintomÃ¡ticos tinha muito poucos anticorpos apÃ³s seis meses de infeÃ§Ã£o. Assim, a imunidade natural gerada por uma infeÃ§Ã£o SARS-CoV-2 Ã© muitas vezes imprevisÃ­vel. AlÃ©m disso, os anticorpos provocados pela vacina do mRNA tinham como alvo uma gama mais ampla de locais no DomÃ­nio de LigaÃ§Ã£o ao Recetor (do inglÃªs Receptor Binding Domain, RBD) do que os provocados por infeÃ§Ãµes naturais. </p><section class="e-card"><h4 class="mt-0">ReferÃªncias</h4><ul class="text-sm break-all"><li><a href="https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(21)00675-9/fulltext" target="_blank" rel="noopener noreferrer">https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(21)00675-9/fulltext</a></li><li><a href="https://science.sciencemag.org/content/371/6529/eabf4063" target="_blank" rel="noopener noreferrer">https://science.sciencemag.org/content/371/6529/eabf4063</a></li><li><a href="https://www.nejm.org/doi/full/10.1056/NEJMc2032195" target="_blank" rel="noopener noreferrer">https://www.nejm.org/doi/full/10.1056/NEJMc2032195</a></li><li><a href="https://www.researchsquare.com/article/rs-612205/v1" target="_blank" rel="noopener noreferrer">https://www.researchsquare.com/article/rs-612205/v1</a></li><li><a href="https://stm.sciencemag.org/content/13/600/eabi9915" target="_blank" rel="noopener noreferrer">https://stm.sciencemag.org/content/13/600/eabi9915</a></li></ul></section><h3><span class="text-rose-400">Mito 4:</span> As vacinas contÃªm substÃ¢ncias que podem pÃ´r a vida em risco.</h3><p> As pessoas estÃ£o preocupadas com o uso de formaldeÃ­do, mercÃºrio ou alumÃ­nio nas vacinas. Por um lado, estes quÃ­micos sÃ£o tÃ³xicos para o corpo humano a certos nÃ­veis. Por outro lado, apenas pequenas quantidades destes produtos quÃ­micos podem ser encontradas em vacinas. Essas quantidades sÃ£o menores do que obtemos da nutriÃ§Ã£o ou o formaldeÃ­do Ã© produzido a taxas mais elevadas pelos nossos prÃ³prios sistemas metabÃ³licos. </p><p> Certos elementos, como sais de alumÃ­nio, sÃ£o adicionados Ã s vacinas porque funcionam como adjuvantes, o que significa que sua presenÃ§a aumenta a resposta imune quando vocÃª Ã© vacinado. AlÃ©m disso, apenas algumas vacinas contÃªm sais de alumÃ­nio e as novas vacinas COVID-19 nÃ£o os contÃªm. Algumas vacinas contÃªm timerosal como conservante; no entanto, nenhuma das vacinas usadas em crianÃ§as atualmente contÃ©m isso. O timerosal contÃ©m etilmercÃºrio, que Ã© eliminado do corpo humano rapidamente em comparaÃ§Ã£o com o metilmercÃºrio, que se bioacumula - portanto, tambÃ©m hÃ¡ uma diferenÃ§a na forma de metal tÃ³xico. No entanto, as vacinas COVID-19 nÃ£o contÃªm toxinas (por exemplo). </p><section class="e-card"><h4 class="mt-0">ReferÃªncias</h4><ul class="text-sm break-all"><li><a href="https://stm.sciencemag.org/content/13/600/eabi9915" target="_blank" rel="noopener noreferrer">https://stm.sciencemag.org/content/13/600/eabi9915</a></li><li><a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6373706/" target="_blank" rel="noopener noreferrer">https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6373706/</a></li><li><a href="https://www.technologyreview.com/2020/12/09/1013538/what-are-the-ingredients-of-pfizers-covid-19-vaccine/" target="_blank" rel="noopener noreferrer">https://www.technologyreview.com/2020/12/09/1013538/what-are-the-ingredients-of-pfizers-covid-19-vaccine/</a></li></ul></section>',15),ht=e("div",null,[e("h3",{class:"mt-6 pt-3 mb-10"},"Para mais estudo"),e("ul",{class:"leading-tight"},[e("li",null,[a("ğŸ“º"),e("a",{href:"https://www.youtube.com/watch?v=Atrx1P2EkiQ",target:"_blank",rel:"noopener noreferrer"},"Vaccines and the Immune Response: How Vaccines Work")]),e("li",null,[e("a",{href:"https://www.cdc.gov/vaccines/vac-gen/additives.htm",target:"_blank",rel:"noopener noreferrer"},"Whatâ€™s in Vaccines?")])])],-1),pt=i('<h3><span class="text-rose-400">Mito 5:</span> Uma melhor higiene e um melhor saneamento sÃ£o responsÃ¡veis pela diminuiÃ§Ã£o das infeÃ§Ãµes, nÃ£o as vacinas</h3><p> Em parte, Ã© verdade que as vacinas nÃ£o merecem todo o crÃ©dito pela reduÃ§Ã£o ou eliminaÃ§Ã£o das taxas de doenÃ§as infecciosas. EstÃ¡ provado que a melhoria do saneamento bÃ¡sico, da nutriÃ§Ã£o e o desenvolvimento de antibiÃ³ticos tambÃ©m ajudaram muito. InfecÃ§Ãµes como a febre tifoide e a cÃ³lera, transmitidas por Ã¡gua contaminada, uma das principais causas de doenÃ§a e morte no inÃ­cio do sÃ©culo XX, foram drasticamente reduzidas por um melhor saneamento. Uma anÃ¡lise recente concluiu que a lavagem das mÃ£os contribui para evitar doenÃ§as infecciosas. Outra prova recente vem do confinamento devido Ã  COVID-19 e da melhoria da higiene, com uma reduÃ§Ã£o drÃ¡stica das taxas de gripe sazonal. </p><p> No entanto, quando estes fatores sÃ£o isolados e as taxas de doenÃ§as infeciosas sÃ£o analisadas, o papel das vacinas nÃ£o pode ser negado. Um exemplo Ã© o sarampo nos Estados Unidos. Quando a primeira vacina contra o sarampo foi introduzida em 1963, as taxas de infeÃ§Ã£o tinham sido constantes em cerca de 400.000 casos por ano. E embora os hÃ¡bitos higiÃ©nicos e o saneamento nÃ£o tenham mudado muito na dÃ©cada seguinte, a taxa de infeÃ§Ãµes por sarampo diminuiu precipitadamente apÃ³s a introduÃ§Ã£o da vacina, com apenas cerca de 25.000 casos atÃ© 1970. Outro exemplo Ã© a doenÃ§a hib. De acordo com os dados do CDC, a taxa de incidÃªncia desta doenÃ§a baixou de 20.000 em 1990 para cerca de 1.500 em 1993, apÃ³s a introduÃ§Ã£o da vacina. </p><p> Outra prova vem das Ãºltimas dÃ©cadas. NÃ£o houve alteraÃ§Ãµes na higiene no mundo desenvolvido, mas houve uma diminuiÃ§Ã£o das taxas de vacinaÃ§Ã£o. AlÃ©m disso, vÃ¡rios paÃ­ses, como o Reino Unido, os EUA, a Alemanha, a Espanha, etc., estÃ£o a assistir a um aumento do nÃºmero de sarampo, e outras doenÃ§as evitÃ¡veis pela vacinaÃ§Ã£o, identificadas como uma doenÃ§a emergente &quot;pontos quentes&quot;. </p><section class="e-card"><h4 class="mt-0">ReferÃªncia</h4><ul class="text-sm break-all"><li><a href="https://jptcp.com/index.php/jptcp/article/view/711" target="_blank" rel="noopener noreferrer">https://jptcp.com/index.php/jptcp/article/view/711</a></li><li><a href="https://www.nature.com/articles/d41586-020-01538-8" target="_blank" rel="noopener noreferrer">https://www.nature.com/articles/d41586-020-01538-8</a></li><li><a href="https://www.nature.com/articles/d41586-020-03519-3" target="_blank" rel="noopener noreferrer">https://www.nature.com/articles/d41586-020-03519-3</a></li><li><a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3222407/" target="_blank" rel="noopener noreferrer">https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3222407/</a></li></ul></section><h3><span class="text-rose-400">Mito 6:</span> As vacinas podem infetar a crianÃ§a com a doenÃ§a que estÃ¡ a tentar prevenir</h3><p> Algumas das vacinas sÃ£o vacinas vivas que contÃªm microrganismos/vÃ­rus atenuados vivos, que ainda sÃ£o capazes de se replicar dentro do hospedeiro (vacina). Os microrganismos estÃ£o &quot;enfraquecidos&quot;, o que significa que perderam a maior parte da sua capacidade causadora de doenÃ§as, mas ainda possuem propriedades imunogÃ©nicas. Assim, Ã© sempre muito menos grave do que se uma crianÃ§a for infetada com o vÃ­rus causador da doenÃ§a em si. As vacinas vivas atenuadas sÃ£o para o sarampo, papeira, rubÃ©ola (vacina combinada MMR), rotavÃ­rus, varÃ­ola, varicela e febre amarela. Na maioria dos casos, as vacinas vivas mostram uma imunogenicidade significativamente maior do que as vacinas inativadas, uma vez que a infeÃ§Ã£o natural Ã© imitada quase na perfeiÃ§Ã£o, provocando uma gama mais abrangente de respostas imunolÃ³gicas. No entanto, estas vacinas nÃ£o sÃ£o recomendadas para crianÃ§as com sistemas imunitÃ¡rios enfraquecidos, como as que estÃ£o a ser tratadas com cancro. </p><p> As vacinas vivas podem, de facto, causar sintomas leves que se assemelham Ã  doenÃ§a contra a qual protegem. No entanto, os recetores da vacina estÃ£o a experimentar a resposta imune do corpo Ã  vacina, e nÃ£o Ã  doenÃ§a em si. HÃ¡ apenas um caso registado em que se demonstrou que uma vacina causa doenÃ§as. Esta foi a Vacina contra a Poliomielite Oral (OPV) que jÃ¡ nÃ£o Ã© utilizada e atualmente Ã© substituÃ­da por uma forma de vÃ­rus morto conhecida como a vacina contra a poliomielite inativada (IPV). </p><section class="e-card"><h4 class="mt-0">ReferÃªncia</h4><ul class="text-sm break-all"><li><a href="https://www.sciencedirect.com/science/article/pii/B9781455710768000090" target="_blank" rel="noopener noreferrer">https://www.sciencedirect.com/science/article/pii/B9781455710768000090</a></li></ul></section><h3><span class="text-rose-400">Mito 7:</span> NÃ£o precisamos de vacinar porque muitos paÃ­ses tÃªm baixas taxas de infeÃ§Ã£o</h3><p> A imunidade de grupo ocorre quando uma grande parte de uma comunidade (o grupo) se torna imune a uma doenÃ§a, tornando improvÃ¡vel a propagaÃ§Ã£o da doenÃ§a de pessoa para pessoa. GraÃ§as Ã  &quot;imunidade de grupo&quot;, muitas pessoas nÃ£o vÃªem a necessidade de vacinaÃ§Ã£o. Desde que uma grande maioria de pessoas esteja imunizada numa populaÃ§Ã£o, a minoria nÃ£o imunizada tambÃ©m estarÃ¡ protegida. Isto Ã© importante porque hÃ¡ uma parte da populaÃ§Ã£o - bebÃ©s, mulheres grÃ¡vidas, idosos e pessoas com sistemas imunitÃ¡rios enfraquecidos - que por vezes nÃ£o pode receber vacinas. No entanto, suponhamos que muitas pessoas nÃ£o se vacinam nem vacinam os seus filhos. Nesse caso, a &quot;imunidade de grupo&quot; desaparece, abrindo oportunidades para que os vÃ­rus e as bactÃ©rias se estabeleÃ§am e se espalhem. Com tantas pessoas resistentes, uma doenÃ§a infecciosa nunca terÃ¡ hipÃ³tese de se estabelecer e propagar. </p><p> AlÃ©m disso, as viagens internacionais transportam muitas vezes uma doenÃ§a do estrangeiro e um indivÃ­duo nÃ£o vacinado corre um risco muito maior de ficar doente ou as pessoas que foram infectadas durante a viagem. O aumento da incidÃªncia do sarampo ilustra este facto nos EUA nos Ãºltimos anos. Enquanto existirem doenÃ§as, corremos o risco de ser infectados. </p><section class="e-card"><h4 class="mt-0">ReferÃªncias</h4><ul class="text-sm break-all"><li><a href="https://www.cdc.gov/mmwr/volumes/68/wr/mm6819a4.htm" target="_blank" rel="noopener noreferrer">https://www.cdc.gov/mmwr/volumes/68/wr/mm6819a4.htm</a></li><li><a href="https://bmcpublichealth.biomedcentral.com/articles/10.1186/s12889-021-10652-9" target="_blank" rel="noopener noreferrer">https://bmcpublichealth.biomedcentral.com/articles/10.1186/s12889-021-10652-9</a></li></ul></section>',13),vt=e("a",{href:"https://www.who.int/emergencies/diseases/novel-coronavirus-2019/media-resources/science-in-5/episode-8---myth-vs-science",target:"_blank",rel:"noopener noreferrer"}," WHO - Myth vs Science ",-1);function kt(h,c){const l=v,d=k,r=f,n=g;return o(),u("div",ya,[t(l,{class:"w-full lg:max-w-xs print:hidden"}),e("section",ja,[t(d,{name:"openmoji:scientist-medium-dark-skin-tone",class:"float-right text-[5em]"}),xa,qa,e("section",Va,[Sa,Aa,Ia,Ma,t(r,{src:"https://evidence.onkel.ee/assets/viruses-01__bacteria-vs-virus.webp",credits:"Fonte: https://inducoat.com/?attachment_id=24945&lang=en",elevated:!0},{caption:s(()=>[Da,a(" DiferenÃ§as estruturais entre vÃ­rus e bactÃ©rias ")]),_:1}),za,t(n,{class:"mb-8"},{default:s(()=>[a(" Os antibiÃ³ticos podem ajudar o sistema imunolÃ³gico a eliminar infeÃ§Ãµes bacterianas, mas sÃ£o inÃºteis contra infeÃ§Ãµes virais. Os fÃ¡rmacos antivirais funcionam de forma diferente dos antibiÃ³ticos e atualmente sÃ³ sÃ£o eficazes contra algumas doenÃ§as virais, tais como a gripe, herpes, hepatite B e C, e HIV. InfeÃ§Ãµes virais podem ser muito mais difÃ­ceis de matar do que infeÃ§Ãµes bacterianas porque o vÃ­rus vai para as cÃ©lulas humanas. O sistema imunolÃ³gico pode por vezes matar as cÃ©lulas infetadas antes que o vÃ­rus se reproduza. No entanto, Ã  medida que o vÃ­rus se reproduz, muitas vezes mata a cÃ©lula infetada explodindo, o que permite que o vÃ­rus se espalhe para outras cÃ©lulas do corpo. ")]),_:1}),Oa]),Ca,e("section",Fa,[Na,$a,Pa,Ba,t(r,{src:"https://evidence.onkel.ee/assets/viruses-03.webp",credits:"Fonte: https://www.nytimes.com/2020/03/13/health/soap-coronavirus-handwashing-germs.html",elevated:!0},{caption:s(()=>[Ta,a(" Para cada novo antigÃ©nio, o nosso corpo precisa de construir um anticorpo especÃ­fico. ")]),_:1}),Ea,Ra,Ha,t(r,{src:"https://evidence.onkel.ee/assets/viruses-04.webp",credits:"Fonte: https://www.who.int/news-room/feature-stories/detail/how-do-vaccines-work",elevated:!0},{caption:s(()=>[Wa,a(" Desenvolvimento de anticorpos atravÃ©s da vacinaÃ§Ã£o ")]),_:1}),Ka]),Ya,e("section",Ua,[Ja,La,Qa,Ga,e("div",Xa,[t(r,{src:"https://evidence.onkel.ee/assets/viruses-06__mask-01.webp"},{caption:s(()=>[a(" MÃ¡scara cirÃºrgica ")]),_:1}),t(r,{src:"https://evidence.onkel.ee/assets/viruses-06__mask-02.webp",caption:""},{caption:s(()=>[a(" MÃ¡scara FFP2 (respirador) ")]),_:1}),t(r,{src:"https://evidence.onkel.ee/assets/viruses-06__mask-03.webp"},{caption:s(()=>[a(" MÃ¡scara FFP3 (respirador) com vÃ¡lvula ")]),_:1}),t(r,{src:"https://evidence.onkel.ee/assets/viruses-06__mask-04.webp"},{caption:s(()=>[a(" MÃ¡scara de filtragem ")]),_:1})]),Za,t(n,{class:"my-8",theme:"sky-500",icon:"material-symbols:edit-document"},{default:s(()=>[et]),_:1})]),at,e("section",tt,[st,e("div",it,[t(r,{src:"https://evidence.onkel.ee/assets/viruses-07.webp",credits:"Fonte: https://www.nytimes.com/2020/03/13/health/soap-coronavirus-handwashing-germs.html"},{caption:s(()=>[rt,a(" MolÃ©culas de sabÃ£o a destruir o vÃ­rus ")]),_:1}),t(r,{src:"https://evidence.onkel.ee/assets/viruses-08.webp",credits:"Fonte: https://www.nytimes.com/2020/03/13/health/soap-coronavirus-handwashing-germs.html"},{caption:s(()=>[nt,a(" Micela composta por molÃ©culas de sabÃ£o e fragmento de vÃ­rus ")]),_:1})]),ot]),lt,e("section",dt,[ct,t(n,{class:"my-8",theme:"sky-500",icon:"material-symbols:edit-document"},{default:s(()=>[mt]),_:1}),ut,t(n,{class:"my-8",theme:"sky-500",icon:"material-symbols:edit-document"},{default:s(()=>[ht]),_:1}),pt,t(n,{class:"my-8",theme:"sky-500",icon:"material-symbols:edit-document"},{default:s(()=>[a(" Mais mitos COVID-19 e investigaÃ§Ã£o cientÃ­fica relacionada podem ser encontrados a partir de: "),vt]),_:1})])])])}const ft=b(_a,[["render",kt]]),gt={},bt={class:"flex flex-col items-start lg:flex-row-reverse lg:justify-end xl:gap-10 2xl:gap-20"},wt={class:"e-article",lang:"sv",style:{hyphens:"auto"}},_t=e("h1",{class:"mb-0"},"Virus",-1),yt=e("h5",{class:"font-normal uppercase leading-tight"},"Vetenskaplig bakgrundsinformation",-1),jt={id:"s1"},xt=e("h2",{id:"s1t"},"1. Virus kontra bakterier",-1),qt=e("p",{class:"font-bold"},"Bakterier och virus kan orsaka mÃ¥nga vanliga infektioner. Men vad Ã¤r skillnaden mellan dessa tvÃ¥ typer av smittsamma organismer?",-1),Vt=e("p",null,[e("span",{class:"e-term font-Heading"},"Bakterier"),a(" Ã¤r smÃ¥ mikroorganismer som bestÃ¥r av en enda cell. De Ã¤r vÃ¤ldigt olika och kan ha mÃ¥nga former och strukturella egenskaper. Bakterier kan leva i nÃ¤stan alla tÃ¤nkbara miljÃ¶er, inklusive i eller pÃ¥ mÃ¤nniskokroppen. Endast en handfull bakterier orsakar infektioner hos mÃ¤nniskor. Dessa bakterier kallas patogena bakterier.")],-1),St=e("p",null,[e("span",{class:"e-term font-Heading"},"Virus"),a(" Ã¤r en annan typ av smÃ¥ mikroorganismer, till och med mindre Ã¤n bakterier. Liksom bakterier Ã¤r de vÃ¤ldigt olika och har en mÃ¤ngd olika former och egenskaper. Virus Ã¤r parasitÃ¤ra. Det betyder att de krÃ¤ver levande celler eller vÃ¤vnad att vÃ¤xa i. Virus kan invadera cellerna i din kropp och anvÃ¤nda komponenterna i dina celler fÃ¶r att vÃ¤xa och fÃ¶rÃ¶ka sig. Vissa virus dÃ¶dar till och med vÃ¤rdceller som en del av deras livscykel. Skillnader mellan virus och bakterier kan ses i figur 1 och finns i tabell 1.")],-1),At=e("b",null,"Figur 1.",-1),It=i('<table class="mt-20"><caption class="text-left pb-4"><b>Tabell 1.</b> Skillnader mellan bakterier och virus</caption><thead><tr><th></th><th>Bakterie</th><th>Virus</th></tr></thead><tbody><tr><th class="align-baseline"> Levande </th><td><b>Levande organism.</b><br>Bakterier Ã¤r levande organismer med en enda cell som kan generera energi, rÃ¶ra sig och fÃ¶rÃ¶ka sig (vanligtvis genom enkel celldelning). Detta gÃ¶r att bakterier kan leva pÃ¥ mÃ¥nga stÃ¤llen â€“ jord, vatten, vÃ¤xter och mÃ¤nniskokroppen â€“ och tjÃ¤na mÃ¥nga syften.<br>Bakterier inkluderar bÃ¥de parasiter och icke-parasiter. </td><td><b>Icke levande.</b><br>Virus vÃ¤xer och fortplantar sig bara inuti vÃ¤rdcellerna som infekteras. NÃ¤r virus hittas utanfÃ¶r dessa levande celler Ã¤r virus vilande. Deras &quot;liv&quot; krÃ¤ver dÃ¤rfÃ¶r kapning av en levande cells biokemiska aktiviteter.<br>Alla virus Ã¤r intracellulÃ¤ra parasiter. </td></tr><tr><th class="align-baseline">Antal celler</th><td>Encellig, en cell</td><td>Inga celler, inte levande</td></tr><tr><th class="align-baseline">Fortplantning</th><td>En modercell delas upp i tvÃ¥ identiska dotterceller</td><td>Invaderar en vÃ¤rdcell och tar Ã¶ver cellen och gÃ¶r kopior av virusets DNA/RNA. FÃ¶rstÃ¶r vÃ¤rdcellen och slÃ¤pper ut nya virus</td></tr><tr><th class="align-baseline">Storlek</th><td>Bakterier Ã¤r mycket stÃ¶rre Ã¤n virus, frÃ¥n 800 nm till 1000 nm. Bakterier kan ses i ljusmikroskop.</td><td>Storleken pÃ¥ virus Ã¤r mellan 20 nm och 400 nm. Virus Ã¤r bara synliga i elektronmikroskop.</td></tr><tr><th class="align-baseline">Nytta</th><td class="align-baseline">Vissa bakterier kan vara nyttiga, t.ex. vissa bakterier behÃ¶vs i tarmen.</td><td>Virus Ã¤r inte nyttiga fÃ¶r kroppen. Virus kan vara till hjÃ¤lp vid genteknik.</td></tr><tr><th class="align-baseline">Infektion</th><td>Bakteriell infektion Ã¤r vanligtvis begrÃ¤nsad till en del av kroppen, beskriven som en lokaliserad infektion. Infektioner kan orsakas av bakterier eller av toxiner (endotoxiner) som produceras.</td><td>En virusinfektion Ã¤r systemisk (som drabbar hela kroppen). Virus infekterar en vÃ¤rdcell och fÃ¶rÃ¶kar sig i tusental, lÃ¤mnar vÃ¤rdcellen och infekterar andra kroppsceller.</td></tr><tr><th class="align-baseline">Sjukdom</th><td>Bakteriesjukdomar inkluderar lunginflammation, tuberkulos, stelkramp och matfÃ¶rgiftning.</td><td>Systemiska sjukdomar orsakade av virusinfektion inkluderar influensa, mÃ¤ssling, polio, AIDS och covid-19.</td></tr><tr><th class="align-baseline">Behandling</th><td>Antibiotika och vacciner fÃ¶rebygger sjukdomen.</td><td>Vacciner fÃ¶rhindrar spridningen och antivirala lÃ¤kemedel hjÃ¤lper till att bromsa reproduktionen men kan inte stoppa den helt.</td></tr></tbody></table>',1),Mt=i(`<section class="e-card"><h4 class="mt-4">Referenser</h4><ul class="text-sm break-all"><li><a href="https://courses.lumenlearning.com/suny-biology2xmaster/chapter/prevention-and-treatment-of-viral-infections/">https://courses.lumenlearning.com/suny-biology2xmaster/chapter/prevention-and-treatment-of-viral-infections/</a></li><li><a href="https://bodell.mtchs.org/OnlineBio/BIOCD/text/chapter16">https://bodell.mtchs.org/OnlineBio/BIOCD/text/chapter16</a></li><li><a href="
                            http://www.hcrowder.com/disease-reading.html"> http://www.hcrowder.com/disease-reading.html</a></li></ul></section>`,1),Dt=i('<hr class="mt-10 mb-40"><section id="s2"><h2 id="s2t">2. VarfÃ¶r dÃ¶dar inte antibiotika virus?</h2><p>Antibiotika riktar in sig pÃ¥ tillvÃ¤xtmaskineriet i bakterier (inte virus) fÃ¶r att dÃ¶da eller hÃ¤mma just dessa bakterier. Antibiotika kan inte dÃ¶da virus eftersom virus har en annan uppbyggnad Ã¤n bakterier och replikerar dÃ¤rfÃ¶r ocksÃ¥ annorlunda. Dessutom leder Ã¶veranvÃ¤ndning av antibiotika Ã¶ver hela vÃ¤rlden till Ã¶kningen av den globala <a href="https://www.drugs.com/article/antibiotic-resistance.html" target="_blank" rel="noopener noreferrer">antibiotikaresistensen</a>. Se Tabell 2 under vilka tillstÃ¥nd antibiotika kan vara till hjÃ¤lp (OBS! Beslutet om dess anvÃ¤ndning tas av behandlande lÃ¤kare).</p><table class="leading-tight e-card"><caption class="text-left pb-4"><b>Tabell 2.</b> Behov av antibiotika vid vanliga luftvÃ¤gsinfektioner </caption><thead class="border text-center"><tr><th rowspan="2" class="border p-1">Common respiÂ­ratory infections</th><th colspan="3" class="border p-1">Common cause</th><th rowspan="2" class="border p-1">Are<br>antiÂ­biotics needed</th></tr><tr><th class="border p-1">Virus</th><th class="border p-1">Virus or bacteria</th><th class="border p-1">Bacteria</th></tr></thead><tbody class="text-center"><tr><td class="border p-1">Common cold / runny nose</td><td class="border p-1">Yes</td><td class="border p-1"></td><td class="border p-1"></td><td class="border p-1">No</td></tr><tr><td class="border p-1">Sore throat (except strep)</td><td class="border p-1">Yes</td><td class="border p-1"></td><td class="border p-1"></td><td class="border p-1">No</td></tr><tr><td class="border p-1">COVID-19</td><td class="border p-1">Yes</td><td class="border p-1"></td><td class="border p-1"></td><td class="border p-1">No</td></tr><tr><td class="border p-1">Flu</td><td class="border p-1">Yes</td><td class="border p-1"></td><td class="border p-1"></td><td class="border p-1">No</td></tr><tr><td class="border p-1">Bronchitis / chest cold<br><span class="text-sm italic">(in otherwise healthy children and adults)</span> *</td><td class="border p-1"></td><td class="border p-1">Yes</td><td class="border p-1"></td><td class="border p-1">No *</td></tr><tr><td class="border p-1">Middle ear infection</td><td class="border p-1"></td><td class="border p-1">Yes</td><td class="border p-1"></td><td class="border p-1">Maybe</td></tr><tr><td class="border p-1">Sinus infection</td><td class="border p-1"></td><td class="border p-1">Yes</td><td class="border p-1"></td><td class="border p-1">Maybe</td></tr><tr><td class="border p-1">Strep throat</td><td class="border p-1"></td><td class="border p-1"></td><td class="border p-1">Yes</td><td class="border p-1">Yes</td></tr><tr><td class="border p-1">Whooping couch</td><td class="border p-1"></td><td class="border p-1"></td><td class="border p-1">Yes</td><td class="border p-1">Yes</td></tr></tbody><tfoot class="border text-center"><tr><td colspan="5" class="py-0 px-3"><p class="text-sm italic">* Studies shows that in otherwise healthy children and adults, antibiotics for bronchitis won&#39;t help patients feel better.</p><p class="text-xs text-slate-400">KÃ¤lla: https://www.cdc.gov/antibiotic-use/images/VirusOrBacteria-Original-1200by675.jpg</p></td></tr></tfoot></table><section class="e-card"><h4 class="mt-0">Referens</h4><ul class="text-sm break-all"><li><a href="https://www.drugs.com/article/antibiotics-and-viruses.html" target="_blank" rel="noopener noreferrer">https://www.drugs.com/article/antibiotics-and-viruses.html</a></li><li><a href="https://www.virology.ws/2009/10/19/ten-cool-facts-about-viruses/" target="_blank" rel="noopener noreferrer">https://www.virology.ws/2009/10/19/ten-cool-facts-about-viruses/</a></li></ul></section></section><hr class="mt-10 mb-40">',3),zt={id:"s3"},Ot=e("h2",{id:"s3t"},"3. Hur vacciner fungerar",-1),Ct=e("h3",null,"Kroppens naturliga svar",-1),Ft=e("p",null,[a("En "),e("span",{class:"e-term font-Heading"},"patogen"),a(" Ã¤r en bakterie, virus, parasit eller svamp som kan orsaka sjukdom i kroppen. Varje patogen bestÃ¥r av flera delar, vanligtvis unika fÃ¶r den specifika patogenen och sjukdom den orsakar. Den del av en patogen som orsakar bildandet av antikroppar kallas antigen. Antikropparna som produceras som svar pÃ¥ patogenens antigen Ã¤r vÃ¤sentliga fÃ¶r immunsystemet. Du kan betrakta antikroppar som soldaterna i din kropps fÃ¶rsvarssystem. Varje antikropp, eller soldat, i vÃ¥rt system, Ã¤r trÃ¤nad att kÃ¤nna igen ett specifikt antigen. Vi har tusentals olika antikroppar i vÃ¥ra kroppar. NÃ¤r mÃ¤nniskokroppen exponeras fÃ¶r ett antigen fÃ¶r fÃ¶rsta gÃ¥ngen tar det tid fÃ¶r immunsystemet att svara pÃ¥ och producera antikroppar specifika mot det antigenet (fig. 2).")],-1),Nt=e("p",null,"Antikroppar mot en patogen skyddar i allmÃ¤nhet inte mot en annan patogen fÃ¶rutom nÃ¤r tvÃ¥ patogener Ã¤r vÃ¤ldigt lika varandra, som kusiner. NÃ¤r de antigenspecifika antikropparna vÃ¤l har producerats arbetar de med resten av immunsystemet fÃ¶r att fÃ¶rstÃ¶ra patogenen och stoppa sjukdomen. NÃ¤r kroppen vÃ¤l producerar antikroppar i sitt primÃ¤ra svar pÃ¥ ett antigen, skapar den ocksÃ¥ antikroppsproducerande minnesceller, som fÃ¶rblir vid liv Ã¤ven efter att antikropparna besegrat patogenen. Anta att kroppen utsÃ¤tts fÃ¶r samma patogen mer Ã¤n en gÃ¥ng. I sÃ¥ fall Ã¤r antikroppssvaret mycket snabbare och mer effektivt Ã¤n fÃ¶rsta gÃ¥ngen eftersom minnescellerna Ã¤r redo att pumpa ut antikroppar mot det antigenet. Detta innebÃ¤r att om personen utsÃ¤tts fÃ¶r en farlig patogen i framtiden, kommer immunfÃ¶rsvaret att kunna reagera omedelbart och skydda personen mot sjukdomar.",-1),$t=e("b",null,"Figur 2.",-1),Pt=e("h3",null,"Hur hjÃ¤lper vacciner?",-1),Bt=e("p",null,"Vacciner minskar riskerna fÃ¶r att fÃ¥ en sjukdom genom att arbeta med din kropps naturliga fÃ¶rsvar fÃ¶r att bygga skydd. NÃ¤r du fÃ¥r ett vaccin svarar ditt immunfÃ¶rsvar.",-1),Tt=e("p",null,"Vaccin innehÃ¥ller fÃ¶rsvagade eller inaktiva delar av en viss organism (antigen) som utlÃ¶ser ett immunsvar i kroppen (fig. 3). Nyare vacciner innehÃ¥ller â€ritningenâ€ fÃ¶r att producera antigener snarare Ã¤n sjÃ¤lva antigenet. Oavsett om vaccinet bestÃ¥r av sjÃ¤lva antigenet eller ritningen sÃ¥ att kroppen ska producera antigenet, kommer denna fÃ¶rsvagade version inte att orsaka sjukdomen hos den som fÃ¥r vaccinet. Det kommer dock att fÃ¥ deras immunsystem att svara ungefÃ¤r som det skulle ha gjort pÃ¥ sin fÃ¶rsta reaktion pÃ¥ den faktiska patogenen.",-1),Et=e("b",null,"Figur 3.",-1),Rt=i('<p>Vaccin fungerar genom att introducera/utsÃ¤tta dina vita blodkroppar fÃ¶r det frÃ¤mmande proteinet i ett virus. NÃ¤r din kropp har stÃ¶tt pÃ¥ ett virus och byggt upp ett immunsvar (producerat B- och T-celler) mot viruset, sparas B- och T-celler sÃ¥ att om samma virus eller bakterier nÃ¥gonsin infekterar kroppen igen, kan immunsystemet snabbt komma igÃ¥ng och fÃ¶rhindra att patogenen gÃ¶r dig sjuk.</p><h3>Immunisering och relaterade utmaningar</h3><p>Vi har nu vacciner fÃ¶r att fÃ¶rhindra spridningen av mer Ã¤n 20 livshotande sjukdomar, vilket hjÃ¤lper mÃ¤nniskor i alla Ã¥ldrar att leva lÃ¤ngre och hÃ¤lsosammare liv. Immunisering fÃ¶rhindrar fÃ¶r nÃ¤rvarande 2-3 miljoner dÃ¶dsfall Ã¥rligen frÃ¥n sjukdomar som difteri, stelkramp, kikhosta, influensa och mÃ¤ssling.</p><p>Vi har vaccinationer mot mÃ¥nga allvarliga virusinfektioner (mÃ¤ssling, pÃ¥ssjuka, hepatit A, hepatit B och vissa virus â€“ som de som orsakar fÃ¶rkylning). Ã„ndÃ¥ kvarstÃ¥r problemet att virus kan mutera frÃ¥n en person till en annan. NÃ¤r viruset muterar fÃ¶rÃ¤ndras det tillrÃ¤ckligt mycket sÃ¥ att immunsystemet inte lÃ¤ngre kÃ¤nner igen det. Immuncellerna som lagras fÃ¶r att dÃ¶da viruset kÃ¤nner inte lÃ¤ngre igen det som samma sjukdom och vet inte hur de ska fÃ¶rgÃ¶ra det. Det Ã¤r sÃ¥ en infektion med ursprungligen samma men aningen muterat virus kan fortsÃ¤tta att undvika immunfÃ¶rsvaret. Vaccination mot dessa virus Ã¤r svÃ¥rt eftersom de redan har Ã¤ndrat sin uppbyggnad nÃ¤r vaccinerna utvecklas.</p><section class="e-card"><h4 class="mt-0">Referenser</h4><ul class="text-sm break-all"><li><a href="https://www.who.int/news-room/feature-stories/detail/how-do-vaccines-work" target="_blank" rel="noopener noreferrer">https://www.who.int/news-room/feature-stories/detail/how-do-vaccines-work</a></li><li><a href="https://www.nytimes.com/interactive/2020/health/pfizer-biontech-covid-19-vaccine.html" target="_blank" rel="noopener noreferrer">https://www.nytimes.com/interactive/2020/health/pfizer-biontech-covid-19-vaccine.html</a></li><li><a href="https://media.nature.com/original/magazine-assets/d41586-021-03552-w/d41586-021-03552-w.pdf" target="_blank" rel="noopener noreferrer">https://media.nature.com/original/magazine-assets/d41586-021-03552-w/d41586-021-03552-w.pdf</a></li><li><a href="https://opentextbc.ca/biology/chapter/12-1-viruses/" target="_blank" rel="noopener noreferrer">https://opentextbc.ca/biology/chapter/12-1-viruses/</a></li></ul></section>',5),Ht=i('<hr class="mt-10 mb-40"><section id="s4"><h2 id="s4t">4. Vaccinutveckling och vaccinsÃ¤kerhet</h2><h3>Utveckling</h3><p>Vaccinutveckling bÃ¶rjar vanligtvis i ett forskningslaboratorium belÃ¤get pÃ¥ ett universitet, vÃ¥rdcentral eller ett bioteknikfÃ¶retag. Under vaccinutvecklingsprocessen utvecklar forskare olika reagenser fÃ¶r att testa och mÃ¤ta deras effekt (eller brist pÃ¥ sÃ¥dan). Ofta behÃ¶vs flera Ã¥r av forskning fÃ¶r att hitta idÃ©er som fungerar.</p><p>Olika forskare eller forskargrupper kan arbeta mot samma mÃ¥l under vaccinutvecklingen. Arbetets framsteg presenteras i olika mÃ¶ten och refereegranskade (granskade av andra forskare) artiklar i tidskrifter. Om nÃ¥got arbete verkar lovande, kan lÃ¤kemedelsforskare vÃ¤nda sig till dem som arbetar med det fÃ¶r att utÃ¶ka sin forskning mot produktutveckling.</p><h3>Testning</h3><p>Om en lovande vaccinkandidat har hittats mÃ¥ste den testas pÃ¥ djur. Detta kallas den prekliniska fasen. FÃ¶rst anvÃ¤nds smÃ¥ djur som mÃ¶ss, rÃ¥ttor, kaniner och andra. Om vaccinkandidaten visar effekt pÃ¥ smÃ¥ djur, mÃ¥ste effekten vanligtvis bevisas pÃ¥ stÃ¶rre djur som apor. Om vaccinet utlÃ¶ser ett immunsvar testas det i tre faser i kliniska prÃ¶vningar pÃ¥ mÃ¤nniskor (WHO, 2021).</p><p>I fas 1 ges vaccinet till nÃ¥gra frivilliga fÃ¶r att bedÃ¶ma dess sÃ¤kerhet, bekrÃ¤fta att det genererar ett immunsvar och man behÃ¶ver bestÃ¤mma rÃ¤tt dos. Generellt i denna fas testas vacciner pÃ¥ en liten grupp unga, friska vuxna frivilliga.</p><p>I fas 2 ges vaccinet till flera hundra frivilliga fÃ¶r att bedÃ¶ma dess sÃ¤kerhet och fÃ¶rmÃ¥ga att ytterligare generera ett immunsvar. Deltagare i denna fas har samma egenskaper (sÃ¥som Ã¥lder och kÃ¶n) som de som vaccinet Ã¤r avsett fÃ¶r. Det finns vanligtvis flera fÃ¶rsÃ¶k i denna fas fÃ¶r att utvÃ¤rdera olika Ã¥ldersgrupper (Ã¤ldre, vuxna, barn). En grupp som inte fÃ¥r vaccinet brukar ocksÃ¥ inkluderas i bedÃ¶mningen om fÃ¶rÃ¤ndringarna i den vaccinerade gruppen tillskrivs vaccinet eller har skett av en slump.</p><p>I fas 3 ges vaccinet till tusentals frivilliga â€“ jÃ¤mfÃ¶rt med en liknande grupp mÃ¤nniskor som inte fick vaccinet utan fick placebo. Detta syftar till att avgÃ¶ra om vaccinet Ã¤r effektivt mot sjukdomen det Ã¤r designat fÃ¶r att skydda mot. Det syftar ocksÃ¥ till att studera dess sÃ¤kerhet i en mycket stÃ¶rre grupp mÃ¤nniskor. Fas 3-prÃ¶vningar genomfÃ¶rs ofta Ã¶ver flera lÃ¤nder och platser inom ett land fÃ¶r att sÃ¤kerstÃ¤lla att resultaten av vaccinets prestanda gÃ¤ller mÃ¥nga olika populationer.</p><p>Under fas 2- och 3-prÃ¶vningar vet inte de frivilliga och inte heller forskarna som genomfÃ¶r studien vilka frivilliga som hade fÃ¥tt det vaccin som testas eller en placebo. Detta kallas &quot;blindning&quot; och Ã¤r nÃ¶dvÃ¤ndigt fÃ¶r att sÃ¤kerstÃ¤lla att varken frivilliga eller forskarna pÃ¥verkas i sin bedÃ¶mning av effektivitet eller sÃ¤kerhet genom att veta vem som fick vilken produkt.</p><section class="e-card"><h4 class="mt-0">Referens</h4><ul class="text-sm break-all"><li><a href="https://www.who.int/news-room/feature-stories/detail/how-are-vaccines-developed" target="_blank" rel="noopener noreferrer">https://www.who.int/news-room/feature-stories/detail/how-are-vaccines-developed</a></li></ul></section><h3>Auktorisation och Ã¶vervakning</h3><p>NÃ¤r resultaten av alla dessa kliniska prÃ¶vningar Ã¤r tillgÃ¤ngliga krÃ¤vs en rad steg. TjÃ¤nstemÃ¤n vid Europeiska lÃ¤kemedelsmyndigheten och senare i varje land granskar noggrant studiedata och beslutar om vaccinet ska godkÃ¤nnas. Alla fÃ¶rsÃ¶k mÃ¥ste vara korrekt utfÃ¶rda och vÃ¤ldokumenterade. Ett vaccin mÃ¥ste bevisas sÃ¤kert och effektivt i en bred population innan det godkÃ¤nns. Ribban fÃ¶r vaccinets sÃ¤kerhet och effektivitet Ã¤r exceptionellt hÃ¶g. Detta inkluderar granskning av effektivitet och sÃ¤kerhet fÃ¶r godkÃ¤nnanden av regulatoriska och folkhÃ¤lsopolicyer.</p><p>Ytterligare Ã¶vervakning av sÃ¤kerhet och effektivitet sker under anvÃ¤ndningen av vacciner. Detta gÃ¶r det mÃ¶jligt fÃ¶r forskare att hÃ¥lla reda pÃ¥ vaccinets effekt och sÃ¤kerhet Ã¤ven om de anvÃ¤nds av mÃ¥nga mÃ¤nniskor under en lÃ¥ng tidsram. Dessa data anvÃ¤nds fÃ¶r att justera policyerna fÃ¶r vaccinanvÃ¤ndning.</p><section class="e-card"><h4 class="mt-0">Referens</h4><ul class="text-sm break-all"><li><a href="https://www.worldscientific.com/doi/pdf/10.1142/S2529732521400034" target="_blank" rel="noopener noreferrer">https://www.worldscientific.com/doi/pdf/10.1142/S2529732521400034</a></li></ul></section></section><hr class="mt-10 mb-40">',3),Wt={id:"s5"},Kt=e("h2",{id:"s5t"},"5. Ansiktsmasker mot virus och bakterier",-1),Yt=e("p",null,"Ansiktsmasker anvÃ¤nds ofta fÃ¶r att skydda mot virus och bakterier. Dess anvÃ¤ndning har Ã¶kat betydligt eftersom de anvÃ¤ndes som skydd mot SARS-CoV-2-viruset Bland olika typer av ansiktsmasker Ã¤r kirurgiska ansiktsmasker bland de mest anvÃ¤nda ansiktsskydden i COVID-19-pandemin. Vanligtvis Ã¤r de blÃ¥fÃ¤rgade frÃ¥n ena sidan, vilket Ã¤r det yttre lagret (fig. 4). Huvudsyftet med kirurgiska ansiktsmasker Ã¤r att skydda patienter frÃ¥n potentiell kontakt med bakterier och virus som andas ut av bÃ¤raren. De fÃ¶rhindrar spridningen vÃ¤l av coronaviruset genom luften men Ã¤r mindre effektivt pÃ¥ att skydda bÃ¤raren frÃ¥n viruset.",-1),Ut=e("p",null,"FFP2- eller FFP3-masker (ofta kallade andningsskydd) bÃ¶r anvÃ¤ndas fÃ¶r att filtrera och bÃ¤ttre andas in luft. Numreringssystemet (FFP1, FPP2, FFP3) indikerar dessa enheters filtreringseffektivitet (certifierade enligt EN 149-2001-standarden). FFP2 och FPP3 har en filtreringseffektivitet fÃ¶r luftburna partiklar (inklusive de som innehÃ¥ller viruset) pÃ¥ 92 % respektive 98 %. BÃ¥da maskerna har Ã¤ven litet inÃ¥tlÃ¤ckage: <8% respektive <2%. I FFP2 anvÃ¤nds ofta specialgummi pÃ¥ andningsskyddets yttre skikt. Om en ventil (som underlÃ¤ttar utandning) i yrkesmiljÃ¶er har tillÃ¥tits, i fallet med SARS-CoV-2, bÃ¶r endast andningsskydd utan ventil anvÃ¤ndas fÃ¶r att Ã¤ven filtrera utandningsluft.",-1),Jt=e("p",null,"Med covid-19-pandemin har en ny ansiktsmask introducerats: filtreringsmasken. Denna typ av mask Ã¤r gjord av flerskiktstyg (det mÃ¥ste vara ett nanofiberfilter som garanterar en bakteriell och skadlig finfilterkapacitet pÃ¥ minst 90%). Denna mask kombinerar hÃ¶g filtreringskapacitet med Ã¥teranvÃ¤ndbarhet dÃ¥ den kan tvÃ¤ttas i maskin i 60 grader.",-1),Lt={class:"grid gap-3 my-15 md:grid-cols-2 e-card"},Qt=i('<p><i><b>Figur 4</b>. Olika typer av ansiktsmasker</i></p><p>Ansiktsmaskernas effektivitet har testats i speciella laboratorier, t.ex. i exponeringskammaren. I dessa studier, bÃ¤r en person pÃ¥ virus. DÃ¤refter fyller partikelkoncentrationerna bakom partikelgeneratorn exponeringskammaren med smÃ¥ partiklar; i likhet med aerosoler mÃ¤ts maskerna och jÃ¤mfÃ¶rs med koncentrationen i den allmÃ¤nna atmosfÃ¤ren i exponeringskammaren.</p><p>Det starkaste beviset Ã¤r dock baserat pÃ¥ epidemiologiska data frÃ¥n verkliga situationer. Till exempel avtar den dagliga tillvÃ¤xttakten fÃ¶r COVID-19 efter krav pÃ¥ ansiktsmask i 15 delstater och District of Columbia i USA. En annan studie undersÃ¶kte dÃ¶dsfall i coronavirus i 198 lÃ¤nder och fann att de med kulturella normer eller regeringspolitik som gynnar anvÃ¤ndning av ansiktsmasker hade lÃ¤gre dÃ¶dsfrekvens.</p><p>MÃ¥nga Facebook- och sociala medieranvÃ¤ndare har delat vilseledande inlÃ¤gg dÃ¤r det antyds att lÃ¥ngvarig anvÃ¤ndning av ansiktsmasker orsakar syrebrist i kroppen â€“ hypoxi. Ã„ndÃ¥ antyder forskningsartiklar och experter att sÃ¥dana symtom Ã¤r osannolikt fÃ¶rekommande hos de flesta mÃ¤nniskor om inte bÃ¤raren har redan existerande luftvÃ¤gssjukdomar som astma eller kronisk obstruktiv lungsjukdom (KOL). Risken fÃ¶r hypoxi och hyperkapni (att ha fÃ¶r mycket koldioxid i blodomloppet) Ã¤r osannolik med tyg- och kirurgiska ansiktsmasker eftersom de inte sitter tÃ¤tt. Ã„ndÃ¥ varnas det fÃ¶r att ansiktsmasker inte ska placeras pÃ¥ smÃ¥ barn under tvÃ¥ Ã¥r, de med andningssvÃ¥righeter eller vid trÃ¤ning.</p><section class="e-card"><h4 class="mt-0">Referenser</h4><ul class="text-sm break-all"><li><a href="https://bmcpublichealth.biomedcentral.com/articles/10.1186/s12889-021-10652-9" target="_blank" rel="noopener noreferrer">https://bmcpublichealth.biomedcentral.com/articles/10.1186/s12889-021-10652-9</a></li><li><a href="https://jamanetwork.com/journals/jamainternalmedicine/fullarticle/2774266" target="_blank" rel="noopener noreferrer">https://jamanetwork.com/journals/jamainternalmedicine/fullarticle/2774266</a></li><li><a href="https://www.healthaffairs.org/doi/10.1377/hlthaff.2020.00818" target="_blank" rel="noopener noreferrer">https://www.healthaffairs.org/doi/10.1377/hlthaff.2020.00818</a></li><li><a href="https://www.ajtmh.org/view/journals/tpmd/103/6/article-p2400.xml" target="_blank" rel="noopener noreferrer">https://www.ajtmh.org/view/journals/tpmd/103/6/article-p2400.xml</a></li><li><a href="https://www.epa.gov/sciencematters/epa-researchers-test-effectiveness-face-masks-disinfection-methods-against-covid-19" target="_blank" rel="noopener noreferrer">https://www.epa.gov/sciencematters/epa-researchers-test-effectiveness-face-masks-disinfection-methods-against-covid-19</a></li><li><a href="https://journals.asm.org/doi/full/10.1128/mSphere.00637-20" target="_blank" rel="noopener noreferrer">https://journals.asm.org/doi/full/10.1128/mSphere.00637-20</a></li><li><a href="https://pubmed.ncbi.nlm.nih.gov/33626065/" target="_blank" rel="noopener noreferrer">https://pubmed.ncbi.nlm.nih.gov/33626065/</a></li></ul></section>',5),Gt=e("div",null,[e("h3",{class:"mt-6 pt-3 mb-10"},"FÃ¶r elever att studera vidare"),e("ul",{class:"leading-tight break-all"},[e("li",null,[e("a",{href:"https://drive.google.com/file/d/1ziN9u4ukz-FZR3jz5JSBxZPSnnBzZgWK/view?usp=drive_link",target:"_blank",rel:"noopener noreferrer"},"https://drive.google.com/file/d/1ziN9u4ukz-FZR3jz5JSBxZPSnnBzZgWK/view?usp=drive_link"),a(" - om effektiviteten hos maskerna fÃ¶r att filtrera partiklar ")]),e("li",null,[e("a",{href:"https://drive.google.com/file/d/1ZXOhGczMUQ4Ec5spEjx24MYcRj4GR1xz/view?usp=drive_link",target:"_blank",rel:"noopener noreferrer"},"https://drive.google.com/file/d/1ZXOhGczMUQ4Ec5spEjx24MYcRj4GR1xz/view?usp=drive_link"),a(" - om maskernas effektivitet fÃ¶r att fÃ¶rebygga sjukdomar ")]),e("li",null,[e("a",{href:"https://www.fda.gov/medical-devices/personal-protective-equipment-infection-control/n95-respirators-surgical-masks-face-masks-and-barrier-face-coverings#s3",target:"_blank",rel:"noopener noreferrer"},"https://www.fda.gov/medical-devices/personal-protective-equipment-infection-control/n95-respirators-surgical-masks-face-masks-and-barrier-face-coverings#s3")]),e("li",null,[e("a",{href:"https://www.sciencedirect.com/science/article/pii/S2452199X20301481",target:"_blank",rel:"noopener noreferrer"},"https://www.sciencedirect.com/science/article/pii/S2452199X20301481")]),e("li",null,[e("a",{href:"https://www.weforum.org/agenda/2020/10/covid-19-coronavirus-disease-size-compairson-zika-health-air-pollution/",target:"_blank",rel:"noopener noreferrer"},"https://www.weforum.org/agenda/2020/10/covid-19-coronavirus-disease-size-compairson-zika-health-air-pollution/")])])],-1),Xt=e("hr",{class:"mt-10 mb-40"},null,-1),Zt={id:"s6"},es=i('<h2 id="s6t">6. Virus och handhygien</h2><h3>Handdesinfektionsmedel eller tvÃ¥l?</h3><p>VÃ¥ra hÃ¤nder kan vara en viktig faktor fÃ¶r Ã¶verfÃ¶ring av infektioner. NÃ¤r alkoholbaserade handdesinfektionsmedel och tvÃ¥l appliceras pÃ¥ hÃ¤nderna och noggrant <a href="https://www.cdc.gov/handwashing/when-how-handwashing.html" target="_blank" rel="noopener noreferrer">skrubbas i minst 20 sekunder</a>, kommer de att stoppa coronaviruset. TvÃ¥l stÃ¶r dock det klibbiga bandet mellan patogener och din hud, vilket gÃ¶r att patogenerna kan direkt glida av huden. Du neutraliserar inte bara viruset, utan du fÃ¥r ocksÃ¥ fysiskt bort det frÃ¥n dina hÃ¤nder. Att utÃ¶va god handhygien Ã¤r en enkel fÃ¶rebyggande strategi som de flesta kan genomfÃ¶ra utan problem, och mÃ¥nga studier har visat effektiviteten av handhygien fÃ¶r att fÃ¶rhindra Ã¶verfÃ¶ring av smittsamma patogener, inklusive coronavirus som SARS-CoV-2.</p><section class="e-card"><h4 class="mt-0">Referens</h4><ul class="text-sm break-all"><li><a href="https://www.uchealth.org/today/why-soap-and-water-work-better-than-hand-sanitizer-to-remove-the-coronavirus/" target="_blank" rel="noopener noreferrer">https://www.uchealth.org/today/why-soap-and-water-work-better-than-hand-sanitizer-to-remove-the-coronavirus/</a></li></ul></section><h3>FÃ¶rsvaga coronaviruset med tvÃ¥l</h3><p>Coronaviruset har fÃ¥tt sitt namn frÃ¥n de koronaliknande â€proteinspikarâ€ som Ã¤r inbÃ¤ddade pÃ¥ virusets yta. â€Spikarnaâ€, som Ã¤r ansvariga fÃ¶r att infektera vÃ¤rden, Ã¤r fÃ¶rankrade i ett membran. Membranet Ã¤r virusets &quot;skal&quot; och virusets svaga punkt.</p><p>TvÃ¥lens molekyler har tvÃ¥ kemiskt distinkta delar: ett hydrofilt (â€vattenÃ¤lskandeâ€) &#39;huvud&#39; och en hydrofob (â€vattenhatandeâ€) &#39;svans&#39;. Huvudet hjÃ¤lper tvÃ¥len att blandas med vatten, medan svansen kan interagera med andra hydrofoba molekyler som lipider.</p><p>Lyckligtvis bestÃ¥r coronavirusets membran huvudsakligen av lipidmolekyler. De hÃ¥lls samman av svaga kemiska interaktioner mellan enskilda molekyler. De hydrofoba (vattenhatande) &quot;svansarna&quot; av tvÃ¥lens molekyler kan bryta interaktionerna mellan lipidmolekylerna i coronavirusmembranet (se fig. 5).</p><p>TvÃ¥lens svans kan stÃ¶ra de svaga interaktionerna mellan lipidmolekyler i membranet och slita isÃ¤r det. Antag att viruset bryts upp innan det skyddas sÃ¤kert i en vÃ¤rdcell. I sÃ¥ fall kommer det inte lÃ¤ngre att kunna spridas till andra celler. TvÃ¥lmolekyler omger sedan virusfragmentet med alla svansar vÃ¤nda inÃ¥t. Detta kluster kallas en micell (se fig. 6). De utÃ¥tvÃ¤nda hydrofila huvudena gÃ¶r att micellen kan skÃ¶ljas ner i avloppet med vatten. Att tvÃ¤tta hÃ¤nderna med enbart vatten rÃ¤cker inte.</p>',9),as={class:"grid gap-2 md:grid-cols-2 e-card"},ts=e("b",null,"Figur 5.",-1),ss=e("b",null,"Figur 6.",-1),is=i('<p>Den givna informationen gÃ¤ller Ã¤ven fÃ¶r andra hÃ¶ljefÃ¶rsedda virus (influensa, hepatit B och C och Ebolavirus) eftersom deras hÃ¶lje bestÃ¥r av fosfolipider.</p><section class="e-card"><h4 class="mt-0">Referens</h4><ul class="text-sm break-all"><li><a href="https://www.science.org.au/curious/people-medicine/hand-sanitiser-or-soap-making-informed-choice-covid-19" target="_blank" rel="noopener noreferrer">https://www.science.org.au/curious/people-medicine/hand-sanitiser-or-soap-making-informed-choice-covid-19</a></li></ul></section><h3>Att vÃ¤lja handsprit</h3><p>VÃ¤rldshÃ¤lsoorganisationen (WHO) rekommenderar alkoholbaserade handdesinfektionsmedel om du inte har tvÃ¥l till hands.</p><p><b>Alkoholbaserade handdesinfektionsmedel tros fungera genom att fÃ¶rhindra normal funktionalitet hos proteiner frÃ¥n mikrober â€“ inklusive bakterier och vissa virus. Handdesinfektionsmedel med hÃ¶g alkoholhalt kan ocksÃ¥ fÃ¶rstÃ¶ra lipidskalet som omger coronaviruset.</b> FÃ¶r att vara effektivt mÃ¥ste handsprit innehÃ¥lla minst 60 procent alkohol. Tillsatser i desinfektionsmedlet kan hindra alkoholen frÃ¥n att avdunsta fÃ¶r snabbt, vilket gÃ¶r att viruset kan drÃ¤nkas lÃ¤ngre.</p><p>Det finns dock vissa risker med att anvÃ¤nda alkoholbaserade handdesinfektionsmedel. Det finns en Ã¶kad risk fÃ¶r alkoholfÃ¶rgiftning hos barn, och frekvent anvÃ¤ndning av handsprit kan resultera i antimikrobiell resistens. Det finns alternativa alkoholfria handdesinfektionsmedel, dÃ¤r bensalkonium Ã¤r vanligast. Nyligen genomfÃ¶rda studier har visat att alkoholfritt handdesinfektionsmedel fungerar lika bra och inte orsakar den vÃ¤lbekanta svidande kÃ¤nslan man kÃ¤nner vid anvÃ¤ndande av alkoholhandsprit.</p><section class="e-card"><h4 class="mt-0">Referenser</h4><ul class="text-sm break-all"><li><a href="https://www.sciencedirect.com/science/article/abs/pii/S0048969720340833?via%3Dihub" target="_blank" rel="noopener noreferrer">https://www.sciencedirect.com/science/article/abs/pii/S0048969720340833?via%3Dihub</a></li><li><a href="https://www.journalofhospitalinfection.com/article/S0195-6701(20)30547-8/fulltext#secsectitle0040" target="_blank" rel="noopener noreferrer">https://www.journalofhospitalinfection.com/article/S0195-6701(20)30547-8/fulltext#secsectitle0040</a></li></ul></section>',7),rs=e("hr",{class:"mt-10 mb-40"},null,-1),ns={id:"s7"},os=i('<h2 id="s7t" class="mt-40 text-5xl">7. Vaccinmyter</h2><h3><span class="text-rose-400">Myt 1:</span> Vacciner orsakar autism/allvarliga biverkningar.</h3><p>Den utbredda rÃ¤dslan fÃ¶r att vacciner Ã¶kar risken fÃ¶r autism har sitt ursprung i en studie frÃ¥n 1997 publicerad av den brittiske kirurgen Andrew Wakefield. Artikeln publicerades i The Lancet, en prestigefylld medicinsk tidskrift, som tyder pÃ¥ att vaccinet mot mÃ¤ssling, pÃ¥ssjuka och rÃ¶da hund (MMR) Ã¶kade autism hos brittiska barn.</p><p>Uppsatsen har sedan dess misskrediterats grundligt pÃ¥ grund av allvarliga procedurfel, med endast 12 deltagare i studien, hemliga ekonomiska intressekonflikter och etiska krÃ¤nkningar. Andrew Wakefield fÃ¶rlorade sin medicinska licens och artikeln drogs tillbaka frÃ¥n The Lancet.</p><p>FÃ¶r nÃ¤rvarande, mot teorin om autism-vaccination, har flera studier nu identifierat symtom pÃ¥ autism hos barn lÃ¥ngt innan de fÃ¥r MMR-vaccinet. Dessutom ger ny forskning bevis fÃ¶r att autism utvecklas i livmodern, lÃ¥ngt innan ett barn fÃ¶ds eller fÃ¥r vaccinationer. Ingen av de senare studierna har rapporterat ett samband mellan nÃ¥got vaccin och sannolikheten fÃ¶r att utveckla autism.</p><section class="e-card"><h4 class="mt-0">Referenser</h4><ul class="text-sm break-all"><li><a href="https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(97)11096-0/fulltext" target="_blank" rel="noopener noreferrer">https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(97)11096-0/fulltext</a></li><li><a href="https://www.nejm.org/doi/full/10.1056/NEJMoa1307491?query=featured_home" target="_blank" rel="noopener noreferrer">https://www.nejm.org/doi/full/10.1056/NEJMoa1307491?query=featured_home</a></li></ul></section>',6),ls=e("div",null,[e("h3",{class:"mt-6 pt-3 mb-10"},"FÃ¶r ytterligare studier"),e("ul",{class:"leading-tight"},[e("li",null,[e("a",{href:"https://archive.cdc.gov/#/details?url=https://www.cdc.gov/coronavirus/2019-ncov/vaccines/expect/after.html",target:"_blank",rel:"noopener noreferrer"},"Possible Side Effects After Getting a COVID-19 Vaccine")]),e("li",null,[e("a",{href:"https://www.bbc.com/news/health-55932832",target:"_blank",rel:"noopener noreferrer"},"Study reveals extent of Covid vaccine side-effects")]),e("li",null,[e("a",{href:"https://www.nature.com/articles/d41586-021-00290-x",target:"_blank",rel:"noopener noreferrer"},"COVID vaccines and safety: what the research says")]),e("li",null,[e("a",{href:"https://health.clevelandclinic.org/covid-19-vaccine-side-effects/",target:"_blank",rel:"noopener noreferrer"},"Hereâ€™s What to Know About the COVID-19 Vaccine Side Effects")]),e("li",null,[e("a",{href:"https://www.historyofvaccines.org/content/articles/vaccine-side-effects-and-adverse-events",target:"_blank",rel:"noopener noreferrer"},"Vaccine Side Effects and Adverse Events")]),e("li",null,[e("a",{href:"https://www.bbc.com/news/health-56375307",target:"_blank",rel:"noopener noreferrer"},"Vaccine side effects: My experience of them and what they mean")]),e("li",null,[e("a",{href:"https://vk.ovg.ox.ac.uk/vk/vaccine-side-effects",target:"_blank",rel:"noopener noreferrer"},"Vaccine side effects and adverse reactions")]),e("li",null,[a("ğŸ“º"),e("a",{href:"https://www.youtube.com/watch?v=F6NKbQzo4aE",target:"_blank",rel:"noopener noreferrer"},"Vaccine side effects are actually a good thing")]),e("li",null,[a("ğŸ“º"),e("a",{href:"https://www.youtube.com/watch?v=Atrx1P2EkiQ",target:"_blank",rel:"noopener noreferrer"},"Vaccines and the Immune Response: How Vaccines Work")])])],-1),ds=i('<h3><span class="text-rose-400">Myt 2:</span> SpÃ¤dbarns immunsystem kan inte hantera flera vacciner</h3><p>Barn fÃ¥r vaccin i unga Ã¥r eftersom de lÃ¶per stÃ¶rst risk att bli sjuka eller dÃ¶ om de fÃ¥r dessa sjukdomar. Ã„ven nyfÃ¶dda barn Ã¤r immuna mot vissa sjukdomar (t.ex. vattkoppor) eftersom de fÃ¥r antikroppar frÃ¥n sina mÃ¶drar; denna immunitet varar bara nÃ¥gra mÃ¥nader. Dessutom fÃ¥r de flesta spÃ¤dbarn inte skyddande antikroppar mot difteri, kikhosta, polio, stelkramp, hepatit B eller Hib frÃ¥n sina mÃ¶drar.</p><p>FÃ¶r att minska antalet sprutor ett barn fÃ¥r vid ett lÃ¤karbesÃ¶k erbjuds vissa vacciner som en kombination (tvÃ¥ eller flera olika vacciner har kombinerats till en enda spruta). Exempel pÃ¥ kombinationsvaccin Ã¤r difteri-stelkramp-kikhosta (DTap) och mÃ¤ssling-pÃ¥ssjuka-rÃ¶da hund (MMR).</p><p>Vetenskapliga data visar att fÃ¥ flera vacciner samtidigt inte orsakar nÃ¥gra hÃ¤lsoproblem. SpÃ¤dbarns immunfÃ¶rsvar Ã¤r tuffare Ã¤n man tror. Baserat pÃ¥ antalet antikroppar som finns i blodet, skulle ett barn teoretiskt ha fÃ¶rmÃ¥ga att svara pÃ¥ ett mycket stÃ¶rre antal vacciner Ã¤n vad som nÃ¥gonsin anvÃ¤nts (frÃ¥gan Ã¤r om det skulle vara 1 000, 10 000 eller 100 000 pÃ¥ en gÃ¥ng). Ã„ven om alla ~10 (beroende pÃ¥ nationell vaccinationsplan) schemalagda vacciner gavs pÃ¥ en gÃ¥ng, skulle det bara anvÃ¤nda en brÃ¥kdel av ett barns immunfÃ¶rsvar. I verkligheten utsÃ¤tts spÃ¤dbarn fÃ¶r otaliga bakterier och virus varje dag, och immuniseringar Ã¤r fÃ¶rsumbara i jÃ¤mfÃ¶relse. Studier har inte heller visat att exponering fÃ¶r flera vacciner under de fÃ¶rsta 23 levnadsmÃ¥naderna skulle vara associerad med en Ã¶kad risk fÃ¶r infektioner som inte riktas mot vaccin.</p><section class="e-card"><h4 class="mt-0">Referenser</h4><ul class="text-sm break-all"><li><a href="https://www.nejm.org/doi/full/10.1056/NEJMoa1307491?query=featured_home" target="_blank" rel="noopener noreferrer">https://www.nejm.org/doi/full/10.1056/NEJMoa1307491?query=featured_home</a></li><li><a href="https://www.bmj.com/content/364/bmj.l1481/rr-11" target="_blank" rel="noopener noreferrer">https://www.bmj.com/content/364/bmj.l1481/rr-11</a></li><li><a href="https://pubmed.ncbi.nlm.nih.gov/11773551/" target="_blank" rel="noopener noreferrer">https://pubmed.ncbi.nlm.nih.gov/11773551/</a></li></ul></section><h3><span class="text-rose-400">Myt 3:</span> Immunitet fÃ¶rvÃ¤rvad genom en sjukdom Ã¤r bÃ¤ttre Ã¤n immunitet fÃ¶rvÃ¤rvad genom vaccination</h3><p>Det Ã¤r sant att en naturlig infektion nÃ¤stan alltid resulterar i en starkare immunitet mot sjukdomen Ã¤n en vaccination. Farorna med detta tillvÃ¤gagÃ¥ngssÃ¤tt Ã¶vervÃ¤ger dock vida de relativa fÃ¶rdelarna. Priset fÃ¶r immunitet efter naturlig infektion kan vara lunginflammation frÃ¥n vattkoppor eller pneumokocker, intellektuell funktionsnedsÃ¤ttning frÃ¥n Haemophilus influenzae typ b (Hib), fosterskador frÃ¥n rÃ¶da hund, levercancer frÃ¥n hepatit B-virus, dÃ¶d i mÃ¤ssling, etc. Om du Ã¶nskade fÃ¥ immunitet mot exempelvis mÃ¤ssling, genom att insjukna i sjukdomen, skulle du ha en chans pÃ¥ 500 att dÃ¶ av dina symtom. DÃ¤remot Ã¤r antalet personer som har haft svÃ¥ra allergiska reaktioner frÃ¥n ett MMR-vaccin mindre Ã¤n en pÃ¥ en miljon.</p><p>Ã„ndÃ¥ Ã¤r det en del vaccin som inducerar ett bÃ¤ttre immunsvar Ã¤n naturlig infektion. Till exempel innehÃ¥ller humant papillomvirus(HPV)-vaccinet en hÃ¶g renhet av det specifika proteinet, vilket leder till ett bÃ¤ttre immunsvar Ã¤n naturlig infektion. Andra exempel inkluderar stelkramp, Haemophilus influenzae typ b (Hib) och pneumokockvaccin.</p><p>NÃ¤r det gÃ¤ller covid-19 mÃ¥ste vissa saker klargÃ¶ras. Det har visat sig att ett permanent skydd efter infektion Ã¤r osannolikt. Ã„ven om coronapatienter fick &quot;avsevÃ¤rt immunminne&quot; som involverade alla fyra viktiga delar av immunsystemet: minnes B-celler, antikroppar, minnes CD4+ T-celler och minnes CD8+ T-celler, bÃ¶rjade skyddet minska efter ett halvÃ¥r. Dessutom har forskare pÃ¥visat en &quot;massiv dynamisk vidd&quot; i immunsvaret mellan individer, med en 200-faldig skillnad i antikroppsnivÃ¥er.</p><p>Andra studier har visat att frivilliga som fick Moderna-vaccinet (mRNA) hade fler antikroppar â€“ en markÃ¶r fÃ¶r immunsvar â€“ i blodet Ã¤n personer som hade varit sjuka med covid-19. Detta faktum kan dock modifieras av sjukdomens svÃ¥righetsgrad eftersom det finns en korrelation mellan sjukdomens svÃ¥righetsgrad och bestÃ¥ende immunsvar â€“ de flesta asymptomatiska patienter hade mycket fÃ¥ antikroppar efter sex mÃ¥naders infektion. SÃ¥ledes Ã¤r den naturliga immuniteten som genereras frÃ¥n en SARS-CoV-2-infektion ofta ofÃ¶rutsÃ¤gbar. Antikropparna som framkallades av mRNA-vaccinet riktade sig dessutom mot ett bredare spektrum av platser pÃ¥ den receptorbindande domÃ¤nen (RBD) Ã¤n de som framkallades av naturlig infektion.</p><section class="e-card"><h4 class="mt-0">Referenser</h4><ul class="text-sm break-all"><li><a href="https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(21)00675-9/fulltext" target="_blank" rel="noopener noreferrer">https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(21)00675-9/fulltext</a></li><li><a href="https://science.sciencemag.org/content/371/6529/eabf4063" target="_blank" rel="noopener noreferrer">https://science.sciencemag.org/content/371/6529/eabf4063</a></li><li><a href="https://www.nejm.org/doi/full/10.1056/NEJMc2032195" target="_blank" rel="noopener noreferrer">https://www.nejm.org/doi/full/10.1056/NEJMc2032195</a></li><li><a href="https://www.researchsquare.com/article/rs-612205/v1" target="_blank" rel="noopener noreferrer">https://www.researchsquare.com/article/rs-612205/v1</a></li><li><a href="https://stm.sciencemag.org/content/13/600/eabi9915" target="_blank" rel="noopener noreferrer">https://stm.sciencemag.org/content/13/600/eabi9915</a></li></ul></section><h3><span class="text-rose-400">Myt 4:</span> Vacciner innehÃ¥ller livshotande Ã¤mnen.</h3><p>MÃ¤nniskor Ã¤r oroade Ã¶ver fÃ¶rekomsten av formaldehyd, kvicksilver eller aluminium i vacciner. Ã… ena sidan Ã¤r dessa kemikalier giftiga fÃ¶r mÃ¤nniskokroppen i vissa nivÃ¥er. Ã… andra sidan kan endast smÃ¥ mÃ¤ngder av dessa kemikalier hittas i vacciner. Dessa mÃ¤ngder Ã¤r mindre Ã¤n vad vi fÃ¥r naturligt frÃ¥n nÃ¤ring eller den formaldehyd som produceras i hÃ¶gre hastighet av vÃ¥ra egna metabola system.</p><p>Vissa grundÃ¤mnen, sÃ¥som aluminiumsalter, tillsÃ¤tts i vacciner eftersom de fungerar som en adjuvans, vilket innebÃ¤r att deras nÃ¤rvaro Ã¶kar immunsvaret nÃ¤r du vaccineras. Dessutom innehÃ¥ller endast vissa vacciner aluminiumsalter, och nya covid-19-vacciner innehÃ¥ller dem inte alls. Ett fÃ¥tal vacciner har innehÃ¥llit tiomersal som konserveringsmedel; dock innehÃ¥ller inget av de vacciner som anvÃ¤nds till barn fÃ¶r nÃ¤rvarande detta. Tiomersal innehÃ¥ller etylkvicksilver, som snabbt avlÃ¤gsnas frÃ¥n mÃ¤nniskokroppen jÃ¤mfÃ¶rt med metylkvicksilver, som bioackumuleras â€“ sÃ¥ det Ã¤r ocksÃ¥ skillnad i vilken form den giftiga metallen finns. Ã„ndÃ¥ innehÃ¥ller covid-19-vaccin inte gifter.</p><section class="e-card"><h4 class="mt-0">Referenser</h4><ul class="text-sm break-all"><li><a href="https://stm.sciencemag.org/content/13/600/eabi9915" target="_blank" rel="noopener noreferrer">https://stm.sciencemag.org/content/13/600/eabi9915</a></li><li><a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6373706/" target="_blank" rel="noopener noreferrer">https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6373706/</a></li><li><a href="https://www.technologyreview.com/2020/12/09/1013538/what-are-the-ingredients-of-pfizers-covid-19-vaccine/" target="_blank" rel="noopener noreferrer">https://www.technologyreview.com/2020/12/09/1013538/what-are-the-ingredients-of-pfizers-covid-19-vaccine/</a></li></ul></section>',15),cs=e("div",null,[e("h3",{class:"mt-6 pt-3 mb-10"},"FÃ¶r vidare studier"),e("ul",{class:"leading-tight"},[e("li",null,[a("ğŸ“º"),e("a",{href:"https://www.youtube.com/watch?v=Atrx1P2EkiQ",target:"_blank",rel:"noopener noreferrer"},"Vaccines and the Immune Response: How Vaccines Work")]),e("li",null,[e("a",{href:"https://www.cdc.gov/vaccines/vac-gen/additives.htm",target:"_blank",rel:"noopener noreferrer"},"Whatâ€™s in Vaccines?")])])],-1),ms=i('<h3><span class="text-rose-400">Myt 5:</span> BÃ¤ttre hygien och sanitet leder till minskade infektioner, inte vacciner</h3><p>Det Ã¤r delvis sant att vacciner inte fÃ¶rtjÃ¤nar all Ã¤ra fÃ¶r att minska eller eliminera andelen infektionssjukdomar. Det har visat sig att bÃ¤ttre sanitet, nÃ¤ring och utveckling av antibiotika har hjÃ¤lpt till mycket. Infektioner som tyfus och kolera som Ã¶verfÃ¶rs av fÃ¶rorenat vatten, en viktig orsak till sjukdom och dÃ¶d i bÃ¶rjan av 1900-talet, har minskat dramatiskt genom bÃ¤ttre sanitet. En nyligen genomfÃ¶rd granskning drog slutsatsen att handtvÃ¤tt bidrar till att avvÃ¤rja infektionssjukdomar. Ytterligare ett nytt bevis kommer frÃ¥n covid-19-karantÃ¤n (lockdown) och fÃ¶rbÃ¤ttrad hygien med dramatiskt minskade sÃ¤songsinfluensafrekvenser.</p><p>Men nÃ¤r dessa faktorer isoleras och antalet infektionssjukdomar analyseras kan vaccinernas roll inte fÃ¶rnekas. Ett exempel Ã¤r mÃ¤ssling i USA. NÃ¤r det fÃ¶rsta mÃ¤sslingsvaccinet introducerades 1963 hade infektionssiffrorna legat konstant pÃ¥ cirka 400 000 fall per Ã¥r. Och Ã¤ven om hygieniska vanor och sanitet inte fÃ¶rÃ¤ndrades mycket under det fÃ¶ljande decenniet, sjÃ¶nk frekvensen av mÃ¤sslingsinfektioner hastigt efter vaccinets introduktion, med endast cirka 25 000 fall 1970. Ett annat exempel Ã¤r Hib-sjukdomen (Haemophilus influenzae typ b). Enligt CDC-data sjÃ¶nk incidensen fÃ¶r denna sjukdom frÃ¥n 20 000 1990 till cirka 1 500 1993 efter vaccinets introduktion.</p><p>Ytterligare ett bevis kommer frÃ¥n de senaste decennierna. Det har inte skett nÃ¥gra fÃ¶rÃ¤ndringar i hygienen i den utvecklade vÃ¤rlden, men det har skett en minskning av vaccinationsfrekvensen. (det mÃ¥ste vara ett nanofiberfilter som garanterar en bakteriell och skadlig finfilterkapacitet pÃ¥ minst 90%).</p><section class="e-card"><h4 class="mt-0">Referenser</h4><ul class="text-sm break-all"><li><a href="https://jptcp.com/index.php/jptcp/article/view/711" target="_blank" rel="noopener noreferrer">https://jptcp.com/index.php/jptcp/article/view/711</a></li><li><a href="https://www.nature.com/articles/d41586-020-01538-8" target="_blank" rel="noopener noreferrer">https://www.nature.com/articles/d41586-020-01538-8</a></li><li><a href="https://www.nature.com/articles/d41586-020-03519-3" target="_blank" rel="noopener noreferrer">https://www.nature.com/articles/d41586-020-03519-3</a></li><li><a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3222407/" target="_blank" rel="noopener noreferrer">https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3222407/</a></li></ul></section><h3><span class="text-rose-400">Myt 6:</span> Vacciner kan infektera barnet med sjukdomen det fÃ¶rsÃ¶ker fÃ¶rebygga</h3><p>Vissa av vaccinerna Ã¤r levande vacciner som innehÃ¥ller levande fÃ¶rsvagade mikroorganismer / virus, som fortfarande kan replikera i den vaccinerade vÃ¤rden. Mikroorganismerna Ã¤r &quot;fÃ¶rsvagade&quot;, vilket betyder att de har fÃ¶rlorat det mesta av sin sjukdomsframkallande fÃ¶rmÃ¥ga men har fortfarande immunogena egenskaper. Det Ã¤r alltsÃ¥ alltid mycket mindre allvarligt Ã¤n om ett barn skulle bli infekterat med sjÃ¤lva det sjukdomsframkallande viruset. Levande fÃ¶rsvagade vacciner Ã¤r fÃ¶r vaccin mot mÃ¤ssling, pÃ¥ssjuka, rÃ¶da hund (MMR-kombinerat vaccin), rotavirus, smittkoppor, vattkoppor och gula febern. I de flesta fall visar levande vacciner signifikant hÃ¶gre immunogenicitet Ã¤n inaktiverade vacciner eftersom naturlig infektion imiteras nÃ¤stan perfekt genom att framkalla ett mer omfattande spektrum av immunologiska svar. Dessa vacciner Ã¤r dock inte gynnade fÃ¶r barn med fÃ¶rsvagat immunfÃ¶rsvar, sÃ¥som de som behandlas fÃ¶r cancer.</p><p>Levande vacciner kan ju orsaka milda symtom som liknar den sjukdom de skyddar mot, men de som tagit vaccin upplever inte sjÃ¤lva sjukdomen utan kroppens immunsvar mot vaccinet. Det finns bara ett registrerat fall dÃ¤r ett vaccin visade sig orsaka sjukdom. Detta var det orala poliovaccinet (OPV) som inte lÃ¤ngre anvÃ¤nds och fÃ¶r nÃ¤rvarande ersÃ¤tts med en dÃ¶dad virusform som kallas det inaktiverade poliovaccinet (IPV).</p><section class="e-card"><h4 class="mt-0">Referens</h4><ul class="text-sm break-all"><li><a href="https://www.sciencedirect.com/science/article/pii/B9781455710768000090" target="_blank" rel="noopener noreferrer">https://www.sciencedirect.com/science/article/pii/B9781455710768000090</a></li></ul></section><h3><span class="text-rose-400">Myt 7:</span> Vi behÃ¶ver inte vaccinera eftersom mÃ¥nga lÃ¤nder har lÃ¥ga infektionsfrekvenser</h3><p>Flockimmunitet uppstÃ¥r nÃ¤r en stor del av ett samhÃ¤lle (flocken) blir immun mot en sjukdom, vilket gÃ¶r osannolikt att sjukdomen sprids frÃ¥n person till person. Tack vare &quot;flockimmunitet&quot; ser mÃ¥nga mÃ¤nniskor inte behovet av vaccination. SÃ¥ lÃ¤nge en stor majoritet av mÃ¤nniskor Ã¤r immuniserade i nÃ¥gon befolkning, kommer den oimmuniserade minoriteten ocksÃ¥ att skyddas. Detta Ã¤r viktigt eftersom det finns en del av befolkningen â€“ spÃ¤dbarn, gravida kvinnor, Ã¤ldre och de med fÃ¶rsvagat immunfÃ¶rsvar â€“ som sÃ¥ ofta inte kan fÃ¥ vaccin. Anta dock att mÃ¥nga mÃ¤nniskor inte vaccinerar sig sjÃ¤lva eller sina barn. I sÃ¥ fall fÃ¶rsvinner &quot;flockimmuniteten&quot;, vilket Ã¶ppnar mÃ¶jligheter fÃ¶r virus och bakterier att etablera sig och sprida sig. Med sÃ¥ mÃ¥nga mÃ¤nniskor som Ã¤r resistenta kommer en infektionssjukdom aldrig att fÃ¥ en chans att etablera sig och spridas.</p><p>Dessutom bÃ¤r internationella resenÃ¤rer ofta pÃ¥ sjukdom frÃ¥n utlandet, och en ovaccinerad individ lÃ¶per mycket stÃ¶rre risk att bli sjuk eller att mÃ¤nniskor har blivit smittade under resan. Den Ã¶kade incidensen av mÃ¤ssling illustrerar detta i USA de senaste Ã¥ren. SÃ¥ lÃ¤nge sjukdomen existerar riskerar vi att bli smittade.</p><section class="e-card"><h4 class="mt-0">Referenser</h4><ul class="text-sm break-all"><li><a href="https://www.cdc.gov/mmwr/volumes/68/wr/mm6819a4.htm" target="_blank" rel="noopener noreferrer">https://www.cdc.gov/mmwr/volumes/68/wr/mm6819a4.htm</a></li><li><a href="https://bmcpublichealth.biomedcentral.com/articles/10.1186/s12889-021-10652-9" target="_blank" rel="noopener noreferrer">https://bmcpublichealth.biomedcentral.com/articles/10.1186/s12889-021-10652-9</a></li></ul></section>',13),us=e("a",{href:"https://www.who.int/emergencies/diseases/novel-coronavirus-2019/media-resources/science-in-5/episode-8---myth-vs-science",target:"_blank",rel:"noopener noreferrer"}," WHO - Myt vs Vetenskap ",-1);function hs(h,c){const l=v,d=k,r=f,n=g;return o(),u("div",bt,[t(l,{class:"w-full lg:max-w-xs print:hidden"}),e("section",wt,[t(d,{name:"openmoji:scientist-medium-dark-skin-tone",class:"float-right text-[5em]"}),_t,yt,e("section",jt,[xt,qt,Vt,St,t(r,{src:"https://evidence.onkel.ee/assets/viruses-01__bacteria-vs-virus.webp",credits:"KÃ¤lla: https://inducoat.com/?attachment_id=24945&lang=en",elevated:!0},{caption:s(()=>[At,a(" Strukturella skillnader mellan virus och bakterier ")]),_:1}),It,t(n,{class:"mb-8"},{default:s(()=>[a(" Antibiotika kan underlÃ¤tta fÃ¶r immunsystemet att bli av med bakterieinfektioner men det rÃ¥r ej pÃ¥ virusinfektioner. Antivirala lÃ¤kemedel fungerar annorlunda Ã¤n antibiotika och Ã¤r fÃ¶r nÃ¤rvarande endast effektiva mot ett fÃ¥tal virussjukdomar, sÃ¥som influensa, herpes, hepatit B och C samt HIV. Virusinfektioner kan vara mycket svÃ¥rare att bli av med Ã¤n bakterieinfektioner eftersom viruset gÃ¥r in i mÃ¤nskliga celler. Immunsystemet kan ibland dÃ¶da de infekterade cellerna innan viruset kan fortplanta sig. Men eftersom viruset fÃ¶rÃ¶kar sig dÃ¶dar det ofta den infekterade cellen genom att cellen exploderar, vilket gÃ¶r att viruset kan spridas till andra celler i kroppen. ")]),_:1}),Mt]),Dt,e("section",zt,[Ot,Ct,Ft,Nt,t(r,{src:"https://evidence.onkel.ee/assets/viruses-03.webp",credits:"KÃ¤lla: https://www.nytimes.com/2020/03/13/health/soap-coronavirus-handwashing-germs.html",elevated:!0},{caption:s(()=>[$t,a(" FÃ¶r varje nytt antigen behÃ¶ver vÃ¥r kropp bygga en specifik antikropp ")]),_:1}),Pt,Bt,Tt,t(r,{src:"https://evidence.onkel.ee/assets/viruses-04.webp",credits:"KÃ¤lla: https://www.who.int/news-room/feature-stories/detail/how-do-vaccines-work",elevated:!0},{caption:s(()=>[Et,a(" Antikroppsutveckling genom vaccination ")]),_:1}),Rt]),Ht,e("section",Wt,[Kt,Yt,Ut,Jt,e("div",Lt,[t(r,{src:"https://evidence.onkel.ee/assets/viruses-06__mask-01.webp"},{caption:s(()=>[a(" Kirurgisk mask ")]),_:1}),t(r,{src:"https://evidence.onkel.ee/assets/viruses-06__mask-02.webp",caption:""},{caption:s(()=>[a(" FFP2 mask (respirator) ")]),_:1}),t(r,{src:"https://evidence.onkel.ee/assets/viruses-06__mask-03.webp"},{caption:s(()=>[a(" FFP3-mask (respirator) med ventil ")]),_:1}),t(r,{src:"https://evidence.onkel.ee/assets/viruses-06__mask-04.webp"},{caption:s(()=>[a(" Filtrerande mask ")]),_:1})]),Qt,t(n,{class:"my-8",theme:"sky-500",icon:"material-symbols:edit-document"},{default:s(()=>[Gt]),_:1})]),Xt,e("section",Zt,[es,e("div",as,[t(r,{src:"https://evidence.onkel.ee/assets/viruses-07.webp",credits:"KÃ¤lla: https://www.nytimes.com/2020/03/13/health/soap-coronavirus-handwashing-germs.html"},{caption:s(()=>[ts,a(" TvÃ¥lmolekyler som fÃ¶rstÃ¶r viruset ")]),_:1}),t(r,{src:"https://evidence.onkel.ee/assets/viruses-08.webp",credits:"KÃ¤lla: https://www.nytimes.com/2020/03/13/health/soap-coronavirus-handwashing-germs.html"},{caption:s(()=>[ss,a(" Micell bestÃ¥ende av tvÃ¥lmolekyler och virusfragment ")]),_:1})]),is]),rs,e("section",ns,[os,t(n,{class:"my-8",theme:"sky-500",icon:"material-symbols:edit-document"},{default:s(()=>[ls]),_:1}),ds,t(n,{class:"my-8",theme:"sky-500",icon:"material-symbols:edit-document"},{default:s(()=>[cs]),_:1}),ms,t(n,{class:"my-8",theme:"sky-500",icon:"material-symbols:edit-document"},{default:s(()=>[a(" Fler covid-19-myter och relaterad vetenskaplig forskning kan hittas frÃ¥n: "),us]),_:1})])])])}const ps=b(gt,[["render",hs]]),vs={},ks={class:"flex flex-col items-start lg:flex-row-reverse lg:justify-end xl:gap-10 2xl:gap-20"},fs={class:"e-article",lang:"en",style:{hyphens:"auto"}},gs=e("h1",{class:"mb-0"},"Viruses",-1),bs=e("h5",{class:"font-normal uppercase leading-tight"},"Scientific background information",-1),ws={id:"s1"},_s=e("h2",{id:"s1t"},"1. Viruses versus bacteria",-1),ys=e("p",{class:"font-bold"}," Bacteria and viruses can cause many common infections. But what are the differences between these two kinds of infectious organisms? ",-1),js=e("p",null,[e("span",{class:"e-term font-Heading"},"Bacteria"),a(" are tiny microorganisms that are made up of a single cell. They're very diverse and can have many shapes and structural features. Bacteria can live in almost every conceivable environment, including in or on the human body. Only a handful of bacteria cause infections in humans. These bacteria are referred to as pathogenic bacteria. ")],-1),xs=e("p",null,[e("span",{class:"e-term font-Heading"},"Viruses"),a(" are another type of tiny microorganism, even smaller than bacteria. Like bacteria, they're very diverse and have a variety of shapes and features. Viruses are parasitic. That means they require living cells or tissue in which to grow. Viruses can invade the cells of your body, using the components of your cells to grow and multiply. Some viruses even kill host cells as part of their life cycle. Differences between viruses and bacteria can be seen in figure 1 and found in table 1. ")],-1),qs=e("b",null,"Figure 1.",-1),Vs=i('<table class="mt-20"><caption class="text-left pb-4"><b>Table 1.</b> Differences between bacteria and viruses</caption><thead><tr><th></th><th>Bacteria</th><th>Viruses</th></tr></thead><tbody><tr><th class="align-baseline"> Living </th><td><b>Living organism.</b><br>Bacteria are living organisms with a single cell that can generate energy, make their own food, move and reproduce (typically by binary fission). This allows bacteria to live in many places - soil, water, plants, and the human body - and serve many purposes.<br>Bacteria include both parasites and non-parasites. </td><td><b>Nonliving.</b><br>Viruses only grow and reproduce inside the host cells they infect. When found outside of these living cells, viruses are dormant. Their â€œlife,â€ therefore, requires the hijacking of the biochemical activities of a living cell.<br>All viruses are intracellular parasites. </td></tr><tr><th class="align-baseline">Number of cells</th><td>Unicellular, one cell</td><td>No cells, not living</td></tr><tr><th class="align-baseline">ReproÂ­duction</th><td>Split into 2</td><td>Invades a host cell and takes over the cell causing it to make copies of the viral DNA/RNA. Destroys the host cell releasing new viruses</td></tr><tr><th class="align-baseline">Size</th><td>Bacteria are much bigger, ranging from 800 nm to 1000 nm. Bacteria can be seen under a light microscope.</td><td>The size of viruses is between 20 nm to 400 nm. Viruses are visible only under electron microscopes.</td></tr><tr><th class="align-baseline">Benefits</th><td>Some bacteria are beneficial, e.g., certain bacteria are required in the gut.</td><td>Viruses are not beneficial. Viruses can be helpful in genetic engineering.</td></tr><tr><th class="align-baseline">Infection</th><td>Bacterial infection is usually confined to a part of the body, described as a localized infection. Infections may be caused by bacteria or by toxins (endotoxins) produced.</td><td>A viral infection is systemic. Viruses infect a host cell and multiply by thousands, leaving the host cell and infecting other body cells.</td></tr><tr><th class="align-baseline">Disease</th><td>Bacterial diseases include pneumonia, tuberculosis, tetanus, and food poisoning.</td><td>Systemic diseases caused by viral infection include influenza, measles, polio, AIDS, and COVID-19.</td></tr><tr><th class="align-baseline">TreatÂ­ment</th><td>Antibiotics and vaccines prevent the disease.</td><td>Vaccines prevent the spread, and antiviral medications help to slow reproduction but cannot stop it completely.</td></tr></tbody></table>',1),Ss=i(`<section class="e-card"><h4 class="mt-4">References</h4><ul class="text-sm break-all"><li><a href="https://courses.lumenlearning.com/suny-biology2xmaster/chapter/prevention-and-treatment-of-viral-infections/">https://courses.lumenlearning.com/suny-biology2xmaster/chapter/prevention-and-treatment-of-viral-infections/</a></li><li><a href="https://bodell.mtchs.org/OnlineBio/BIOCD/text/chapter16">https://bodell.mtchs.org/OnlineBio/BIOCD/text/chapter16</a></li><li><a href="
                            http://www.hcrowder.com/disease-reading.html"> http://www.hcrowder.com/disease-reading.html</a></li></ul></section>`,1),As=i('<hr class="mt-10 mb-40"><section id="s2"><h2 id="s2t">2. Why do antibiotics not kill viruses?</h2><p> Antibiotics target the growth machinery in bacteria (not viruses) to kill or inhibit those particular bacteria. Antibiotics cannot kill viruses because viruses have different structures and replicate differently than bacteria. Moreover, overuse and inappropriate prescribing of antibiotics worldwide are leading to the global healthcare issue of <a href="https://www.drugs.com/article/antibiotic-resistance.html" target="_blank" rel="noopener noreferrer">antibiotic resistance</a>. See Table 2 in which conditions antibiotics may be helpful (NB! the decision on its use will be made by your doctor). </p><table class="leading-tight e-card"><caption class="text-left pb-4"><b>Table 2.</b> Need for antibiotics by common respiratory infections </caption><thead class="border text-center"><tr><th rowspan="2" class="border p-1">Common respiÂ­ratory infections</th><th colspan="3" class="border p-1">Common cause</th><th rowspan="2" class="border p-1">Are<br>antiÂ­biotics needed</th></tr><tr><th class="border p-1">Virus</th><th class="border p-1">Virus or bacteria</th><th class="border p-1">Bacteria</th></tr></thead><tbody class="text-center"><tr><td class="border p-1">Common cold / runny nose</td><td class="border p-1">Yes</td><td class="border p-1"></td><td class="border p-1"></td><td class="border p-1">No</td></tr><tr><td class="border p-1">Sore throat (except strep)</td><td class="border p-1">Yes</td><td class="border p-1"></td><td class="border p-1"></td><td class="border p-1">No</td></tr><tr><td class="border p-1">COVID-19</td><td class="border p-1">Yes</td><td class="border p-1"></td><td class="border p-1"></td><td class="border p-1">No</td></tr><tr><td class="border p-1">Flu</td><td class="border p-1">Yes</td><td class="border p-1"></td><td class="border p-1"></td><td class="border p-1">No</td></tr><tr><td class="border p-1">Bronchitis / chest cold<br><span class="text-sm italic">(in otherwise healthy children and adults)</span> *</td><td class="border p-1"></td><td class="border p-1">Yes</td><td class="border p-1"></td><td class="border p-1">No *</td></tr><tr><td class="border p-1">Middle ear infection</td><td class="border p-1"></td><td class="border p-1">Yes</td><td class="border p-1"></td><td class="border p-1">Maybe</td></tr><tr><td class="border p-1">Sinus infection</td><td class="border p-1"></td><td class="border p-1">Yes</td><td class="border p-1"></td><td class="border p-1">Maybe</td></tr><tr><td class="border p-1">Strep throat</td><td class="border p-1"></td><td class="border p-1"></td><td class="border p-1">Yes</td><td class="border p-1">Yes</td></tr><tr><td class="border p-1">Whooping couch</td><td class="border p-1"></td><td class="border p-1"></td><td class="border p-1">Yes</td><td class="border p-1">Yes</td></tr></tbody><tfoot class="border text-center"><tr><td colspan="5" class="py-0 px-3"><p class="text-sm italic">* Studies shows that in otherwise healthy children and adults, antibiotics for bronchitis won&#39;t help patients feel better.</p><p class="text-xs text-slate-400">Source: https://www.cdc.gov/antibiotic-use/images/VirusOrBacteria-Original-1200by675.jpg</p></td></tr></tfoot></table><section class="e-card"><h4 class="mt-0">References</h4><ul class="text-sm break-all"><li><a href="https://www.drugs.com/article/antibiotics-and-viruses.html" target="_blank" rel="noopener noreferrer">https://www.drugs.com/article/antibiotics-and-viruses.html</a></li><li><a href="https://www.virology.ws/2009/10/19/ten-cool-facts-about-viruses/" target="_blank" rel="noopener noreferrer">https://www.virology.ws/2009/10/19/ten-cool-facts-about-viruses/</a></li></ul></section></section><hr class="mt-10 mb-40">',3),Is={id:"s3"},Ms=e("h2",{id:"s3t"},"3. How vaccines work",-1),Ds=e("h3",null,"The body's natural response",-1),zs=e("p",null,[a(" A "),e("span",{class:"e-term font-Heading"},"pathogen"),a(" is a bacterium, virus, parasite, or fungus that can cause disease within the body. Each pathogen is made up of several subparts, usually unique to that specific pathogen and the disease it causes. The subpart of a pathogen that causes the formation of antibodies is called an antigen. The antibodies produced in response to the pathogen's antigen are essential to the immune system. You can consider antibodies as the soldiers in your body's defense system. Each antibody, or soldier, in our system, is trained to recognize one specific antigen. We have thousands of different antibodies in our bodies. When the human body is exposed to an antigen for the first time, it takes time for the immune system to respond and produce antibodies specific to that antigen (Fig. 2). ")],-1),Os=e("p",null," Antibodies to one pathogen generally do not protect against another pathogen except when two pathogens are very similar to each other, like cousins. Once the antigen-specific antibodies are produced, they work with the rest of the immune system to destroy the pathogen and stop the disease. Once the body produces antibodies in its primary response to an antigen, it also creates antibody-producing memory cells, which remain alive even after the antibodies defeat the pathogen. Suppose the body is exposed to the same pathogen more than once. In that case, the antibody response is much faster and more effective than the first time because the memory cells are ready to pump antibodies against that antigen. This means that if the person is exposed to a dangerous pathogen in the future, their immune system will be able to respond immediately, protecting against disease. ",-1),Cs=e("b",null,"Figure 2.",-1),Fs=e("h3",null,"How vaccines help?",-1),Ns=e("p",null," Vaccines reduce the risks of getting a disease by working with your body's natural defenses to build protection. When you get a vaccine, your immune system responds. ",-1),$s=e("p",null," Vaccines contain weakened or inactive parts of a particular organism (antigen) that triggers an immune response within the body (Fig. 3). Newer vaccines contain the blueprint for producing antigens rather than the antigen itself. Regardless of whether the vaccine is made up of the antigen itself or the blueprint so that the body will produce the antigen, this weakened version will not cause the disease in the person receiving the vaccine. However, it will prompt their immune system to respond much as it would have on its first reaction to the actual pathogen. ",-1),Ps=e("b",null,"Figure 3.",-1),Bs=i('<p> Vaccines work by exposing your white blood cells to the foreign protein in a virus. Once your body has encountered a virus and performed an immune response (making B and T cells) to the virus, it saves the B and T cells so that if the same virus or bacteria ever infects the body again, the immune system can stage and all-out war, preventing the pathogen from ever making you feel sick. Vaccines introduce the body to the virus so that the body can save up B and T cells without ever making you sick. </p><h3>Immunization and related challenges</h3><p> We now have vaccines to prevent more than 20 life-threatening diseases, helping people of all ages live longer, healthier lives. Immunization currently prevents 2-3 million deaths yearly from diseases like diphtheria, tetanus, pertussis, influenza, and measles. </p><p> We have vaccinations against many serious viral infections (measles, mumps, hepatitis A, hepatitis B, and some viruses - such as those that cause the common cold). Still, the problem remains that they can mutate from one person to the next. When the virus mutates, it changes enough that the immune system no longer recognizes it. The immune cells stored for killing the virus no longer recognize it as the same disease and do not know how to kill it. This is how an infection with the same virus can keep dodging the immune system. Vaccination for these viruses is difficult because they have already changed their format by the time vaccines are develop. </p><section class="e-card"><h4 class="mt-0">References</h4><ul class="text-sm break-all"><li><a href="https://www.who.int/news-room/feature-stories/detail/how-do-vaccines-work" target="_blank" rel="noopener noreferrer">https://www.who.int/news-room/feature-stories/detail/how-do-vaccines-work</a></li><li><a href="https://www.nytimes.com/interactive/2020/health/pfizer-biontech-covid-19-vaccine.html" target="_blank" rel="noopener noreferrer">https://www.nytimes.com/interactive/2020/health/pfizer-biontech-covid-19-vaccine.html</a></li><li><a href="https://media.nature.com/original/magazine-assets/d41586-021-03552-w/d41586-021-03552-w.pdf" target="_blank" rel="noopener noreferrer">https://media.nature.com/original/magazine-assets/d41586-021-03552-w/d41586-021-03552-w.pdf</a></li><li><a href="https://opentextbc.ca/biology/chapter/12-1-viruses/" target="_blank" rel="noopener noreferrer">https://opentextbc.ca/biology/chapter/12-1-viruses/</a></li></ul></section>',5),Ts=i('<hr class="mt-10 mb-40"><section id="s4"><h2 id="s4t">4. The process of developing vaccines, vaccines safety</h2><h3>Development</h3><p> Vaccine development typically begins in a research laboratory located in a university, medical center, or small biotech company. During vaccine development, scientists develop different reagents to test and measure their effect (or lack thereof). Often years of research are needed to find ideas that work. </p><p> Different scientists or research groups may work toward the same goals during vaccine development. The progress of the work is presented in different meetings and peer-reviewed articles in journals. If any work seems promising, pharmaceutical scientists may approach those working on it to expand their research toward product development. </p><h3>Testing</h3><p> If a promising vaccine candidate has been found, it has to be tested on animals. This is called the pre-clinical phase. First small animals like mice, rats, rabbits, and others are used. If the candidate affects small animals, the effect has to be usually proven on larger animals like monkeys. If the vaccine triggers an immune response, it is tested in three phases in human clinical trials (WHO, 2021). </p><p> In Phase 1, the vaccine is given to a few volunteers to assess its safety, confirm it generates an immune response, and determine the proper dosage. Generally, in this phase, vaccines are tested in a small group of young, healthy adult volunteers. </p><p> In phase 2, the vaccine is given to several hundred volunteers to assess its safety and ability further to generate an immune response. Participants in this phase have the same characteristics (such as age and sex) as those for whom the vaccine is intended. There are usually multiple trials in this phase to evaluate various age groups (elderly, adults, children) and different vaccine formulations. Also, a group that does not get the vaccine is usually included in determining whether the changes in the vaccinated group are attributed to the vaccine or have happened by chance. </p><p> In phase 3, the vaccine is given to thousands of volunteers â€“ compared to a similar group of people who did not get the vaccine but received a comparator product. This aims to determine if the vaccine is effective against the disease it is designed to protect against. Also, it aims to study its safety in a much larger group of people. Phase 3 trials are often conducted across multiple countries and sites within a country to ensure the findings of the vaccine performance apply to many different populations. </p><p> During phase 2 and 3 trials, the volunteers and the scientists conducting the study are shielded from knowing which volunteers had received the vaccine being tested or the comparator product. This is called â€œblindingâ€ and is necessary to ensure that neither the volunteers nor the scientists are influenced in their assessment of effectiveness or safety by knowing who got which product. </p><section class="e-card"><h4 class="mt-0">References</h4><ul class="text-sm break-all"><li><a href="https://www.who.int/news-room/feature-stories/detail/how-are-vaccines-developed" target="_blank" rel="noopener noreferrer">https://www.who.int/news-room/feature-stories/detail/how-are-vaccines-developed</a></li></ul></section><h3>Authorization and monitoring</h3><p> When the results of all these clinical trials are available, a series of steps are required. Officials in European Medicines Agency and later in each country closely review the study data and decide whether to authorize the vaccine. All the trials have to be correctly done and well documented. A vaccine must be proven safe and effective across a broad population before it is approved. The bar for vaccine safety and efficacy is exceptionally high. This includes reviews of efficacy and safety for regulatory and public health policy approvals. </p><p> Further monitoring of safety and effectiveness takes place during the use of vaccines. This enables scientists to keep track of vaccine impact and safety even as they are used in many people over a long time frame. These data are used to adjust the policies for vaccine usage. </p><section class="e-card"><h4 class="mt-0">References</h4><ul class="text-sm break-all"><li><a href="https://www.worldscientific.com/doi/pdf/10.1142/S2529732521400034" target="_blank" rel="noopener noreferrer">https://www.worldscientific.com/doi/pdf/10.1142/S2529732521400034</a></li></ul></section></section><hr class="mt-10 mb-40">',3),Es={id:"s5"},Rs=e("h2",{id:"s5t"},"5. Masks against viruses and bacteria",-1),Hs=e("p",null," Masks are often used to protect against viruses and bacteria. They had become widespread in the sense of protection against the SARS-CoV-2 virus. Among different types of masks, surgical face masks are among the most commonly used face coverings in the COVID-19 pandemic. Typically, they are blue colored from one side, which should be kept as an outer layer (Fig. 4). The main aim of surgical masks is to protect patients from potential contact with bacteria and viruses exhaled by the wearer. So, they well prevent the spread of the coronavirus through the air but are less effective means of protecting the wearer from the virus. ",-1),Ws=e("p",null," FFP2 or FFP3 masks (often called respirators) should be used to filter and better inhale air. The numbering system (FFP1, FPP2, FFP3) indicates these devices' filtration efficiency (certified as meeting the EN 149-2001 standard). FFP2 and FPP3 have a filtration efficiency for airborne particles (including those that contain the virus) of 92% and 98%, respectively. Both masks also have small inward leakage: <8% and <2%, respectively. In FFP2, special rubber is often used on the outer layer of the respirator. If in occupational environments, a valve (that makes exhaling easier) has been allowed, in the case of SARS-CoV-2, only non-valve respirators should be used in order to filter also exhaled air. ",-1),Ks=e("p",null," With the COVID-19 pandemic, a new face mask has been introduced: the filtering mask. This type of mask is made of multilayer fabric (one has to be a nanofibre filter that guarantees a bacterial and harmful fine dust filtering capacity of at least 90%). This mask combines high filtration capacity with reusability as it can be machine washed at 60 degrees. ",-1),Ys={class:"grid gap-3 my-15 md:grid-cols-2 e-card"},Us=i('<p> The efficiency of the masks has been tested in special laboratories, e.g., in the exposure chamber. In those studies, a carrying the viruses. Subsequently, particle concentrations behind the particle generator fill the exposure chamber with small particles; similar to aerosols, the masks are measured and compared to the concentration in the general atmosphere of the exposure chamber. </p><p> However, the strongest evidence is based on epidemiologic data from real-life situations. For instance, the daily COVID-19 growth rate is slowdown after mask mandates in 15 states and the District of Columbia in the US. Another study examined coronavirus deaths across 198 countries and found that those with cultural norms or government policies favoring mask-wearing had lower death rates. </p><p> Many Facebook and social media users have shared misleading posts regarding the prolonged use of face masks causing oxygen deficiency in the body - hypoxia. Nevertheless, research articles and experts suggest that such symptoms are unlikely to occur in most people unless the wearer has pre-existing respiratory illnesses such as asthma or chronic obstructive pulmonary disease (COPD). The risk of hypoxia and hypercapnia (having excessive carbon dioxide in the bloodstream) are unlikely to occur with cloth and surgical masks as they are not tight-fitting. Still, it is warned that face masks should not be placed on young children under two years old, those with breathing difficulty, or when exercising. </p><section class="e-card"><h4 class="mt-0">References</h4><ul class="text-sm break-all"><li><a href="https://bmcpublichealth.biomedcentral.com/articles/10.1186/s12889-021-10652-9" target="_blank" rel="noopener noreferrer">https://bmcpublichealth.biomedcentral.com/articles/10.1186/s12889-021-10652-9</a></li><li><a href="https://jamanetwork.com/journals/jamainternalmedicine/fullarticle/2774266" target="_blank" rel="noopener noreferrer">https://jamanetwork.com/journals/jamainternalmedicine/fullarticle/2774266</a></li><li><a href="https://www.healthaffairs.org/doi/10.1377/hlthaff.2020.00818" target="_blank" rel="noopener noreferrer">https://www.healthaffairs.org/doi/10.1377/hlthaff.2020.00818</a></li><li><a href="https://www.ajtmh.org/view/journals/tpmd/103/6/article-p2400.xml" target="_blank" rel="noopener noreferrer">https://www.ajtmh.org/view/journals/tpmd/103/6/article-p2400.xml</a></li><li><a href="https://www.epa.gov/sciencematters/epa-researchers-test-effectiveness-face-masks-disinfection-methods-against-covid-19" target="_blank" rel="noopener noreferrer">https://www.epa.gov/sciencematters/epa-researchers-test-effectiveness-face-masks-disinfection-methods-against-covid-19</a></li><li><a href="https://journals.asm.org/doi/full/10.1128/mSphere.00637-20" target="_blank" rel="noopener noreferrer">https://journals.asm.org/doi/full/10.1128/mSphere.00637-20</a></li><li><a href="https://pubmed.ncbi.nlm.nih.gov/33626065/" target="_blank" rel="noopener noreferrer">https://pubmed.ncbi.nlm.nih.gov/33626065/</a></li></ul></section>',4),Js=e("div",null,[e("h3",{class:"mt-6 pt-3 mb-10"},"For further study"),e("ul",{class:"leading-tight break-all"},[e("li",null,[e("a",{href:"https://www.fda.gov/medical-devices/personal-protective-equipment-infection-control/n95-respirators-surgical-masks-face-masks-and-barrier-face-coverings#s3",target:"_blank",rel:"noopener noreferrer"},"N95 Respirators, Surgical Masks, Face Masks, and Barrier Face Coverings")]),e("li",null,[e("a",{href:"https://www.sciencedirect.com/science/article/pii/S2452199X20301481",target:"_blank",rel:"noopener noreferrer"},"An overview of filtration efficiency through the masks: Mechanisms of the aerosols penetration")]),e("li",null,[e("a",{href:"https://www.weforum.org/agenda/2020/10/covid-19-coronavirus-disease-size-compairson-zika-health-air-pollution/",target:"_blank",rel:"noopener noreferrer"},"This is how coronavirus compares to the world's smallest particles")])])],-1),Ls=e("hr",{class:"mt-10 mb-40"},null,-1),Qs={id:"s6"},Gs=i('<h2 id="s6t">6. Viruses and hand hygiene</h2><h3>Hand sanitiser or soap?</h3><p> Our hands can be a critical vector in the transmission of infections. When applied to hands thoroughly and scrubbed for at least 20 seconds, alcohol-based hand sanitizers and soap will stop the coronavirus. However, soap disrupts the sticky bond between pathogens and your skin, allowing the pathogens to slide right off. Not only are you neutralizing the virus, but you are also physically knocking it off your hands. Practicing good hand hygiene is a simple preventative strategy that most people can easily undertake, and many studies have demonstrated the effectiveness of hand hygiene in preventing the transmission of infectious pathogens, including coronaviruses such as SARS-CoV-2. </p><section class="e-card"><h4 class="mt-0">References</h4><ul class="text-sm break-all"><li><a href="https://www.uchealth.org/today/why-soap-and-water-work-better-than-hand-sanitizer-to-remove-the-coronavirus/" target="_blank" rel="noopener noreferrer">https://www.uchealth.org/today/why-soap-and-water-work-better-than-hand-sanitizer-to-remove-the-coronavirus/</a></li></ul></section><h3>Weakening the corona virus with soap</h3><p> Coronaviruses get their name from the &quot;corona&quot; surrounding the virusâ€” the protein spikes embedded in its surface. The spikes, which are responsible for infecting the host, are anchored into a membrane. The membrane is the &quot;shell&quot; of the virus and the virus&#39;s weak point. </p><p> Soap molecules have two chemically distinct parts: a hydrophilic (water-loving) &quot;head&quot; and a hydrophobic (water-hating) &quot;tail&quot;. The head helps the soap mix with water, while the tail can interact with other hydrophobic molecules like lipids. </p><p> Luckily, the coronavirus&#39;s membrane is mainly made up of lipid molecules. They are held together by weak chemical interactions between individual molecules. The hydrophobic (water-hating) &quot;tails&quot; of soap molecules can break interactions between lipid molecules in the coronavirus membrane (see Fig. 5). </p><p> The soap&#39;s tail can disrupt the weak interactions between lipid molecules in the membrane, tearing it apart. Suppose the virus is broken up before being safely sheltered in a host cell. In that case, it will no longer be able to do its infectious job â€” like a machine with its parts falling out. Soap molecules then surround virus fragments with all tails facing inside. This cluster is called a micelle (see Fig. 6). The outward-facing hydrophilic heads allow the micelle to be washed down the drain with water. Water alone will not do. </p>',9),Xs={class:"grid gap-2 md:grid-cols-2 e-card"},Zs=e("b",null,"Figure 5.",-1),ei=e("b",null,"Figure 6.",-1),ai=i('<p> The given information is also valid for the other enveloped viruses (Influenza, Hepatitis B and C, and Ebola Virus Disease) as their envelopes consist of phospholipids. </p><section class="e-card"><h4 class="mt-0">Reference</h4><ul class="text-sm break-all"><li><a href="https://www.science.org.au/curious/people-medicine/hand-sanitiser-or-soap-making-informed-choice-covid-19" target="_blank" rel="noopener noreferrer">https://www.science.org.au/curious/people-medicine/hand-sanitiser-or-soap-making-informed-choice-covid-19</a></li></ul></section><h3>Choosing hand sanitizer</h3><p> The World Health Organization (WHO) recommends alcohol-based hand sanitizers if you have no soap on hand. </p><p><b>Alcohol-based hand sanitizers are thought to work by preventing the proteins of microbesâ€”including bacteria and some virusesâ€”from functioning normally. Hand sanitizers with a high alcohol content might also interfere with the lipid shell surrounding the coronavirus.</b> To be effective, hand sanitizers must contain at least 60 percent alcohol. The additives in the sanitizer can keep the alcohol from evaporating too fast, allowing the virus to be drenched for longer. </p><p> However, there are also certain risks related to using alcohol-based hand sanitizers. There is an increased alcohol poisoning risk for children, and frequent usage of hand sanitizers could result in antimicrobial resistance. There are alternative alcohol-free hand sanitizers, where benzalkonium is most commonly used. Recent studies have indicated that alcohol-free hand sanitizer works just as well and does not cause the familiar &quot;burn&quot; feeling known from using alcohol hand sanitizer. </p><section class="e-card"><h4 class="mt-0">References</h4><ul class="text-sm break-all"><li><a href="https://www.sciencedirect.com/science/article/abs/pii/S0048969720340833?via%3Dihub" target="_blank" rel="noopener noreferrer">https://www.sciencedirect.com/science/article/abs/pii/S0048969720340833?via%3Dihub</a></li><li><a href="https://www.journalofhospitalinfection.com/article/S0195-6701(20)30547-8/fulltext#secsectitle0040" target="_blank" rel="noopener noreferrer">https://www.journalofhospitalinfection.com/article/S0195-6701(20)30547-8/fulltext#secsectitle0040</a></li></ul></section>',7),ti=e("hr",{class:"mt-10 mb-40"},null,-1),si={id:"s7"},ii=i('<h2 id="s7t">7. Vaccine myths</h2><h3><span class="text-rose-400">Myth 1:</span> Vaccines cause autism/serious side effects.</h3><p> The widespread fear that vaccines increase the risk of autism originated with a 1997 study published by Andrew Wakefield, a British surgeon. The article was published in The Lancet, a prestigious medical journal, suggesting that the measles, mumps, and rubella (MMR) vaccine increased autism in British children. </p><p> The paper has since been thoroughly discredited due to serious procedural errors, having only 12 participants in the study, undisclosed financial conflicts of interest, and ethical violations. Andrew Wakefield lost his medical license, and the paper was retracted from The Lancet. </p><p> Currently, against the autism-vaccination link theory, several studies have now identified symptoms of autism in children well before they receive the MMR vaccine. Moreover, recent research provides evidence that autism develops in utero, well before a baby is born or receives vaccinations. None of the latter studies has reported a link between any vaccine and the likelihood of developing autism. </p><section class="e-card"><h4 class="mt-0">References</h4><ul class="text-sm break-all"><li><a href="https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(97)11096-0/fulltext" target="_blank" rel="noopener noreferrer">https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(97)11096-0/fulltext</a></li><li><a href="https://www.nejm.org/doi/full/10.1056/NEJMoa1307491?query=featured_home" target="_blank" rel="noopener noreferrer">https://www.nejm.org/doi/full/10.1056/NEJMoa1307491?query=featured_home</a></li></ul></section>',6),ri=e("div",null,[e("h3",{class:"mt-6 pt-3 mb-10"},"For further study"),e("ul",{class:"leading-tight"},[e("li",null,[e("a",{href:"https://archive.cdc.gov/#/details?url=https://www.cdc.gov/coronavirus/2019-ncov/vaccines/expect/after.html",target:"_blank",rel:"noopener noreferrer"},"Possible Side Effects After Getting a COVID-19 Vaccine")]),e("li",null,[e("a",{href:"https://www.bbc.com/news/health-55932832",target:"_blank",rel:"noopener noreferrer"},"Study reveals extent of Covid vaccine side-effects")]),e("li",null,[e("a",{href:"https://www.nature.com/articles/d41586-021-00290-x",target:"_blank",rel:"noopener noreferrer"},"COVID vaccines and safety: what the research says")]),e("li",null,[e("a",{href:"https://health.clevelandclinic.org/covid-19-vaccine-side-effects/",target:"_blank",rel:"noopener noreferrer"},"Hereâ€™s What to Know About the COVID-19 Vaccine Side Effects")]),e("li",null,[e("a",{href:"https://www.historyofvaccines.org/content/articles/vaccine-side-effects-and-adverse-events",target:"_blank",rel:"noopener noreferrer"},"Vaccine Side Effects and Adverse Events")]),e("li",null,[e("a",{href:"https://www.bbc.com/news/health-56375307",target:"_blank"},"Vaccine side effects: My experience of them and what they mean")]),e("li",null,[e("a",{href:"https://vk.ovg.ox.ac.uk/vk/vaccine-side-effects",target:"_blank",rel:"noopener noreferrer"},"Vaccine side effects and adverse reactions")]),e("li",null,[a("ğŸ“º"),e("a",{href:"https://www.youtube.com/watch?v=F6NKbQzo4aE",target:"_blank",rel:"noopener noreferrer"},"Vaccine side effects are actually a good thing")]),e("li",null,[a("ğŸ“º"),e("a",{href:"https://www.youtube.com/watch?v=Atrx1P2EkiQ",target:"_blank",rel:"noopener noreferrer"},"Vaccines and the Immune Response: How Vaccines Work")])])],-1),ni=i('<h3><span class="text-rose-400">Myth 2:</span> Infant immune systems cannot handle multiple vaccines</h3><p> Children are given vaccines at a young age because they are at the highest risk of getting sick or dying if they get these diseases. Even newborn babies are immune to some diseases (e.g., chickenpox) because they get antibodies from their mothers; this immunity lasts only a few months. Moreover, most babies do not get protective antibodies against diphtheria, whooping cough, polio, tetanus, hepatitis B, or Hib from their mothers. </p><p> To reduce the number of shots a child receives in a doctor&#39;s visit, some vaccines are offered as a combination (two or more different vaccines have been combined into a single shot). Examples of combination vaccines are diphtheria-tetanus-pertussis (DTap) and measles-mumps-rubella (MMR). </p><p> Scientific data show that getting several vaccines simultaneously does not cause any health problems. Infant immune systems are tougher than you might think. Based on the number of antibodies present in the blood, a baby would theoretically have the ability to respond to a far larger number of vaccines than are ever shot (the question has risen if it is 1,000, 10,000, or 100,000 at one time). Even if all ~10 (depending on national vaccination plan) scheduled vaccines were given at once, it would only use a fraction of a baby&#39;s immune capacity. In reality, babies are exposed to countless bacteria and viruses every day, and immunisations are negligible in comparison. Also, studies have not shown that exposure to multiple vaccines through the first 23 months of life would be associated with an increased risk for infections not targeted by vaccines. </p><section class="e-card"><h4 class="mt-0">References</h4><ul class="text-sm break-all"><li><a href="https://www.nejm.org/doi/full/10.1056/NEJMoa1307491?query=featured_home" target="_blank" rel="noopener noreferrer">https://www.nejm.org/doi/full/10.1056/NEJMoa1307491?query=featured_home</a></li><li><a href="https://www.bmj.com/content/364/bmj.l1481/rr-11" target="_blank" rel="noopener noreferrer">https://www.bmj.com/content/364/bmj.l1481/rr-11</a></li><li><a href="https://pubmed.ncbi.nlm.nih.gov/11773551/" target="_blank" rel="noopener noreferrer">https://pubmed.ncbi.nlm.nih.gov/11773551/</a></li></ul></section><h3><span class="text-rose-400">Myth 3:</span> Immunity acquired through a disease is better than immunity acquired through vaccination</h3><p> It is true that natural infection almost always results in a stronger immunity to the disease than a vaccination. However, the dangers of this approach far outweigh the relative benefits. The price for immunity after natural infection might be pneumonia from chickenpox or pneumococcus, intellectual disability from Haemophilus influenzae type b (Hib), birth defects from rubella, liver cancer from hepatitis B virus, death from measles, etc. If you wanted to gain immunity to measles, for example, by contracting the disease, you would face a 1 in 500 chance of death from your symptoms. In contrast, the number of people who have had severe allergic reactions from an MMR vaccine is less than one-in-one million. </p><p> Nevertheless, few vaccines induce a better immune response than natural infection. For instance, the Human papillomavirus (HPV) vaccine contains a high purity of the specific protein, leading to a better immune response than natural infection. Other examples include tetanus, Haemophilus influenzae type b (Hib), and pneumococcal vaccine. </p><p> Regarding COVID-19, it needs to be clarified. It has been shown that permanent protection after infection is unlikely. Even though coronavirus patients gained â€œsubstantial immune memoryâ€ that involved all four significant parts of the immune system: memory B cells, antibodies, memory CD4+ T cells, and memory CD8+ T cells, the protection started to reduce after half a year. Also, scientists have shown a â€œmassive dynamic rangeâ€ in the immune response between individuals, with a 200-fold difference in antibody levels. </p><p> Other studies have shown that volunteers who received the Moderna vaccine (mRNA) had more antibodies â€” one marker of immune response â€” in their blood than did people who had been sick with COVID-19. However, this fact can be modified by the severity of the disease as there is a correlation between disease severity and lasting immune response â€“ most asymptomatic patients had very few antibodies after six months of infection. Thus, the natural immunity generated from a SARS-CoV-2 infection is often unpredictable. Moreover, the antibodies elicited by the mRNA vaccine targeted a broader range of places on the Receptor Binding Domain (RBD) than those elicited by natural infection. </p><section class="e-card"><h4 class="mt-0">References</h4><ul class="text-sm break-all"><li><a href="https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(21)00675-9/fulltext" target="_blank" rel="noopener noreferrer">https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(21)00675-9/fulltext</a></li><li><a href="https://science.sciencemag.org/content/371/6529/eabf4063" target="_blank" rel="noopener noreferrer">https://science.sciencemag.org/content/371/6529/eabf4063</a></li><li><a href="https://www.nejm.org/doi/full/10.1056/NEJMc2032195" target="_blank" rel="noopener noreferrer">https://www.nejm.org/doi/full/10.1056/NEJMc2032195</a></li><li><a href="https://www.researchsquare.com/article/rs-612205/v1" target="_blank" rel="noopener noreferrer">https://www.researchsquare.com/article/rs-612205/v1</a></li><li><a href="https://stm.sciencemag.org/content/13/600/eabi9915" target="_blank" rel="noopener noreferrer">https://stm.sciencemag.org/content/13/600/eabi9915</a></li></ul></section><h3><span class="text-rose-400">Myth 4:</span> Vaccines contain life-threatening substances.</h3><p> People are concerned about using formaldehyde, mercury, or aluminium in vaccines. On the one hand, these chemicals are toxic to the human body at certain levels. On the other hand, only tiny amounts of these chemicals can be found in vaccines. Those amounts are smaller than we get from nutrition or formaldehyde is produced at higher rates by our own metabolic systems. </p><p> Certain elements, such as aluminium salts, are added to vaccines because they work as an adjuvant, which means their presence boosts the immune response when you are vaccinated. Also, only certain vaccines contain aluminium salts, and new COVID-19 vaccines do not contain them. A few vaccines have contained thimerosal as a preservative; however, none of the vaccines used in children currently contains this. Thimerosal contains ethylmercury, which is cleared from the human body quickly compared to methylmercury, which bioaccumulates â€“ so there is also a difference in which form toxic metal is. Nevertheless, COVID-19 vaccines do not contain toxins (e.g.). </p><section class="e-card"><h4 class="mt-0">References</h4><ul class="text-sm break-all"><li><a href="https://stm.sciencemag.org/content/13/600/eabi9915" target="_blank" rel="noopener noreferrer">https://stm.sciencemag.org/content/13/600/eabi9915</a></li><li><a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6373706/" target="_blank" rel="noopener noreferrer">https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6373706/</a></li><li><a href="https://www.technologyreview.com/2020/12/09/1013538/what-are-the-ingredients-of-pfizers-covid-19-vaccine/" target="_blank" rel="noopener noreferrer">https://www.technologyreview.com/2020/12/09/1013538/what-are-the-ingredients-of-pfizers-covid-19-vaccine/</a></li></ul></section>',15),oi=e("div",null,[e("h3",{class:"mt-6 pt-3 mb-10"},"For further study"),e("ul",{class:"leading-tight"},[e("li",null,[a("ğŸ“º"),e("a",{href:"https://www.youtube.com/watch?v=Atrx1P2EkiQ",target:"_blank",rel:"noopener noreferrer"},"Vaccines and the Immune Response: How Vaccines Work")]),e("li",null,[e("a",{href:"https://www.cdc.gov/vaccines/vac-gen/additives.htm",target:"_blank",rel:"noopener noreferrer"},"Whatâ€™s in Vaccines?")])])],-1),li=i('<h3><span class="text-rose-400">Myth 5:</span> Better hygiene and sanitation are responsible for decreased infections, not vaccines</h3><p> This is partly true that vaccines do not deserve all the credit for reducing or eliminating rates of infectious diseases. It has been shown that better sanitation, nutrition, and the development of antibiotics have also helped a lot. Infections such as typhoid and cholera transmitted by contaminated water, a major cause of illness and death early in the 20th century, have been reduced dramatically by better sanitation. A recent review concluded that handwashing in averting infectious diseases. Another recent evidence comes from the COVID-19 lockdown and improved hygiene with dramatically reduced seasonal flu rates. </p><p> However, when these factors are isolated, and infectious disease rates are analysed, the role of vaccines cannot be denied. One example is measles in the United States. When the first measles vaccine was introduced in 1963, infection rates had been steady at around 400,000 cases a year. And while hygienic habits and sanitation did not change much over the following decade, the rate of measles infections dropped precipitously following the vaccine&#39;s introduction, with only around 25,000 cases by 1970. Another example is Hib disease. According to CDC data, the incidence rate for this malady plummeted from 20,000 in 1990 to around 1,500 in 1993 following the vaccine&#39;s introduction. </p><p> Another piece of evidence comes from recent decades. There have not been changes in hygiene in the developed world, but there has been a decrease in vaccination rates. Now several countries, such as the UK, the USA, Germany, Spain, etc., are seeing increasing numbers of measles, and other vaccine-preventable diseases, identified as an emerging disease &quot;hot spots&quot;. </p><section class="e-card"><h4 class="mt-0">References</h4><ul class="text-sm break-all"><li><a href="https://jptcp.com/index.php/jptcp/article/view/711" target="_blank" rel="noopener noreferrer">https://jptcp.com/index.php/jptcp/article/view/711</a></li><li><a href="https://www.nature.com/articles/d41586-020-01538-8" target="_blank" rel="noopener noreferrer">https://www.nature.com/articles/d41586-020-01538-8</a></li><li><a href="https://www.nature.com/articles/d41586-020-03519-3" target="_blank" rel="noopener noreferrer">https://www.nature.com/articles/d41586-020-03519-3</a></li><li><a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3222407/" target="_blank" rel="noopener noreferrer">https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3222407/</a></li></ul></section><h3><span class="text-rose-400">Myth 6:</span> Vaccines can infect the child with the disease it is trying to prevent</h3><p> Some of the vaccines are live vaccines that contain live attenuated microorganisms/viruses, which are still capable of replicating within the host (vaccinee). The microorganisms are &#39;weakened&#39;, meaning they have lost most of their disease-causing capacity but still possess immunogenic properties. Thus, it is always much less severe than if a child became infected with the disease-causing virus itself. Live-attenuated vaccines are for measles, mumps, rubella (MMR combined vaccine), rotavirus, smallpox, chickenpox, and yellow fever vaccine. In most cases, live vaccines show significantly higher immunogenicity than inactivated vaccines since natural infection is imitated almost perfectly by eliciting a more comprehensive range of immunologic responses. However, these vaccines are not favoured for kids with weakened immune systems, such as those being treated for cancer. </p><p> Live vaccines can indeed cause mild symptoms resembling the disease they protect against. However, the vaccine recipients are experiencing a body&#39;s immune response to the vaccine, not the disease itself. There is only one recorded instance in which a vaccine was shown to cause disease. This was the Oral Polio Vaccine (OPV) which is no longer used and currently replaced with a killed virus form known as the inactivated polio vaccine (IPV). </p><section class="e-card"><h4 class="mt-0">Reference</h4><ul class="text-sm break-all"><li><a href="https://www.sciencedirect.com/science/article/pii/B9781455710768000090" target="_blank" rel="noopener noreferrer">https://www.sciencedirect.com/science/article/pii/B9781455710768000090</a></li></ul></section><h3><span class="text-rose-400">Myth 7:</span> We do not need to vaccinate because many countries have low infection rates</h3><p> Herd immunity occurs when a large portion of a community (the herd) becomes immune to a disease, making the spread of disease from person to person unlikely. Thanks to &quot;herd immunity,&quot; many people do not see the need for vaccination. As long as a large majority of people are immunised in any population, the unimmunised minority will also be protected. This is important because there is a portion of the population â€“ infants, pregnant women, the elderly, and those with weakened immune systems â€“ that cannot sometimes receive vaccines. However, suppose many people do not vaccinate themselves or their children. In that case, the &quot;herd immunity&quot; disappears, opening up opportunities for viruses and bacteria to establish themselves and spread. With so many people resistant, an infectious disease will never get a chance to establish itself and spread. </p><p> Moreover, international travel often carries a disease from abroad, and an unvaccinated individual will be at far greater risk of getting sick or people have got infected while travelling. The increased measles incidence illustrates this in the US in recent years. As long as disease exists, we are at risk of getting infected. </p><section class="e-card"><h4 class="mt-0">References</h4><ul class="text-sm break-all"><li><a href="https://www.cdc.gov/mmwr/volumes/68/wr/mm6819a4.htm" target="_blank" rel="noopener noreferrer">https://www.cdc.gov/mmwr/volumes/68/wr/mm6819a4.htm</a></li><li><a href="https://bmcpublichealth.biomedcentral.com/articles/10.1186/s12889-021-10652-9" target="_blank" rel="noopener noreferrer">https://bmcpublichealth.biomedcentral.com/articles/10.1186/s12889-021-10652-9</a></li></ul></section>',13),di=e("a",{href:"https://www.who.int/emergencies/diseases/novel-coronavirus-2019/media-resources/science-in-5/episode-8---myth-vs-science",target:"_blank",rel:"noopener noreferrer"}," WHO - Myth vs Science ",-1);function ci(h,c){const l=v,d=k,r=f,n=g;return o(),u("div",ks,[t(l,{class:"w-full lg:max-w-xs print:hidden"}),e("section",fs,[t(d,{name:"openmoji:scientist-medium-dark-skin-tone",class:"float-right text-[5em]"}),gs,bs,e("section",ws,[_s,ys,js,xs,t(r,{src:"https://evidence.onkel.ee/assets/viruses-01__bacteria-vs-virus.webp",credits:"Source: https://inducoat.com/?attachment_id=24945&lang=en",elevated:!0},{caption:s(()=>[qs,a(" Structural differences between viruses and bacteria ")]),_:1}),Vs,t(n,{class:"mb-8"},{default:s(()=>[a(" Antibiotics can help the immune system to kill off bacterial infections but are useless against viral infections. Antiviral drugs work differently than antibiotics and are currently only effective against a few viral diseases, such as influenza, herpes, hepatitis B and C, and HIV. Viral infections can be much harder to kill than bacterial infections because the virus goes into human cells. The immune system can sometimes kill the infected cells before the virus can reproduce. However, as the virus reproduces, it often kills the infected cell by exploding out, which allows the virus to spread to other cells in the body. ")]),_:1}),Ss]),As,e("section",Is,[Ms,Ds,zs,Os,t(r,{src:"https://evidence.onkel.ee/assets/viruses-03.webp",credits:"Source: https://www.nytimes.com/2020/03/13/health/soap-coronavirus-handwashing-germs.html",elevated:!0},{caption:s(()=>[Cs,a(" For every new antigen, our body needs to build a specific antibody ")]),_:1}),Fs,Ns,$s,t(r,{src:"https://evidence.onkel.ee/assets/viruses-04.webp",credits:"Source: https://www.who.int/news-room/feature-stories/detail/how-do-vaccines-work",elevated:!0},{caption:s(()=>[Ps,a(" Antibody development through vaccination ")]),_:1}),Bs]),Ts,e("section",Es,[Rs,Hs,Ws,Ks,e("div",Ys,[t(r,{src:"https://evidence.onkel.ee/assets/viruses-06__mask-01.webp"},{caption:s(()=>[a(" Surgical mask ")]),_:1}),t(r,{src:"https://evidence.onkel.ee/assets/viruses-06__mask-02.webp",caption:""},{caption:s(()=>[a(" FFP2 mask (respirator) ")]),_:1}),t(r,{src:"https://evidence.onkel.ee/assets/viruses-06__mask-03.webp"},{caption:s(()=>[a(" FFP3 mask (respirator) with valve ")]),_:1}),t(r,{src:"https://evidence.onkel.ee/assets/viruses-06__mask-04.webp"},{caption:s(()=>[a(" Filtering mask ")]),_:1})]),Us,t(n,{class:"my-8",theme:"sky-500",icon:"material-symbols:edit-document"},{default:s(()=>[Js]),_:1})]),Ls,e("section",Qs,[Gs,e("div",Xs,[t(r,{src:"https://evidence.onkel.ee/assets/viruses-07.webp",credits:"Source: https://www.nytimes.com/2020/03/13/health/soap-coronavirus-handwashing-germs.html"},{caption:s(()=>[Zs,a(" Soap molecules destroying the virus ")]),_:1}),t(r,{src:"https://evidence.onkel.ee/assets/viruses-08.webp",credits:"Source: https://www.nytimes.com/2020/03/13/health/soap-coronavirus-handwashing-germs.html"},{caption:s(()=>[ei,a(" Micelle consisting of soap molecules and virus fragment ")]),_:1})]),ai]),ti,e("section",si,[ii,t(n,{class:"my-8",theme:"sky-500",icon:"material-symbols:edit-document"},{default:s(()=>[ri]),_:1}),ni,t(n,{class:"my-8",theme:"sky-500",icon:"material-symbols:edit-document"},{default:s(()=>[oi]),_:1}),li,t(n,{class:"my-8",theme:"sky-500",icon:"material-symbols:edit-document"},{default:s(()=>[a(" More COVID-19 myths and related scientific research can be found from: "),di]),_:1})])])])}const mi=b(vs,[["render",ci]]),wi={__name:"background",setup(h){const{locale:c}=x();return(l,d)=>{const r=_e,n=wa,m=ft,_=ps,y=mi;return o(),u("div",null,[w(c)==="et"?(o(),p(r,{key:0})):w(c)==="el"?(o(),p(n,{key:1})):w(c)==="pt"?(o(),p(m,{key:2})):w(c)==="sv"?(o(),p(_,{key:3})):(o(),p(y,{key:4}))])}}};export{wi as default};
